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ABSTRACT 
Exposure to air pollution, particularly fine and ultrafine particulate matter 
derived from combustion sources, has been consistently associated with 
increased cardiovascular morbidity and mortality. Recent controlled 
exposure studies demonstrate that short-term exposure to diesel exhaust, 
which can contribute up to 40% of urban particulate air pollution, results in 
impaired vascular endothelial and fibrinolytic function in healthy volunteers, 
and increased exercise-induced myocardial ischaemia in patients with 
coronary heart disease. These observations may, in part, explain the 
observed increase in cardiovascular events following exposure to air 
pollution. 
 
Despite these observations there remain uncertainties regarding the key 
constituents of the air pollution mixture that mediate these adverse effects, 
and the underlying physiological and biological pathways involved. In these 
studies, using two controlled exposure facilities, I explored the vascular 
effects of the most prevalent gaseous component of the air pollution mixture 
– nitrogen dioxide – and the mechanisms responsible for impaired 
vasomotor function following exposure to diesel exhaust. Furthermore, I 
investigated the effect of acute exposure to “real-world” urban air pollution 
in both healthy volunteers and patients with coronary heart disease, and the 
effect of reducing that exposure using a simple facemask. 
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In total, 10 healthy volunteers were exposed to nitrogen dioxide, and 29 
healthy volunteers exposed to dilute diesel exhaust in a series of double-
blind randomised crossover studies. Exposure to nitrogen dioxide had no 
effect on either vasomotor function or endogenous fibrinolysis, providing 
indirect evidence that the adverse vascular effects are predominantly driven 
by particulate components. Following exposure to diesel exhaust there was 
no up regulation of endothelin-1 production, although there was increased 
vasoconstriction to intra-arterial infusion of endothelin-1. Following 
endothelin A receptor antagonism, there was attenuated vasodilatation 
following exposure to diesel exhaust as compared to air, an effect abrogated 
by endothelin B receptor antagonism. My findings suggest that the 
endothelin system does not play a central role in the adverse vascular effects 
of air pollution, but given the tonic interaction between the endothelin and 
nitric oxide systems, these observations could be explained by reduced nitric 
oxide bioavailability. Following diesel exhaust inhalation, plasma nitrite 
concentrations (as a marker for nitric oxide generation) are markedly 
increased without changes in haemodynamics or basal blood flow consistent 
with increased nitric oxide consumption. In the presence of a nitric oxide 
clamp, and without endogenous nitric oxide release, the vascular responses 
to vasodilators are similar. This perturbation of nitric oxide consumption and 
release appears to underlie the observed vascular endothelial effects. 
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Fifteen healthy volunteers and 98 patients with coronary artery disease were 
recruited in Beijing, China. Subjects walked along a predefined city centre 
route for 2 hours in the presence and absence of a highly efficient facemask 
to reduce personal particulate air pollution exposure in an open label 
randomised crossover study. When wearing a facemask, there was an 
attenuation of exercise-induced increases in blood pressure, an improvement 
in heart rate variability, reduced myocardial ischaemia and subjects reported 
fewer symptoms. 
 
My findings have identified the biological mechanisms underlying the 
adverse vascular effects of exposure to diesel exhaust, and have helped to 
clarify the components responsible for these effects. Moreover, I have 
identified important benefits of reducing personal exposure to particulate 
matter using a simple facemask that have the potential to reduce 
cardiovascular events in patients living in urban or industrialised areas. 
Ongoing research in this area will provide further insight into the underlying 
vascular mechanisms, and the potential benefits of reducing particulate air 
pollution exposure, and may result in important targeted interventions to 
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“…how much the Respiration is perturb'd, and concern'd, when the Lungs are 
prepossessed with these grosse and dense vapours, brought along in the Aer; 
which on the other side being pure and fitly qualified, and so conducted to them, 
is there commixed with the circulating blood, insinuating it self into the left 
ventricle of the heart by the Arteria Venosa, to rarifie and subtilize that precious 
vehicle of the Spirits and vital flame: The Vena Arteriosa disposing themselves 
into many branches through the Pulmonique lobes, for its Convoy the Aer (as we 
say'd) being first brought into them out of the Bronchia (together with the 
returning blood) to the very Heart it self; so as we are not at all to wonder, at the 
suddain and prodigious Effects of a poysonous or less wholesome Aer, when it 
comes to invade such noble Parts, Vessells, Spirits, and Humours, as it visits 
and attaques, through those subtile and curious passages… 
 
…this acrimonious Soot produces another sad effect, by rendring the people 
obnoxious to Inflammations, and comes (in time) to exulcerate the Lungs, which 
is a mischief so incurable that it carries away multitudes by Languishing and 
deep Consumptions, as the Bills of Mortality do Weekly inform us… 
 
…The Consequences then of all this is, that (as was said) almost one half of them 
who perish in London, dye of Phthisical and Pulmonic distempers; That the 
Inhabitants are never free from Coughs and importunate Rheumatisms, spitting 
of Impostumated and corrupt matter: for remedy whereof, there is none so 
infallible, as that, in time, the Patient change his Aer, and remove into the 
Country: Such as repair to Paris (where it is excellent) and other like Places, 
perfectly recovering of their health; which is a demonstration sufficient to 
confirm what we have asserted…” 
John Evelyn Esq., 1661 
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1.1 OVERVIEW 
Air pollution is a major public health concern and is robustly and 
consistently associated with an increase in cardiovascular morbidity and 
mortality. The World Health Organisation estimate that exposure to outdoor 
urban air pollution results in around 800,000 premature deaths each year, 
and indoor air pollution (mainly as a result of biomass combustion) to a 
further 2.4 million annual deaths [United Nations Environment Programme 
2006]. In all, this represents about 5% of the total worldwide deaths each 
year. 
 
It is evident that the link with increased cardiovascular morbidity and 
mortality is strongest for inhaled fine and ultrafine particulate matter. The 
pathophysiological mechanisms underlying these observed adverse effects 
remain unclear, but there is evidence of enhanced atherosclerosis in both 
animal models and in man. Acute exposures to particulate air pollution have 
been associated with increases in blood pressure and central arterial stiffness, 
alterations in the autonomic control of the heart, platelet activation and 
increased thrombogenicity. In addition, vascular endothelial responses – 
vasomotor function and endogenous fibrinolysis – are shown to be impaired 
by exposure to particulate air pollution. 
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Whilst many questions remain as to the exact pathophysiological 
mechanisms underlying these observed responses, in combination these 
effects go some way to explaining the epidemiological data. 
 
1.2 AIR POLLUTION AND CARDIORESPIRATORY RISK 
In August 2008, the XXIXth Olympic Games held in Beijing China brought 
the hazards of air pollution exposure into the public eye. International 
headlines highlighted the poor air quality and the potential health effects 
that might have an adverse impact on the performance of athletes, as well as 
on those with chronic cardiorespiratory diseases. At least one high profile 
marathon runner declared that he would not run in Beijing because of the 
poor air quality, and on arrival to Beijing, the United States of America 
cycling team wore close-fitting face masks designed to reduce personal 
exposure to airborne particles. So was this international concern justified? 
 
Air pollution represents a major public health concern, and has been 
recognised as being detrimental to health for many years. Indeed, John 
Evelyn Esq. presented Charles II with a treatise entitled “Fumifugium: or the 
inconvenience of the aer and smoake of London Dissipated” in which he 
proposed that air pollution would shorten the lives of Londoners in 1661 
(extract reproduced on title page) [Evelyn 1661]. 
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Between 5th and 8th December 1952 prevalent atmospheric conditions along 
with major industrial emissions resulted in Greater London being enveloped 
by dense smog. It was later recognised that this “pollution episode” was 
accompanied by a sharp rise in mortality, and that around 4000 more people 
died during those four days than would have been expected under normal 
conditions. Overall it is estimated that an additional 12,000 deaths resulted 
from this “Great Smog” [Greater London Authority 2002; Dooley 2002]. 
 
This episode focussed attention on air quality standards, and resulted both in 
scientific interest in the adverse effects of air pollution and the introduction 
in the UK of the Clean Air Act 1956 [Greater London Authority 2002]. Since 
the introduction of this act, which regulated the burning of fossil fuels, 
controlled the heights of chimneys and introduced “smokeless zones” air 
quality standards have improved dramatically. However, pollution remains 
a major public health concern and currently the World Health Organisation 
estimates that each year it results in around 3 million premature deaths 
worldwide [United Nations Envorinment Programme 2006], representing 
around 5% of the 55 million annual deaths worldwide. Here in the UK the 
government has estimated that around 8,000 excess deaths occur each year in 





1.3 CHRONIC AIR POLLUTION EXPOSURE 
1.3.1 Epidemiology 
A number of large, well-conducted epidemiological studies have now shown 
clear associations between chronic air pollution exposure and mortality. 
Whilst estimates vary, increasing chronic exposure to particulate air 
pollution by 10 !g/m3 (equivalent to the difference between background 
particulate air pollution concentrations in London and Edinburgh) increases 
all cause mortality by between 2 and 4% [Anderson, et al. 1996; Pope, et al. 
2002]. In their study of mortality across six cities in the USA Dockery and 
colleagues demonstrated that, after adjustment for smoking and other risk 
factors, living in the most polluted city as compared to the least polluted was 
associated with a mortality-rate ratio of 1.26 (95% confidence interval 1.08 to 
1.47) [Dockery, et al. 1993]. 
 
Perhaps surprisingly, given that after inhalation the air pollution is delivered 
directly to the respiratory tract, much of this excess mortality is attributed to 
cardiovascular causes. Typical estimates suggest that for every 10 !g/m3 
increase in background particulate air pollution, cardiovascular mortality 
increases by between 8 and 18% [Pope, et al. 2004], although in one recent 
study of 65,893 women without clinically identified cardiovascular disease 
enrolled in the Women’s Health Initiative (WHI) study it was shown that the 
same increase in background air pollution concentrations resulted in a 76% 
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increase in cardiovascular mortality and a 24% increased risk of acute 
cardiovascular events [Miller, et al. 2007]. 
 
Conversely by compiling data on life expectancy, demographics, and 
socioeconomic status along with matching data on particulate air pollution 
concentrations from the 1970s to the early 2000s, Pope and colleagues have 
demonstrated that for each 10 !g/m3 reduction in background fine 
particulate air pollution concentrations, life expectancy in the USA increased 
by approximately 7 months [Pope, et al. 2009]. 
 
So how does the risk attributable to air pollution compare to traditionally 
quoted cardiovascular risk factors? The well-defined risk factors of 
hypertension, hypercholesterolaemia, diabetes mellitus, family history and 
smoking have been studied in depth in large epidemiological studies. In 
comparison to these variables, chronic exposure to fine particulate air 
pollution gives a dose-dependent and similar risk to hypertension or 
hypercholesterolaemia (Figure 1.1). 
 
Evidence from these epidemiological studies, and the observation that there 
appears to be no absolute threshold for this increased risk prompted 
reanalysis of environmental health standards and implementation of strict 
guidelines across Europe and the USA [Pope, et al. 2002]. Indeed following 
implementation of these standards in the USA, the Environmental Protection 
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Agency were challenged by industry groups in the courts, but an 
independent review of the evidence by the Health Effects Institute [Krewski, 
et al. 2005; Krewski, et al. 2005] reaffirmed the associations and the case was 
lost [Kaiser 1997; Ware 2000]. In fact, recent evidence suggests that the 
association between exposure and mortality is not linear, and is relatively 
steep at low levels of exposure and flattens out towards higher levels [Pope, 
et al. 2009] – making these controls in Europe and the USA (where air quality 
standards are generally relatively good compared to China and the Indian 

























Figure 1.1. Percentage increase in population attributable risk with traditional 
cardiovascular risk factors for an acute cardiovascular event from the Framingham (solid 
bars) and QRESEARCH (striped bars) cohorts [Hippisley-Cox, et al. 2008]. For comparison, 
risk attributed to each 10!g/m3 increase in PM2.5 concentrations (hashed bars) is shown 
[Miller, et al. 2007]. Diabetes Mellitus refers to type II diabetes. Hypertension means 
incidence of hypertension in Framingham study and per 20 mmHg increase in systolic blood 









Table 1.1. Average air 
quality in the world’s 
cities showing the top 20 
most polluted cities, with 
European cities included 
for comparison. Data 
published by the World 
Bank [World Bank 2007]. 
Rank Country City 
Average PM10 
Concentration, !g/m3 (2004) 
1 Egypt Cairo 169 
2 India Delhi 150 
3 India Kolkata 128 
4 China Tianjin 125 
5 China Chongqing 123 
6 India Kanpur 109 
7 India Lucknow 109 
8 Indonesia Jakarta 104 
9 China Shenyang 101 
10 China Zhengzhou 97 
11 China Jinan 94 
12 China Lanzhou 91 
13 China Beijing 89 
14 China Tiyuan 88 
15 China Chengdu 86 
16 India Ahmadabad 83 
17 China Anshan 82 
18 China Wuhan 79 
19 Thailand Bangkok 79 
20 China Nanchang 78 
50 Greece Athens 43 
74 Italy Rome 29 
85 Germany Berlin 22 
91 UK London 21 
107 France Paris 11 
110 Sweden Stockholm 11 
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1.3.2 Components of the air pollution mixture 
Air pollution is a complex mixture of gases, particulate matter and volatile 
agents, which may be derived from a variety of sources. The exact 
components responsible for the harmful effects are not yet known, but the 
epidemiological link is strongest for fine particulate matter [Laden, et al. 
2006; Samet, et al. 2000]. Indeed reanalysis of data from the US six cities study 
after chemical analysis and source apportionment of the air pollution in each 
location has shown that fine particulate air pollution resulting from 
combustion (mobile and coal) sources is associated with increased mortality 
whereas crustal particles (soil and road dust) is not [Laden, et al. 2000]. 
 
Similar positive associations between exposure and cardiovascular mortality 
have been demonstrated for long-term exposure to nitrogen dioxide, sulphur 
dioxide and ozone [Anderson, et al. 1996; Elliott, et al. 2007; Hoek, et al. 2001; 
Rosenlund, et al. 2008]. Nitrogen dioxide and sulphur dioxide are major 
constituents of combustion-derived air pollution, and the associations of 
gaseous exposure with adverse outcomes has usually been attributed to the 
close association of fine particulate matter with gaseous concentrations – 
suggesting that concentrations of these gaseous pollutants are merely 
markers for fine particulate air pollution [Sarnat, et al. 2001]. However, 
isolated real life exposures to nitrogen dioxide have been linked to 
respiratory illness and susceptibility to airway infection [Guidotti 1978; Love, 
et al. 1982; Mostardi, et al. 1981], and controlled exposure to nitrogen dioxide 
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induces airway inflammation and modifies antioxidants in the respiratory 
tract lining fluid [Kelly, et al. 1996], and it may therefore be premature to 
state that these gaseous co-pollutants are inert. 
 
Concordant with the hypothesis that it is combustion-derived fine particulate 
matter that is responsible for the increased cardiorespiratory mortality, a 
reduction in fine particulate air pollution is associated with reduced total 
mortality [Laden, et al. 2006]. This is elegantly demonstrated by Clancy and 
colleagues who studied the effect of a public health intervention in Dublin, 
Ireland designed to reduce the levels of combustion-derived particulate air 
pollution [Clancy, et al. 2002]. At the time of the study, domestic households 
were predominantly using bituminous coal that was cheap and readily 
available. However, concerns over air quality resulted in the government 
banning the marketing, sale and distribution of bituminous coal within the 
city of Dublin, and a subsequent 70% reduction in daily average black smoke 
concentrations, along with a 15% reduction in respiratory and a 10% 







1.3.3 Underlying mechanisms 
Epidemiological studies can, by their very nature, describe only association 
and interpreting this evidence requires a plausible underlying mechanism. 
One explanation is that chronic exposure to particulate air pollution may 
increase atherosclerotic burden. Chronic exposure to particulate air pollution 
is associated with the degree of coronary atherosclerosis and coronary artery 
calcium scores using electron-beam computed tomography [Hoffmann, et al. 
2007]. Consistent with this, particulate air pollution exposure has been linked 
to increased carotid intima-media thickness (CIMT; measured using high-
resolution B-mode ultrasound scanning), with the CIMT increasing by nearly 
6% for each 10 !g/m3 increase in background fine particulate matter (PM2.5) 
exposure [Kunzli, et al. 2005]. Furthermore, the same investigators recently 
reported that progression of CIMT is closely associated with particulate air 
pollution exposure [Kunzli, et al. 2010]. 
 
Animal studies have shown that apolipoprotein-E deficient (Apo E -/-) mice 
exposed daily to concentrated ambient particles collected near a freeway (in 
Los Angeles and Tuxedo, New York) exhibited larger early atherosclerotic 
lesions than mice exposed to just filtered air [Araujo, et al. 2008; Sun, et al. 
2005]. Watanabe heritable hyperlipidaemic rabbits exposed to urban dust 
(Ottowa particles, EHC-93) by intrapharyngeal instillation twice weekly for 
four weeks resulted in the development of larger and more advanced 
atherosclerotic plaques [Suwa, et al. 2002]. 
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1.4 ACUTE EXPOSURE TO AIR POLLUTION 
1.4.1 Epidemiology 
In a case-crossover study of 12,865 patients in Utah USA, Pope and 
colleagues showed that for each 10 !g/m3 increase in background PM2.5 
concentrations the risk of an acute ischaemic coronary event increased by 
4.5% [Pope, et al. 2006]. Krishnan Bhaskaran and colleagues have recently 
subjected this association to careful systematic review. The authors performed 
a robust systematic analysis of the current evidence linking short-term exposure 
to air pollution and the incidence of acute myocardial infarction and identified 
26 studies that demonstrate an effect of exposure to particulate matter, ozone, 
carbon monoxide, nitrogen oxides or sulphur dioxide. The authors included 
only those studies that specifically addressed the incidence of myocardial 
infarction as an outcome and carefully controlled for potential confounders. 
They conclude that there is “fairly persuasive evidence of [a] short-term effect 
on myocardial infarction risk”, with the risk of increasing by 5-17% for each 10 
!g/m3 increase in PM2.5 (particulate matter with a mean diameter of "2.5 !m) 
exposure [Bhaskaran, et al. 2009]. Similarly, short-term exposure to fine 
particulate air pollution has been linked to increased hospital readmissions 
among survivors of myocardial infarction [von Klot, et al. 2005] and in 
patients with congestive cardiac failure [Mann, et al. 2002; Morris 2001; Pope, 





Figure 1.2. Odds ratio of being in traffic in the hours leading up to the onset of symptoms in 
691 survivors of myocardial infarction. Data shown as mean ± standard deviation. Data 
adapted from Peters, et al. 2004. †P=0.02, *P<0.0001 and ‡P=0.004. 
 
In a pivotal study by Peters and colleagues, 691 patients admitted with 
myocardial infarction in Augsburg, Germany completed a standardized 
interview-based diary following their admission to hospital, where they were 
asked to record their activities in the hours leading up to admission [Peters, 
et al. 2004]. The authors found that patients were nearly three times more 
likely to have been in traffic in the 2 hours prior to the onset of symptoms 
(Figure 1.2). A similar pattern was seen during an equivalent study by the 
same authors in Boston, USA [Peters, et al. 2001]. The authors suggest that 
acute exposure to traffic-derived air pollution may trigger the onset of acute 
myocardial infarction. Recent evidence from the UK using the MINAP 
(Myocardial Infarction National Audit Project) database has strengthened 

























this hypothesis, and the authors demonstrate a dose-dependent increase in 
risk of myocardial infarction 1 to 6 hours after exposure to particulate air 
pollution [Bhaskaran, et al. 2011]. A recent meta-regression analysis of factors 
associated with the triggering of acute myocardial infarction suggests that on 
a population-wide level, exposure to traffic-derived air pollution emerges as 
the leading risk factor given the ubiquitous nature of exposure, with an effect 
similar in magnitude to well accepted risk factors such as physical exertion 
[Nawrot, et al. 2011]. 
 
1.4.2 Mechanisms 
Whilst increased coronary atherosclerotic burden may go some way towards 
explaining the increase in cardiovascular risk, there remain many 
unanswered questions, with regards to how and why atherosclerotic plaque 
formation is increased and why plaques should become more unstable 
resulting in an increase in cardiovascular events and mortality. There is now 
a large body of work that has begun to explore these mechanisms in depth. 
 
1.4.2.1 Human exposure systems 
Ideally studies looking at the mechanisms underlying the acute 
cardiovascular responses to air pollutants would be performed using 
controlled exposures to urban ambient air pollution at atmospheric 
concentrations. The major advantage of such an approach is the realistic 
nature of the exposure, and the generalisability of any results to similar 
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exposure scenarios.  However, these studies may be limited by the day-to-
day variability in ambient pollutant concentration and chemical composition, 
depending on traffic density, activity of nearby industry, weather conditions 
and a multitude of other factors.  Because of this inherent variability, and the 
fact that ambient air exposures are comprised of complex mixtures of air 
pollutants, an alternative approach is needed in order to study the biological 
and pathophysiological effects of individual inhaled air pollutants.  
 
Facilities have been developed to enable the carefully controlled exposure of 
human subjects to commonly encountered air pollutants, resulting in a stable 
and predictable exposure [Langrish, et al. 2010]. Such exposures have been 
carried out in both large room-sized facilities, as in Umeå, Sweden [Salvi, et 
al. 1999], Rochester, NY [Morrow, et al. 1988; Utell, et al. 1984] and Seattle, 
Washington [Gould, et al. 2008], and in a modified body-box as in the mobile 
exposure facility described by Mills et al. [Mills, et al. 2008]. 
 
It has been demonstrated that the link between cardiovascular morbidity and 
mortality and air pollution exposure is strongest for exposure to combustion-
derived fine and ultrafine particulate matter from coal and mobile sources 
[Laden, et al. 2000]. In the urban environment, up to 40% of airborne 
particulate matter is derived from diesel exhaust [Zheng, et al. 2007], a 
fraction that is likely to increase with the increasing restrictions on industry 
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and the current drive for “green” taxation on road vehicles linked to carbon 
dioxide production. 
 
Diesel engines produce a cloud of carbon-centred nano-particulate that 
includes unburnt fuel, lube oil, polycyclic aromatic hydrocarbons, metals and 
sulphates [Scheepers, et al. 1992; Sydbom, et al. 2001]. Although diesel 
engines produce less carbon monoxide and carbon dioxide than gasoline 
engines, they produce more nitrogen oxides and aldehydes, and the particle 
emissions are up to 100 times greater – of which >80% (by particle number) 
are within the ultra-fine fraction (<100 nm in diameter), proposed to be the 
most closely associated with adverse health effects [Donaldson, et al. 2001]. 
 
Exposure to diluted diesel exhaust has been used as a stable and predictable 
model of pure combustion-derived air pollution in the study of the health 
effects of particulate air pollution in controlled human exposure studies 
[Gould, et al. 2008; Mills, et al. 2005]. Briefly, fresh diesel exhaust is produced 
by a commercial diesel engine under either idling conditions, or during 
transient running cycles such as the European City Cycle. More than 90% of 
the exhaust is vented externally, with a small fraction collected and delivered 
to a conditioning chamber where it is mixed with clean HEPA-filtered air. 
The conditioning chamber allows complete mixing and the maintenance of a 
stable temperature and humidity within the aerosol. This is then drawn 
through an airtight exposure chamber in which the subject is situated. The 
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air within the chamber is sampled from the breathing zone of the subject and 
monitored as described previously. The concentration of airborne particulate 
is normally maintained at 200-300 !g/m3 and can be adjusted by altering the 
amount of exhaust drawn into the conditioning chamber (Figure 1.3). 
Control exposures to filtered air are generated in the same facility, without 
adding any diesel exhaust to the chamber.  
 
 
Figure 1.3. Schematic diagram of a diesel exhaust exposure facility. 
 
Using a predictable model of exposure, such as diesel exhaust, offers many 
advantages. In order to ensure consistency of approach, exposures can be 
performed identically on different study days, thus making interpretation of 
the results much easier. The inherent variability of chemical composition and 



















technology required to produce a diesel exposure does not rely on complex 
impactors that are sensitive to environmental and weather conditions, 
meaning that studies can be carried out on any particular day – a definite 
advantage in scheduling clinical experiments involving human subjects. For 
all these advantages, diesel exhaust exposures will always be open to 
criticism. Diesel exhaust is used as a model of ambient combustion-derived 
air pollution. Whilst it is true that diesel exhaust can make up a large 
proportion of an individual’s exposure to air pollution in urban areas, 
exposure to pure diesel exhaust (or indeed pure combustion-derived 
particulate) is artificial. Therefore, extrapolating the results from 
experimental diesel exhaust exposure chamber studies to the ambient 
exposure situation is fraught with uncertainty. However, to gain important 
mechanistic information on air pollution-induced health effects, it should be 
emphasised that experimental exposure chamber studies should be used to 
complement “real-world” exposures. 
 
1.4.2.2 Pulmonary and systemic inflammatory response 
The mechanisms underlying the adverse effects of inhaled particulate matter 
are still unclear, and particularly the pathway of effect following inhalation 
of particles into the lungs. It was hypothesised that inhalation of airborne 
particulate matter causes alveolar inflammation and subsequent release of 
inflammatory cytokines that then result in exacerbation of chronic lung 
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diseases and affect blood coagulability and thus increase acute 
cardiovascular events [Seaton, et al. 1995]. 
 
The ability of inhaled particulate matter to cause local inflammation is now 
well established. In animal models, intratracheal instillation of urban 
ambient particulate matter (PM10) in rats results in an influx of neutrophils, a 
depletion of antioxidants (GSH, glutathione) and an increase in tumour 
necrosis factor ! (TNF-!) release within the alveolae [Li, et al. 1996]. Similar 
findings have been shown after inhalation of concentrated ambient 
particulate matter [Elder, et al. 2004]. 
 
In clinical studies of healthy volunteers exposed to concentrated ambient 
particulate matter in a whole body exposure chamber similar to described 
above for 2 hours, there is an increased neutrophil count in bronchoalveolar 
lavage fluid along with increased plasma fibrinogen in blood 18 hours after 
exposure [Ghio, et al. 2000]. Similarly, 6 hours after exposure to dilute diesel 
exhaust there is an increase in both neutrophil and lymphocyte cell count in 
bronchoalveolar fluid, and evidence of early inflammatory change on 
bronchial biopsies [Salvi, et al. 1999]. 
 
In vitro studies on alveolar macrophages incubated with particulate matter 
demonstrate dose-dependent release of the proinflamatory cytokines TNF-!, 
interleukin (IL)-1", IL-6 and granulocyte macrophage colony-stimulating 
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factor (GM-CSF) [van Eeden, et al. 2001]. Co-culture experiments of alveolar 
macrophages with human bronchial epithelial cells have shown 
amplification of this inflammatory response, and supernatants from these co-
cultures instilled into the lungs increase circulating polymorphonuclear 
leucocytes through the bone marrow in rabbits [Fujii, et al. 2002], suggesting 
that this local inflammatory stimulus can generate a systemic response. 
Ultrafine carbon particles instilled into rat lung cause an increase in both 
plasma fibrinogen and circulating neutrophils in both normal [Elder, et al. 
2004] and spontaneously hypertensive rats [Cassee, et al. 2005]. 
 
Concordant with these findings, clinical panel studies have demonstrated an 
inflammatory response following exposure to ambient air pollution. Blood 
samples taken from 30 healthy male volunteers during a “pollution episode” 
(the forest fires in South Asia in 1997) and again once the haze had cleared 
showed an increase in the proinflammatory cytokines IL-1", IL-6 and GM-
CSF in peripheral blood during the high exposure to particulate air pollution 
seen during the fires. In subjects investigated during an air pollution episode 
in Augsburg Germany, plasma viscosity [Peters, et al. 1997] and C-reactive 
protein (CRP) [Peters, et al. 2001] were significantly increased suggesting an 
acute phase response. Increasing exposure to nitrogen dioxide and black 
smoke is also associated with an increase in plasma fibrinogen, again 




Controlled exposure studies in man have been less conclusive. In healthy 
volunteers exposed to dilute diesel exhaust (300 !g/m3) for 1 hour with 
intermittent exercise, plasma concentrations of TNF-! and IL-6 are increased 
at 24 hours [Törnqvist, et al. 2007], but not at 6 hours [Mills, et al. 2005], 
although these changes are not associated with an increase in peripheral 
leucocyte counts. 
 
It is proposed that the inflammatory response to inhaled particulate matter is 
driven by oxidative stress. Diesel exhaust particles are able to generate large 
amounts of oxygen-centred free radicals in the absence of tissue, as measured 
by electron paramagnetic resonance [Miller, et al. 2009]. In vitro studies have 
shown that diesel exhaust particles are able to oxidise LDL cholesterol 
particles [Ikeda, et al. 1995], thus increasing the inflammatory and 
atherogenic properties of the particles. Diesel exhaust particles cause an 
upregulation of the antioxidant enzyme haem-oxygenase-1 (HO-1) and 
upregulation of the MAPK/NF-#B (mitogen-activated protein kinase/nuclear-
factor kappa light chain enhancer of activated B cells) pathways when incubated 
with human epithelial cell lines, effects that can be inhibited with co-
administration of antioxidants [Bonvallot, et al. 2001; Hirano, et al. 2003; Li, et 
al. 2000; Marano, et al. 2002]. Moreover, instillation of diesel exhaust particles 
into mouse lungs causes a dose-dependent increase in systemic 8-hydroxy-
2’-deoxyguanosine (8-OHdG; an oxidative DNA adduct and a marker of 
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systemic oxidative stress) concentrations [Ichinose, et al. 1997], and effect that 
can be offset in vitro using superoxide dismutase or desferrioxamine 
[Arimoto, et al. 1999]. Indeed, systemic 8-OHdG concentrations are 
associated with background particulate matter exposure in 76 healthy 
students studied in Taipei Taiwan [Chuang, et al. 2007]. 
 
It is possible that local inflammation with a subsequent systemic 
inflammatory response may contribute to the adverse vascular responses to 
inhaled air pollutants (see sections 1.4.2.4 and 1.4.2.5) and hence to the 
increased cardiovascular morbidity and mortality described. However, this 
effect is of slow onset and cannot be the whole story as effects on the 
vascular system can be robustly demonstrated immediately after any 
exposure – and indeed during the exposure itself. Therefore there must be an 
additional explanation. 
 
1.4.2.3 Particle translocation 
One such hypothesis is the direct translocation of particles into the 
bloodstream after inhalation, resulting in a direct effect on the cardiovascular 
system from within blood vessels. Airborne particulate matter in the fine 
(PM2.5) and ultrafine fractions (UFP, particles with a mean diameter of 0.1 !m 
or less) can penetrate deeply into the lungs, largely bypassing filtration in the 
nasal tract and by bronchial cilia. Interestingly, it is these fine and UFP 
fractions that appear to be most closely associated with the demonstrated 
-24- 
adverse effects [Donaldson, et al. 2001]. Once deep in the lungs, any inhaled 
particles (which are approximately the same size as an LDL-cholesterol 
particle) are separated from the bloodstream by only a monolayer of alveolar 
cells. It is proposed that these particles may then translocate through the 
epithelium into the blood stream and from there mediate their effects. 
 
Previous attempts to identify particle translocation have proved 
inconclusive. Human studies have used an aerosol of technetium-99m 
(99mTc)–labeled carbon nanoparticles, Technegas (Vita Medical Ltd., 
Sydney, Australia), which is used routinely in clinical practice for 
radionuclide lung ventilation imaging to try and address this issue. Nemmar 
and colleagues demonstrated that following inhalation of Technegas, thin-
layer chromatography of whole blood identified the presence of 99mTc-
labeled carbon nanoparticles in the bloodstream as early as 1 min after 
Technegas inhalation [Nemmar, et al. 2002]. However, Technegas generation 
has many technical challenges. It is generated in a pure argon atmosphere to 
avoid the formation of the soluble, unbound sodium pertechnate. It was 
subsequently suggested that the very rapid detection of a signal in the 
bloodstream was suggestive of a significant amount of soluble pertechnate in 
the inhaled aerosol, and further attempts at repeating the study (with very 
careful attention to the exclusion of oxygen from the generation atmosphere) 
did not show systemic translocation and demonstrated instead that the 
labeled carbon particles remained within the lung at 6 hours post inhalation 
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[Mills, et al. 2006]. Möller and colleagues recently reported a similar study in 
smokers and patients with chronic obstructive lung disease in which inhaled 
Technegas remained within the lung parenchyma even up to 48 hours after 
the exposure, without significant evidence of systemic translocation [Moller, 
et al. 2008]. However, in both of the latter studies, a small amount of 
technetium was detectable in the systemic circulation, consistent with the 
leaching of a small amount of soluble sodium pertechnate from the labeled 
particles despite the careful attention to the test atmosphere. It is difficult to 
be absolutely sure that a small fraction of these particles did not in fact 
translocate, and animal studies have clearly demonstrated evidence of 
systemic translocation for a range of nanoparticles following inhalation and 
intra-tracheal installation [Kreyling, et al. 2002; Nemmar, et al. 2004; Nemmar, 
et al. 2001; Oberdorster, et al. 2002] and this hypothesis remains to be refuted. 
 
1.4.2.4 Vascular vasomotor function 
Vascular endothelial dysfunction, which is generally characterised by the 
reduced bioavailability of endothelium-derived nitric oxide, is an 
independent risk factor for cardiovascular morbidity and mortality 
[Schachinger, et al. 2000; Suwaidi, et al. 2000]. Indeed, endothelial dysfunction 
– manifesting as an attenuated vasomotor response – is an early marker for 
atherosclerosis and may be present long before structural changes within 
blood vessels are apparent on clinical investigation [Davignon, et al. 2004; 
Ross 1999]. The vascular vasomotor response is complex, and is the result of 
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the interaction of tonic vasoconstrictors and vasodilators working in balance 
to maintain normal vascular tone (Figure 1.4). 
 
A 2-hour exposure to concentrated ambient particles (approximately 150 
!g/m3) and ozone (120 ppb) [Brook, et al. 2002] or dilute diesel exhaust 
[Peretz, et al. 2008] causes acute arterial vasoconstriction, measured 
immediately after completing the exposure. Similarly, a transient increase in 
central arterial stiffness as measured using applanation tonometry has been 
demonstrated following a 1-hour exposure to dilute diesel exhaust 
(approximately 350 !g/m3) [Lundback, et al. 2009]. A 1-hour exposure to 
dilute diesel exhaust (300 !g/m3) results in an attenuated vascular 
vasomotor response to infused vasodilators, measured using venous 
occlusion plethysmography, 2-hours after the exposure [Törnqvist, et al. 
2007]. This effect is still present 6-hours following the exposure [Mills, et al. 






Figure 1.4. Schematic drawing showing the major vasoconstrictor and vasodilator 
influences on basal vascular tone and the vascular vasomotor response. Blue cells represent 
the vascular endothelium, the red cells the underlying smooth muscle cells. EDHF: 
endothelium-derived hyperpolarisation factor; Arach. Acid: arachadonic acid; K+: potassium 
ions; Ca2+: calcium ions; GTP: guanosine triphosphate; cGMP: cyclic guanosine 
monophosphate; ATP: adenosine triphosphate; cAMT: cyclic adenosine monophosphate; 
NOS: nitric oxide synthase; COX: cycloxygenase; sGC: soluble guanylate cyclase; sAC: 
soluble adenylyl cyclase 
 
 
The mechanisms underlying these adverse vasomotor responses remain 
unclear. Preclinical studies have demonstrated a reduced release of nitric 
oxide from vascular endothelium following treatment with diesel exhaust 
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particles [Miller, et al. 2009; Nurkiewicz, et al. 2009], an effect proposed to be 
driven by the generation of oxygen-centred free radicals [Miller, et al. 2009] 
and the uncoupling of nitric oxide synthase [Knuckles, et al. 2008]. However, 
it has also been proposed that these responses may be driven by endothelin-1 
(ET-1). 
 
The endothelin system plays a major role in cardiovascular and renal 
physiology [Goddard, et al. 2004], and although its actions are complex, ET-1 
is a powerful endogenous vasoconstrictor which contributes to the 
maintenance of basal vascular tone and blood pressure in man [Haynes, et al. 
1994; Haynes, et al. 1996]. Recent work has suggested that plasma ET-1 
concentrations are increased by exposure to air pollution. Rats raised with 
daily exposure to diesel exhaust particles and urban particulate matter have 
increased blood pressure, plasma ET-1 concentrations [Vincent, et al. 2001], 
and endothelin-A receptor expression in cardiac tissue [Ito, et al. 2008]. In 
children from Mexico City, plasma ET-1 concentrations correlated with the 
degree of air pollution exposure [Calderón-Garcidueñas, et al. 2007]. Peretz et 
al recently demonstrated elevated plasma ET-1 concentrations in a 
heterogeneous population of healthy volunteers and patients with the 
metabolic syndrome, 3 hours after a controlled 2-hour resting exposure to 






Short-term exposure to particulate air pollution has been linked to the 
triggering of acute myocardial infarction, which is usually a result of 
atheromatous plaque rupture and subsequent thrombus formation leading to 
vessel occlusion. It has been demonstrated in a pre-clinical arterial injury 
model that instillation of diesel exhaust particles into the lungs of hamsters 
results in enhanced arterial thrombus formation and significantly increased 
platelet activation [Nemmar, et al. 2003]. Similarly, using an ex-vivo model of 
arterial thrombus formation – the Badimon chamber [Badimon, et al. 1987] – 
a 1-hour exposure to dilute diesel exhaust (approximately 350 !g/m3) causes 
increased platelet activation and increased thrombus formation in man 
[Lucking, et al. 2008]. As well as causing enhanced arterial thrombus 
generation, inhalation of diesel exhaust reduces the fibrinolytic activity of the 
vascular endothelium, with reduced release of tissue-plasminogen activator 
(t-PA) [Mills, et al. 2007]. 
 
Interestingly, there is now some evidence that venous clotting may also be 
enhanced, with small reductions in prothrombin times with increasing 
background particulate air pollution exposure [Baccarelli, et al. 2007] and an 
increased risk of developing deep vein thrombosis when subjects lived closer 




1.4.2.6 Blood pressure changes 
Population studies have confirmed a link between increases in blood 
pressure and particulate air pollution exposure. In 2,607 adults studied in 
Augsburg Germany during an air pollution episode in January 1985, systolic 
blood pressure was seen to rise by nearly 2 mmHg for every 90 !g/m3 
increase in airborne particulate matter, an effect further exaggerated in those 
with high resting heart rates or increased plasma viscosity [Ibald-Mulli, et al. 
2001]. Similarly, among 5,112 adults without cardiovascular disease studied 
in the Multi-Ethnic Study of Athersclerosis (MESA) study, linear increases in 
both pulse-pressure and systolic blood pressure were found with increases in 
PM2.5 concentrations [Auchincloss, et al. 2008]. 
 
Controlled exposure studies in man have also demonstrated changes in 
blood pressure. Twenty-three healthy non-smoking adults were exposed to 
concentrated ambient particles (approximately 150 !g/m3) and ozone (120 
ppb) for 2-hours whilst resting in an exposure chamber. During the exposure 
diastolic blood pressure (and mean arterial blood pressure) increased 
proportionately to the organic carbon content of the concentrated particles 
(measured as a marker for combustion-derived particulate matter) [Urch, et 
al. 2005]. More recently, the same investigators describe similar acute 
changes in diastolic blood pressure during controlled exposures in 81 
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subjects during exposure to concentrated ambient particles with and without 
ozone in Toronto and Ann Arbor [Brook, et al. 2009]. 
 
1.4.2.7 Myocardial ischaemia 
Particulate air pollution exposure is associated with exercise-induced 
myocardial ischaemia in patients with coronary artery disease. In one study, 
repeated clinic recorded exercise stress tests performed by patients with 
stable treated coronary artery disease were paired with mean regional 
ambient particle concentrations as a crude assessment of pollution exposure 
[Pekkanen, et al. 2002]. The authors demonstrated a three-fold increase in the 
risk of developing more than 1 mm ST segment depression during exercise 
with increasing particulate air pollution exposure. More recently, 48 patients 
were investigated up to 4 times during the first 12 months following a 
percutaneous intervention for myocardial infarction, acute coronary 
syndrome or stable angina with ambulatory electrocardiography. The risk of 
developing clinically-relevant ST segment depression (>1 mm) during the 
monitoring period was increased around 1.5-fold for each interquartile 
increase in the black carbon level (used as a measure of combustion-derived 
particulate air pollution) over the preceding 24-hours [Chuang, et al. 2008]. 
 
In a controlled exposure study, 20 patients with asymptomatic coronary 
heart disease who had suffered a prior myocardial infarction were exposed 
to dilute diesel exhaust (300 !g/m3) or filtered air. During the exposure they 
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alternated between periods of rest or moderate exercise. Myocardial 
ischaemia was quantified by ST-segment analysis using continuous 12-lead 
electrocardiography. This study demonstrated a three-fold increase in ST 
segment depression and increased ischaemic burden during the exposure to 
diesel exhaust [Mills, et al. 2007]. 
 
1.4.2.8 Autonomic regulation of the heart 
Short-term increases in ambient particulate air pollution exacerbate chronic 
cardiovascular conditions, and lead to increased hospital admissions with 
cardiac arrhythmias [Hoek, et al. 2001] as well as myocardial infarction and 
heart failure. In patients with implantable cardiac defibrillators, there is a 
relationship between ambient particulate matter and the incidence of 
ventricular tachycardia and fibrillation [Berger, et al. 2006; Dockery, et al. 
2005; Peters, et al. 2000]. 
 
Autonomic control of the cardiac cycle has been linked to the incidence of 
arrhythmias and to cardiovascular mortality [Task Force of the European 
Society of Cardiology and the North American Society of Pacing and 
Electrophysiology 1996]. The simplest, and therefore most widely used 
measurement of autonomic control of the heart, is heart rate variability 
(HRV) – a measure of the variation in the interval between consecutive heart 
beats, and a measure of the contrasting effects of the sympathetic and 
parasympathetic nervous systems. Reduced HRV suggests either an increase 
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in sympathetic drive or a decrease in vagal parasympathetic tone and has 
been linked to cardiovascular morbidity and mortality in both healthy 
individuals [Tsuji, et al. 1996] and patients following acute myocardial 
infarction [Kleiger, et al. 1987]. 
 
More than 30 panel studies have now been reported showing an effect of 
exposure to particulate air pollution on measures of HRV, although the 
reported effects are far from consistent, with marked variation in the nature, 
magnitude, direction and duration of these associations (a summary of some 
of these is illustrated in Table 1.2). Liao and colleagues were the first to 
report an association between particulate air pollution and reduced HRV in a 
small panel of elderly residents of Baltimore Maryland [Liao, et al. 1999], 
where they showed evidence of an effect on both high-frequency (related to 
parasympathetic activity) and low-frequency (related to sympathetic 
activity) components of HRV. In the largest study to date, the same authors 
subsequently reported a weak association between particulate air pollution 
and reduced HRV in 6,784 healthy adults – with a one standard deviation 
increase in ambient fine particulate matter being associated with a 0.32 beats 
per minute reduction in heart rate and a 1.03 ms decrease in SDNN (standard 
deviation of successive RR intervals) [Liao, et al. 2004]. 
 
Few controlled exposure studies have been performed to investigate the 
effect of exposure to particulate air pollution on HRV. Zareba and colleagues 
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investigated the effect of a 2-hour exposure to carbon ultrafine particles on 
electrocardiographic parameters including HRV. They reported a small 
decrease in RMSSD (root mean square of the difference in RR intervals) and 
suggested a trend towards an increase in parasympathetic tone (based on 
analysis of T-wave morphology) in their healthy young subjects [Zareba, et 
al. 2008]. Similarly, in healthy volunteers and patients with coronary heart 
disease exposed to pure carbon particles (50 !g/m3), Routledge and 
colleagues demonstrated a fall in heart rate and an increase in high-
frequency components of HRV suggesting increased parasympathetic vagal 
stimulation of the heart [Routledge, et al. 2006]. In 31 healthy volunteers 
investigated in Toronto Canada, a 2-hour exposure to concentrated ambient 
particles resulted in a reduction in SDNN, RMSSD, high-frequency power 
and low-frequency power measures of HRV during the exposure itself 
[Brook, et al. 2009]. Concordantly, Gong and colleagues also reported modest 
changes in HRV consistent with parasympathetic stimulation following a 2-
hour exposure to concentrated ambient particles in both healthy volunteers 
and patients with asthma in Los Angeles California [Gong, et al. 2003]. 
 
However when using dilute diesel exhaust as a model exposure, Peretz and 
colleagues recently demonstrated that a 3-hour exposure to dilute diesel 
exhaust was not associated with changes in HRV [Peretz, et al. 2008], and this 
is consistent with the findings of our group [Mills, et al. 2011]. Therefore the 
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effects of air pollution on HRV remain controversial, inconsistent and 
undefined. 
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Table 1.2. The acute effect of exposure to particulate air pollution on heart rate variability . 
Author Population Number Pollutant HR SDNN RMSSD HF LF HF/LF 
[Liao, et al. 1999] Elderly 26 PM2.5 - ! - - - - 
[Pope, et al. 1999] Healthy 7 PM " ! " - - - 
[Gold, et al. 2000] Elderly 21 PM ! ! ! - - - 
[Magari, et al. 2001] Occupational 40 PM2.5 " ! - - - - 
[Brauer, et al. 2001] COPD 16 PM10 # # # - - - 
    PM2.5 # # # - - - 
[Holguin, et al. 2003] Elderly 34 PM2.5 - - - ! ! " 
[Pope, et al. 2004] Elderly 88 PM2.5 # ! ! - - - 
[Liao, et al. 2004] Community 6,784 PM10 " ! - ! # - 
[Chan, et al. 2004] Healthy 19 PN0.02-1 - ! ! ! ! - 
[de Paula Santos, et al. 2005] Occupational 48 PM10 # # # - - - 
[Park, et al. 2005] Elderly 497 PM2.5 - - - ! # " 
[Schwartz, et al. 2005] Elderly 28 PM2.5 - # ! - - # 
[Sullivan, et al. 2005] Elderly 34 PM2.5 - - # # - - 
[Vallejo, et al. 2006] Young 40 PM2.5 - # - - - - 
[Timonen, et al. 2006] CHD 84 PN - # # # - ! 
    PM2.5 - # # # - # 
[Lipsett, et al. 2006] CHD 19 PM2.5 - # # # # - 
    PM2.5-10 - ! " # # - 
[Luttmann-Gibson, et al. 2006] Healthy 32 PM2.5 " ! ! ! ! - 
[Park, et al. 2006] Elderly 518 PM2.5 - - - ! - - 
[Chuang, et al. 2007] Young 76 PM10, PM2.5 - # # # # - 
[Chahine, et al. 2007] Elderly 539 PM2.5 - ! - ! # - 
[Min, et al. 2008] Community 1,349 PM10 - ! - # ! - 
[Cavallari, et al. 2008] Occupational 36 PM2.5 - ! - - - - 
[Cardenas, et al. 2008] Young 52 PM2.5 - - - ! ! - 
[Baccarelli, et al. 2008] Elderly 549 PM2.5 - # - # # - 
[Cavallari, et al. 2008] Occupational 26 PM2.5 metal - - ! - - - 
[Chang, et al. 2007] Elderly 15 PM1-2.5 " # # - ! " 
   PM2.5-10 # ! ! - - " 
                                                
 SDNN = SD of NN-interval values; RMMSD = root mean square of successive NN interval differences; HF = high frequency; LF – low frequency; CHD 
= coronary heart disease; COPD = chronic obstructive pulmonary disease; PM = particulate matter; PN = particle number 
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1.4.2.9 Summary of acute effects of particulate air pollution 
It is now well accepted that short-term exposure to increases in ambient 
particulate air pollution, and particularly that associated with combustion, is 
associated with an increase in acute cardiovascular events. Following a 
number of controlled exposure experiments, plausible mechanisms are now 
proposed that might underlie these observations (summarised in Figure 1.5). 
 
During the exposure itself, there is evidence of both an acute rise in blood 
pressure, with concordant arterial vasoconstriction and increased central 
arterial stiffness – most plausibly the result of alterations in autonomic 
control of the heart and the vascular tree. Within 2-hours of the exposure 
there is an impairment of vascular endothelial function, with impaired 
vasomotor responses. Concordant with this there is an increase in 
thrombogenicity with platelet activation along with a reduction in activity of 
the endogenous fibrinolytic system. The events leading to these later changes 
are unclear – they may be due to a direct oxidative effect of particles on the 
vascular system and platelets if they are indeed able to translocate into the 
systemic circulation, or maybe via early inflammatory influences mediated 
via alveolar macrophages. Later there is evidence of established local 




Taken together, these responses can help to explain the increase in 
cardiovascular morbidity and mortality consistently observed following 
exposure to ambient air pollution, and the triggering of myocardial 
infarction (Figure 1.6), although questions still remain as to the exact 






















Figure 1.5. The acute cardiovascular responses to inhalation of fine particulate air pollution 
over the first 24-hours. 
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Figure 1.6. Schematic drawing showing how the demonstrated responses to particulate air 
pollution exposure may result in increased cardiovascular morbidity and mortality. (A) 
shows the effects of chronic exposure to air pollutants resulting in increased atherosclerotic 
burden. The factors that may predispose to subsequent plaque instability and rupture are 
shown in (B). (C) and (D) summarise the abnormal thrombotic and adaptive responses to 
plaque rupture following exposure to airborne particulate matter that may explain the 









1.5 AIMS AND HYPOTHESES 
Air pollution is now well accepted as a risk factor for increased 
cardiovascular mortality and morbidity, and through a series of 
observational studies and controlled exposure studies and understanding of 
some of the mechanisms underlying these effects is emerging. 
 
In a series of clinical studies in both healthy volunteers and patients with 
cardiovascular disease, I aim to further the understanding of the mechanisms 
that lead to vascular endothelial dysfunction following exposure to 
particulate matter. In addition, I intend investigate the importance of one of 
the major gaseous co-pollutants found in both ambient settings and within 
the controlled exposure facilities: nitrogen dioxide. Finally, I intend to 
examine the “real-world” effects of acute exposure to particulate air 
pollution, and begin to address the important of how we can protect 
susceptible populations from the adverse effects of air pollution. 
 
The following hypotheses will be tested: 
1. The adverse effects of exposure to particulate air pollution and diesel 
exhaust are a result of the presence of nitrogen dioxide. An exposure 
to pure nitrogen dioxide (4 ppm) will attenuate vascular endothelium-
dependent vasodilatation (Chapter 3); 
2. Diesel exhaust inhalation causes an increase in plasma 
endothelin(ET)-1 and big ET-1 concentrations, increases ET-1 induced 
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vasoconstriction and the contribution of ET-1 to the maintenance of 
basal vascular tone (Chapter 4); 
3. Following inhalation of diesel exhaust, vasoconstriction to nitric oxide 
synthase inhibition will be enhanced and plasma nitrite 
concentrations suppressed. In the presence of a nitric oxide clamp, the 
responses to infused vasodilators will be equivalent following 
exposure to diesel exhaust or filtered air (Chapter 5); 
4. Wearing a simple facemask to reduce personal exposure to particulate 
air pollution reduces blood pressure and increases heart rate 
variability in healthy volunteers exposed to high ambient air pollution 
(Chapter 6); 
5. Wearing a simple facemask to reduce personal exposure to particulate 
air pollution reduced blood pressure, improves heart rate variability, 
reduces myocardial ischaemia and symptoms of angina in a 
susceptible population with coronary heart disease exposed to high 































2.1 SUBJECT RECRUITMENT 
2.1.1 Ethical considerations 
All studies were reviewed an approved by the local research ethics 
committees at Umeå University, Sweden or the Chinese Academy of Medical 
Sciences in Beijing as appropriate. All subjects were provided with written 
information and gave their written informed consent to participate in the 
studies in accordance with the Declaration of Helsinki. Further details of the 
ethical review process can be found at http://www.ClinicalTrials.gov/ 
(NCT00774514, Chapter 3; NCT00745693, Chapter 4; NCT00845767, Chapter 
5; NCT00809432, Chapter 6; NCT00809653, Chapter 7). 
 
2.1.2 Healthy volunteers 
Healthy volunteers (aged between 18 and 40 years) were recruited by either 
local advertisement or from volunteer databases held at the Department for 
Respiratory Medicine and Allergy, University Hospital, Umeå or the Fuwai 
Cardiovascular Hospital, Beijing China. All subjects took no regular 
medication (except for the oral contraceptive pill), had normal lung function 
and were non-smokers. Those with an intercurrent illness were excluded and 
all subjects were free of the symptoms of respiratory tract infection for more 
than 6 weeks before participation. 
 
Subjects participating in the vascular studies attended the Department of 
Respiratory Medicine and Allergy, University Hospital, Umeå for a 
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screening visit prior to their enrolment. At this visit standard lung function 
tests, comprising FEV1 (forced expiratory volume in 1 second), FVC (forced 
vital capacity) and slow vital capacity, were performed. Subjects had a 
baseline full blood count performed and a 12-lead electrocardiogram. 
Subjects then performed a standardised cardiopulmonary exercise stress test 
on a bicycle ergometer to determine the exercise intensity required to 
maintain an average ventilation rate of 20 L/min/m2. The determined 
workload was then used during the subjects’ exposures to produce an 
equivalent exposure in all. Subjects were instructed to abstain from alcoholic 
beverages for the 24-hours prior to attendance for all their visits, and from 
caffeinated drinks for at least 8-hours. All subjects were then fasted for at 
least 4-hours prior to performing the vascular studies. 
 
2.1.3 Patients with coronary heart disease 
Patients were recruited from the outpatient departments of 5 local hospitals 
in the city of Beijing, China – coordinated by the Fuwai Cardiovascular 
Hospital - or from the HPS2-THRIVE (more information available at 
http://clinicaltrials.gov/ct2/show/NCT00461630) patient database held at 
the Fuwai Hospital. All patients were non-smokers and had a history of 
coronary heart disease, having had a previous myocardial infarction, 
percutaneous coronary intervention or coronary bypass surgery. Subjects 
were maintained on their normal medical therapy throughout the studies. 
The exclusion criteria for the study were a history of arrhythmia (including 
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atrial fibrillation), severe three-vessel coronary artery disease or left main 
stem stenosis that had not been revascularised, a resting conduction 
abnormality on the electrocardiogram, digoxin therapy, uncontrolled 
hypertension, renal or hepatic failure or an acute coronary syndrome within 




















2.2 DIESEL EXHAUST EXPOSURES 
Exposures to dilute diesel exhaust were performed in Umeå, Sweden in a 
specially built and well-characterised human exposure facility [Rudell, et al. 
1996] that is situated within the Svensk Maskinprovning AB facility 
(http://www.smp.nu). This comprises of a ~15.6 m3 (2.5 x 2.5 x 2.5 m) room 
chamber into which the test atmosphere is introduced (Figure 2.1). Diesel 
exhaust was generated from an idling diesel engine (Volvo TD40 GJE, 4.5 L, 
four cylinders, 680 rpm) situated in the room adjacent to the exposure 
chamber. More than 90% of the exhaust was shunted away, and the 
remaining part diluted with filtered air in a conditioning chamber of ~1 m3 to 
allow complete mixing before being introduced into the exposure chamber. 
 
The aerosol within the chamber was sampled continuously during the 
exposures from the breathing zone of the participants (Figure 2.1), and 
monitored for concentrations of nitric oxide (NO), nitrogen dioxide (NO2) 
and total oxides of nitrogen (NOx) using a chemiluminescent technique (ECO 
Physics CLD700, AL Med, Switzerland) and total hydrocarbons (measured as 
propane) using a flame-ionization detection method (Hydrocarbon 
Analyszer model 3-300, JUM Engineering Co., Oakland, CA, USA). Particle 
mass concentration was measured in real-time with a tapered-element 
oscillating microbalance (TEOM 1400, Rupprecht & Patashnick, East 
Greenbush, NY, USA) at 50 °C. In addition to this, the particle mass 
concentration was determined gravimetrically using glass fibre filter 















Figure 2.1. The human exposure facility in Umeå showing diesel engine used and exposure chamber, along with schematic description. The exercise 











condensation particle counter (CPC Model 3010, TSI Instruments Inc., St 
Paul, MN, USA). During the exposures, the particle mass concentration was 
maintained at approximately 300 !g/m3 which equates to a particle number 
concentration of approximately 1.2 x 106 particles/cm3 [Mills, et al. 2005]. The 
chamber was maintained at a constant temperature of 22 °C and at 50% 
relative humidity. 
 
Filtered air control exposures were performed in the same exposure 
chamber, and to ensure adequate blinding the engine was running as during 
the diesel exhaust exposure. However, the valve allowing the side-flow from 
the exhaust pipe to enter the conditioning chamber remained closed 













2.3 NITROGEN DIOXIDE EXPOSURES 
Nitrogen dioxide exposures were performed in a second specially built 
exposure chamber [Kelly, et al. 1996], situated at the Medical Division of the 
National Institute for Working Life in Umeå. Ambient air was drawn 
through this large room-sized exposure chamber at a constant flow rate of 30 
m3/h after HEPA filtration, which was maintained at a temperature of 20 °C 
and a relative humidity of 50%. Bottled nitrogen dioxide (AGA Special Gas, 
Lidingö, Sweden) was passed through a mass flow controller (Model 
5850TR, Brooks Instrument BV., Veenendaal, Netherlands) and a flow meter 
(Rota, Hannover, Germany) to control the gas flow before being introduced 
into the ventilating duct just before the air reached the exposure chamber. 
Air within the chamber was monitored within the breathing zone of the 
subjects and analysed constantly for nitrogen dioxide concentration using an 
oxides of nitrogen analyser (CSI-1600, Columbia Scientific Industries, Austin, 
Tx, USA). The concentration of NO2 in the chamber was kept constant at 4 
ppm. Control exposures were produced in the same facility, without the 













2.4 VASCULAR STUDIES 
Vascular endothelial dysfunction, which is generally characterised by the 
reduced bioavailability of endothelium-derived nitric oxide, has been shown 
to be an independent risk factor for cardiovascular morbidity and mortality 
[Schachinger, et al. 2000; Suwaidi, et al. 2000]. Endothelial cell dysfunction 
results in adaptive changes within the vasculature that lead to increased 
leucocyte adhesion, an enhanced inflammatory response, and increased 
permeability – changes that eventually lead to the development of 
atherosclerotic lesions [Ross 1999]. Indeed, it has been shown that 
endothelial dysfunction – manifesting as an attenuated vasomotor response – 
is an early marker for atherosclerosis and may be present long before 
structural changes within blood vessels are apparent on clinical investigation 
[Davignon, et al. 2004; Ross 1999]. Whilst it would be ideal to study vascular 
vasomotor responses within the coronary arteries, this is clearly not without 
risk. However, it has been demonstrated that the responses of peripheral 
resistance vessels are well correlated with coronary responses and can be 
used an accurate and validated surrogate [Anderson, et al. 1995]. 
 
The technique of venous occlusion plethysmography to measure forearm 
blood flow was first described by Hewlett and van Zwaluwenburg in 1909 
and has been used widely since then. The use of venous occlusion 
plethysmography along with unilateral intra-brachial infusion of vasoactive 
mediators has allowed the in-depth study of vascular homeostatic 
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mechanisms and vascular pharmacology, and is now regarded as the “gold-
standard” method of determining vascular vasomotor function [Wilkinson, 
et al. 2001]. 
 
2.4.1 Venous occlusion plethysmography 
Venous occlusion plethysmography is a technique of measuring blood flow 
by determining the change in volume of the forearm with time, and can be 
applied to both arms simultaneously. An occluding cuff, inflated above 
systolic blood pressure (usually 200 mmHg), is placed around the wrist to 
exclude the hand – in which there are a large number of arterio-venous 
connections and where the blood flow is highly temperature-dependent 
resulting in a different physiology and pharmacology to the rest of the 
forearm [Wilkinson, et al. 2001]. A second cuff is placed around the upper 
arm and is inflated and deflated cyclically (40 mmHg) to occlude venous 
outflow from the arm. When this cuff is inflated, blood flows into the arm 
but does not escape, and a linear increase in forearm volume is seen. This is 
detected by the use of a mercury-in-silastic strain gauge placed around the 
widest part of the forearm – effectively measuring stretch. The change in 
volume (calculated by assuming the forearm is a truncated cone in shape, 
with the widest part at the strain gauge) can then be expressed as blood flow 
per 100 mL tissue per minute (Figure 2.2). In resting conditions, it is known 
that around 70% of the blood flow goes to skeletal muscle, the remaining 
30% to the skin [Cooper, et al. 1955]. As skin blood flow is dependent on 
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temperature, it is important that ambient temperature is constant, and for all 
these studies the room was maintained at 22-24 °C. 
 
Here, vascular studies were carried out two hours after termination of the 
exposure (to diesel exhaust or nitrogen dioxide). Previous studies have 
demonstrated pronounced and reproducible effects of exposure on vascular 
endothelial function by this 2-hour time point, that are still present at 6-hours 
but largely resolved by 24-hours [Mills, et al. 2005]. 
 
Subjects lay supine on a bed with both arms supported in a quiet, warm 
room. Forearm blood flow was measured in both arms using venous-

















Figure 2.2. (A) Shows the subject resting supine on the bed, attached to the 
plethysmography equipment. (B) The occluding wrist cuff and upper arm cuff in situ. The 
mercury-in-silastic strain gauge can be seen around the forearm. In this subject, a venous 
cannula is placed in a large ante-cubital vein for venous blood sampling and the brachial 
artery is cannulated with a 27G needle. (C) Representative trace obtained showing the linear 




2.4.2 Brachial artery cannulation 
The brachial artery of the non-dominant hand was cannulated at the start of 
the vascular studies using a sterile 27-standard wire gauge steel needle 
(Coopers Needle Works Ltd, Birmingham, UK) under aseptic techniques. 
This needle was attached to a sterile epidural catheter and secured with 
sticky dental wax. This technique has been shown to be safe and simple and 
allows infusion of vasoactive drugs into the forearm with minimal trauma to 
the vessel itself. 
 
2.4.3 Venous blood sampling 
At the start of the study, subjects had 17 or 18 gauge intravenous cannulae 
inserted into a large antecubital vein in each arm. This enabled venous blood 
sampling in both the infused and non-infused arms during the study without 
further venepuncture. 
 
2.4.4 Intra-arterial vasoactive mediators 
After a baseline infusion of 0.9% sodium chloride (to allow a true baseline 
forearm blood flow measurement to be obtained) subjects received intra-
arterial infusions of endothelin-1 (5 pmol/min), endothelin-receptor 
antagonists (BQ-123, 10 nmol/min; BQ-788, 1 nmol/min), L-NG-
monomethylarginine (L-NMMA, 2-8 !mol/min), sodium nitroprusside 
(SNP, 90 ng/min – 8 !g/min), acetylcholine (ACh, 5-20 !g/min) or 
bradykinin (100-1000 pmol/min) as per the individual study protocol. These 
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doses are much lower than would be required to result in a systemic effect, 
as they need to act only within the forearm – a major advantage of this 
model. Subjects’ blood pressure was monitored throughout the studies to 
assess for systemic spill over of drug using a validated, semi-automated, 
oscillometric sphygmomanometer (Omron Healthcare Ltd., Japan) placed 
around the upper part of the non-infused arm. Forearm blood flow was 
determined at defined timepoints during the infusion of all drugs. A 20 
minute 0.9% saline infusion separated multiple drug used during a single 
protocol to allow blood flow to return to baseline. The infusion rate was kept 












2.5 FACEMASK SELECTION 
Masks designed for use by cyclists, pedestrians and occupational settings 
were tested for penetrance of fresh diesel exhaust particulate. Diesel engine 
exhaust was generated from the idling (1500 rpm) engine (F3M2011, Deutz 
Ag, Köln, Germany) of a 35KVA generator (Bredenoord, Apeldoorn, 
Netherlands). The exhaust was diluted with filtered air to obtain a mass 
concentration of 75±12 !g/m3 (as measured by gravimetric analysis) and a 
particle number concentration of 500,000 particles/cm3 (condensation 
particle counter [CPC] model 3022, TSI Instruments, High Wycombe, UK). 
Sections of each mask filter were mounted in a filter holder. After 5 min of 
baseline measurements, filters were introduced between the exhaust and the 
CPC that sampled at a flow rate of 1.5 L/min. Particle number was recorded 
for 5 min and penetrance defined as the percentage of particles passing 
through the filter compared to baseline.  
 
Mask penetrance was highly dependent on mask type (Figure 2.3). The 3M 
Dust Respirator (Model 8812, 3M, St Pauls, USA) was selected for the 
subsequent intervention studies as it provided good filtration performance, 











Figure 2.3. Penetrance of commercially available filters: 3M Dust Respirator 8812, Dust 
Respirators A and B, Cyclist Masks A to D. The Teflon filter is an industry standard filter for 
aerosol studies included as a control. Cotton handkerchiefs and surgical masks are often 
seen worn in public areas in parts of Asia. Inset: subjects wearing the mask at the beginning 
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2.6 AMBIENT POLLUTION MONITORING 
One of the problems with air pollution research in ambient settings, and the 
reason why model exposure systems such as the diesel exhaust system 
described previously are widely used in toxicological and mechanistic 
studies, is that there are myriad factors that affect local pollution levels 
including traffic density, activity of nearby industry and weather conditions. 
Indeed, particulate air pollution measured at a background monitoring 
station away from the roadside may give a significantly false impression of 
an individual’s real exposure to air pollution when walking along a busy 
roadside [Buzzard, et al. 2009; Watt, et al. 1995]. 
 
In light of this we collected ambient air pollution data both from the local 
background monitoring stations, but we also measured personal exposure to 
air pollutants using portable air pollution monitoring equipment contained 
within a backpack, sampling from near the breathing zone of the participants 
(Figure 2.4). During the patient study we also collected particles in size 















Figure 2.4. Pollution monitoring equipment contained 
within a small backpack, sampling from the tubes and 
sensors on the outside of the bag. 
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2.6.1 Personal pollution exposure assessment 
Using a similar approach to that described before by McCreanor and 
colleagues who measured personal exposure to air pollutants using 
equipment pushed in a handcart [McCreanor, et al. 2007], personal exposure 
to air pollutants was monitored using a collection of portable monitoring 
equipment mounted in a backpack. Particle mass concentration (particle 
diameter <2.5 !m; PM2.5) was measured in using a light-scattering 
nephelometric method with a DataRAM monitor (pDR-1500, Thermo 
Scientific, Franklin, USA). Particle number was measured using a handheld 
condensation particle counter (CPC 3007, TSI Instruments Ltd, High 
Wycombe, UK). Ambient temperature and relative humidity were recorded 
using a sensor on the outside of the backpack (Omegaette® HH-314, Omega 
Engineering Ltd, Connecticut, USA). Gaseous pollutants were measured 
using a multigas analyser (X-am 7000, Dräger Safety, Pittsburgh, USA) 
measuring carbon monoxide (CO), nitrogen dioxide (NO2) and sulphur 
dioxide (SO2) using electrochemical sensors with a sensitivity of 1 part per 
million. 
 
2.6.2 Activity assessment 
Physical activity was assessed using a portable global positioning system 
(GPS) monitor secured to the outside of the bag (eTrex Summit HC, Garmin, 
USA). This recorded the route taken by volunteers, their total distance 
travelled, and average speed. This information was used, along with baseline 
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anthropometric measurements, to calculate the energy expended during the 
walk in kilocalories and metabolic equivalents (METS). 
 
2.6.3 Background pollution exposure assessment 
In addition to the personal exposure measurements, during the patient study 
background air pollution exposure was recorded from permanent city centre 
monitoring stations in the same district as the patients’ walk (Xicheng for the 
Fuwai Hospital, ChaoYang for the ChaoYang Hospital); freely available 
online  at http://www.bjepb.gov.cn/air2008/olympic.aspx. A MOUDI 
cascade impactor was set up in the front of the Fuwai Hospital (Figure 2.5), 
at the start point of the 2-hour walk, and attached to a high-volume sampling 
pump running at 30 L/min. Particles were collected onto Teflon filters (Pall 
Corp., Ann Arbor, MI, USA) in three size fractions: coarse (with mean 
aerodynamic diameter 2.5-10 !m), fine (0.18-2.5 !m) and ultrafine (<0.18 
!m). Samples were collected over 24 hours and stored in airtight containers 
prior to analysis. The mass collected on the filters was determined 















Figure 2.5. (A) Shows representative filter samples from MOUDI impactor in the three size fractions: ultrafine, fine and coarse from left to right. (B) 
Shows MOUDI impactor in situ at the Fuwai Hospital entrance at the start of the walk, indicated by the yellow circle in panel C. (D) shows the location 
of the impactor looking out onto the roadside, adjacent to a major traffic interchange.
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2.6.4 Particle chemical and toxicological analysis 
Collected particulate samples were analysed for total carbon content, as well 
as elemental and organic carbon fractions, using the Sunset method (NIOSH 
5040; http://www.cdc.gov/niosh/docs/2003-154/pdfs/5040.pdf). Metals 
and cations were determined using inductively-coupled plasma mass 
spectrometry (ICP-MS) following pre-treatment with nitric acid. Nitrate and 
sulphate anions were determined following extraction with water using LC-
ICP-MS (liquid chromatography paired with ICP-MS). Organic matter was 
extracted from filters by ultrasonification with toluene and analysed using 
gas chromatography-mass spectrometry (GC-MS). 
 
Oxidative potential of particles was assessed using electron paramagnetic 
resonance (EPR) [Miller, et al. 2009]. EPR was used to establish oxygen-
centred free radical generation from the collected particulate matter in the 
absence of tissue. Filters for all size fractions were pooled and sonicated in 
phosphate buffered saline to give a final concentration of particles of 1 
mg/mL. Solutions were incubated with the spin-trap 1-hydroxyl-2,2,6,6,-
tetramethyl-4-oxo-piperidine (Tempone-H; 1 mM), loaded into a capillary 
tube and assessed at 37 oC in an X-band EPR spectrometer (Magnettech MS-
200, Berlin, Germany) as described previously [Miller, et al. 2009]. Pyrogallol 
(100 !M) was used as a positive control, and samples were compared to the 
NIST (National Institute of Standards and Technology, Gaithersburg, MD, 
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USA) standard reference materials: urban dust (SRM-1649a; 1 mg/mL) and 




2.7 PHYSIOLOGICAL PARAMETERS 
2.7.1 Ambulatory blood pressure 
Subjects were fitted with an ambulatory blood pressure monitor (Model 
90217, Spacelabs Healthcare, Chesham, UK) at the beginning of the study 
days (Figure 2.6). During the controlled exposure studies, this recorded 
blood pressure every 30 minutes during the day (07:00 to 22:00) and every 
hour overnight (22:00 to 07:00). When taking part in the ambient studies, 
blood pressure was determined every 15 minutes during the 2-hour walk, 
then every 30 minutes for the rest of the day and every hour overnight as 














Figure 2.6. Subject wearing 12-lead 
electrocardiography Holter monitor and 
ambulatory blood pressure monitor at 
the start of a study day. 
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2.7.2 Electrocardiography 
Subjects were fitted with a 12-lead continuous electrocardiographic Holter 
monitor (Lifecard 12, Spacelabs Healthcare, Chesham, UK) at the beginning 
of the study (Figure 2.6), which they were asked to wear for 24 hours. Holter 
electrocardiographic traces were analysed using DelMar Reynolds 
proprietary software packages. The quality of the trace was visually assessed 
before automated arrhythmia analysis was performed using the Pathfinder 
package. Identified arrhythmias were individually inspected and verified or 
deleted as appropriate. Heart rate variability was assessed using the HRV 
Tools software package in the time and frequency domains, with identified 
arrhythmias excluded from this analysis.  
 
During the patient study, ST segment analysis was performed over the 
whole 24-hour period and during the 2-hour walk. Three representative 
leads were chosen, leads II, V2 and V5, and analysed separately for each 
subject. The baseline ST segment amplitude was defined as the average over 
the entire 24-hour period, and all subsequent measurements were compared 
to this. ST segment deviation was determined at the J-point +80 ms. The 
maximal ST segment depression during the two time periods was recorded 
and ischaemic burden determined (calculated as the product of the change in 
ST segment amplitude and the duration of the recording) for each lead 
individually and as a composite [Mills, et al. 2007]. Clinically relevant ST 
segment events were recorded and defined as horizontal or downsloping ST 
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segment deviation of at least 1 mm (100 !V), lasting at least 60 s and 
























2.8 BIOCHEMICAL ANALYSES 
2.8.1 Endothelins 
Blood samples were collected into ethylene diamine tetra-acetic acid and 
kept on ice until centrifuged at 3000 rpm for 30 min. Plasma samples were 
immediately frozen and stored at -80 ºC. Plasma ET-1 and big-ET-1 
concentrations were measured according to an acetic acid extraction 
technique using a commercial radioimmunoassay with rabbit anti-human 
ET-1 or big-ET-1 (Peninsular Laboratories Europe Ltd, St Helens, UK) as 
described previously [Adam, et al. 2001]. 
 
2.8.2 Nitrites 
Blood samples were obtained for the measurement of plasma nitrite from 
both infused and non-infused arms during the vascular assessment via 
indwelling 17-gauge venous cannulae inserted into a large antecubital vein 
on each arm. Samples were obtained before and after each incremental dose 
of L-NMMA, acetylcholine and SNP and were collected into lithium heparin, 
immediately transferred to eppendorf tubes prewashed with Milli-Q de-
ionised water and immediately centrifuged at 5000 g for 1 minute. Plasma 
was then transferred into a dark coloured eppendorf tube containing 100 !L 
of a solution containing 1 mM diethylenetriaminepentaacetic acid and 62.5 
mM N-ethylmaleimide before being snap-frozen on dry ice and stored at -
80oC prior to further analysis. 
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Plasma nitrite samples were defrosted and deproteinised using acetonitrile 
and chloroform as described previously [Romitelli, et al. 2007]. Aliquots of 
the aqueous fraction were injected into a reaction vial containing glacial 
acetic acid and ascorbate [Nagababu, et al. 2007]. Nitric oxide generated in 
the reaction chamber was driven off by a continual stream of nitrogen and 
detected using a chemiluminescent analyzer (Seivers, Melbourne, Australia) 
with a detection limit of 10-20 nM. Analyses were performed in 
quadruplicate. 
 
Blood samples for arginine, homoarginine (nitric oxide synthase substrates), 
ADMA and SDMA (endogenous nitric oxide synthase antagonists) were 
collected into ethylene diamine tetra-acetic acid and kept on ice until 
centrifuged at 3000 rpm for 30 min. Plasma samples were immediately 
frozen and stored at -80°C. Plasma concentrations were determined by high-
performance liquid chromatography as described previously [Blackwell, et 
al. 2009]. 
 
2.8.3 Fibrinolytic system 
Blood samples were obtained during the forearm vascular study from 
indwelling 17-gauge venous cannulae inserted into a large antecubital vein 
on both arms before and after each dose of bradykinin. Bradykinin is an 
endothelium-dependent vasodilator that also stimulates the release of stored 
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tissue-plasminogen activator (t-PA) from the vascular endothelium [Brown, 
et al. 2000; Brown, et al. 1999]. Samples were collected into acidified buffered 
citrate (Stabilyte, Biopool International) for analysis of t-PA and into citrate 
(BD Vacutainer) for plasminogen-activator inhibitor type 1 (PAI-1) assays to 
assess the activity of the endogenous fibrinolytic pathway.  
 
t-PA and PAI-1 antigen concentrations were determined by commercially 
available ELISA assays (t-PA combi Actibind, Technoclone, Vienna, Austria; 
Elitest PAI-1, Hyphen BioMed, Neuville-sue-Oise, France). As much of the t-
PA present in the circulation is bound to PAI-1, thus rendering both inactive 
and leading to hepatic clearance [Chandler, et al. 1997], both t-PA and PAI-1 
activity were assessed using enzymatic assays (t-PA combi Actibind, 
Technoclone, Vienna, Austria; Zymutest PAI-1, Hyphen BioMed, Neuville-
sur-Oise) as described previously [Mills, et al. 2005]. 
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2.9 DATA ANALYSIS AND STATISTICS 
For the vascular studies, nursing staff at the clinical research facility at 
University Hospital, Umeå, Sweden, randomised exposure type and the 
associated vascular study protocol. The investigators were blinded to the 
exposure received. Plethysmography data were analysed as described 
previously [Newby, et al. 1999]. Estimated net release of t-PA activity and 
antigen was calculated as described previously [Newby, et al. 1997] as below, 
where FBF if forearm blood flow, Hct is haematocrit, t-PAinf and t-PAnon the 
concentrations of t-PA (antigen or activity) in the infused and non infused 
arms respectively: 
 
Estimated net t-PA release = FBF x (1 – Hct) x ([t-PA]inf – [tPA]non) 
 
Statistical analyses were performed using paired Student’s t-tests and two-
way analysis-of-variance (ANOVA) with repeated measures including time 
and exposure as variables where appropriate.  
 
For the ambient studies, subjects were randomised to wearing a mask on 
their first or second visit on recruitment by the use of a random number 
generator. Data were compared using paired Student’s t-tests or Wilcoxon 
matched pairs signed rank test as appropriate. Symptom data were collected 
using a visual analogue scale, from 0 to 10. Occurrence of arrhythmias, 
reported symptoms and ST segment event frequency were compared using 
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the Chi-squared analysis and subsequent average event data compared using 
Mann-Whitney U tests. 
 
All data were analysed using GraphPad Prism (Version 4 for Macintosh, 
GraphPad Software, San Diego, USA) on a Macintosh personal computer. 




























Exposure to nitrogen dioxide is not associated 
with vascular dysfunction in man 
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3.1 SUMMARY 
Exposure to air pollution is associated with increased cardiorespiratory 
morbidity and mortality. It is unclear whether these effects are mediated 
through combustion-derived particulate matter or gaseous components, such 
as nitrogen dioxide. The objective of this study was to investigate the effect 
of nitrogen dioxide exposure on vascular vasomotor and fibrinolytic 
function. 
 
Ten healthy male volunteers were exposed to nitrogen dioxide at 4 ppm or 
filtered air for 1 hour during intermittent exercise in a randomised double-
blind crossover study. Bilateral forearm blood flow and fibrinolytic markers 
were measured before and during unilateral intrabrachial infusion of 
bradykinin (100-1000 pmol/min), acetylcholine (5-20 !g/min), sodium 
nitroprusside (2-8 !g/min) and verapamil (10-100 !g/min) 4 hours after the 
exposure. Lung function was determined before and after the exposure, and 
exhaled nitric oxide at baseline, 1 and 4 hours after the exposure. 
 
There were no differences in resting forearm blood flow after either 
exposure. There was a dose-dependent increase in forearm blood flow with 
all vasodilators but this was similar after either exposure for all vasodilators 
(P>0.05 for all). Bradykinin caused a dose-dependent increase in plasma 
tissue-plasminogen activator, but again there was no difference between the 
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exposures. There were no changes in lung function or exhaled nitric oxide 
following either exposure. 
 
We conclude that inhalation of nitrogen dioxide does not impair vascular 
vasomotor or fibrinolytic function and therefore does not appear to be a 




















Exposure to air pollution is a major public health problem, and is associated 
with an increased risk of cardiorespiratory morbidity and mortality. 
Epidemiological studies have consistently shown a strong association of 
cardiorespiratory illness and fine particulate matter [Dockery, et al. 1993; 
Miller, et al. 2007; Pope, et al. 2002], although similar positive associations 
have been shown for long-term exposure to nitrogen dioxide [Anderson, et 
al. 1996; Hoek, et al. 2001; Rosenlund, et al. 2008]. Nitrogen dioxide and other 
oxides of nitrogen are major constituents of combustion-derived air 
pollution, such as diesel exhaust, and the associations of nitrogen dioxide 
with adverse outcomes have usually been attributed to the close association 
of fine particulate with nitrogen dioxide concentrations [Sarnat, et al. 2001]. 
However, isolated real life exposures to nitrogen dioxide have been linked to 
increases in respiratory illness and susceptibility to airway infection 
[Guidotti 1978; Love, et al. 1982; Mostardi, et al. 1981]. Controlled exposure to 
nitrogen dioxide induces airway inflammation and modifies antioxidants in 
the respiratory tract lining fluid [Kelly, et al. 1996]. 
 
The cardiovascular effects of inhaled diesel exhaust are well documented. 
We have demonstrated that controlled exposures to diesel exhaust, as a 
model of combustion-derived fine particulate air pollution, causes acute 
vascular endothelial effects [Mills, et al. 2005; Törnqvist, et al. 2007]. In these 
models, the actual exposure is a complicated mixture of carbon centred 
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particulate matter, volatile organic compounds and gaseous pollutants 
[Scheepers and Bos 1992]. The predominant gaseous components are 
nitrogen dioxide and other oxides of nitrogen, with NOx concentrations 
reaching around 4 ppm in previous controlled exposures to diesel exhaust 
[Behndig, et al. 2006; Mills, et al. 2005; Salvi, et al. 1999]. These models have 
consistently demonstrated an impairment of vascular endothelial function 
and endogenous fibrinolysis following exposure to diesel exhaust, that 
appears to be mediated through increased oxidative stress and reduced nitric 
oxide bioavailability [Miller, et al. 2009; Mills, et al. 2005]. Although 
particulate matter appears to be a major arbiter of these adverse vascular 
effects, the question remains as to the independent effect of a pure exposure 
to nitrogen dioxide. Nitrogen dioxide is itself a powerful oxidising species, 
and this is proposed to underlie the airway inflammatory and antioxidant 
responses, as well as the vascular dysfunction previously described 
[Blomberg, et al. 1997; Patel and Block 1986]. 
 
The aim of this study was to explore the effect of a pure exposure to 4 ppm of 
nitrogen dioxide on vascular endothelial and fibrinolytic function, and to test 
the hypothesis that the previously demonstrated adverse effects are driven 







Ten healthy male volunteers were recruited into the trial. Women were not 
included to avoid the potential confounding influence of cyclical changes in 
estrogen on vascular endothelial function [Ganz, 2002]. One subject 
developed a respiratory tract infection during the study and was excluded 
and replaced. All subjects were non-smokers, had no intercurrent illness, 
took no regular medication, and all had normal lung function. All subjects 
had been free of symptoms of upper airway infection for at least 6 weeks 
prior to the study. All subjects gave their written informed consent, and the 
trial was approved by the local research ethics committee in accordance with 
the Declaration of Helsinki. 
 
3.3.2 Exposure protocol 
The exposures to nitrogen dioxide or filtered air took place at the Medical 
Division of the National Institute for Working Life in Umeå as described 
previously [Kelly, et al. 1996]. Briefly, ambient air was drawn continuously 
through a large exposure chamber at a constant rate of 30 m3/h, which was 
maintained at a temperature of 20 °C and relative humidity of 50%. Nitrogen 
dioxide (AGA Special Gas, Lidingö, Sweden) was passed through a mass 
flow controller (Model 5850TR, Brooks Instrument B.V., Veenendaal, 
Netherlands) and a flow meter (Rota, Hannover, Germany) to control the gas 
flow, and was introduced to the ventilating duct just before reaching the 
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chamber. Air was sampled in the breathing zone of the subjects and analysed 
continuously for nitrogen dioxide, nitric oxide and total NOx using a CSI 
1600 oxides of nitrogen analyser (Columbia Scientific Industries, Austin, Tx, 
USA). The concentration of nitrogen dioxide within the chamber was 
maintained at 4 ppm, a concentration selected to match that of NOx 
concentrations seen in controlled exposures to diesel exhaust as described 
previously [Behndig, et al. 2006; Mills, et al. 2005; Salvi, et al. 1999]. Filtered 
air exposures were performed by HEPA filtration of air prior to introduction 
into the exposure chamber without introduction of additional nitrogen 
dioxide. 
 
3.3.3 Study design 
Subjects attended the clinical research facility at Umeå University Hospital 
on two occasions, each at least one week apart. In a randomised double-blind 
cross over trial, subjects were exposure to either filtered air or nitrogen 
dioxide at 4 ppm for 1 hour with intermittent exercise. Subjects performed 
exercise on a bicycle ergometer whilst in the chamber at a pre-designated 
workload to achieve a mean ventilation rate of 20 L/min/m2, based on a pre-
study screening exercise ventilation stress test. Subjects then returned to the 
clinical research facility for forearm vascular plethysmography studies with 
active drug infusions commencing 4 hours after the exposure. 
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3.3.4 Outcome measures 
3.3.4.1 Vascular assessments 
Subjects underwent forearm venous occlusion plethysmography as described 
previously [Wilkinson and Webb 2001]. The brachial artery of the non-
dominant arm was cannulated with a 27-gauge steel needle under aseptic 
technique and local anaesthesia. After a 30-minute baseline saline infusion, 
forearm blood flow was recorded during infusion of the endothelial-
dependent (acetylcholine, 5, 10 and 20 !g/min; bradykinin, 100, 300 and 1000 
pmol/min) and –independent (sodium nitroprusside, 2, 4 and 8 !g/min; 
verapamil, 10, 30 and 100 !g/min) vasodilators. The vasodilators were 
infused for 6 minutes at each dose, with the blood flow determined for last 3 
minutes of the infusion. Vasodilators were administered in a random order, 
except for verapamil that was always administered last given its prolonged 
vascular action, and were separated by a washout period of 20 minutes 
during which saline was infused.  
 
3.3.4.2 Biochemical analyses 
Peripheral venous blood samples were obtained at baseline and at 4 and 6 
hours after exposure for total and differential cell counts. Analysis was 
performed on an autoanalyser by the local haematology reference laboratory 
(Department of Clinical Chemistry, University Hospital, Umeå). Blood 
samples were obtained during the forearm vascular study from indwelling 
17-gauge venous cannulae inserted into a large antecubital vein on both arms 
before and after each dose of bradykinin. Bradykinin is an endothelial-
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dependant vasodilator that also stimulates the release of stored tissue-
plasminogen activator (t-PA) from the vascular endothelium [Brown, et al. 
2000; Brown, et al. 1999]. Samples were collected into acidified buffered 
citrate (Stabilyte, Biopool International) for analysis of t-PA and into citrate 
(BD Vacutainer) for plasminogen-activator inhibitor type 1 (PAI-1) assays to 
assess the activity of the endogenous fibrinolytic pathway.  
 
t-PA and PAI-1 antigen concentrations were determined by commercially 
available ELISA assays (t-PA combi Actibind, Technoclone, Vienna, Austria; 
Elitest PAI-1, Hyphen BioMed, Neuville-sue-Oise, France). As much of the t-
PA present in the circulation is bound to PAI-1, thus rendering both inactive 
and leading to hepatic clearance [Chandler, et al. 1997], both t-PA and PAI-1 
activity were assessed using enzymatic assays (t-PA combi Actibind, 
Technoclone, Vienna, Austria; Zymutest PAI-1, Hyphen BioMed, Neuville-
sur-Oise) as described previously [Mills, et al. 2005]. 
 
 
3.3.4.3 Exhaled nitric oxide and lung function 
The standardised fractional exhaled nitric oxide (FENO) was measured in 
duplicate at expiratory flow rates of 10, 50, 100 and 250 mL/s at baseline, 1 
hours and 4 hours after both exposures using a chemiluminescence analyser 
(NiOX, Aerocrine AB, Stockholm, Sweden) [ATS/ERS 2005]. Lung function 
was measured using simple spirometry (Vitalograph, Bucks, UK) at baseline 
-81- 
and after the exposure, recording forced vital capacity (FVC), forced 
expiratory volume in 1 second (FEV1), and slow vital capacity (VC). 
 
3.3.5 Statistical analysis 
We calculate, based on previous studies [Mills, et al. 2005], that a sample size 
of 10 gives an 80% power of detecting a difference in forearm blood flow 
responses of 20% at a 2-sided statistical significance level of 5%. All 
investigators were blinded to the exposure received. Plethysmography data 
were analysed as described previously [Newby, et al. 1999]. Data were 
analysed using 2-way analysis-of-variance (ANOVA) with repeated 
measures. The variables included in the ANOVA were dose and exposure for 
the forearm blood flow data, and time and exposure for the other outcome 
measures. All data are expressed as mean ± standard deviation unless 
otherwise stated. Statistical significance was taken as a two-sided P value of 
0.05. Data were analysed using GraphPad Prism (Version 4 for Macintosh, 










Ten subjects, median age 24 years, completed the study (Table 3.1). There 
were no changes in any indices of lung function seen following the nitrogen 
dioxide exposure (Table 3.2). Exhaled nitric oxide (FENO), measured as a 
surrogate of airway inflammation, was unchanged at all time points 
following either nitrogen dioxide or filtered air exposure (Table 3.2). 
 
Table 3.1. Baseline characteristics of the 10 subjects completing the study.  
  
Age, years (median, range) 24 (22-28) 
Male sex, % 100% 
Height, cm 181±5 
Weight, kg 79±10 
BMI, kgm-2 24±2 
FEV1, L 4.95±0.33 
FVC, L 5.99±0.52 
VC, L 5.91±0.47 
Systolic blood pressure, mmHg 136±11 
Diastolic blood pressure, mmHg 67±8 
Heart rate, bpm 60±12 
Haemoglobin, g/L 146±7 
White cell count, x109/L 4.9±1.5 
Platelet count, x109/L 224±53 
PAI-1 antigen, ng/mL 6.87±4.04 
PAI-1 activity, U/mL 0.27±0.22 
t-PA antigen, ng/mL 2.82±1.85 
t-PA activity, U/mL 1.25±0.54 
 
Data expressed as mean ± standard deviation unless otherwise stated. Slow vital capacity, 
VC; forced expiratory volume in 1 second, FEV1; forced vital capacity, FVC. Plasminogen 
activator type 1 (PAI-1) and tissue plasminogen activator (t-PA) concentrations measured 
during forearm study on control air day before infusion of bradykinin. 
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Table 3.2. Basic spirometry and exhaled nitric oxide (FENO) at flow rates of 10, 50, 100 and 
250 mL/s after 1 hour of nitrogen dioxide (4 ppm) or filtered air exposure with intermittent 
exercise.  
Data shown as mean ± standard deviation. P values shown from 2-way ANOVA with 
repeated measures showing effect of time and exposure. Slow vital capacity, VC; forced 
expiratory volume in 1 second, FEV1; forced vital capacity, FVC. 
 
 




Pre exposure 5.82±0.41 5.91±0.47 
0.959 0.153 
Post exposure 5.88±0.44 5.87±0.48 
FEV1, L 
Pre exposure 4.95±0.24 4.95±0.33 
0.979 0.920 
Post exposure 4.95±0.33 4.94±0.33 
FVC, L 
Pre exposure 5.93±0.47 5.99±0.52 
0.882 0.570 




Pre exposure 6.28±2.77 6.49±2.36 
0.796 0.424 1 hours 5.80±2.31 6.14±2.10 




Pre exposure 10.23±5.62 10.53±3.22 
0.867 0.819 1 hours 10.33±5.45 10.52±5.32 




Pre exposure 16.55±9.67 15.71±9.02 
0.863 0.700 1 hours 16.94±9.71 16.34±8.32 




Pre exposure 51.15±32.65 51.87±32.59 
0.829 0.992 1 hours 55.74±32.00 54.28±33.16 
4 hours 58.57±27.16 59.48±35.41 
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The forearm vascular studies revealed a dose-dependent increase in blood 
flow in the infused arm compared to the non-infused arm in all subjects after 
each infused vasodilator. There was no difference in the vascular responses 
to any of the vasodilators (endothelium-dependent or –independent) 
following air or nitrogen dioxide exposure (Figure 3.1). Bradykinin 
stimulated a dose-dependent increase in release of plasma tissue-
plasminogen activator (t-PA) although the response was similar following 
each exposure (Table 3.3). Plasma plasminogen-activator inhibitor 1 (PAI-1) 
concentrations were unchanged (P>0.05 for both infused and non-infused 
arms, data not shown) following infusion of bradykinin with no differences 













Figure 3.1. Forearm venous occlusion plethysmography with intra-arterial infusion of 
vasodilators performed 4 hours after exposure. Data plotted as mean and T-bars show 
standard error of the mean. Solid lines show infused arm, dotted lines show non-infused 
arm after exposure to air (!) or nitrogen dioxide (") at 4 ppm. P values shown from 2-way 
ANOVA with repeated measures showing effect of exposure for both infused and non-
infused arms.
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Table 3.3. Plasma tissue-plasminogen activator (t-PA) antigen concentrations and activity and estimated net t-PA release following infusion of 
bradykinin after 1 hour of nitrogen dioxide (4 ppm) or filtered air exposure with intermittent exercise. Data shown as mean ± standard deviation. P 
values shown from 2-way ANOVA with repeated measures showing effect of time and exposure (Exp.). 
Bradykinin 
(pmol/min) 
Air NO2 P Value 






















































There was no difference in white cell count, differential cell count, or platelet 
count through the study following either exposure (Table 3.4). We did 
observe a small fall in systemic haemoglobin concentrations through the 
study period consistent with repeated venesection, although there was no 
difference between the study exposures (Table 3.4). 
 
 
Table 3.4. Differential cell count and hemoglobin concentrations before and after a 1 hour 
nitrogen dioxide (4 ppm) or filtered air exposure with intermittent exercise.  





Pre exposure 148±8 146±7 
0.012* 0.284 4 hours 142±8 143±7 




Pre exposure 4.8±0.9 4.9±1.5 
0.243 0.434 4 hours 5.6±1.5 5.7±1.6 
6 hours 6.2±2.1 5.7±1.5 
Platelet count 
(x109/L) 
Pre exposure 209±44 224±53 
0.836 0.237 4 hours 214±55 226±50 
6 hours 209±46 209±45 
Neutrophils 
(x109/L) 
Pre exposure 2.37±0.75 2.34±1.14 
0.158 0.296 4 hours 3.14±1.10 3.15±1.21 
6 hours 3.57±1.78 3.00±1.22 
Lymphocytes
(x109/L) 
Pre exposure 1.89±0.34 1.91±0.47 
0.623 0.676 4 hours 1.91±0.55 1.92±0.44 
6 hours 2.12±0.54 2.04±0.48 
Monocytes 
(x109/L) 
Pre exposure 0.39±0.11 0.40±0.10 
0.669 0.965 4 hours 0.41±0.15 0.43±0.13 
6 hours 0.45±0.16 0.43±0.12 
Data shown as mean ± standard deviation. P values shown from 2-way ANOVA with 






We have demonstrated for the first time that direct exposure to nitrogen 
dioxide in isolation is not associated with vascular vasomotor or fibrinolytic 
dysfunction. This suggests there are components other than nitrogen dioxide 
that are responsible for the previously documented adverse cardiovascular 
effects of air pollution. 
 
3.5.1 Vascular Effects 
In this study we have employed a robust and well-validated technique to 
assess vascular endothelial function following a short-term exposure to 
nitrogen dioxide. Exposure to nitrogen dioxide, a major component of 
combustion-derived air pollution, has been linked to cardiovascular 
morbidity and mortality in epidemiological studies. Why then did we not 
observe adverse vascular effects? Many workers have attributed the 
epidemiological link with nitrogen dioxide to a bystander association or epi-
phenomenon rather than a casual relationship. Nitrogen dioxide is a co-
pollutant that correlates tightly with fine and ultrafine particulate matter 
[Sarnat, et al. 2001]. Our current and previous findings are in agreement with 
this hypothesis. Using controlled exposures to dilute diesel exhaust, we have 
previously demonstrated marked adverse effects on vascular endothelial 
function [Mills, et al. 2005] that are present 2 and 6 hours after the exposure 
but have largely resolved by 24 hours [Törnqvist, et al. 2007]. In the present 
study, performed 4 hours after the exposure and well within the time 
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window of the previously demonstrated adverse vascular effects, we aimed 
to separate the effects of the major gaseous co-pollutant, nitrogen dioxide, by 
using a pure gaseous exposure.  
 
It is important to note that the nitrogen dioxide concentration employed in 
this study has been previously demonstrated to cause airway inflammatory 
responses [Blomberg, et al. 1997; Sandstrom, et al. 1991]. In homes with gas 
stoves and in certain industries, nitrogen dioxide concentrations may peak at 
1-2 ppm [Samet, et al. 1987]. Alongside busy roads, nitrogen dioxide 
concentrations may reach 0.6 ppm [WHO, 1999]. Whilst the concentration of 
nitrogen dioxide chosen for this study was matched to the overall 
concentration of oxides of nitrogen from previous diesel exhaust exposure 
studies [Mills, et al. 2005; Salvi, et al. 1999], in these studies nitrogen dioxide 
concentrations reached an average of 1.6 ppm. Therefore, even at levels 
above those encountered in dilute diesel exposures, when pronounced 
adverse vascular effects were demonstrated, we have clearly demonstrated 
that short-term exposure to pure nitrogen dioxide is not associated with 
vascular endothelial dysfunction in healthy young male subjects, although 
we cannot rule out a small effect in women or elderly people with co-
morbidities who may be more sensitive to environmental pollutants. 
 
Nitrogen dioxide is a powerful oxidising species, and we have demonstrated 
that its inhalation is associated with mild airway inflammation and changes 
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in airway antioxidant responses [Blomberg, et al. 1997; Kelly, et al. 1996]. 
Moreover, after exposure to nitrogen dioxide in in vitro studies, porcine 
pulmonary artery and aortic endothelial cells have been shown to suffer a 
significant oxidant injury, with lipid peroxidation and impaired cell 
membrane function [Patel and Block 1986]. We have suggested that the 
vascular effects of air pollution exposure are mediated by oxidative stress 
[Miller, et al. 2008], so why has inhalation of nitrogen dioxide failed to have 
an effect on vascular function? Nitrogen dioxide is relatively insoluble, and 
does not easily diffuse across to the bloodstream from the lungs. In fact, its 
penetration of the alveolar space is further inhibited by the normal 
respiratory tract lining fluid [Postlethwait, et al. 1991]. Therefore it is likely 
that inhaled nitrogen dioxide is confined mainly to the lungs where it exerts 
a localised and specific pulmonary inflammatory stimulus [Blomberg, et al. 
1997], without any significant vascular or systemic oxidative insult.  
 
In light of these findings, we suggest that the vascular endothelial effects we 
have previously demonstrated following exposure to diesel exhaust are 
driven by exposure to fine and ultrafine particulate matter, rather than any 
gaseous component. 
 
3.5.2 Thrombotic effects 
Thrombosis plays a central role in coronary heart disease. Formation of 
thrombus on disrupted atherosclerotic plaques may cause acute vessel 
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occlusion, and acute coronary syndromes. Exposure to air pollution is 
proposed to be procoagulant. Exposure to ambient nitrogen dioxide and 
carbon monoxide has been associated with increased plasma fibrinogen 
[Pekkanen, et al. 2000] and a reduced prothrombin time [Baccarelli, et al. 
2007], and ambient sulphur dioxide with plasma viscosity [Peters, et al. 1997], 
but again the question of whether exposure to nitrogen dioxide and carbon 
monoxide is a surrogate for exposure to combustion-derived particulate 
matter arises. We have previously demonstrated that short term exposure to 
dilute diesel exhaust results in increased platelet activation and enhanced 
thrombus formation [Lucking, et al. 2008], and at the same time impairs 
vascular release of tissue-plasminogen activator (t-PA), an endogenous 
fibrinolytic enzyme [Mills, et al. 2005] responsible for local dissolution of 
formed blood clot.  
 
In this study we have not shown impaired release of tissue-plasminogen 
activator, or any increase in its endogenous inhibitor plasminogen-activator 
inhibitor type 1 (PAI-1), following exposure to nitrogen dioxide. Therefore 
we propose that the previously demonstrated procoagulant and 
antifibrinolytic effects of air pollution exposure are primarily driven by 




3.5.3 Pulmonary Effects 
Our study demonstrated no change in exhaled nitric oxide (FENO) or simple 
spirometry following exposure to nitrogen dioxide. Spirometry provides a 
basic measure of lung function, assessing airway restriction and obstruction 
and forms a critical part of the diagnosis of chronic lung conditions such as 
asthma and chronic obstructive pulmonary disease. Small effects on lung 
function have been demonstrated in patients with asthma following 
exposure to inhaled ambient air pollution [McCreanor, et al. 2007]. In light of 
this, we chose to assess changes in airway reactivity using simple spirometry 
in this group of healthy volunteers. Our study findings of no change in 
spirometry indices are in concordance with similar studies performed after 
exposure to diesel exhaust in healthy volunteers [Nightingale, et al. 2000]. 
 
Exhaled nitric oxide is proposed as a marker of airway inflammation, 
especially in asthmatic patients [ATS/ERS, 2005], and is closely correlated 
with eosinophilic inflammation [Lim and Mottram 2008]. As a marker it is 
helpful in obtaining a diagnosis of asthma [Dupont, et al. 2003] and may be 
used to track response to treatment [Yates, et al. 1995]. Whilst FENO has been 
used in other airway conditions, such as chronic obstructive pulmonary 
disease, interstitial lung diseases and allergic rhinitis [ATS/ERS, 2005], its 
usefulness as a marker of airway inflammation in healthy volunteers is 
unclear. Although exposure to the strong oxidative air pollutant ozone does 
not affect exhaled nitric oxide concentrations at an ozone dose known to 
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induce a pronounced neutrophilic airway inflammation [Olin, et al. 2001], we 
have recently demonstrated a significant increase in FENO following a 1-hour 
exposure to dilute diesel exhaust in young healthy volunteers [Barath, et al. 
2007] and for this reason we chose FENO as a marker of airway inflammation 
in this study. 
 
In healthy volunteers we have previously demonstrated a mild airway 
inflammatory response, with increases in interleukin-8 (IL-8) concentrations 
in bronchial washings 90 minutes after a 4-hour exposure to nitrogen dioxide 
(2 ppm). At 6 hours after the exposure we demonstrated increased IL-8 
concentrations and neutrophil counts within bronchial washings but no signs 
of inflammatory cell recruitment into the endobronchial mucosa [Blomberg, 
et al. 1997]. We therefore believe that our measurements of FENO were 
performed within the established timeframe of an early airway inflammatory 
response.  
 
Allowing for the limitations of FENO as a sensitive marker of airway 
inflammation as a result of air pollution exposure, we suggest that our study 
provides no strong evidence for an early marked airway inflammatory 
response following short-term nitrogen dioxide exposure. However, we also 
acknowledge that measurements of FENO  can be highly variable [Olin, et al. 
2001], and therefore that our small study may be underpowered to detect a 
clinically significant change. We therefore suggest that further investigation 
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into the ability of short-term high-dose nitrogen dioxide to cause an 
inflammatory response is warranted. 
 
3.5.4 Conclusions 
Using a robust controlled study design we have demonstrated for the first 
time that exposure to nitrogen dioxide in isolation is not associated with any 
vascular vasomotor or fibrinolytic dysfunction. The adverse cardiovascular 
effects of combustion-derived air pollution appear to be mediated via 
components other than nitrogen dioxide, and it is plausible that these 
vascular effects are rather driven by the fine and ultrafine particle fractions. 
It remains possible that nitrogen dioxide is a synergistic factor, and is 
required in addition to the presence of particles to result in the previously 



























Contribution of endothelin-1 to the vascular 
effects of diesel exhaust inhalation 
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4.1 SUMMARY 
Diesel exhaust inhalation impairs vascular function and, although the 
underlying mechanism remains unclear, endothelin-1 and nitric oxide are 
potential mediators. The aim of this study was to identify whether diesel 
exhaust inhalation affects the vascular actions of endothelin-1 in man. 
 
In a randomised double-blind cross-over study, 13 healthy male volunteers 
were exposed to either filtered air or dilute diesel exhaust (331±13 µg/m3). 
Plasma concentrations of endothelin-1 and big-endothelin-1 were 
determined at baseline, and throughout the 24-hour study period. Bilateral 
forearm blood flow was measured 2 hours after the exposure during infusion 
of either endothelin-1 (5 pmol/min) or the endothelin A receptor antagonist, 
BQ-123 (10 nmol/min) alone and in combination with the endothelin B 
receptor antagonist, BQ-788 (1 nmol/min).  
 
Diesel exhaust exposure had no effect on plasma endothelin-1 and big-
endothelin-1 concentrations (P>0.05 for both), or 24-hour mean blood 
pressure or heart rate (P>0.05 for all). Endothelin-1 infusion increased 
plasma endothelin-1 concentrations by 58% (P<0.01) but caused 
vasoconstriction only following diesel exhaust exposure (-17% versus 2% 
after air; P<0.001). In contrast, diesel exhaust exposure reduced 
vasodilatation to isolated BQ-123 infusion (20% versus 59% after air; P<0.001) 
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but had no effect on vasodilatation to combined BQ-123 and BQ-788 
administration (P>0.05).  
 
Diesel exhaust inhalation increases vascular sensitivity to ET-1 and reduces 
vasodilatation to ETA receptor antagonism despite unchanged plasma ET-1 
concentrations. Given the tonic interaction between the endothelin and nitric 
oxide systems, we conclude that diesel exhaust inhalation alters vascular 


















Exposure to combustion-derived fine particulate air pollution is a recognised 
risk factor for cardiorespiratory mortality and morbidity [Dockery, et al. 1993; 
Miller, et al. 2007]. There is a strong relationship between acute exposure to 
traffic-derived particulate matter and the incidence of acute myocardial 
infarction [Peters, et al. 2004] and hospital readmission in survivors of 
myocardial infarction [von Klot, et al. 2005]. The WHO estimate that annually 
around 3 million deaths worldwide can be attributable to air pollution 
[UNEP, 2006]. 
 
Recent controlled exposure studies have demonstrated that inhalation of 
concentrated ambient particles and ozone causes acute arterial 
vasoconstriction 2 hours after the exposure [Brook, et al. 2002]. Inhalation of 
diesel exhaust, a major component of fine particulate air pollution in urban 
environments, impairs vasomotor function and endogenous fibrinolysis 
[Mills, et al. 2005]. The fundamental mechanisms underlying these 
detrimental vascular endothelial effects remain poorly understood. 
Furthermore, the exact components of air pollution responsible for these 
effects have not been defined, although it is proposed that airborne 
particulate matter is likely to be the major arbiter [Miller, et al. 2007]. 
 
Endothelin-1 (ET-1), an endogenous vasoconstrictor 100-fold more potent 
that norepinephrine [Levin 1995], is a 21-amino acid peptide produced by the 
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vascular endothelium in response to stress. It is produced initially as 
preproendothelin-1, which is processed to form big ET-1, before being 
cleaved by endothelin converting enzyme (ECE) into ET-1. The actions of ET-
1 are mediated by two G-protein coupled receptors; the ETA and ETB 
receptors. Stimulation of either the ETA or ETB receptor causes 
vasoconstriction, although the ETB receptor is also expressed on endothelial 
cells where it releases nitric oxide. The endothelin system plays a major role 
in cardiovascular and renal physiology [Goddard, et al. 2004], and although 
its actions are complex, ET-1 contributes to the maintenance of basal vascular 
tone and blood pressure in man [Haynes and Webb 1994; Haynes, et al. 1996]. 
 
Recent work has suggested that plasma ET-1 concentrations are increased by 
exposure to air pollution. Rats raised with daily exposure to diesel exhaust 
particles and urban particulate matter have increased blood pressure, plasma 
ET-1 concentrations [Vincent, et al. 2001], and ET-1 expression in cardiac 
tissue [Ito, et al. 2008]. In children from Mexico City, plasma ET-1 
concentrations correlated with the degree of air pollution exposure 
[Calderón-Garcidueñas, et al. 2007]. Peretz et al recently demonstrated 
elevated plasma ET-1 concentrations in a heterogeneous population of 
healthy volunteers and patients with the metabolic syndrome, 3 hours after a 
controlled 2-hour resting exposure to diesel exhaust [Peretz, et al. 2008]. 
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The aims of this study were to assess the effect of diesel exhaust inhalation 
on plasma ET-1 and big-ET-1 concentrations, ET-1 mediated 
























Fifteen healthy male volunteers were recruited between February and March 
2008 at the University Hospital, Umeå, Sweden. All subjects had normal lung 
function, were non-smokers and took no regular medication. Those with a 
significant occupational exposure to air pollution and those with an 
intercurrent illness were excluded. The trial was performed with the 
approval of the local research ethics committee, in accordance with the 
Declaration of Helsinki, and with the written informed consent of each 
participant. 
 
4.3.2 Study design 
Subjects attended for two consecutive days on four occasions at least one 
week apart. In a double-blind randomised cross-over study, subjects were 
exposed to either filtered air or dilute diesel exhaust at 300 !g/m3 for 1 hour 
in a specially built diesel exposure chamber as described previously [Salvi, et 
al. 1999]. During the exposure, subjects performed 15-min periods of exercise 
on a bicycle ergometer (minute ventilation of 20 L/min/m2) alternated with 
15-min periods of rest. 
 
Based on previous studies [Mills, et al. 2005], vascular assessments and intra-
arterial infusions were commenced 2 hours after the exposure. All subjects 
abstained from alcohol for 24 hours, caffeine-containing drinks for at least 8 
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hours and fasted for at least 4 hours before commencement of the vascular 
study. All subjects remained indoors at rest between the exposure and the 
vascular assessment to minimise additional exposure to air pollution. 
 
A validated ambulatory blood pressure monitor (Model 90217, Spacelabs 
Healthcare, Washington, USA) was applied to the right arm 2 hours prior to 
the start of the exposure, and monitoring was continued for a total of 24 
hours. 
 
4.3.3 Diesel exposure 
Diesel exhaust emissions were generated using an idling Volvo (Volvo TD45, 
4.5L, 4-cylinders, 680 rpm) diesel engine. Over 90% of the exhaust was 
shunted away, and the remaining part diluted with air and fed into the 
exposure chamber at steady state concentration. During the exposure, air 
was sampled in the breathing zone of the subjects and monitored for 
nitrogen oxides, particle number and total hydrocarbons (measured as 
propane). Filter samples were collected and analysed for mass concentration. 
The exposures were standardised by keeping the particle (diameter <10 !m) 
mass concentration at ~300 !g/m3. Temperature and humidity in the 
chamber were controlled at 22°C and 50% respectively. 
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4.3.4 Vascular studies 
All subjects underwent brachial artery cannulation in the non-dominant arm 
using a 27-gauge steel needle under controlled conditions. After a 30-min 
baseline infusion of 0.9% saline, subjects received either a 60-min infusion of 
endothelin-1 (American Peptide, CA, USA) at 5 pmol/min [Haynes, et al. 
1991] or infusion of BQ-123 (an ETA receptor antagonist, American Peptide) 
at 10 nmol/min for 60 min [Verhaar, et al. 1998] followed by co-infusion of 
BQ-123 (10 nmol/min) and BQ-788 (an ETB receptor antagonist, American 
Peptide; 1 nmol/min) [Ishikawa, et al. 1994; Strachan, et al. 2000] for a further 
60 min.  
 
Forearm blood flow was measured in the infused and non-infused arms by 
venous occlusion plethysmography with mercury-in-silicone elastomer 
strain gauges as described previously [Wilkinson and Webb 2001]. Supine 
heart rate and blood pressure were determined in the non-infused arm at 
intervals throughout the study using the ambulatory blood pressure 
monitor. 
 
Venous cannulae (17-gauge) were inserted into large subcutaneous veins in 
the antecubital fossae of both arms. Blood (10 mL) was drawn 
simultaneously from each arm at the end of the baseline saline infusion, and 
at the end of each 60-min infusion period. Blood samples were also obtained 
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by separate venepuncture at baseline, immediately, 6 and 24 hours after the 
exposure. 
 
4.3.5 Biochemical analyses 
Blood samples taken at baseline, 6 and 24 hours after the exposure were 
analysed for total and differential cell counts by an autoanalyser. Plasma 
samples were collected into ethylene diamine tetra-acetic acid and kept on 
ice until centrifuged at 3000 rpm for 30 min. Plasma samples were 
immediately frozen and stored at -80 ºC. Plasma ET-1 and big-ET-1 
concentrations were measured according to an acetic acid extraction 
technique using a commercial radioimmunoassay with rabbit anti-human 
ET-1 or big-ET-1 (Peninsular Laboratories Europe Ltd, St Helens, UK) as 
described previously [Adam, et al. 2001]. 
 
4.3.6 Data and statistical analysis 
Nursing staff at the clinical research facility at University Hospital, Umeå, 
Sweden, randomised exposure type and the associated vascular study 
protocol. The investigators were blinded to the exposure received. 
Plethysmography data were analysed as described previously [Newby, et al. 
1999]. Data are expressed as mean ± standard error of the mean (SEM) unless 
otherwise stated. Statistical analyses were performed using paired Student’s 
t-tests and two-way analysis-of-variance (ANOVA) with repeated measures 
including time and exposure as variables where appropriate. Statistical 
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significance was taken at the 5% level. All analyses were performed using 
GraphPad Prism (Version 4 for Macintosh, GraphPad Software, San Diego, 






















Thirteen subjects, median age 23 years (Table 4.1), completed the study 
(Figure 4.1). The diesel exposure generated a mean particle mass 
concentration of 331 ± 13 !g/m3 and this was associated with concentrations 
of NO2 of 1.0 ± 0.04 ppm, NO of 3.3 ± 0.13 ppm and total hydrocarbons of 1.4 
± 0.04 ppm. There were no differences in 24-hour mean systolic or diastolic 
blood pressure or mean heart rate after exposure to air or diesel exhaust 
(P>0.05 for all) although there was a slightly lower nocturnal diastolic blood 
pressure following diesel exhaust exposure (62 ± 1 vs. 65 ± 1 mmHg; P<0.01). 
There was a rise in blood pressure following exercise on both study visits 
although there was no difference between the two exposures (data not 
shown, P>0.05). 
 
Table 4.1. Baseline characteristics of the 13 subjects who completed the study. Mean ± 
standard error of the mean (SEM) unless otherwise stated. 
Parameter n=13 
Age, years (median, range) 23 (21-28) 
Height, cm  181 ± 2 
Weight, kg 79 ± 3 
BMI, kg/m2 24 ± 1 
Haemoglobin concentration, g/L 153 ± 3 
White cell count, x109/L 5.1 ± 0.4 
Neutrophil count, x109/L 2.5 ± 0.3 
Lymphocyte count, x109/L 2.0 ± 0.1 
Monocyte count, x109/L 0.4 ± 0.03 




Figure 4.1. Consort flow chart of study participants. 
 
Infusion of ET-1 caused a slow onset vasoconstriction following diesel 
exhaust inhalation (17 ± 10 % peak reduction in blood flow) although there 
was little effect following filtered air (Figure 4.2; ANOVA, P<0.001 for 
exposure effect). Infusion of the endothelin receptor antagonists, BQ-123 and 
BQ-788, caused a slow onset vasodilatation (77 ± 14 % peak increase in blood 
flow after filtered air; Figure 4.3). This vasodilatation was greater following 
filtered air compared with the diesel exhaust exposure (Figure 4.3; ANOVA, 
 
15 patients recruited 
Screening visit 
Randomization – 4 visits 
(n=14) 
Air Exposure Diesel exposure (~300!g/m
3
) 
ET-1 BQ-123 & 
BQ-788 
ET-1 BQ-123 & 
BQ-788 
13 patients completed study 
1 subject withdrawn 
by investigators due 
to abnormal ECG for 
further investigation 
1 subject withdrawn 
by investigators due 




P<0.001). The difference was greatest at 60 min but, after infusion of the BQ-
788, there was little difference in blood flow by 120 min (P>0.05). 
 
 
Figure 4.2. (A) Forearm blood flow (FBF) during infusion of ET-1 (5pmol/min) after 
exposure to air (!) and diesel exhaust (") (ANOVA, P<0.001). (B) Maximal effect at 60 
minutes and (C) comparison of plasma ET-1 concentrations in infused and non-infused arms 
before and at the end of the forearm vascular study following air (hashed bars; P<0.001 for 
infused, P>0.05 for non-infused) and diesel exhaust inhalation (solid bars; P<0.0001 for 
infused, P>0.05 for non-infused). Paired Student’s t-test of air vs. diesel.  
 
 
Plasma ET-1 and big-ET-1 concentrations were unchanged at all time points 






























































Comparison of the infused and non-infused arm plasma ET-1 concentrations 
confirmed that the ET-1 infusion increased local plasma ET-1 concentrations 
by 58±9 % (Figure 4.2; P<0.01 for infused arms, and P>0.05 for non-infused 
arms for both exposures). 
 
 
Figure 4.3. (A) Forearm blood flow (FBF) during infusion of BQ-123 (10nmol/min) and BQ-
788 (1nmol/min) after exposure to air (!) and diesel exhaust (") (ANOVA, P<0.001). (B) 














































Although diesel exhaust inhalation had no effect on plasma ET-1 or big ET-1 
concentrations, there was an increase in vascular sensitivity to ET-1 
associated with a reduced ETA induced vasodilatation. These apparently 
contradictory findings can be explained by impaired ET-1 induced nitric 
oxide release and are consistent with pre-clinical evidence of nitric oxide 
mediated alterations in vascular reactivity to ET-1 [Knuckles, et al. 2008]. We 
conclude that diesel exhaust inhalation, at levels commonly encountered in 
the urban environment, does not affect plasma ET-1 concentrations but alters 




We did not demonstrate any change in plasma concentrations of endothelin-
1 or its immediate precursor, big-endothelin-1, following exposure to filtered 
air or diesel exhaust. Whilst this is consistent with our own previous work 
[Mills, et al. 2005], it is at odds with other reports. In rodent studies, plasma 
ET-1 (and ET-3) concentrations were up regulated following exposure to 
diesel exhaust and concentrated urban particles [Ito, et al. 2008; Vincent, et al. 
2001]. It is possible that there are species differences in the response to diesel 
exhaust inhalation, and up regulation of ET-1 in rats may not translate into 
man. However, Peretz et al studied a heterogeneous group of individuals 
comprising of patients with metabolic syndrome and healthy volunteers 
-110- 
[Peretz, et al. 2008], and showed an increase in plasma ET-1 concentrations 3 
hours after diesel exhaust exposure. Their study was not designed 
specifically to look at ET-1 and was limited by missing data, and small 
numbers in a heterogeneous population in whom vascular endothelial 
function may not be equivalent [Melikian, et al. 2008]. In contrast, our study 
was specifically designed to address the endothelin hypothesis, and 
employed a robust cross-over study design, in a homogenous group of 
healthy volunteers, with samples optimally collected to assess plasma ET-1 
and big-ET-1 concentrations [Adam, et al. 2001]. Taken together with our 
previous study, our experience represents the largest sample size to date 
(n=43). We therefore think it is unlikely that diesel exhaust inhalation causes 
major changes in plasma endothelin concentrations.  
 
We recognise that plasma ET-1 concentrations may not reflect the activity of 
the endothelin system since 90% of ET-1 synthesised by the vascular 
endothelium is secreted abluminally and acts locally on vascular smooth 
muscle in a paracrine manner [Levin 1995]. Therefore, in addition to 
measuring plasma ET-1 concentrations, we assessed the effects of endothelin 
agonism and antagonism on peripheral vascular tone.  
 
4.5.2 Endothelin Agonism 
We demonstrated increased vasoconstriction following exposure to diesel 
exhaust, but little effect following exposure to filtered air, suggesting an 
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increased vascular sensitivity to ET-1. We were surprised to see little 
vasoconstriction with ET-1 following exposure to filtered air having 
previously reported approximately 30-40% reductions in forearm blood flow 
during infusions of 5 pmol/min [Ferro, et al. 1997; Haynes and Webb 1994]. 
In the present study, we used an alternative preparation of ET-1 and suggest 
that the disparity in vascular effects is attributable to differing potencies of 
the preparations. Because of this, we measured plasma ET-1 concentrations 
in both forearms and demonstrated a selective 60% increase in plasma ET-1 
concentrations in the infused arm. Assuming a forearm blood flow of 25 
mL/min, we achieved an end-organ concentration approximately a tenth of 
that anticipated. However, this simple calculation does assume that there is 
no clearance or extraction of ET-1 across the forearm. However, we do not 
believe that the modest increase in venous ET-1 concentrations can be solely 
accounted for by clearance and conclude that it reflects a reduced activity of 
the infused peptide preparation. Although the reduced activity of ET-1 limits 
comparisons with other studies, this was perhaps fortuitous since it enabled 
us to assess the vasoreactivity to ET-1 at the threshold for vasoconstriction, 
and to observe an alteration in ET-1 sensitivity.  
 
4.5.3 Endothelin A Receptor Antagonism 
The reduction in vasodilatation to BQ-123 infusion following diesel exhaust 
inhalation has several potential explanations. First, this may relate to 
reduced production or increased clearance of active ET-1 from the 
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vasculature. However, this seems unlikely given that plasma endothelin-1 
and big-endothelin-1 concentrations were unchanged although we 
acknowledge that an effect on the abluminal release of endothelin-1 cannot 
be excluded. Second, a reduced sensitivity of the vascular smooth muscle 
ETA receptor could have occurred but this is at odds with the increased ET-1 
vasoconstriction and is therefore unlikely. We believe that there is third more 
likely explanation. 
 
Looking closely at ETA receptor antagonism, it is clear that the mechanism of 
vasodilatation is complex. This reflects the distribution and basal activity of 
both the ETA and ETB receptors. Both receptors contribute to the maintenance 
of basal vascular tone but have differing actions and vascular distributions: 
ETA receptors are present on vascular smooth muscle cells only and mediate 
vasoconstriction, whereas ETB receptors are present on both vascular smooth 
muscle and endothelial cells where they mediate vasoconstriction and 
vasodilatation respectively. Moreover, selective ETA receptor antagonism 
leads not only to inhibition of the ETA receptor but potentially 
hyperstimulation of the ETB receptor. Indeed, we have demonstrated that 
BQ-123 induced vasodilatation can be markedly attenuated by concomitant 
blockade of nitric oxide release [Verhaar, et al. 1998] suggesting that selective 
ETA receptor antagonism does indeed lead to significant ETB receptor 
mediated vasodilatation through endothelial nitric oxide release. Given the 
central role of nitric oxide in modulating and balancing the effects of the 
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endothelin system, we propose that changes in the L-arginine-NO pathway 
offer the most plausible hypothesis for the impaired vasodilatation to BQ-
123. This would also explain the enhanced vasoconstriction to ET-1 with a 
reduction in the opposing vasodilatory actions of nitric oxide. Moreover, we 
have previously shown that diesel exhaust impairs nitric oxide 
bioavailability [Miller, et al. 2009; Mills, et al. 2005] and suggest that the 
observed effects on ET-1 vasoreactivity can be explained by the reduction in 
endothelin induced nitric oxide release and bioavailability.  
 
The finding of reduced vasodilatation in response to ETA receptor blockade 
is at odds with previous studies demonstrating enhanced response in 
patients with conditions such as hypertension and hypercholesterolaemia 
who have pre-existing endothelial dysfunction mediated by reduced nitric 
oxide bioavailability [Cardillo, et al. 2002b; Cardillo, et al. 2000]. The reason 
for this discrepancy is unclear but here we have induced an acute and brief 
episode of endothelial dysfunction in an otherwise healthy population of 
volunteers. Chronic dysfunctional states are likely to invoke compensatory 




4.5.4 Combined Endothelin A and B Receptor Antagonism 
Previous data, including our own work [Verhaar, et al. 1998], would suggest 
that combined ETA/ETB receptor antagonism should produce less 
vasodilatation, and have less of an effect on systemic haemodynamics 
[Leslie, et al. 2005], than selective ETA receptor antagonism. We were 
therefore surprised to observe the continued further modest vasodilatation 
when ETB receptor antagonism was superimposed on ETA receptor 
antagonism. We believe that the explanation for this observation is three-
fold. First, vasodilatation to endothelin agonism and antagonism is of slow 
onset and offset. In our own hands, BQ-123 induced vasodilatation appears 
to reach a peak effect by 60 min [Verhaar, et al. 1998] but may take up to 90 
min [Haynes and Webb 1994]. The continued vasodilatation may therefore 
reflect further and more complete ETA receptor antagonism. Second, we 
chose this study design to minimise the number of visits given the invasive 
nature of the studies. We attempted to assess both ETA receptor antagonism 
and combined ETA/ETB receptor antagonism on the same visit. This 
approach has been used once before by Cardillo and colleagues [Cardillo, et 
al. 2002a] in a small subgroup of patients with diabetes mellitus. Here, they 
demonstrated a brisk vasodilatation to BQ-123 of around 65% with maximal 
vasodilatation by 60 minutes. Importantly, the predicted “tailing-off” of the 
response when BQ-788 was added did not occur and the vasodilatation 
plateaued rather than fell. This is consistent with the findings in our study. 
Finally, there may be an interaction when ETA receptor antagonism precedes 
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combined ETA/ETB receptor antagonism. This may reflect alterations in ETB 
receptor expression on both the endothelium and vascular smooth muscle 
cells in the face of ETA receptor antagonism. Indeed, there is considerable 
cross-talk between the receptors as we have previously described [Mickley, et 
al. 1997]. Thus the differing profile of responses may reflect the dynamic 
interaction of the two receptors over the course of the study.  
 
This altered profile of vasodilatation does not detract from the comparison 
between the filtered air and diesel exhaust exposure. Combined ETA and ETB 
receptor antagonism appears to be unaffected by diesel exhaust exposure 
whereas selective ETA receptor antagonism is impaired. This is likely to 
reflect the greater and marked dependence of ETA receptor antagonism on 





Our data demonstrate that the previously documented impairment of 
endothelium-dependent vasodilatation following a one-hour exposure to 
combustion-derived air pollutants is not mediated by an upregulation of the 
endothelin system. Furthermore we have shown that diesel exhaust 
inhalation has no effect on plasma ET-1 concentrations or systemic blood 
pressure. Our data are consistent with the hypothesis that the diesel exhaust-
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induced vascular effects are predominantly driven by reduced endothelial 
nitric oxide bioavailability. However, we cannot exclude a role for other 
vasoactive mediators, such endothelium-derived hyperpolarising factor, and 
further studies are warranted to investigate the L-arginine:nitric oxide and 
other pathways in more detail.  
 
4.5.6 Perspectives 
Air pollution exposure is associated with increased cardiovascular morbidity 
and mortality, and is thought to lead to around 3 million deaths worldwide 
each year. Understanding the underlying mechanism for these detrimental 
effects is crucial in trying to reduce this significant disease burden. In this 
study, we show that the well-established adverse vascular endothelial effects 
demonstrated following inhalation of diesel exhaust are not directly 
mediated through the endothelin system. We propose instead that these may 
be driven by changes in nitric oxide bioavailability. Further studies are 
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5.1 SUMMARY 
Diesel exhaust inhalation causes cardiovascular dysfunction including 
impaired vascular reactivity, increased blood pressure and arterial stiffness. 
We investigated the role of nitric oxide (NO) bioavailability in mediating 
these effects. 
 
In a randomized double-blind crossover study, healthy non-smokers were 
exposed to diesel exhaust or filtered air. Bilateral forearm blood flow was 
measured during intrabrachial infusions of acetylcholine (ACh; 5-20 !g/min) 
and sodium nitroprusside (SNP; 2-8 !g/min) in the presence of the NO 
clamp (NO synthase inhibitor NG-monomethyl-L-arginine, L-NMMA, 8 
!g/min co-infused with the NO donor SNP at 90-540 ng/min to restore basal 
blood flow).  
 
Following diesel exhaust inhalation, plasma nitrite concentrations were 
increased (68±48 vs 41±32 nM; P=0.006) despite similar L-NMMA-induced 
reductions in basal blood flow (-20.6±14.7 vs -21.1±14.6 %; P=0.559) compared 
to air. In the presence of the NO clamp, ACh and SNP caused dose-
dependent vasodilatation that was not affected by diesel exhaust inhalation 
(P>0.05 for both).  
 
Diesel exhaust inhalation disturbs normal vascular homeostasis with 
enhanced NO generation unable to compensate for excess consumption. We 
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suggest the adverse cardiovascular effects of air pollution are, in part, 
mediated through reduced NO bioavailability. 
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5.2 Introduction 
Exposure to air pollution increases cardiovascular morbidity and mortality 
[Anderson, et al. 1996; Dockery, et al. 1993; Miller, et al. 2007; Pope, et al. 
2002], and is associated with the triggering of acute myocardial infarction 
[Peters, et al. 2004]. Recent controlled exposure studies in man have shown 
that inhalation of dilute diesel exhaust, at environmentally relevant 
concentrations, leads to an impairment of both vascular vasomotor and 
fibrinolytic function [Mills, et al. 2005]. Similarly, exposure to concentrated 
ambient particles causes acute arterial vasoconstriction [Brook, et al. 2002] 
and an increase in diastolic blood pressure [Urch, et al. 2005]. Although 
providing plausible explanations for the increase in cardiovascular events 
[Heitzer, et al. 2001], the mechanisms of how air pollution induces these 
cardiovascular abnormalities remain to be established.  
 
Inhalation of fine particulate matter causes inflammation within the lungs 
[Nightingale, et al. 2000; Salvi, et al. 1999] in part through local oxidative 
stress [Baulig, et al. 2003; Behndig, et al. 2006]. Vascular oxidative stress may 
subsequently develop as a consequence of the systemic response to 
pulmonary inflammation and oxidative stress, or through reactive oxygen 
species generation within the vascular wall following translocation of 
particles into the circulation [Nemmar, et al. 2002; Nemmar, et al. 2004]. 
Irrespective of the site of generation, it has been proposed that this oxidative 
stress has a direct influence on the function of the vascular endothelium 
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[Lum, et al. 2001] as well as reducing the vascular bioavailability of nitric 
oxide (NO) [Ikeda, et al. 1998; Mills, et al. 2005]. 
 
NO is a powerful endogenous vasodilator and plays a crucial role in the 
maintenance of basal vascular tone [Moncada, et al. 1993]. In patients with 
pre-existing vascular endothelial dysfunction, such as those with 
hypercholesterolemia, stimulated endothelium-dependent NO-mediated 
vasodilatation is impaired, and this is thought to be mediated through 
oxidative stress-mediated depression of NO bioavailability [Verma, et al. 
2002]. In rats exposed to inhaled particles, the generation of oxygen-centred 
free radicals leads to the scavenging of NO, thereby reducing its 
bioavailability [Nurkiewicz, et al. 2009]. 
 
In this study, we investigated the hypothesis that changes in NO 
bioavailability contribute to the cardiovascular dysfunction induced by 




Eighteen healthy non-smoking volunteers were recruited from the 
Department of Medicine, Division of Respiratory Medicine and Allergy, 
University Hospital, Umeå. Subjects taking regular medication (except the 
oral contraceptive pill), with a significant occupational exposure to air 
pollution or those with intercurrent illness were excluded. All subjects were 
free of symptoms of respiratory tract infection for at least 6 weeks before the 
study. The trial was performed with the approval of the local research ethics 
committee, in accordance with the Declaration of Helsinki, and with the 
written informed consent of each participant. 
 
5.3.2 Diesel exhaust exposure 
Diesel exhaust was generated using an idling Volvo diesel engine (Volvo 
TD40 GJE, 4.0 L, four cylinders, 680 rpm). Over 90 % of the exhaust was 
shunted away, the remaining part diluted with HEPA filtered air and fed 
into the exposure chamber at steady state concentration. During the 
exposure, air was sampled in the breathing zone of the subjects for oxides of 
nitrogen, particle mass concentration and total hydrocarbons (measured as 
propane). Filter samples were collected and analysed gravimetrically to 
determine mass concentration. The exposures were standardised based on 
particulate matter (particles with a mean aerodynamic diameter "10 !m 
[PM10]) concentrations and a mean airborne particle concentration of 313 ± 11 
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!g/m3 was generated. The particle exposure was associated with 
concentrations of nitrogen dioxide (NO2) of 0.9 ± 0.1 ppm, NO of 3.1 ± 0.2 
ppm and total hydrocarbons of 2.5 ± 0.2 ppm. Temperature and humidity in 
the chamber were controlled at 22oC and 50% respectively.  
 
5.3.3 Study design 
Subjects attended on two occasions at least one week apart. In a randomized 
double-blind crossover study, subjects were exposed to either filtered air or 
dilute diesel exhaust at ~300 !g/m3 in a specially built diesel exposure 
chamber for 1 hour as described previously [Rudell, et al. 1996]. During the 
exposures, subjects performed 15-min periods of exercise on a bicycle 
ergometer, to achieve a mean minute ventilation of 20 L/min/m2 as 
determined by a pre-study exercise test, alternating with 15 min of rest. 
 
Based on previous studies, vascular assessments were commenced 2 h after 
the exposure [Langrish, et al. 2009; Mills, et al. 2005]. All subjects abstained 
from alcohol for 24 h, caffeinated drinks for 8 h and food for 4 h prior to the 
cardiovascular assessments. All subjects remained indoors between the 
exposure and assessments to minimise additional exposure to air pollution. 
Venous blood samples were collected for measurement of plasma nitrite 
concentration, endogenous NOS inhibitors and total and differential cell 
counts. Lung function was determined by spirometry at baseline and 2 h 
following the exposure (Jaeger Masterlab, Jaeger AG, Würzburg, Germany) 
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recording forced vital capacity (FVC), forced expiratory volume in one 
second (FEV1) and slow vital capacity (VC). 
 
5.3.4 Vascular assessments 
Forearm blood flow was determined using forearm venous occlusion 
plethysmography and detected using mercury-in-silastic strain gauges 
placed around each forearm as described previously [Wilkinson, et al. 2001]. 
All subjects underwent unilateral brachial artery cannulation using a 27-
gauge steel needle (Coopers Needle Works Ltd., Birmingham, UK) under 
controlled conditions. After a 30-min baseline infusion of 0.9% saline, 
subjects received an infusion of the NO synthase (NOS) inhibitor NG-
monomethyl-L-arginine (L-NMMA; Clinalfa® basic, Bachem, Weil an Rhein, 
Germany) at incremental doses of 2, 4 and 8 !mol/min. The infusion of L-
NMMA was continued at 8 !mol/min for the remainder of the study to fully 
inhibit all basal NOS activity [Japp, et al. 2008; Stroes, et al. 1997]. Sodium 
nitroprusside (SNP), an NO donor, was then co-infused with L-NMMA at 
doses of 90 to 540 ng/min and titrated to restore basal blood flow. Once 
basal blood flow was restored, the SNP infusion was continued for the 
remainder of the study to produce an “NO clamp” as described previously 
[Japp, et al. 2008]. This permits the assessment of vascular function in the 
absence of endogenous NO generation but without the potential 




The dose-response relationship of the vasodilators acetylcholine (5, 10 and 20 
!g/min [Mills, et al. 2005]; endothelium-dependent NO donor) and SNP (2, 4 
and 8 !g/min [Mills, et al. 2005]; endothelium-independent NO donor) were 
assessed in the presence of the clamp. The vasodilators were given in a 
random order and were separated by an infusion of 0.9% saline for 20 min. 
The combined total infusion rate of the parallel infusions was kept constant 
at 1 mL/min throughout the study. 
 
5.3.5 Biochemical analyses 
Blood samples were analysed for total and differential cell counts by an auto 
analyser (Sysmex XE2100, Sysmex Europe GmbH, Hamburg, Germany). 
Plasma samples were collected into ethylene diamine tetra-acetic acid and 
kept on ice until centrifuged at 2000 g for 30 min at 4oC. Serum samples were 
collected and left to clot on melting ice for 60 min before being centrifuged at 
2000 g for 10 min at 4oC. Samples were immediately frozen and stored at -
80oC prior to subsequent analysis. 
 
Plasma was analysed for the endogenous NOS inhibitors asymmetric 
dimethylarginine (ADMA) and symmetric dimethylarginine (SDMA) as well 
as the NO precursors L-arginine and L-homoarginine using a high 
performance liquid chromatography (HPLC) method as described 
previously [Blackwell, et al. 2009]. Briefly, arginine, homoarginine, ADMA 
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and SDMA were extracted from plasma using Isolute PRS cation exchange 
solid phase extraction columns (1 mL/50 mg; Kinesis Ltd., Epping, UK). The 
columns were consecutively washed with borate buffer (1 mL), water (3 mL) 
and methanol (3 mL) before analytes were eluted with 3 mL of a solution 
containing 50% methanol and 10% concentrated ammonia in water. The 
eluent was then evaporated to dryness at 80oC under air. The dried extract 
was then dissolved in 0.1 mL water and 0.1 mL of the derivization reagent 
(10 mg of ortho-phthaldialdehyde dissolved in 0.2 mL methanol followed by 
the addition of 1.8 mL of 200 nM borate buffer and 10 !L of 3-
mercaptopropionic acid, then diluted 5-fold using 200 nM borate buffer 
immediately before use) before being transferred to autosampler vials, 
maintained at 10oC, and 20 !L was injected into the HPLC analytical column 
for chromatography. Following separation, arginine, homoarginine, ADMA 
and SDMA were measured fluorimetrically (Waters 2475, Waters, Watford 
UK) and quantified using single level calibration using an internal standard 
(80 !L of 5 !M monoethylarginine) added before sample extraction. 
 
Blood samples obtained for the measurement of plasma nitrite were collected 
into lithium heparin, immediately transferred to Eppendorf® tubes 
prewashed with Milli-Q de-ionised water and immediately centrifuged at 
5000 g for 1 min. Plasma was then transferred into a dark coloured 
Eppendorf® tube containing 100 !L of a solution containing 1 mM 
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diethylenetriamine-pentaacetic acid and 62.5 mM N-ethylmaleimide before 
being snap-frozen on dry ice and stored at -80oC prior to further analysis. 
 
Plasma nitrite samples were defrosted on ice before 100 !L was injected into 
a reaction vial containing glacial acetic acid and iodide [Nagababu, et al. 
2007]. NO generated in the reaction chamber was driven off by a continual 
stream of oxygen-free nitrogen and detected in the exhaust gas using a 
Sievers NOA 280i chemiluminescent analyzer (Analytix, Co Durham, UK). 
Analyses were performed in triplicate. The limit of detection of this assay 
was ~30 nM with a co-efficient of variation of 3.1% for a 250 nM standard. 
 
 
5.3.6 Data analysis and statistics 
Plethysmography data were analysed as described previously [Newby, et al. 
1999; Petrie, et al. 1998]. Data are expressed as mean ± standard error of the 
mean (SEM) unless otherwise stated. Statistical analyses were performed 
using Student’s paired t-tests and 2-way analysis-of-variance (ANOVA) with 
repeated measures where appropriate. Statistical significance was taken as 
two-sided P<0.05. All analyses were performed using GraphPad Prism 
(Version 4 for Macintosh, GraphPad Software, San Diego, USA) on a 
Macintosh personal computer. 
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5.4 Results 
Sixteen subjects, median age 23 years (Table 5.1), completed the study 
protocol: one subject failed to attend scheduled visits and one was 
withdrawn for technical reasons (failed cannulation). The study was well 
tolerated with no significant adverse events. 
 
There were no changes in any indices of lung function (FEV1, FVC and VC), 
although the study was powered for the vascular outcomes and as such may 
be underpowered to see a small difference, or in haemoglobin concentration, 
white cell count (or differential cell counts) or platelet count (P>0.05 for all; 
data not shown).  
 
Table 5.1. Baseline characteristics of study participants. 
Baseline Characteristics  (n=16) 
Age, years (median, range) 23 (21 to 27) 
Male / Female 9 (56%)  /  7 (44%) 
Use of oral contraceptive (female) 5 (72%) 
Height, cm 
All 176 ± 9 
Male 181 ± 7 
Female 169 ± 6 
Weight, kg 
All 72 ± 13 
Male 80 ± 11 
Female 60 ± 4 
BMI, kg.m-2 
All 23.1 ± 2.8 
Male 24.6 ± 2.8 
Female 21.2 ± 1.0 
Data expressed as mean ± standard deviation unless otherwise stated 
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5.4.1 Plasma Nitrite and Arginine Concentrations 
Two hours following exposure to diesel exhaust, plasma nitrite 
concentrations were higher as compared to the filtered air exposure (68±48 vs 
41±32 nM; P=0.006). In contrast, there were no differences in plasma 
concentrations of the NO precursor L-homoarginine, or in the endogenous 
NOS inhibitors ADMA and SDMA at 2 or 6 h following exposures (Table 
5.2). The plasma concentration of L-arginine was lower throughout the study 
day during the diesel exposures, but this is present in vast molar excess in 
the circulation and as such cannot account for the changes in NO seen. 
 
Table 5.2. Plasma concentrations of NOS substrates and endogenous NOS inhibitors. 




Air 61.6 ± 17.8 59.3 ± 10.6 
0.471 0.043 
Diesel 58.2 ± 10.0 54.6 ± 10.3 
L-Homoarginine 
!mol/L 
Air 1.66 ± 0.48 1.70 ± 0.51 
0.768 0.727 
Diesel 1.63 ± 0.48 1.69 ± 0.53 
ADMA 
!mol/L 
Air 0.44 ± 0.09 0.51 ± 0.07 
0.017 0.756 
Diesel 0.44 ± 0.06 0.50 ± 0.07 
SDMA 
!mol/L 
Air 0.41 ± 0.07 0.43 ± 0.05 
0.257 0.808 
Diesel 0.41 ± 0.05 0.43 ± 0.05 
Plasma concentrations of endogenous NOS inhibitors and NOS substrates at baseline, 2 and 6 hr 
after the exposure during Study 1 (Local L-NMMA administration. All data expressed as mean ± 




5.4.2 Vascular vasomotor responses 
Blood pressure, heart rate and baseline forearm blood flow were not 
different following either exposure (P>0.05 for all; data not shown). 
 
Infusion of the NOS inhibitor, L-NMMA, resulted in a similar dose-
dependent vasoconstriction following both exposures (P=0.559; Figure 5.1A). 
After establishing the NO clamp by restoring basal blood flow with SNP co-
infusion (208±33 and 236±26 ng/min following air and diesel exhaust 
exposure respectively; P=0.453), both acetylcholine and SNP caused dose-
dependent vasodilatation (P<0.01 for both) that was attenuated in 
comparison to previous studies [Mills, et al. 2005]. However, this 
vasodilatation was similar following both exposures (dilute diesel exhaust vs 
filter air: P=0.209 for acetylcholine and P=0.613 for sodium nitroprusside; 
Figure 5.1B).  
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Figure 5.1. Panel A: forearm blood flow response during infusion of L-NMMA (2-way 
repeated measures ANOVA: P=0.559 for exposure). Panel B: forearm blood flow during 
infusion of the vasodilators acetylcholine and sodium nitroprusside (2-way repeated 






We have demonstrated that inhalation of dilute diesel exhaust increases 
plasma nitrite concentrations suggesting an increase in basal NO release. 
However, local NO synthase inhibition causes similar degrees of 
vasoconstriction following both diesel exhaust and filtered air exposure, 
suggesting a balanced increase in basal NO generation and consumption that 
attempts to maintain basal peripheral resistance vessel tone. This is 
consistent with our observation that diesel exhaust inhalation-induced 
vasomotor dysfunction is no longer demonstrable in the presence of the NO 
clamp. 
 
5.5.1 Plasma nitrite concentrations 
We demonstrated higher basal venous plasma nitrite concentrations 
following diesel exhaust exposure. These data are consistent with the up-
regulation of vascular NO generation, which we suggest may represent a 
homeostatic feedback loop to compensate for increased consumption by local 
oxidative stress in order to maintain basal vascular tone and blood pressure. 
We also observed no changes in plasma concentrations of the NO precursors 
and endogenous NOS inhibitors, such as ADMA. This is not surprising given 
that the precursors, L-arginine and L-homoarginine, are present in vast 
molar excess and short-term modest increases in NO generation are unlikely 
to affect their plasma concentrations or indeed those of the naturally 
occurring endogenous NOS inhibitors.  
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We have previously demonstrated in isolated rat aortic rings that diesel 
exhaust particles attenuate endothelium-derived vasorelaxation. This effect is 
reversed by co-incubation with superoxide dismutase thereby reducing 
oxygen-centred free radical production [Miller, et al. 2009]. We have also 
shown that diesel exhaust particles themselves reduce the concentrations of 
bioavailable NO from the NO donor DEA/NO (2-(N,N-diethylamino)-
diazenolate-2-oxide) [Verma, et al. 2002]. Nurkiewicz and colleagues have 
reported that, following inhalation of titanium dioxide nanoparticles, local 
NO was scavenged by oxygen-centred free radicals [Nurkiewicz, et al. 2009]. 
This reduction in NO bioavailability appears to be driven by uncoupling of 
endothelial NOS by diesel exhaust particles or by local oxidative stress 
[Knuckles, et al. 2008]. However, whilst reflective of production and 
consumption of NO across the vascular bed, plasma nitrite concentrations do 
not definitively describe the activity of the NOS enzymes and their isoforms, 
and it remains feasible that some of the increase in plasma nitrite is in fact 
due to absorption from the higher oxides of nitrogen during the exposure 
itself. Knuckles and colleagues have recently reported that following diesel 
exhaust exposure, rats had increased plasma NOx (nitrate and nitrite 
combined) concentrations that appeared to be predominantly as a result of 
absorption of NO from the exposure itself, although they demonstrate 
significant increase in eNOS expression consistent with increased NO 
production [Knuckles, et al. 2011]. Controlled exposures to NO and nitrogen 
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dioxide in man with subsequent measurement of plasma nitrite 
concentrations may help to define this further.  
 
5.5.2 Vascular vasomotor function 
Individuals with hypercholesterolemia have impaired vascular vasomotor 
dysfunction: the classic paradigm of vascular endothelial dysfunction as a 
result of changes in the L-arginine-NO pathway [Chowienczyk, et al. 1992; 
Creager, et al. 1990]. However, these subjects have normal responses to NOS 
inhibition with L-NMMA, but reduced vasodilatation to endothelium-
dependent vasodilators such as acetylcholine and serotonin [Stroes, et al. 
1995]. In the present studies, we demonstrate the same pattern of vascular 
dysfunction following the inhalation of dilute diesel exhaust. Indeed in the 
presence of the NO clamp, and the absence of endogenous NO release, the 
previously demonstrated attenuation in vascular vasomotor responses 
following diesel exhaust inhalation [Mills, et al. 2005] is abolished.  These 
findings are consistent with the suggestion that basal NO generation is 
already increased and therefore further stimulation may be proportionately 
less effective, and that the NO released may be consumed more rapidly by 
local oxidative stress. Furthermore, given that the responses to stimulation 
with acetylcholine are similar in the absence of endogenous NO release, this 
would suggest that the other key vasodilator mechanisms, such as 
endothelium-derived hyperpolarising factor (EDHF) or prostaglandins, are 
intact and unaffected by diesel exhaust inhalation. We recognise a limitation 
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of our study design is that we have not reproduced the findings of vascular 
vasomotor impairment prior to investigating the nitric oxide pathways in 
depth. The findings of vascular vasomotor function are however robust and 
repeatable and we have repeatedly demonstrated this finding in more than 6 
studies in over 100 subjects, and we have no reason to suppose that on this 
occasion this will not have occurred. 
 
Whilst we suggest that changes in NO bioavailability are consistent with our 
findings, a similar effect may be seen with other mechanisms, such as 
activation of the autonomic nervous system. Indeed changes in autonomic 
nervous system activation may underlie the acute vasoconstriction [Brook, et 
al. 2002] and changes in heart rate variability previously reported [Gold, et al. 
2000]. Further studies are warranted to evaluate the contribution of the 
autonomic nervous system in these important vascular effects. 
 
5.5.3 Conclusions 
In these studies we have demonstrated for the first time in man that 
inhalation of dilute diesel exhaust results in higher basal plasma nitrite 
concentrations. This is consistent with homeostatic regulation in the presence 
of increased NO consumption due to local oxidative stress. Similarly, we 
have shown that in the presence of the NO clamp, and the absence of 
endogenous NO production, diesel exhaust inhalation does not result in 
further vascular impairment. We conclude that the vascular dysfunction 
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associated with diesel exhaust inhalation is mediated predominantly by 
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6.1 SUMMARY 
Exposure to air pollution is an important risk factor for cardiovascular 
morbidity and mortality, and is associated with increased blood pressure, 
reduced heart rate variability, endothelial dysfunction and myocardial 
ischaemia. Our objectives were to assess the cardiovascular effects of 
reducing air pollution exposure by wearing a facemask. 
 
In an open-label cross-over randomised controlled trial, 15 healthy 
volunteers (median age 28 years) walked on a predefined city centre route in 
Beijing in the presence and absence of a highly efficient facemask. Personal 
exposure to ambient air pollution and exercise was assessed continuously 
using portable real-time monitors and global positional system tracking 
respectively. Cardiovascular effects were assessed by continuous 12-lead 
electrocardiographic and ambulatory blood pressure monitoring. 
 
Ambient exposure (PM2.5 86±61 vs 140±113 !g/m3; particle number 2.4±0.4 vs 
2.3±0.4 x 104 particles/cm3), temperature (29±1 vs 28±3 °C) and relative 
humidity (63±10 vs 64±19%) were similar (P>0.05 for all) on both study days. 
During the 2-hour city walk, systolic blood pressure was lower (114±10 vs 
121±11 mmHg, P<0.01) when subjects wore a facemask, although heart rate 
was similar (91±11 vs 88±11 /min; P>0.05). Over the 24-hour period heart 
rate variability increased (SDNN 65.6±11.5 vs 61.2±11.4 ms, P<0.05; LF-power 
919±352 vs 816±340 ms2, P<0.05) when subjects wore the facemask. 
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Wearing a facemask appears to abrogate the adverse effects of air pollution 
on blood pressure and heart rate variability. This simple intervention has the 
potential to protect susceptible individuals and prevent cardiovascular 























Air pollution, and especially traffic-derived particulate matter [Laden, et al. 
2000], is now established as a major cause of cardiorespiratory morbidity and 
mortality [Anderson, et al. 1996; Dockery, et al. 1993; Pope, et al. 2002]. 
Epidemiological studies have shown that chronic air pollution exposure is 
associated with the degree of atherosclerosis [Hoffmann, et al. 2007; Kunzli, et 
al. 2005], and the risk of cardiovascular events [Miller, et al. 2007]. Acute 
exposure causes exacerbation of existing cardiorespiratory conditions 
leading to an increase in hospital admissions [von Klot, et al. 2005] and 
deaths [Peters, et al. 2004].  
 
The mechanisms of these associations are unclear but recent controlled 
exposure studies have demonstrated that air pollution causes vascular 
endothelial dysfunction [Mills, et al. 2005], arterial vasoconstriction [Brook, et 
al. 2002], increased blood pressure [Urch, et al. 2005] and myocardial 
ischaemia [Mills, et al. 2007]. Observational studies have also suggested that 
air pollution exposure impairs regulation of the autonomic nervous system 
and reduces heart rate variability [Chuang, et al. 2007; Gold, et al. 2000]. A 
combination of these effects is likely to account for the increase in 
cardiovascular events seen following exposure to air pollution. There is 
therefore a need to consider approaches that can reduce ambient air 
pollution exposure on both a personal and societal level. 
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In Beijing China, particulate matter (particle diameter <10 !m; PM10) air 
pollution averages around 150 !g/m3 and, in 2006, levels exceeded the 
World Health Organisation recommended national standards (PM10 
concentration <50 !g/m3) on 241 out of 365 days [UNEP, 2008]. Despite 
considerable efforts to improve air quality, pollution remains the single 
largest environmental and public health issue affecting Beijing. The extensive 
use of coal and the growing number of motor vehicles (estimated 3.3 million 
vehicles on the roads in August 2008) have contributed to air pollution. In 
addition, the city’s geographical location exacerbates the problem with the 
surrounding mountain ranges impeding air circulation and dispersion of 
pollutants. 
 
Increasing concern relating to the health effects of air pollution has led many 
individuals to use facemasks to reduce personal exposure. The efficiency of 
these masks and the potential cardiovascular benefits on people exposed to 
urban air pollution has yet to be established. The aims of this study were to 
assess the efficacy of facemasks in removing potentially hazardous 
particulate air pollution and to determine the potential cardiovascular 








Fifteen healthy volunteers were recruited from the Fuwai Hospital, Beijing in 
August 2008. All subjects were non-smokers, received no regular medication, 
and had no intercurrent illnesses. All subjects gave their written consent to 
participate in the study, which was reviewed and approved by the local 
ethics committee, in accordance with the Declaration of Helsinki. 
 
6.3.2 Assessment of mask efficacy 
Masks designed for use by cyclists, pedestrians and occupational settings 
were tested for penetrance of fresh diesel exhaust particulate. Diesel engine 
exhaust was generated from the idling (1500 rpm) engine (F3M2011, Deutz 
Ag, Köln, Germany) of a 35KVA generator (Bredenoord, Apeldoorn, 
Netherlands). The exhaust was diluted with filtered air to obtain a mass 
concentration of 75±12 !g/m3 (as measured by gravimetric analysis) and a 
particle number concentration of 500,000 particles/cm3 (condensation 
particle counter [CPC] model 3022, TSI Instruments, High Wycombe, UK). 
Sections of each mask filter were mounted in a filter holder. After 5 min of 
baseline measurements, filters were introduced between the exhaust and the 
CPC that sampled at a flow rate of 1.5 L/min. Particle number was recorded 
for 5 min and penetrance defined as the percentage of particles passing 
through the filter compared to baseline.  
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6.3.3 Study design 
All 15 subjects attended the Fuwai Hospital on two occasions, each at least 
one week apart, during August 2008. In a randomised open-label controlled 
cross-over study, subjects were randomised to wear no mask or a highly 
efficient facemask filter (Dust Respirator 8812, 3M, St Paul USA). When 
randomised to wear the facemask, subjects were asked to wear the mask for 
24 hours prior to the study day and 24 hours of the study day. Subjects were 
asked to wear the mask at all times when outside, and as much as possible 
whilst indoors. On the study day, subjects were asked to walk for 2 hours in 
a city centre location (Figure 6.1) along the inner ring road in Beijing between 
8 and 10 am. 
 
6.3.4 Pollution and activity monitoring 
Personal exposure to air pollutants was monitored using a collection of 
portable monitoring equipment mounted in a backpack. Particle mass 
concentration (particle diameter <2.5 !m; PM2.5) was measured in using a 
light-scattering nephelometric method using a DataRAM monitor (pDR-
1500, Thermo Scientific, Franklin, USA). Particle number was measured 
using a handheld condensation particle counter (CPC 3007, TSI Instruments 
Ltd, High Wycombe, UK). Ambient temperature and relative humidity were 
recorded using a sensor on the outside of the backpack (Omegaette® HH-
314, Omega Engineering Ltd, Connecticut, USA). Gaseous pollutants were 
measured using a multigas analyser (X-am 7000, Dräger Safety, Pittsburgh, 
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USA) measuring carbon monoxide (CO), nitrogen dioxide (NO2) and sulphur 




Figure 6.1. City centre route chosen in central Beijing. A representative recording from the 
GPS device contained in the monitoring backpack is shown. The walk goes from the Fuwai 
Hospital (A), along the inner ring road (B) and towards the city centre (C) before turning 
back. Image courtesy of Google™ Earth. 
 
 
Physical activity was assessed using a portable global positioning system 
(GPS) monitor secured to the outside of the bag (eTrex Summit HC, Garmin, 
USA). This recorded the route taken by volunteers, their total distance 
travelled, and average speed. This information was used, along with baseline 
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anthropometric measurements, to calculate the energy expended during the 
walk in kilocalories and metabolic equivalents (METS). 
 
6.3.5 Holter monitoring 
Subjects were fitted with a 12-lead continuous electrographic Holter monitor 
(Lifecard 12, Spacelabs, UK) at the beginning of the study day for 24 hours. 
Holter electrographic traces were analysed using DelMar Reynolds 
proprietary software packages by two blinded observers. The quality of the 
electrocardiographic trace was manually inspected before arrhythmias were 
automatically detected using the Pathfinder software package. Identified 
arrhythmias were then individually inspected, verified or deleted as 
appropriate. Average heart rate and heart rate variability in both time and 
frequency domains were analysed using the HRV Tools software package, 
with identified arrhythmias excluded from this analysis. 
 
6.3.6 Ambulatory blood pressure 
Subjects were fitted with an ambulatory blood pressure monitor (Model 
90217, Spacelabs, UK) at the beginning of the study day. Blood pressure was 
recorded at the left brachial artery every 15 minutes during the 2-hour walk, 
every 30 minutes for the rest of the daytime (07:00 to 22:00), and every hour 
overnight (22:00 – 07:00). 
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6.3.7 Symptom questionnaire 
Subjects were asked to complete a symptom questionnaire using a visual 
analogue scale at the beginning of the study day, after the 2-hour walk and at 
the 24-hour visit. They were asked to record any physical symptoms, as well 
as report a perception of the degree of pollution and the tolerability of the 
mask.  
 
6.3.8 Data analysis and statistical methods 
Subjects were randomised to wearing a mask on their first or second visit 
using a random number generator. All data are expressed as mean (95% 
confidence interval [CI]) unless otherwise stated. The symptom 
questionnaire was based on a visual analogue scale. Scores were converted 
into a percentage, and analysed using 2-way analysis of variance (ANOVA) 
with repeated measures using time and the mask intervention as variables. 
The occurrences of arrhythmias during the 24-hour monitoring period were 
compared using the Wilcoxon matched pairs method. All other parameters 
were evaluated using paired Student’s t-tests. Statistical significance was 
taken at the 5% level. All data were analysed using GraphPad Prism (Version 







6.4.1 Mask efficiency 
Mask penetrance was highly dependent on mask type (Figure 6.2). The 3M 
Dust Respirator (Model 8812, 3M, St Pauls, USA) was selected for the 
intervention study as it provided good filtration performance and was 
extremely efficient and comfortable to wear.  
 
 
Figure 6.2. Penetrance of commercially available filters: 3M Dust Respirator 8812, Dust 
Respirators A and B, Cyclist Masks A to D. The Teflon filter is an industry standard filter for 
aerosol studies included as a control. Cotton handkerchiefs and surgical masks are often 
seen worn in public areas in parts of Asia. 
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6.4.2 Intervention study 
Fifteen subjects (20-45 years) completed the study. Subjects were 
predominantly female (13:2) with a mean height of 164 cm (95% CI, 160 – 
167), weight of 55 kg (95% CI, 50 – 60) and body mass index of 20.5 kg/m2 
(95% CI, 19.3 – 21.7). There were no differences (P>0.05 for all parameters) in 
ambient pollution exposure during the 2-hour walk between the two visits 
(Table 6.1). Based on the measured penetrance of 3.4%, assuming a perfect 
facial fit and similar flow rates, we predict that the particle count to which 
subjects were exposed when wearing a mask was reduced to just 795 (95% 
CI, 726 – 864) particles/cm3.  
 
Table 6.1. Exposure characteristics during city centre walks. 
 Without Mask With Mask 
PM2.5, !g/m3 
86 
(52 – 120) 
140 




(22061 – 26306) 
23379 
(21350 – 25409) 
CO, number of peaks 6.2 (3.2 – 9.3) 
3.3 
(1.3 – 5.2) 
NO2, number of 
peaks Nil Nil 
SO2, number of peaks Nil Nil 
Temperature, oC 29.2 (28.6 – 29.8) 
28.1 
(26.3 – 29.9) 
Relative humidity, % 63 (58 – 68) 
64 
(53 – 74) 
Data expressed as mean (95% confidence interval). 




There were no differences in 24-hour average heart rate or blood pressure 
during the two study days (Table 6.2). Holter analysis revealed an increased 
SDNN (65.6±11.5 vs 61.2±11.4 ms, P<0.05) and LF-power (919±352 vs 816±340 
ms2, P<0.05) over the 24 hours when subjects wore the mask. There were no 
clinically relevant arrhythmias recorded in any subject (Table 6.3). 
 
During the 2-hour walk, there was no difference in exercise intensity in the 
presence or absence of the facemask (Table 6.4) although subjects had a 
lower systolic blood pressure (114±10 vs 121±11 mmHg; P<0.01) when 
wearing a mask. This was not associated with a change in diastolic blood 
pressure, heart rate or in heart rate variability measurements. As expected, 
parameters of HRV changed during exercise as compared to the 24 hour 
period consistent with immediate withdrawal of vagal tone. 
 
Subjects reported only very minor symptoms (Table 6.5) during the study 
period. The mask was generally well tolerated with an average score of 






Table 6.2. 24-hour ambulatory blood pressure monitoring and Holter analysis for heart rate 
variability with each visit. 
 Without Mask With Mask 
24 hour 
SBP, mmHg 106 
(100 – 112) 
106 
(101 – 111) 
DBP, mmHg 69 (66 – 73) 
70 
(67 – 73) 
MAP, mmHg 82 
(79 – 86) 
82 
(78 – 86) 
Heart rate, bpm 
74 
(70 – 77) 
72 
(68 – 76) 
Night 
SBP, mmHg 100 
(93 – 107) 
101 
(95 – 106) 
DBP, mmHg 63 (60 – 67) 
64 
(61 – 67) 
MAP, mmHg 76 
(73 – 79) 
75 
(71 – 79) 
Heart rate, bpm 64 (61 – 67) 
61 
(58 – 65) 
Day 
SBP, mmHg 110 
(104 – 116) 
109 
(104 – 114) 
DBP, mmHg 73 (69 – 76) 
73 
(70 – 76) 
MAP, mmHg 85 
(81 – 88) 
85 
(81 – 89) 
Heart rate, bpm 79 (74 – 84) 
78 

















(789 – 869) 
850 
(805 – 896) 
pNN50, % 15.9 
(10.7 – 21.0) 
17.9 
(14.2 – 21.6) 
RMSSD, ms 35.1 (29.2 – 41.0) 
37.1 
(32.2 – 42.0) 
SDNN, ms 61.2 
(54.9 – 67.5) 
65.6* 
(59.0 – 72.2) 
Triangular Index 12.9 (11.9 – 13.9) 
13.8 
(13.0 – 14.5) 
LF-power, ms2 816 
(628 – 1004) 
919* 
(717 – 1122) 
HF-power, ms2 460 (325 – 595) 
485 
(400 – 569) 
LFn, ms 62.8 
(56.7 – 68.9) 
64.5 
(60.6 – 68.4) 
HFn, ms 29.2 (25.5 – 32.8) 
30.0 
(27.0 – 33.1) 
HF/LF ratio 0.738 
(0.507 – 0.970) 
0.680 
(0.519 – 0.842) 
All data expressed as mean (95% confidence interval). *P<0.05 compared to control (no mask) day, 
Student’s paired t-test. 
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Table 6.3. Arrhythmia analysis from 24-hour Holter electrocardiograms. 
 Without Mask With Mask 
Pause 0 0 
Dropped beat 0 0 
Ventricular tachycardia 0 0 
Salvo 0 0 
Triplet 0 0 
Couplet 0 0 
Bradycardia ("50bpm) 71 227 
Supraventricular tachycardia 0 0 
Bigeminy 57 157 
Trigeminy 4 7 
“R on T” 0 0 
Premature aberrant 3246 4698 
Isolated aberrant 18 3 
Premature normal 11 17 
Maximum heart rate 
134 
(126 – 143) 
128 
(120 – 137) 
Minimum heart rate 51 
(48 – 54) 
49 
(46 – 53) 
Data shown are total number of events recorded in each condition over all subjects. 
P>0.05 for all (Wilcoxon matched pairs test). Maximum and minimum heart rates shown as mean 








Table 6.4. Exercise performed and physiological parameters during 2-hour walk. 





y Energy expenditure, kcals 
340 
(314 – 367) 
364 
(304 – 426) 
Energy expenditure, METS 3.33 (3.09 – 3.57) 
3.61 
















Systolic blood pressure, mmHg 121 
(115 – 127) 
114* 
(108 – 120) 
Diastolic blood pressure, mmHg 81 
(75 – 87) 
79 
(74 – 83) 
Mean arterial pressure, mmHg 94 
(89 – 99) 
90 
(86 – 94) 
Heart rate, bpm 88 
(82 – 94) 
91 













Data validity, % 99.1 97.8 
Average NN interval, ms 
594 
(562 – 627) 
613 
(571 – 655) 
pNN50, % 
3.3 
(0.8 – 5.7) 
2.1 
(-0.1 – 4.4) 
RMSSD, ms 17.2 (13.4 – 21.0) 
20.0 
(15.5 – 24.6) 
SDNN, ms 45.8 (36.8 – 54.8) 
54.8 
(42.5 – 67.0) 
Triangular Index 10.7 
(9.1 – 12.4) 
11.4 
(9.4 – 13.3) 
LF-power, ms2 313 
(170 – 455) 
414 
(233 – 595) 
HF-power, ms2 76.5 
(33.6 – 120.0) 
116.8 
(52.6 – 181.0) 
LFn, ms 
68.2 
(60.9 – 75.5) 
67.9 
(61.9 – 73.9) 
HFn, ms 
16.1 
(11.9 – 20.3) 
16.0 
(12.5 – 19.4) 
HF/LF ratio 
0.259 
(0.173 – 0.344) 
0.247 
(0.180 – 0.314) 
All data expressed as mean (95% confidence interval). 
*P<0.01 compared to control (without mask) day, paired Student’s t-test. 




Table 6.5. Symptom questionnaire. 
Symptoms assessed by visual analogue scale (0 – 100) 
 
Without mask With mask 
P 
Before walk After walk 24 hours after 
walk 
Before walk After walk 24 hours after 
walk 
Headache 0 (0-1) 0 (0-2) 0 (0-2) 0 (0-1) 0 (0-1) 0 (0-1) n/s 
Dizziness 0 (0-0) 0 (0-1) 0 (0-1) 0 (0-0) 0 (0-1) 0 (0-1) n/s 
Tiredness 0 (0-1) 2 (0-15) 1 (0-16) 0 (0-2) 5 (0-10) 0 (0-2) n/s 
Sickness 0 (0-0) 0 (0-1) 0 (0-1) 0 (0-1) 0 (0-2) 0 (0-2) n/s 
Cough 0 (0-1) 1 (0-1) 0 (0-1) 0 (0-1) 0 (0-20_ 0 (0-1) n/s 
Difficulty in breathing 0 (0-0) 0 (0-1) 0 (0-1) 0 (0-2) 1 (0-5) 0 (0-2) <0.05 
Irritation of the eyes 0 (0-0) 0 (0-1) 0 (0-1) 0 (0-1) 0 (0-2) 0 (0-1) n/s 
Irritation of the throat 0 (0-1) 0 (0-1) 0 (0-1) 0 (0-0) 0 (0-1) 0 (0-1) n/s 
Irritation of the nose 0 (0-1) 1 (0-1) 0 (0-1) 0 (0-1) 0 (0-1) 0 (0-1) n/s 
Unpleasant smell 0 (0-1) 1 (0-1) 0 (0-2) 0 (0-1) 0 (0-1) 0 (0-1) n/s 
Bad taste 0 (0-1) 0 (0-1) 0 (0-1) 0 (0-1) 0 (0-1) 0 (0-2) n/s 
Difficulty walking  7 (0-24)   16 (4-28)  n/s 
Perception of pollution  16 (6-25)   9 (2-22)  n/s 
All data expressed as median (interquartile range). “Difficulty walking” and “Perception of pollution” tested using Wilcoxon signed rank test. All other variables 







In this study, we have shown for the first time that a simple well-tolerated 
personal intervention to reduce exposure to airborne particulate air pollution 
leads to a reduction in systolic blood pressure during exercise and an 
increase in heart rate variability. If translated into a susceptible population, 
our findings would suggest that wearing a simple facemask has the potential 
to reduce the incidence of acute cardiovascular events in cities with high 
levels of air pollution, and could influence the advice given to patients with 
chronic cardiovascular diseases. 
 
We tested a range of facemasks that differed widely in their efficiency as 
particle filters. In general, those masks designed to reduce occupational 
exposure to dusts were more efficient than those marketed as personal 
protection to cyclists and pedestrians in an environmental setting. The choice 
of the mask used in this study was influenced by efficiency and comfort. The 
chosen mask was very well tolerated by subjects as demonstrated by the 
visual analogue score, and was predicted to reduce the exposure to 
particulate matter dramatically. When wearing the masks, the subjects did 
report slightly greater difficulty breathing whilst walking although this did 
not reduce the level of exercise undertaken by the subjects. This increased 
resistance to respiration is unlikely to affect the main study findings since 
such stresses would be predicted to increase blood pressure rather than 
reduce it.  
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Recent studies have confirmed a link between blood pressure and exposure 
to air pollution. Population-based studies have shown increases in both 
systolic blood pressure and pulse pressure [Auchincloss, et al. 2008; Ibald-
Mulli, et al. 2001] with increasing levels of ambient pollution exposure. 
Controlled exposure studies to concentrated ambient particles and ozone 
have demonstrated an increase in diastolic blood pressure during a two-hour 
exposure [Urch, et al. 2005]. Although there were no differences in blood 
pressure over the whole 24-hour period, we observed a marked difference in 
systolic blood pressure with exercise. In both groups, blood pressure 
increased during exercise compared to the 24-hour average, although this 
increase was less when wearing a facemask. This, in combination with 
previous controlled exposure studies [Urch, et al. 2005], suggests that 
particulate air pollution may augment exercise-induced increases in blood 
pressure, and that the use of a simple facemask can abrogate this. Exercise 
induced increases in systolic blood pressure have been linked to myocardial 
infarction [Mundal, et al. 1996] as well as stroke [Kurl, et al. 2001], and 
increased blood pressure is an established major risk factor for the 
development of both atherosclerosis and cardiovascular mortality 
[Hippisley-Cox, et al. 2008; Wilson, et al. 1998]. The reduction in systolic 
blood pressure seen in this study is similar to that seen with many 
antihypertensive agents, which have been shown to reduce major 
cardiovascular events. Therefore we predict that the use of a facemask in a 
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susceptible population has the potential to reduce the incidence of acute 
cardiovascular events as well as myocardial ischaemia [Chuang, et al. 2008; 
Mills, et al. 2007].  
 
Heart rate variability is a measure of the variation in the R-R interval on the 
electrocardiogram. A balance of the parasympathetic and sympathetic 
nervous systems controls the heart rate in order to maintain a constant 
cardiac output at rest or to respond to increased demands during exercise. A 
reduction in heart rate variability occurs in various pathophysiological 
conditions including hypertension [Singh, et al. 1998], heart failure [Saul, et 
al. 1988] and diabetes mellitus [Singh, et al. 2000], and predicts cardiovascular 
outcomes [Nolan, et al. 1998]. Previous studies have demonstrated a 
reduction in measures of heart rate variability, particularly the robust and 
simple time-domain measurement SDNN following exposure to air pollution 
[Chang, et al. 2007; Chuang, et al. 2007; Devlin, et al. 2003; Gold, et al. 2000; 
Liao, et al. 1999; Magari, et al. 2001; Park, et al. 2008; Pope, et al. 1999]. In our 
study we report an increase in overall heart rate variability (SDNN) when 
subjects wore a mask, suggesting that wearing a mask can, at least in part, 
prevent the adverse effects of air pollution exposure on heart rate variability. 
 
LF-power also increased with the use of a mask to prevent exposure to air 
pollution although interpreting this change is more challenging. LF-power is 
associated with changes in sympathetic tone, and an increase might suggest 
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an increased contribution of the sympathetic nervous system to basal heart 
rate control.  However, simply wearing the facemask may have had a small 
effect on the measures of heart rate variability described. As previously 
discussed, subjects did report an increased resistance to breathing when 
wearing the facemask that may have increased subject anxiety. This in turn 
could have increased sympathetic nervous system tone and hence lead to a 
small increase in LF-power. This is a limitation of our study, and the use of a 
sham facemask in a blinded fashion would have helped minimise the effect 
of anxiety on these sensitive outcome measures. Furthermore, the 
improvement in parameters of HRV when wearing the mask was small and 
the physiological significance of this change is unclear in healthy volunteers. 
We recognise that the menstrual cycle of the female volunteers may have 
small effects on vascular and autonomic function and this may be a 
confounding factor in our findings. 
 
Our study has a number of important public health messages. First we have 
demonstrated that exposure to ambient air pollution has direct and 
measurable effects on cardiovascular physiological parameters, even young 
healthy individuals habitually exposed to such elevated levels. Second we 
have shown that wearing a facemask can abrogate some of these effects in a 
short period of time. Particle traps are increasingly being fitted to new 
vehicles to reduce the emissions of particulate matter, both by mass and 
number concentrations, and this may well go some way to offsetting the 
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associated health effects. Currently, patients with chronic respiratory and 
cardiovascular conditions are advised to limit their exposure outdoors on 
days when ambient air pollution levels are high [COMEAPS, 2000; British 
Heart Foundation, 2008; Brook, et al. 2004]. We have shown that wearing a 
simple inexpensive and well-tolerated facemask can provide an alternative 
that may lead to reduced cardiovascular morbidity and mortality. We believe 
that this intervention now needs to be tested in patients with pre-existing 
coronary heart disease to define its potential role in reducing the burden of 
cardiovascular disease in polluted environmental settings. 
 
Our study has a number of important limitations. We recruited young 
healthy volunteers rather than those most susceptible to the effects of air 
pollution exposure, such as those with coronary heart disease. Whilst it is 
likely that our findings will be transferrable to this population, further 
studies are required to confirm our findings. In addition, it was not possible 
to assess accurately the efficacy of the mask filter when worn by the subjects. 
Leaks around the facemask will lead to a reduction in the efficacy of particle 
filtration [Yang, et al. 2007; Zhuang, et al. 2005] and therefore our predicted 
exposures during application of the facemask are likely to be an 
underestimate. However, despite this, we were still able to demonstrate 




Air pollution exposure is associated with increased cardiovascular morbidity 
and mortality, and adverse effects on the cardiovascular system. We have 
shown for the first time that a wearing a facemask appears to abrogate the 
adverse effects of air pollution on blood pressure and heart rate variability. 
This simple intervention has the potential to protect susceptible individuals 
and prevent cardiovascular events in cities with high concentrations of 
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Air pollution exposure increases cardiovascular morbidity and mortality, 
and is a major global public health concern. We investigated the benefits of 
reducing personal exposure to urban air pollution in patients with coronary 
heart disease. 
 
In an open randomised crossover trial, 98 patients with coronary heart 
disease walked on a pre-defined route in central Beijing, China in the 
presence and absence of a highly efficient facemask. Symptoms, exercise, 
personal air pollution exposure, blood pressure, heart rate and 12-lead 
electrocardiography were monitored throughout the 24-hour study period.  
 
Ambient air pollutants were dominated by fine and ultrafine particles that 
were present at high levels (74 !g/m3 for particulate matter <2.5 !m). 
Consistent with traffic-derived sources, this particulate matter contained 
organic carbon and polycyclic aromatic hydrocarbons, and were highly 
oxidising generating large amounts of free radicals. The facemask was well 
tolerated, decreased symptoms (P<0.05), and reduced maximal ST segment 
depression (-142 vs -156 !V, P=0.046) over the 24-hour period. Mean arterial 
pressure was lower (93±10 vs 96±10 mmHg; P=0.025) and heart rate 
variability increased (HF-power 54 vs 40 ms2, P=0.005; HFn 23.5  vs 20.5  ms, 
P=0.001; RMSSD 16.7 vs 14.8 ms, P=0.007)  during the prescribed walk, whilst 
heart rate and energy expenditure were similar (P>0.05).  
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Reducing personal exposure to air pollution using a highly efficient facemask 
appears to reduce symptoms, and improve a range of measures of 
cardiovascular health in patients with coronary heart disease. Such 
approaches have the potential to reduce the incidence of cardiovascular 
events in this highly susceptible population. 
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7.2 INTRODUCTION 
Air pollution exposure is an established risk factor for cardiovascular 
morbidity and mortality [Brook, et al. 2010], especially that derived from 
traffic and industrial sources [Laden, et al. 2000; Lall, et al. 2011; Lipfert, et al. 
2006; Pope, et al. 2002; Sarnat, et al. 2008]. Acute exposure to combustion-
derived particulate matter is associated with the onset of myocardial 
infarction, admissions to hospital in survivors of myocardial infarction, and 
is proposed as a trigger for acute cardiovascular events [Klot, et al. 2005; 
Peters, et al. 2004]. Although estimates vary, chronic exposure to air pollution 
increases all-cause mortality by between 2 and 4 % per 10 !g/m3 increase in 
particulate matter [Dockery, et al. 1993; Pope, et al. 2002], with the majority of 
deaths due to cardiovascular disease [Miller, et al. 2007]. The World Health 
Organisation estimates that outdoor urban air pollution results in around 
800,000 deaths worldwide each year [UNEP 2006].  
 
In controlled exposure studies, inhalation of particulate air pollution causes 
changes in blood pressure, abnormalities in vascular function, coagulation 
and myocardial ischaemia [Mills, et al. 2009]. These responses provide a 
plausible mechanism to explain the observed increase in acute 
cardiovascular events and increased cardiovascular mortality following 
exposure to particulate air pollution. However, whilst acute exposure 
induces these adverse effects, it is unclear whether improvements in 
cardiovascular health can be achieved by interventions targeted to reduce 
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exposure in those living and working in highly polluted urban 
environments. 
 
Major environmental health policy interventions can have a substantial 
impact on the health of populations, as can be observed following the 
banning of bituminous coal in Dublin, Ireland in 1990 [Clancy, et al. 2002], 
and more recently with the restriction of smoking in public places [Pell, et al. 
2008], where there were major reductions in cardiovascular events. Such 
environmental interventions are particularly challenging to deliver in rapidly 
developing countries where economic growth is dependent on road traffic 
and heavy industry [Smith, et al. 2009]. More practical solutions to reduce 
individuals’ exposure and protect susceptible persons are urgently required. 
Therefore, we investigated the effects of a simple facemask intervention to 
reduce particulate air pollution exposure on measures of cardiovascular 








One hundred and two patients were recruited from the Fuwai Hospital, 
Beijing in March 2009. All patients were non-smokers and had a history of 
coronary heart disease. Exclusion criteria were a history of arrhythmia, 
severe coronary artery disease without revascularisation, resting conduction 
abnormality, digoxin therapy, uncontrolled hypertension, renal or hepatic 
failure or an acute coronary syndrome within three months. All subjects gave 
their written informed consent and the study was reviewed and approved by 
the local research ethics committee. 
 
7.3.2 Study design 
Subjects attended the Fuwai Hospital or the ChaoYang Hospital in Beijing on 
two occasions, each at least a week apart (median time between visits was 9 
days), between March and May 2009. Each subject attended the same 
hospital on each visit. In a prospective randomised open blinded endpoint 
(PROBE) crossover study, subjects walked for two hours along a prescribed 
city centre route (Figure 7.1) in Beijing between 9 and 11 am, in the presence 
and absence of a highly efficient facemask (Dust Respirator 8812, 3M, St Paul, 
USA). This mask consists of a lightweight polypropylene filter, which is 
effective at removing airborne particles without an effect on ambient gases, 
with an expiration valve, and complies with EN149:2001 FFP1 European 
Standard and has an assigned protection factor of 4 (i.e. it can be worn in 
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atmospheres containing up to 4 times the workplace exposure limit [WEL for 
respirable carbon particles, carbon black, is 3.5 mg/m3 over an 8 hour time 
weighted average] as defined by the UK Health and Safety Executive 
[http://www.hse.gov.uk/]). The mask was worn on one of the two visits 
using balanced computer-generated randomisation incorporating 
concealment of treatment order. In order to maximise the difference in 
particulate air pollution exposure, subjects wore the mask for 24 hours prior 
to, and 24 hours during, the study day, and were given instructions to wear 
the mask at all times whilst outdoors and as much as possible when indoors. 
 
 
Figure 7.1. Prescribed walks from the Fuwai Hospital (west of city centre in Xicheng 
District) and ChaoYang Hospital (east of city centre in ChaoYang District). Map freely 





7.3.3 Personal pollution exposure and activity monitoring 
Personal air pollutant exposure was determined using monitoring 
equipment contained within a backpack. Particle mass concentration (PM2.5; 
particle diameter <2.5 !m) was determined using a DataRAM monitor (pDR-
1500, Thermo Scientific, Franklin, MA, USA), and particle number measured 
using a condensation particle counter (CPC 3007, TSI Instruments Ltd, High 
Wycombe, UK). Ambient temperature and relative humidity were recorded 
using an external sensor (Omegaette® HH-314, Omega Engineering Ltd, 
Stamford, CT, USA). Gaseous pollutants were measured using a multi-gas 
analyser with electrochemical sensors for carbon monoxide, sulphur dioxide 
and nitrogen dioxide (X-am 7000, Dräger Safety, Lübeck, Germany). Physical 
activity was measured using global positioning system (GPS) tracking (eTrex 
Summit HC, Garmin, Olathe, KS, USA), and energy expenditure estimated 
using activity data and anthropometric data as described previously 
[Langrish, et al. 2009]. 
 
7.3.4 Background pollution monitoring 
Background exposure was recorded from permanent monitoring stations in 
the same district as the patients’ walk 
(http://www.bjepb.gov.cn/air2008/olympic.aspx). Airborne particulate 
matter was collected onto Teflon filters (Pall Corp., Ann Arbor, MI, USA) in 
three size fractions: coarse (mean aerodynamic diameter 2.5-10 !m), fine 
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(0.18-2.5 !m) and ultrafine (<0.18 !m) using a MOUDI cascade impactor 
(MSP Corp., Shoreview, MN, USA).  
 
Particulate mass was determined gravimetrically for each size fraction from 
the above filters after temperature and humidity conditioning, and 
subsequently analysed for elemental and organic carbon fractions, metals 
and cations, nitrate and sulphate anions and organic matter.  
 
7.3.5 Chemical and toxicological analysis of collected particulate 
matter 
Collected particulate samples were analysed for total carbon content, as well 
as elemental and organic carbon fractions, using the Sunset method (NIOSH 
5040; http://www.cdc.gov/niosh/docs/2003-154/pdfs/5040.pdf). Metals 
and cations were determined using inductively-coupled plasma mass 
spectrometry (ICP-MS) following pre-treatment with nitric acid. Nitrate and 
sulphate anions were determined following extraction with water using LC-
ICP-MS (liquid chromatography paired with ICP-MS). Organic matter was 
extracted from filters by ultrasonification with toluene and analysed using 
gas chromatography-mass spectrometry (GC-MS). 
 
Oxidative potential of particles was assessed using electron paramagnetic 
resonance (EPR) [Miller, et al. 2009]. EPR was used to establish oxygen-
centred free radical generation from the collected particulate matter in the 
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absence of tissue. Filters for all size fractions were pooled and sonicated in 
phosphate buffered saline to give a final concentration of particles of 1 
mg/mL. Solutions were incubated with the spin-trap 1-hydroxyl-2,2,6,6,-
tetramethyl-4-oxo-piperidine (Tempone-H; 1 mM), loaded into a capillary 
tube and assessed at 37 oC in an X-band EPR spectrometer (Magnettech MS-
200, Berlin, Germany) as described previously [Miller, et al. 2009]. Pyrogallol 
(100 !M) was used as a positive control, and samples were compared to the 
NIST (National Institute of Standards and Technology, Gaithersburg, MD, 
USA) standard reference materials: urban dust (SRM-1649a; 1 mg/mL) and 
diesel exhaust particles (SRM-2975; 10 !g/mL). 
 
7.3.6 Electrocardiographh and blood pressure monitoring 
Continuous 12-lead electrocardiography (Lifecard 12, Spacelabs Healthcare, 
UK) was assessed using the Pathfinder automated arrhythmia analysis 
package (DelMar Reynolds, UK). Identified arrhythmias were individually 
inspected and verified or deleted as appropriate, and heart rate variability 
was assessed using the HRV Tools software package (DelMar Reynolds, UK) 
as described previously [Langrish, et al. 2009]. ST segment analysis was 
performed at the J-point +80 ms in three representative leads (II, V2 and V5) 
that were analysed separately for each subject. Maximal ST segment 
depression and ischaemic burden (product of the change in ST segment 
amplitude and the duration of the recording) were determined for each lead 
and as a composite [Mills, et al. 2007]. 
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Ambulatory blood pressure (Model 90217, Spacelabs Healthcare, UK) was 
measured every 15 min during the 2-hour walk, then every 30 min during 
the day and every hour overnight (22:00 to 07:00).  
 
7.3.7 Symptom questionnaire 
Subjects completed a symptom questionnaire using a visual analogue scale at 
the beginning of the study day, following the 2-hour walk and at the 24-hour 
visit. They were asked to report physical symptoms, their perception of the 
pollution, their perceived workload and the tolerability of the mask. 
 
7.3.8 Data analysis and statistical methods 
In our previous study of healthy volunteers, we demonstrated a difference in 
systolic blood pressure of 7 mmHg with a standard deviation of 5 mmHg 
[Langrish, et al. 2009]. Based on the assumption that the effect size would be 
considerably smaller, we powered the study to detect a 2 mmHg difference 
in systolic blood pressure, giving a sample size of 101 at 80% power and two-
sided P<0.05.  
 
Blood pressure and electrocardiographic endpoints were analysed by 
investigators blinded to treatment allocation. Data were locked before 
undertaking statistical analysis. All data are expressed as median 
(interquartile range) or mean ± standard deviation unless otherwise stated. 
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Treatment-period interactions were assessed as described previously [Hills, 
et al. 1979], before data were compared using paired Student’s t-tests or 
Wilcoxon matched pairs signed rank test as appropriate. Occurrence of 
arrhythmias, reported symptoms and ST segment event frequency were 
compared using the Chi-squared analysis. All data were analysed using 
GraphPad Prism (Version 4 for Macintosh, GraphPad Software, San Diego, 













7.4.1 Subjects and Facemask Intervention 
Ninety-eight patients completed the study protocol (Figure 7.2 and Table 
7.1). All subjects tolerated the mask intervention well, scoring the comfort of 
the mask as 0.64±1.06 on a 0-10 scale (0 represents completely comfortable 
and 10 intolerable). The mask intervention reduced general symptoms, and 
patients’ perceived effort of work (Figure 7.3; P<0.05 for all), as well their 
perception of the level of ambient air pollution (2.46±1.67 vs. 2.73±1.64 on the 
0-10 visual analogue scale; P=0.03). There were no significant treatment-
















Figure 7.3. (A) Perceived effort of work and (B) actual work performed during the 
prescribed walk, and (C) symptoms of well-being in the presence (grey bars) or absence 
(black bars) of the facemask. Data expressed as mean ± SEM or frequency. !P<0.05. 
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Table 7.1. Baseline characteristics of subjects completing the study 
Baseline Characteristics, n=98 
Age, yrs 62 ± 7 
Male / Female 85 (87%)  /  13 (13%) 
Height, cm 169 ± 6 
Weight, kg 74.5 ± 10.4 









Hypertension 79 (81%) 
Diabetes Mellitus 45 (46%) 
Stroke 15 (15%) 
Peripheral Vascular Disease 5 (5%) 
Previous Myocardial Infarction 68 (69%) 
Previous PCI 60 (61%) 
Previous CABG 38 (39%) 









s CCSC Class I 67 (68%) 
CCSC Class II 31 (32%) 














 Random glucose, mmol/L 5.5 ± 1.8 
Triglycerides, mmol/L 1.52 ± 0.69 
Cholesterol, mmol/L 3.9 ± 0.9 
HDL Cholesterol, mmol/L 1.2 ± 0.3 










Aspirin 92 (94%) 
Clopidogrel 17 (17%) 
Warfarin 1 (1%) 
ACE inhibitor or ATII receptor antagonist 54 (55%) 
Beta-blocker 73 (74%) 
Calcium channel blocker 42 (43%) 
Statin, Fibrate or Ezetimibe 83 (85%) 
Nitrate 45 (46%) 
Other anti-anginal 5 (5%) 
Diabetic medication 42 (43%) 
Traditional Chinese medicine 19 (19%) 
Data expressed as mean ± standard deviation or number (%). BMI=body mass index; 
PCI=percutaneous coronary intervention; CABG=coronary artery bypass graft; LV=left ventricle; 
CCS=Canadian Carsiovascular Society; HDL=high density lipoprotein; LDL=low density 
lipoprotein; ACE=angiotensin converting enzyme; ARB=angiotensin II receptor blocker. 
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7.4.2 Air Quality and Pollutants 
Ambient levels of air pollutants were similar on both study days (Table 7.2) 
although we predict from previous studies of filter efficacy (97% reduction in 
particle number) that the particle exposure in the presence of the mask 
would be reduced to ~2 !g/m3 and ~1200 particles/cm3 [Langrish, et al. 
2009]. Temperature (17.3 vs 16.8 oC) and ambient relative humidity (30 vs 
35%) were similar on both visits (P>0.05 for both). Airborne particulate 
matter was predominantly (>99% by particle number) in the fine and 
ultrafine fractions (Figure 7.4) and contained a large amount of organic 
carbon and high concentrations of polycyclic aromatic hydrocarbons, 
nitrates, hopanes and steranes suggesting that much of this is combustion-
derived and related to traffic sources (Appendix 1). These collected particles 
were highly oxidising and generated large amounts of free radicals as 
detected by EPR, exceeding the signal seen with both the standard reference 
NIST urban dust material at an equivalent concentration and the intense free 
radical generating oxidant, pyrogallol (Figure 7.4).  
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Table 7.2. Personal pollution exposure during study. 
Parameter Mask No Mask 
Personal 
monitoring  
PM2.5 exposure, !g/m3 61 (20-88) 89 (25-170) 
Particle count, x104 
particles/cm3 
4.19 ± 1.29 4.39 ± 1.45 
Temperature, oC 17.3 ± 5.2 16.8 ± 5.8 
Relative humidity, % 30.4 ± 14.0 34.8 ± 18.2 
Peaks of NO2 >1 ppm, number None None 
Peaks SO2 >1 ppm, number None None 
Peaks CO >1 ppm, number 5 (2-7.5) 4 (2-8) 
Background 
monitoring  
PM10 exposure, !g/m3 92 (70-117) 103 (83-180) 
SO2 exposure, ppb 38 (29-53) 54 (32-77) 
NO2 exposure, ppb 36 (29-42) 36 (32-47) 
Data expressed as mean ± standard deviation or median (interquartile range). Personal monitoring data 
collected using portable monitoring equipment during the 2–hour walk, background data from permanent 
monitoring stations for the whole 24–hour period. Estimated particulate exposure is calculated based on 
filter efficacy studies where 97% of fresh diesel exhaust particles were removed.18 PM2.5=particulate 
matter with a mean aerodynamic diameter of <2.5 !m; NO2=nitrogen dioxide; SO2=sulphur dioxide; 
CO=carbon monoxide; PM10=particulate matter with a mean aerodynamic diameter of <10 !m; 









Figure 7.4. (A) Representative filter samples collected showing contribution by mass of the 
three size fractions averaged over 3 days. (B) Estimated contribution of each size fraction 
collected on filters by particle number. (C) Oxidative potential of the collected Beijing 
particles (1 mg/mL) using electron paramagnetic resonance (EPR) to assess oxygen-centred 
free radical generation, as compared to NIST (National Institute of Standards and 
Technology) diesel exhaust particles (10 !g/mL) and urban dust (1 mg/mL) and the pro-
oxidant positive control (pyrogallol 100 !M) as described previously [Miller, et al. 2009]. 
Data expressed as mean ± standard deviation (n=2–4). 
 
7.4.3 Effect of the Facemask on Cardiovascular Health  
Over the 24-hour period, the maximal ST segment depression recorded was 
lower (-142 (-179 to -110) vs -156 (-202 to -123) !V; P=0.046) in the presence of 
the facemask. However, myocardial ischaemic burden was similar on both 
visits during the 2-hour walk and over the entire 24-hour period (P>0.05 for 
both, Table 7.3).  
 
During the 2-hour prescribed city centre walks, subjects walked a 
comparable distance, at a similar average speed, and expended the same 
amount of energy (P>0.05 for all, Table 7.4) in the presence and absence of 
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the facemask. Despite this similar workload, mean ambulatory arterial blood 
pressure was lower (93±10 mmHg vs 96±10 mmHg; P=0.025) in the presence 
of the facemask (Table 7.5) although heart rate was similar (P>0.05). During 
the 2-hour walk, heart rate variability (HF-power, HFn, HF/LF ratio and 
RMSSD; P<0.01 for all) was higher when wearing the facemask (Table 7.6). 
There were no differences in overall 24-hour ambulatory blood pressure or 
heart rate variability (Table 7.5, Table 7.6). There was no difference in the 
incidence of arrhythmias on the two visits (P>0.05 for all; Table 7.7).  
 
Where subjects were not wearing a facemask PM2.5 mass concentration did 
not correlate significantly with measures of cardiovascular health (Table 7.8). 
 
Table 7.3. Myocardial ischaemia measured as ischaemic burden, in each individual territory 
and as a composite. Data expressed as median (interquartile range). P>0.05 for all using 
Wilcoxon signed rank test. 
Parameter 
Walk 24-hour 












s Inferior (II) 
territory 
-66 
(-118 to -26) 
-52 
(-149 to -21) 
-641 
(-767 to -504) 
-615 
(-820 to -473) 
Anterior  (V2) 
territory 
-66 
(-142 to -16) 
-50 
(-124 to -13) 
-597 
(-859 to -435) 
-632 




(-104 to -8) 
-43 





(-790 to -412) 
Sum 
(II + V2 + V5) 
-189 
(-382 to -90) 
-188 










Table 7.4. Exercise performed and energy expended during the 2 controlled city centre 
walks. Data expressed as mean ± standard deviation. P>0.05 for all parameters using paired 
Student’s t-tests. 
Parameter Mask No Mask 
Distance travelled, km 6.37 ± 1.44 6.40 ± 1.51 
Average moving speed, 
km/h 
4.25 ± 0.96 4.27 ± 1.01 
Energy expenditure, Kcal 345 ± 87 347 ± 93 






Table 7.5. Blood pressure and heart rate during the 2-hour urban walk and the 24-hour study period. Data expressed as mean ± standard deviation. P 







Walk 24 hours 
Mask No Mask P-value Mask No Mask P-value 
Systolic blood pressure, 
mmHg 
126.9 ± 15.9 128.1 ± 16.5 N/S 121.2 ± 11.9 120.8 ± 12.4 N/S 
Diastolic blood pressure, 
mmHg 
78.0 ± 9.3 79.5 ± 8.6 N/S 73.8 ± 7.2 74.0 ± 7.3 N/S 
Mean arterial pressure, 
mmHg 
93.3 ± 9.7 95.7 ± 10.0 P=0.025 89.8 ± 7.5 90.0 ± 7.9 N/S 
Heart rate, bpm 81.5 ± 8.7 81.5 ± 10.1 N/S 77.6 ± 11.3 76.7 ± 11.1 N/S 
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Table 7.6. Heart rate variability during the 2-hour urban walk and the 24-hour study period. Data expressed as median (interquartile range). *P<0.01 













Walk 24 hours 
Mask No Mask Mask No Mask 




































































































Table 7.7. Cardiac arrhythmias during the 24-hour electrocardiographic monitoring period. 
Data expressed as number of patients or as median (interquartile range). P>0.05 for all using 
Chi-squared (number of patients) and Mann-Whitney U tests (number of events). 
Bradycardia defined as heart rate < 50bpm; VT=ventricular tachycardia; 
SVT=supraventricular tachycardia. 
n=98 Number of patients Events per patient 
Arrhythmia Mask No Mask Mask No Mask 
Dropped beat 2 2 1 (1-1) 1 (1-1) 
VT 1 2 2 (2-2) 1 (1-1) 
Salvo 1 2 4 (4-4) 2 (1-3) 
Bigeminy 15 18 4 (1-33) 6 (2-36) 
Triplet 1 0 11 (11-11) 0 (0-0) 
Couplet 9 4 2 (1-5) 2 (1-10) 
Bradycardia 20 19 52 (3-275) 89 (9-347) 
SVT 2 5 1 (1-1) 1 (1-1) 
Trigeminy 3 4 12 (6-134) 10 (6-230) 
Premature aberrant 79 77 17 (3-122) 22 (3-181) 
Isolated aberrant 52 54 3 (1-16) 5 (1-25) 
Premature normal 81 84 12 (3-56) 12 (3-42) 
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Table 7.8. Correlation between cardiovascular outcome measures and particulate air 
pollution exposure (PM2.5 mass concentration) during the 2-hour city centre walk on the “no 












s Systolic blood pressure -0.038 0.712 
Diastolic blood pressure 0.010 0.926 
Mean arterial pressure 0.027 0.790 













LF power -0.042 0.884 
HF power 0.199 0.054 
HF/LF ratio 0.100 0.334 
pNN50 -0.005 0.959 
RMSSD -0.047 0.654 











 Maximal ST segment 
deviation -0.174 0.093 
Total ischemic burden -0.034 0.746 
LF=low frequency; HF=high frequency; pNN50=percentage of successive RR intervals that differ by 
more than 50 ms; RMSSD=root mean square differences of successive differences; SDNN=standard 
deviation of RR intervals. LF and SDNN reflect mainly sympathetic nervous stimulation; HF, 
pNN50 and RMSSD reflect parasympathetic tone. 
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7.5 DISCUSSION 
Particulate air pollution is a major public health concern and is associated 
with increases in cardiovascular morbidity and mortality. In this study we 
have demonstrated, for the first time, that in patients with coronary heart 
disease reducing personal exposure to urban airborne particulate matter by 
means of a simple facemask appears to be associated with a reduction in 
symptoms, and objective improvements in myocardial ischaemia, blood 
pressure and heart rate variability. Reducing personal exposure to 
particulate air pollution has the potential to reduce the incidence of 
cardiovascular events in patients with coronary heart disease living and 
working in industrialized or urban environments. 
 
Using a robust PROBE design, we have conducted the first randomised 
controlled trial to assess the impact of reducing personal air pollution 
exposure in patients with coronary heart disease in a polluted urban 
environment. Through the use of portable monitoring devices and sample 
collection, we have undertaken a very detailed and sophisticated 
characterisation of air pollutant exposure that has highlighted the 
remarkably complex and toxic composition of ambient air particulate with its 
extremely high pro-oxidative potential. We have combined this 
individualised pollution monitoring with a comprehensive cardiovascular 
assessment that incorporates haemodynamic and electrophysiological 
monitoring in conjunction with GPS tracking. Despite only reducing 
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exposure for a 48-hour period in patients chronically exposed to a polluted 
urban environment, we have shown consistent beneficial effects on a range 
of biomarkers of cardiovascular health following the introduction of this 
simple but highly efficient facemask intervention.  
 
7.5.1 Myocardial ischaemia 
In a cohort of 20 men with stable asymptomatic coronary disease, we 
demonstrated greater exercise-induced maximum ST segment depression 
during exposure to diesel exhaust [Mills, et al. 2007]. However, although 
acute air pollution exposure exacerbates myocardial ischaemia, many people 
around the world are chronically exposed to high levels of air pollution and 
it is unknown whether interventions targeted at reducing exposure will 
decrease myocardial ischaemia.  
 
In the present study, we have shown that in patients with coronary heart 
disease decreasing personal exposure to ambient air pollution reduces 
maximal ST segment depression over a 24-hour period. The significance of 
silent myocardial ischaemia is still debated but it is associated with increases 
in major cardiac events in the general population. Moreover in patients with 
recent myocardial infarction or unstable angina, the occurrence of silent 
ischaemia is a poor prognostic factor and is associated with around a three-
fold increase in major cardiac events and death [Cohn, et al. 2003]. It seems 
plausible therefore that the modest reduction in silent myocardial ischaemia 
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seen in this study is likely to be of benefit and may, if sustained, result in 
significant reductions in major cardiac events and cardiovascular mortality. 
 
7.5.2 Blood pressure 
Chronic exposure to air pollution is associated with increases in blood 
pressure in large epidemiological studies [Auchincloss, et al. 2008]. Similarly 
controlled exposure to concentrated ambient particles and ozone in healthy 
volunteers results in an acute increase in diastolic blood pressure [Urch, et al. 
2005]. Hypertension is a major risk factor for the development of 
atherosclerosis and acute increases in blood pressure may trigger plaque 
rupture leading to an acute cardiovascular event. Consistent with this, 
exercise-related increases in blood pressure are predictive of the incidence of 
myocardial infarction [Mundal, et al. 1996], stroke [Kurl, et al. 2001], and 
cardiovascular mortality [Kikuya, et al. 2000]. 
 
In healthy volunteers (chapter 6), reducing personal particulate air pollution 
exposure with a facemask reduced exercise-related systolic blood pressure 
by 7 mmHg [Langrish, et al. 2009]. This is consistent with the current 
findings, although the lower workload of this older population with heart 
disease and the modifying effects of antihypertensive medication use are 
likely to have contributed to the lower reduction in pressure of 3 mmHg 
[Barclay, et al. 2009]. However, if replicated on a population level, such 
modest changes in blood pressure will be associated with fewer major 
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cardiovascular events, as seen in many interventional trials of blood pressure 
reduction. 
 
7.5.3 Heart rate variability 
Heart rate variability is a reflection of the autonomic control (a balance of the 
sympathetic and parasympathetic nervous systems) of the heart and is a 
measure of the variation in the RR intervals on a continuous 
electrocardiogram. A reduction in heart rate variability has been 
demonstrated in a variety of pathophysiological conditions including 
hypertension, heart failure, and diabetes mellitus. Indeed, reduced heart rate 
variability has been linked to increased cardiovascular mortality [Nolan, et al. 
1998]. There are now a large number of studies linking exposure to air 
pollutants with a reduction in heart rate variability [Brook, et al. 2010]. 
 
Here, we have shown that reducing personal exposure to particulate air 
pollution in patients with coronary heart disease is associated with an 
improvement in heart rate variability during exercise in both general 
measures of variability and in specific frequency bands. In this study, the 
changes demonstrated were predominantly in the HF-power (high-
frequency power) band, which is associated with changes in 
parasympathetic tone, and an improvement may suggest an increased 
contribution of vagal tone to heart rate control. In this study we 
demonstrated that the high-frequency components of HRV were actually 
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higher during exercise than over the 24-hour period. This is an unusual 
finding, and we would expect the HF components to be reduced during 
exercise as the physiological response to increased physical exercise if vagal 
withdrawal. This may be a reflection of the lower quality data from the 24 
hour recording limiting the comparison here. 
 
In our previous healthy volunteer study [Langrish, et al. 2009], heart rate 
variability increased following the facemask intervention although changes 
were seen predominantly in the LF-power band – suggesting effects on 
sympathetic nervous system control. We suggest that this difference (HF-
power vs. LF-power changes) arises as a result of the high use of beta-blocker 
therapy (74% of patients), which is likely to modify any changes in 
sympathetic tone. The significance of acute changes in heart rate variability is 
not clear, although it has been demonstrated that the higher the variability, 
the lower the cardiovascular mortality [Kikuya, et al. 2000]. We suggest that a 
sustained improvement in heart rate variability has the potential to improve 
patients’ prognosis and reduce the impact of air pollution on cardiovascular 
morbidity and mortality. 
 
7.5.4 Symptoms 
Patients perceived an increase in general well-being, a reduction in effort of 
work, and a decline in the background pollution levels when they wore the 
facemask. Whilst we observed no change in the occurrence of anginal 
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symptoms, this is perhaps not surprising given that we recruited a highly 
selected population with stable coronary disease, without significant clinical 
angina, who were maintained on optimal medical therapy. 
 
7.5.5 Limitations 
We chose a PROBE study design because we wanted to determine the 
acceptability of wearing a facemask, as well as its potential beneficial effects 
on both symptoms and objective measures of cardiovascular health. We 
recognise that a double-blind approach incorporating a sham mask has the 
benefits of reducing the potential for subjective bias and being more 
scientifically robust [Smith, et al. 2007] In addition we acknowledge that such 
an intervention may be more readily accepted in Chinese and Asian societies 
where the wearing of a facemask is more common-place due to concern over 
airborne diseases, pollution and even fashion, and furthermore that this may 
have affected patients’ reporting of symptom improvement. However, even 
a sham mask will filter air pollutants to some degree [Langrish, et al. 2009] 
and true blinding is difficult to achieve given that large differences in mask 
efficiency would be readily apparent to trial participants and alterations in 
mask design obvious to investigators. It would also be anticipated that the 
greater effort of breathing through a mask during exercise would lead to an 
increase in blood pressure rather than the reverse.  
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We have assessed an acute intervention and it remains to be seen whether 
wearing a facemask for more prolonged periods would have sustained 




In this randomised controlled crossover intervention trial, we have shown 
for the first time that reducing personal exposure to particulate air pollution 
appears to be associated with small but consistent objective improvements in 
myocardial ischaemia, exercise-related increases in blood pressure and heart 
rate variability in patients with coronary heart disease. Strategies to reduce 
urban air pollution exposure have the potential to reduce the incidence of 






























Conclusions and Future Directions 
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8.1 Conclusions 
Air pollution is emerging as a major risk factor for cardiovascular disease, 
and in epidemiological studies exposure to particulate air pollution is 
consistently associated with small increases in cardiovascular morbidity and 
mortality [Brook, et al. 2010]. Acute exposure to air pollution, and 
particularly that derived from vehicle exhaust has been linked to the 
triggering of myocardial infarction [Bhaskaran, et al. 2011; Peters, et al. 2004]. 
Indeed, a recent meta-regression of factors causing the triggering of 
myocardial infarction suggests that on a population level, given the 
ubiquitous nature of exposure, inhalation of traffic-derived air pollution has 
the highest population-attributable fraction [Nawrot, et al. 2011] and is 
certainly on a par with well-recognised risk factors such as physical exertion 
[Newby 2010]. 
 
Controlled exposure studies in humans are ideal for investigating the acute 
effects of exposure to air pollutants [Langrish, et al. 2010]. Dilute diesel 
exhaust has been used as a model exposure as it is simple to generate, can be 
carefully controlled and is directly relevant to everyday exposures as it has 
been shown that in the urban environment up to 40% of the airborne 
particulate matter is derived from diesel exhaust engines [Zheng, et al. 2007]. 
Previous work has demonstrated that following inhalation of diesel exhaust 
there is an increase in arterial vasoconstriction [Peretz, et al. 2008] and an 
increase in central arterial stiffness [Lundback, et al. 2009]. During the 
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exposure there is an increase in blood pressure [Urch, et al. 2005] and in 
myocardial ischaemia measured using electrocardiography [Mills, et al. 
2007]. Following exposure, changes in vascular endothelial function have 
been demonstrated, with impairment of vascular vasomotor function and 
endogenous fibrinolysis [Mills, et al. 2005]. Furthermore, exposure to dilute 
diesel exhaust leads to an activation of platelets and an increase in overall 
thrombotic tendency [Lucking, et al. 2008]. 
 
Whilst these observations provide mechanisms whereby exposure to air 
pollutants may result in acute cardiovascular events, many unanswered 
questions remain. Here we have investigated the role of different air 
pollutants, the mechanisms underlying the changes in vascular endothelial 
function and begun to address the important public health question of how 
we can protect the vulnerable from the adverse effects of air pollution 
exposure. 
 
8.1.1 Exposure to nitrogen dioxide is not associated with vascular 
dysfunction in man 
Air pollution is a complex mixture of gaseous, volatile and particulate matter 
and the contribution of each individual component in the adverse effects of 
exposure are unknown. Using a robust randomised double-blind controlled 
crossover design 10 healthy volunteers were exposed to filtered air and 
nitrogen dioxide (4 ppm) for 1 hour with intermittent exercise. We have 
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demonstrated for the first time that exposure to nitrogen dioxide, a principal 
gaseous pollutant associated with combustion-derived air pollution, is not 
associated with any vascular vasomotor or fibrinolytic dysfunction. The 
adverse cardiovascular effects of combustion-derived air pollution appear to 
be mediated via components other than nitrogen dioxide, and it is plausible 
that these vascular effects are rather driven by the fine and ultrafine particle 
fractions [Langrish, et al. 2010]. 
 
8.1.2 Contribution of endothelin-1 to the vascular effects of diesel 
exhaust inhalation in humans 
The vascular mechanisms underlying the endothelial dysfunction 
demonstrated following dilute diesel exhaust exposure remain unclear. In 
this study we investigated the role of the endogenous vasoconstrictor 
endothelin-1 in these effects. 13 health volunteers were exposed to dilute 
diesel exhaust and filtered air in a double-blind randomised controlled 
crossover study. Diesel exhaust exposure increased vascular sensitivity to 
endothelin-1 and reduced vasodilatation to endothelin-A receptor 
antagonism despite unchanged plasma endothelin concentrations. These 
data demonstrate that the previously documented impairment of 
endothelium-dependent vasodilatation following a one-hour exposure to 
combustion-derived air pollutants is not mediated by an upregulation of the 
endothelin system. Given the tonic interaction between the endothelin and 
nitric oxide systems, our data are consistent with the hypothesis that the 
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diesel exhaust-induced vascular effects are predominantly driven by reduced 
endothelial nitric oxide bioavailability [Langrish, et al. 2009]. 
 
8.1.3 Altered nitric oxide bioavailability contributes to diesel exhaust 
inhalation-induced vascular dysfunction in man 
In our subsequent study, we addressed the hypothesis that nitric oxide 
bioavailability is central to the adverse vascular effects of diesel exhaust 
inhalation. We demonstrated that plasma nitrite, a marker of vascular nitric 
oxide, is increased after diesel exhaust inhalation consistent with homeostatic 
regulation in the presence of increased nitric oxide consumption due to local 
oxidative stress. In the presence of the nitric oxide clamp and the absence of 
endogenous nitric oxide production, diesel exhaust inhalation does not result 
in further vascular impairment. We conclude that the vascular dysfunction 
associated with diesel exhaust inhalation is predominantly mediated by 
reduced nitric oxide bioavailability. 
 
8.1.4 Cardiovascular effects of reducing exposure to particulate air 
pollution with a simple facemask in healthy volunteers 
Air pollution is something to which we are all exposed on a daily basis, and 
as the evidence mounts as to the detrimental effects of exposure on the 
cardiovascular and respiratory systems, the question of how best to protect 
the vulnerable remains. Increasing concern relating to the health effects of air 
pollution has led many individuals to use facemasks to reduce personal 
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exposure, although the efficacy if such a strategy remains unclear. In this 
study we demonstrate for the first time that in health volunteers wearing a 
facemask appears to abrogate the adverse effects of air pollution on blood 
pressure and heart rate variability. This simple intervention has the potential 
to protect susceptible individuals and prevent cardiovascular events in cities 
with high concentrations of ambient air pollution [Langrish, et al. 2009]. 
  
8.1.5 Reducing particulate air pollution exposure in patients with 
coronary heart disease 
We addressed the potential for facemasks to reduce personal exposure to 
particulate air pollution and improve cardiovascular health in patients with 
coronary heart disease, a population thought to be vulnerable to the adverse 
effects of air pollution exposure. The need for such studies was highlighted 
in the recent American Heart Association statement on particulate air 
pollution and cardiovascular disease [Brook, et al. 2010]. 
 
In an open randomised crossover trial, 98 patients with coronary heart 
disease walked on a pre-defined route in central Beijing, China in the 
presence and absence of a highly efficient facemask.  
 
We demonstrated for the first time that in patients with coronary heart 
disease reducing personal exposure to urban airborne particulate matter by 
means of a simple facemask appears to be associated with a reduction in 
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symptoms, and objective improvements in myocardial ischaemia, blood 
pressure and heart rate variability. We conclude that reducing personal 
exposure to particulate air pollution has the potential to reduce the incidence 
of cardiovascular events in patients with coronary heart disease living and 
working in industrialized or urban environments as well as improving 
patients’ general well-being. 
 
8.2 Future directions 
A number of important questions have arisen from the results and peer 
review of our studies that we plan to explore in future work. 
 
8.2.1 How do inhaled particles influence the vascular endothelium? 
It is now well established that inhalation of particulate air pollution results in 
acute vascular effects and in our studies we have addressed a number of the 
vascular endothelial mechanisms that may underlie these effects. A 
fundamental question of how these particles influence the vascular 
endothelium however remains: namely whether inhaled particles cause a 
local inflammation within the lung and then secondary inflammatory 
mediators cross into the bloodstream and affect the vascular endothelium, or 
whether the particles themselves can access the bloodstream and have a 
direct influence [Mills, et al. 2009]. Previous attempts to address this 
fundamental question have been inconclusive, predominantly due to the 
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difficulties of labelling particles [Mills, et al. 2006; Möller, et al. 2008; 
Nemmar, et al. 2002]. 
 
We plan to investigate this further in man using a model particle exposure. 
Twelve healthy male volunteers will be exposure to an aerosol of gold 
nanoparticles generated in a spark generator for 2 hours during intermittent 
exercise. Gold particles have been chosen as they are of a similar size to air 
pollution particles, are relatively inert, can easily be measured in blood and 
urine and are currently under development as a clinical imaging contrast 
agent and for drug delivery [Thakor, et al. 2011]. Blood samples will be taken 
over the 24 hours after exposure, and urine collected for 24 hours and 
analysed for the presence of gold using high-resolution inductively-coupled 
plasma mass spectroscopy. 
 
The results from this study will clarify the fundamental mechanism by which 
particles enter the body and exert their influence on the cardiovascular 
system. In order to protect the general population, particularly those in high-
risk groups, from the adverse effects of exposure to airborne particulate 
matter it is crucial to understand this step. If particles themselves are capable 
of crossing into the bloodstream, then pharmacological interventions, or 
alterations in the surface chemicals adsorbed onto the particles are unlikely 
to have a big impact on limiting the harmful effects, thus focussing attention 
again on reducing individuals’ exposure. 
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The findings from this study not only have relevance in the study of 
atmospheric air pollution, but also within the continually expanding field of 
nanotechnology. Engineered nanoparticles are already being employed in a 
staggering array of products and their use is rapidly growing. Occupational 
exposure to engineered nanoparticles is therefore a concern, and is likely to 
affect a growing number of the population in the future. Understanding the 
risks associated with such exposures, and the fundamental mechanisms 
underlying the risk, is key to protecting the workforce and limiting harm. 
 
 
8.2.2 If particles do translocate into the bloodstream, is this via the 
lungs or the gastrointestinal tract? 
Following on from the above study, if we are able to identify that particles 
can be detected in blood and urine following exposure, the route of uptake 
still remains unclear. Although most particles will be inhaled deep into the 
respiratory tree and are retained there for a long period of time [Möller, et al. 
2008], many particles will also be swallowed into the gastrointestinal tract by 
collecting in saliva or by transport via the mucociliary escalator.  
 
Ten healthy male volunteers will be recruited and in a similar design to the 
previous study will be asked to drink a suspension of gold nanoparticles 
generated as previously but collected in distilled water, before blood samples 
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and a 24 hour urine collection are performed to determine whether particles 
can be detected in the bloodstream or not. 
 
The results from this study will clarify whether the main route of access to 
the body of airborne particulate matter is through inhalation or by ingestion 
of particles trapped in saliva or respiratory tract secretions. To date, studies 
have focussed on inhalation alone as the route of exposure of patients and all 
interventions have been targeted within the lungs or using respiratory 
protection. Should particles be capable of accessing the body through the 
gastrointestinal tract then this would provide another avenue of study and 
another potential target for limiting the adverse effects of air pollutants. As 
with the proposed gold inhalation study, the findings from this study not 
only have relevance in the study of atmospheric air pollution, but also within 
the continually expanding field of nanotechnology.  
 
8.2.3 What is the role of nitric oxide bioavailability on systemic 
haemodynamics following diesel exhaust exposure? 
Following on from our studies investigating the effects of local nitric oxide 
synthase inhibition, we plan to study the effect of nitric oxide inhibition on 
systemic haemodynamics. Sixteen healthy volunteers will be recruited for a 
randomised double-blind crossover study and will be exposure to dilute 
diesel exhaust and filtered air during intermittent exercise. After the 
exposure, continuous measurements of blood pressure will be recorded by 
-201- 
means of a radial artery catheter inserted under aseptic conditions and 
central arterial stiffness measured using peripheral arterial tonometry. 
Cardiac output and systemic vascular resistance will be determined using 
thoracic bioimpedance  (Hotman®, HemoSapiens, USA). Recordings will be 
taken with subjects lying quietly at rest before the intravenous infusion of L-
NMMA at 3mg/kg over 5 mins followed by normal saline for 10 mins and 
nor-epinephrine at 50 ng/kg/min for 15 mins in a randomised double-blind 
fashion. Recordings will be performed during the infusions and for the 
following 45 minutes, at which time we anticipate responses will have 
returned to baseline. 
 
The vascular endothelium is critical in ensuring the health of our 
cardiovascular system. Changes in endothelial function precede the 
development of clinically relevant atherosclerotic diseases and acute 
cardiovascular events. Understanding the effect of exposure to air pollution 
on nitric oxide bioavailability is crucial both in explaining the current 
observations, but also in designing interventions to protect the population 
against adverse effects in the future. 
 
8.2.4 What is the role of the autonomic nervous system in the adverse 
vascular effects of air pollution exposure? 
Exposure to particulate air pollution is consistently associated with changes 
in heart rate variability, an indirect marker of sympathetic and 
-202- 
parasympathetic nervous system activity [Brook, et al. 2010]. Furthermore, 
acute exposure to particulate air pollution and dilute diesel exhaust is 
associated with increases in blood pressure [Langrish, et al. 2009; Urch, et al. 
2005], increased vascular tone [Brook, et al. 2002; Peretz, et al. 2008], central 
arterial stiffness [Lundbäck, et al. 2009] and myocardial ischaemia [Mills, et 
al. 2007], all of which may be mediated by autonomic nervous system 
activity. Furthermore, our observations that the vascular endothelial effects 
are driven predominantly by changes in nitric oxide bioavailability also 
highlight the possible contribution of the autonomic nervous system. The 
nitric oxide system within the vasculature is intimately linked to the 
autonomic nervous system and dysregulation of either influences the other 
[Zanzinger 1999]. 
 
We therefore propose to investigate the role of the autonomic nervous 
system in the adverse cardiovascular effects of air pollution exposure 
directly. Sixteen healthy male volunteers will be recruited and exposed to 
dilute diesel exhaust or filtered air during intermittent exercise as previously. 
Direct measurement of sympathetic nervous system activity will be 
performed using microneurography and measurement of muscle 
sympathetic nerve activity from the peroneal nerve during intermittent 
autonomic stress by means of the cold pressor test, valsalva manoeuvre, 
deep breathing techniques and lower-body negative pressure as described 
previously [Burke, et al. 2011]. Simultaneous continuous blood pressure, 
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systemic vascular resistance and cardiac output will be recorded using a 
Portapres® (Finapres Medical Systems, Amsterdam, Netherlands) and blood 
and urine samples collected for measurement of catecholamines. 3-lead 
continuous electrocardiography will be performed for measurement of heart 
rate variability. 
 
The autonomic nervous system plays an important role in vascular 
haemostasis and is known to be upregulated in states such as cardiac failure. 
The adverse effects of the autonomic nervous system are readily treated with 
simple pharmacological agents (i.e. beta-blockers) currently used in clinical 
practice. The utility of such agents in limiting harm from exposure is unclear, 
although it is recognised that the effect of exposure is generally lower in 
patients maintained on such medications [Barclay, et al. 2009]. 
Understanding the role of the autonomic nervous system will both further 
the understanding of the fundamental mechanisms underlying the adverse 
effects of exposure, but also lead the way for intervention trials in the future. 
 
8.2.5 Does inhalation of dilute diesel exhaust exacerbate symptoms of 
angina and markers of myocardial ischaemia in patients with stable 
angina pectoris? 
Inhalation of dilute diesel exhaust has been shown to increase sub-clinical 
myocardial ischaemia as measured using 12-lead continuous 
electrocardiography in patients with stable asymptomatic coronary heart 
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disease [Mills, et al. 2007]. The question of whether this will have an 
important functional consequence on patients with coronary heart disease 
remains. Twenty patients with stable angina pectoris and documented 
coronary heart disease will be recruited from the Royal Infirmary of 
Edinburgh cardiology department. In a randomised double-blind crossover 
study, subjects will attend on 4 separate occasions and will be exposed to 
filtered air, and three concentrations of dilute diesel exhaust (30, 100 and 300 
!g/m3) for 1 hour during intermittent exercise as previously. Continuous 12-
lead electrocardiography will be performed, and subjects will complete a 
detailed symptom questionnaire. Immediately following the exposure, 
subjects will complete a symptom limited submaximal treadmill exercise 
stress test using the standard BRUCE protocol, and time to symptoms and 
time to 1 mm ST segment depression recorded. Blood samples will be 
collected and analysed for highly sensitive biomarkers of ischaemia 
including ischaemically-modified albumin and ultra-sensitive troponin I 
(Singulex, Alameda, CA, USA). 
 
The acute and chronic effects of exposure, whilst still incompletely 
understood, are now well-documented and help to explain the 
epidemiological associations with cardiovascular morbidity and mortality. 
However, the key for patients with coronary heart disease is whether these 
effects result in changes in the clinical syndrome of angina pectoris. 
Understanding this important element will enable us to better advise 
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patients with pre-existing cardiovascular conditions, and tailor our 
treatments more effectively. It may enable the targeted use of interventions 
such as facemasks to those at highest risk to limit the clinically apparent 
effects of exposure. 
 
8.2.6 Does inhalation of dilute diesel exhaust reduce myocardial 
perfusion? 
Following on from the above question, twenty subjects with ischaemic heart 
disease will be recruited from the Royal Infirmary of Edinburgh cardiology 
department. In a randomised double-blind crossover study, subjects will be 
exposed to filtered air and dilute diesel exhaust during intermittent exercise. 
Following the exposure, myocardial perfusion will be measured using CT-
PET and dobutamine stress as previously described [Di Carli, et al. 2007]. 
 
The electrocardiographic changes during exposure to particulate air 
pollution are well-documented [Mills, et al. 2007] and suggest an increase in 
acute myocardial ischaemia. Similarly, there are documented effects on 
vascular vasomotor function that may explain the mechanism of reduced 
coronary artery flow. It remains to be shown however, whether exposure can 
indeed reduce myocardial blood flow and alter perfusion, factors clearly 
important both to the individual patient and in advising patients with pre-




In these studies, we have demonstrated that the adverse vascular effects of 
exposure to air pollution are driven predominantly by airborne particulate 
matter, and result in vascular endothelial effects which appear to be 
predominantly driven by changes in nitric oxide bioavailability. 
Furthermore, we have demonstrated that by reducing personal exposure to 
particulate air pollution we can reduce the adverse effects on blood pressure, 
autonomic control of the heart, symptoms and myocardial ischaemia. These 
findings help us to understand the pathophysiology underlying the 
epidemiological observations and provide potential therapeutic targets. The 
demonstration of early and important benefits of reducing exposure to 
particulate exposure, alongside epidemiological observations demonstrating 
the effectiveness of interventions to reduce combustion-derived air pollution 
[Clancy, et al. 2002] and tobacco smoke [Meyers, et al. 2009; Pell, et al. 2008] 
(which shares many physical and chemical similarities with particulate air 
pollution) exposure on deaths from cardiovascular disease lend weight to the 
growing lobby to change environmental health policy and improve air 
quality for all. These findings are important worldwide, but perhaps more so 
in countries with developing economies where the rapid expansion of 
industry, road transport and domestic power supplies is driving the 
economic expansion. Air quality in these developing countries is often poor, 
and the need for economic growth understandably is seen to take priority 
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Particle characteristics and chemical composition 
from Beijing, China 
 
Appendix 1. Particle characteristics and chemical composition for particulate matter collected in Beijing China in March 2009. Data is expressed as 
mean concentrations (< represents result below lower limit of detection). Comparator data is shown for 2 European cities (Amsterdam and Rome) 
collected and analysed employing the same techniques in Spring 2009 [courtesy of Dr Miriam Gerlofs, National Institute for Public Health and the 
Environment, Bilthoven, Netherlands]. 
Particle Characteristics in Beijing and 2 
European Comparators 
Beijing 





Coarse Fine Ultrafine Coarse Fine Coarse Fine 
PM2.5-10 PM0.18-2.5 PM<0.18 PM2.5-10 PM0.18-2.5 PM2.5-10 PM0.18-2.5 
Mass, !g/m3 (% total mass) 114 (34%) 
151 






Total carbon (!g/mg dust) 166 497 571 
Not Tested 
Elemental carbon (!g/mg dust) 12 91 99 
Organic carbon (!g/mg dust) 154 445 472 





s Nitrates (!g/mg dust) 93 590 510 121 222 82 106 





































Napthalene (ng/g dust) 2599 3015 4265 5400 2300 220 2400 
Acenaphthylene (ng/g dust) 2107 1771 7315 1100 900 < < 
Acenaphthene (ng/g dust) 3540 2882 3886 15200 < 4000 < 
Flourene (ng/g dust) 3234 2558 3399 8500 800 2600 < 
Phenanthrene (ng/g dust) 1959 3004 3502 21400 22100 9300 7600 
Anthracene (ng/g dust) 1423 1100 1553 1300 3100 800 1700 
Fluoranthene (ng/g dust) 1649 17858 16071 24500 44800 14600 12700 
Pyrene (ng/g dust) 1780 16689 14485 18500 38800 14200 13600 
Benzo[a]anthracene (ng/g dust) 1728 9501 7343 1600 8600 1500 7400 
Chrysene (ng/g dust) 2323 22107 21533 3500 20700 3300 13600 
Benzo[b]fluoranthene (ng/g dust) 2235 27478 29031 1900 24200 1200 26200 
Benzo[k]fluoranthene (ng/g dust) 1321 22251 18664 900 6200 900 4800 
Benzo[a]pyrene (ng/g dust) 1781 18099 17762 2400 10300 900 13300 
Ideno[123–cd]pyrene (ng/g dust) 1573 16378 15061 800 9300 700 10500 
Dibenzo[ah]anthracene (ng/g dust) 2108 3510 3359 200 2200 < 1700 









(ng/mg dust) 1"9 2"8 17"1 4"7 7"4 2"8 4"7 








(ng/mg dust) 3"2 1"8 24"7 1"0 3"2 1"4 3"4 
20R–5!(H),14!(H),17!(H)–Cholestane 
(ng/mg dust) 0"0 1"3 14"7 1"1 0"9 0"7 0"9 
20R–5!(H),14"(H),17"(H)–24S–
methycholestane (ng/mg dust) 0"0 1"2 12"2 0"6 2"3 1"0 3"4 
20R–5!(H),14"(H),17"(H)–24R–











Aluminium (ng/mg dust) 18733 4093 7486 5954 3564 32514 15764 
Antimony (ng/mg dust) 64 71 75 173 96 145 121 
Barium (ng/mg dust) 2403 678 968 267 117 350 124 
Cadmium (ng/mg dust) 8 30 27 3 11 2 10 
Calcium (ng/mg dust) 64357 12854 20119 18562 3810 47683 13370 
Cerium (ng/mg dust) 50 12 17 11 3 46 21 
Chromium (ng/mg dust) 78 60 58 74 42 93 56 
Copper (ng/mg dust) 303 292 313 638 279 518 272 
Iron (ng/mg dust) 38976 11045 14001 20488 7638 28820 12880 
Lanthanum (ng/mg dust) 25 5 9 7 3 21 9 
Lead (ng/mg dust) 228 1364 1277 111 324 106 364 
Magnesium (ng/mg dust) 18799 3791 6293 23384 10736 15581 6936 
Manganese (ng/mg dust) 847 629 665 359 232 440 243 
Neodymium (ng/mg dust) 20 4 6 3 < 18 7 
Nickel (ng/mg dust) 85 57 70 78 204 47 82 
Potassium (ng/mg dust) 8211 17556 17246 7007 2837 6878 5190 
Silicon (ng/mg dust) 2396 1659 2669 11137 < 59812 28108 
Sodium (ng/mg dust) 9475 5060 5679 22517 4687 7031 2540 
Strontium (ng/mg dust) 326 85 125 122 38 50 29 
Sulphur (ng/mg dust) 13060 33606 32504 Not Tested 























Patient symptom questionnaire 
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Symptom Score Sheet – Before Walk 
Mask over past 24 hours?   Yes !  No ! 
Draw a cross on the lines below….. 














Irritation of the 
eyes: 
 
Irritation of the 
throat: 
 





Bad taste in the 
mouth: 
 
Working scale – how hard has walking today been? 
 
     Very easy                  Impossible 
 
Perception of pollution – how bad do you think it is today?  
 
    None at all                  Worst ever 
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Symptom Score Sheet – After Walk 
Mask during the walk?   Yes !  No ! 
Draw a cross on the lines below….. 














Irritation of the 
eyes: 
 
Irritation of the 
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Bad taste in the 
mouth: 
 
Working scale – how hard has walking today been? 
 
     Very easy                  Impossible 
 
Perception of pollution – how bad do you think it is today?  
 
    None at all                  Worst ever 
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Symptom Score Sheet – 24 hours 
Mask over past 24 hours?   Yes !  No ! 
Draw a cross on the lines below….. 














Irritation of the 
eyes: 
 
Irritation of the 
throat: 
 





Bad taste in the 
mouth: 
 
Working scale – how hard has walking today been? 
 
     Very easy                  Impossible 
 
Perception of pollution – how bad do you think it is today?  
 
    None at all                  Worst ever 
 
How tolerable did you find wearing the mask (if applicable)? 
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Impaired vascular function after exposure to
diesel exhaust generated at urban transient
running conditions
Stefan Barath1,2, Nicholas L Mills3, Magnus Lundbäck1,2, Håkan Törnqvist1,2, Andrew J Lucking3, Jeremy P Langrish3,
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Abstract
Background: Traffic emissions including diesel engine exhaust are associated with increased respiratory and
cardiovascular morbidity and mortality. Controlled human exposure studies have demonstrated impaired vascular
function after inhalation of exhaust generated by a diesel engine under idling conditions.
Objectives: To assess the vascular and fibrinolytic effects of exposure to diesel exhaust generated during urban-
cycle running conditions that mimic ambient ‘real-world’ exposures.
Methods: In a randomised double-blind crossover study, eighteen healthy male volunteers were exposed to diesel
exhaust (approximately 250 !g/m3) or filtered air for one hour during intermittent exercise. Diesel exhaust was
generated during the urban part of the standardized European Transient Cycle. Six hours post-exposure, vascular
vasomotor and fibrinolytic function was assessed during venous occlusion plethysmography with intra-arterial
agonist infusions.
Measurements and Main Results: Forearm blood flow increased in a dose-dependent manner with both
endothelial-dependent (acetylcholine and bradykinin) and endothelial-independent (sodium nitroprusside and
verapamil) vasodilators. Diesel exhaust exposure attenuated the vasodilatation to acetylcholine (P < 0.001),
bradykinin (P < 0.05), sodium nitroprusside (P < 0.05) and verapamil (P < 0.001). In addition, the net release of
tissue plasminogen activator during bradykinin infusion was impaired following diesel exhaust exposure
(P < 0.05).
Conclusion: Exposure to diesel exhaust generated under transient running conditions, as a relevant model of
urban air pollution, impairs vasomotor function and endogenous fibrinolysis in a similar way as exposure to diesel
exhaust generated at idling. This indicates that adverse vascular effects of diesel exhaust inhalation occur over
different running conditions with varying exhaust composition and concentrations as well as physicochemical
particle properties. Importantly, exposure to diesel exhaust under ETC conditions was also associated with a novel
finding of impaired of calcium channel-dependent vasomotor function. This implies that certain cardiovascular
endpoints seem to be related to general diesel exhaust properties, whereas the novel calcium flux-related effect
may be associated with exhaust properties more specific for the ETC condition, for example a higher content of
diesel soot particles along with their adsorbed organic compounds.
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Background
Increasing attention has been directed towards the
adverse health effects associated with particulate matter
(PM) air pollution in terms of both respiratory and car-
diovascular morbidity and mortality [1-3]. Changes in
air pollution levels over previous decades account for as
much as 17% of the change in life expectancy over this
period [4]. Several studies have pointed towards traffic-
related air pollution as being of particular concern.
Living or going to school in proximity to major thor-
oughfares is associated with reduced lung growth in
children and increased risk of asthma, as well as cardio-
vascular events including increased atherosclerosis and
left ventricular hypertrophy in adult populations [5-10].
In a pivotal study, Peters and co-workers demon-
strated that patients admitted with myocardial infarction
were three times more likely to have been in traffic in
the hours prior to the onset of symptoms, suggesting a
causal link to the triggering of acute coronary events.
The authors identified an association between traffic
exposure and the onset of chest pain immediately and
six hours prior to the event, indicating that more than
one mechanism is likely to be involved [11].
Emissions from motor vehicles, in particular combus-
tion-derived particles from diesel engines, contribute to up
to 40% of urban PM and are thought to play a major role
in the adverse effects of PM. Experimental exposure stu-
dies in healthy and asthmatic individuals have demon-
strated oxidative stress, airway inflammation and
worsening of asthma, as well as acute cardiovascular events
[12-17]. Recent studies have confirmed that diesel exhaust
(DE), generated during idling engine conditions, causes
endothelial dysfunction, arterial stiffness, decreased fibri-
nolytic capacity, increased platelet activation and increased
ex-vivo thrombus formation in the first 24 hours following
exposure [12-14,18]. Furthermore, patients with stable cor-
onary heart disease experienced more ST-segment depres-
sion with exercise during exposure to diesel exhaust as
compared to filtered air [19]. Additionally, diesel exhaust
inhalation impaired endogenous fibrinolytic capacity in
these patients with reduced endothelial release of tissue
plasminogen activator (t-PA) six hours following exposure.
The time course of these adverse vascular and prothrom-
botic effects is consistent with the observation of an
immediate and delayed association between traffic expo-
sure and the onset of acute myocardial infarction [20].
Diesel exhaust particles (DEP) generated under differ-
ent engine running conditions vary in size and chemical
composition. It is therefore of interest to elucidate the
associations between physicochemical properties of the
DEP and health effects caused by exposure to DE gener-
ated under various engine running conditions. In general,
the mass of emitted DEP is often dominated by
carbonaceous agglomerated soot particles, typically 50-
300 nm, while the number concentration is dominated
by smaller particles, below 50 nm, mainly composed of
volatile organic material and sulphur compounds.
Adsorbed organic compounds, as well as small amounts
of sulphate, nitrate, metals and other trace elements are
generally also associated with the diesel exhaust. Further,
a fraction of fuel and lube oil generally escape oxidation
in the engine and are emitted as exhaust PM, consisting
of different organic compounds including polycyclic aro-
matic hydrocarbon (PAH) compounds [21,22].
People living in urban areas are mainly exposed to
particulate emissions generated during acceleration and
deceleration conditions rather than from idling engines.
We have therefore designed a human exposure system
using the standardized European Transient Cycle (ETC)
urban sequence that better reflects the exposures gener-
ated in ambient urban settings. The aim of the present
study was to determine whether inhalation of dilute die-
sel exhaust generated during the ETC urban sequence
would affect vasomotor function and fibrinolytic capa-
city in healthy human subjects, in a similar or different




Eighteen healthy non-smoking males mean age 27 years
(range 21-30 years) with normal lung function were
included in the study, following a standardized clinical
examination. All were free from symptoms of respira-
tory tract infections for at least 6 weeks prior to and
during the study. Female subjects were not included due
to the potential for cyclical hormones to affect vascular
responses. The study was approved by the local ethics
committee. All volunteers gave their written informed
consent and the study was performed in accordance to
the Declaration of Helsinki.
Study design
The subjects were exposed to filtered air and diesel
exhaust for one hour according to a randomized, dou-
ble-blind, cross-over design with an interval of 42 (22-
62) days between visits [15,23]. During each exposure,
the subjects performed moderate exercise (average min-
ute ventilation, 20 L/min/m2 body surface) on a bicycle
ergometer alternating with rest at 15-minute intervals.
Based on previous exposure studies exploring respira-
tory and cardiovascular effects of diesel exhaust
[12,13,15,17], vascular assessments using venous forearm
plethysmography were performed 6-hours after diesel and
filtered air exposure. All subjects refrained from alcohol
for 24-hours and from food and caffeine-containing
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beverages for at least 4-hours before each vascular study.
They were not allowed to carry out strenuous exercise
during the day of exposure. The studies were carried out
in a quiet, temperature-controlled room maintained at
22°C to 24°C, with subjects in the supine position.
Diesel exhaust exposure
The exposures were performed in a specially built and
validated human exposure chamber that has been
described in detail elsewhere [23]. Diesel exhaust (DE)
was generated by a diesel engine from 1991 (Volvo
TD40 GJE, 4.0 L, four cylinders) connected to an engine
dynamometer and running under control of a computer
program according to the European Transient Cycle
(ETC). The ETC is a well-established running condition
for standardized tests of engines and vehicles and is
designed to mimic real life running conditions for vehi-
cles in an urban environment. As such, it is based on
authentic recordings of accelerations and retardations,
with variations in engine load as well as periods with
constant speed. The running of the engine was con-
trolled adjusting the actions of the injection system and
an engine dynamometer that varied the load of the
engine. The ETC test cycle has been introduced
together with the European Stationary Cycle (ESC), for
emission certification of heavy-duty diesel engines in
Europe (Directive 1999/96/EC). The ETC comprises
three different driving conditions, including urban, rural
and motorway. In this study we used only the urban
driving part, representing city driving with a maximum
speed of 50 km/h, frequent starts, stops, and idling, i.e.
transient engine running conditions (Figure 1).
The diesel fuel used was Statoil class 1; cetane number
54; aromatics, 4% volume; polycyclic aromatic hydrocar-
bons, < 0.02 vol-%; sulphur < 1ppm. The initial boiling
point was 195°C and 95% volume boiling point was
280°C. More than 90% of the exhaust was shunted away
and the remaining part was accumulated in an approxi-
mately 1 m3 container in order to smooth the concen-
tration variation during the transient running
conditions. A partial flow of DE was continuously
drawn from the container, diluted with filtered air and
fed into the exposure chamber, giving a particle mass
concentration of approximately 250 !g/m3 in the expo-
sure chamber.
The particle mass concentration (as PM10) of diesel
exhaust particles (DEP) in the chamber during the expo-
sures was measured gravimetrically employing standard
glass fibre filter sampling as well as monitored with a
Tapered Element Oscillating Microbalance (TEOM
1400) instrument (at 50°C). Measurements of NOx, NO
and NO2 were performed with standard instruments
using a chemiluminescence technique (ECO Physics
CLD 700 AL Med, Switzerland). Total hydrocarbon in
the exposure aerosol was measured using a flame ioniza-
tion detection method (Hydrocarbon Analyzer, Model 3-
300, JUM Engineering Co, Oakland, California, USA).
Data on exposure characteristics are given in Table 1.
Extensive physicochemical characterisation of the DEP
in the chamber was performed on a single occasion
after the campaign, but under the same conditions as
during the exposures. The aerodynamic particle mass
size distribution in the range of 0.03-10 !m was deter-
mined using a 13 stage low-pressure cascade impactor
(Dekati Ltd, Tampere, Finland). As seen in Figure 2, fine
particles (< 1 !m) totally dominated the PM mass in the
chamber and the fine mode aerodynamic mass median
diameter (MMDa) was determined to be 116 nm
(Table 1).
A scanning mobility particle sizer (SMPS) was used to
classify the particles regarding their number, size distri-
bution and concentration within 0.013 to 0.380 !m
(equivalent mobility diameter). The system consisted of
a differential mobility analyzer (DMA) (TSI model
3071A, TSI, St Paul, Minnesota, USA) and a condensa-
tion particle counter (CPC) (TSI model 3010, TSI,
St Paul, Minnesota, USA). Relatively long scan times,
i.e. 120 s up and 40 s down, were used to enable pur-
ging of the system between the scans. Aerosol flow was
set to 1 L/min and sheath air flow to 7 L/min. The aver-
age total number concentration of fine particles in the
chamber (normalized to a mass concentration of 300
!g/m3) and average count median (equivalent mobility)
diameter (CMDm) are shown in Table 1 and Figure 3.
The DEP were characterized chemically regarding car-
bon fractionation (organic/elemental carbon), PAH and
trace elements. The fraction of organic and elemental
carbon of the PM in the chamber was determined by
thermal-optical carbon analysis (Method NIOSH 5040)
using quartz and teflon+quartz filters in parallel accord-
ing to standard procedures [24]. “Elemental carbon” is
Figure 1 The urban sequence of the European Transient Cycle
applied in the present study.
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in principle a measure of the soot fraction of samples
and the result therefore implies that the mass of DEP
during the present ETC conditions was dominated by
soot particles (Table 1).
PAH were sampled by glass fiber filter sampling (dia-
meter 47 mm) for the particulate fraction followed by a
polyurethane foam (PUF) plug (diameter 75 mm !
50 mm) for the semi-volatile fraction. Forty-nine PAH
compounds were analyzed by gas chromatography-mass
spectrometry (GC-MS) for quantification in the particu-
late and semi-volatile fractions, respectively, according
to procedures described in more detail elsewhere
[25-27]. A total PAH concentration (normalized to a
mass concentration of 300 !g/m3) of 0.96 !g/m3 was
Table 1 Exposure characteristics of the present study during European Transient Cycle urban conditions compared to






Diesel engine Volvo TD40, 4.0 L, four cylinders Volvo TD45, 4.5 L four cylinders
Diesel fuel Diesel class I Diesel class III
PM10 mass concentration (filter), !g/m
3 254 ± 36 330 ± 12 (3)
PM10 mass concentration (TEOM), !g/m
3 228 ± 19 -
NOx, ppm 7.5 ± 0.3 2.8 ± <0.1
(3)
NO2, ppm 0.9 ± 0.1 0.6 ± <0.1
(3)
NO, ppm 6.6 ± 0.3 2.2 ± <0.1 (3)
Total hydrocarbons (THC), ppm 1.2 ± 0.2 1.6 ± 0.2 (3)
Complementary measurements (1)
Particle number concentration, #/cm3 1.2 ! 105 9.5 ! 105 (4)
Particle count median size (CMDmobility), nm 129 55
(4)
Particle mass median size (MMDaerodynamic) nm 116 199
(4)
Organic carbon fraction (OC/TC(2)), % 12 94.5 (4)
Elemental carbon fraction (EC/TC(2)), % 88 5.5 (4)
Total PAH concentration, !g/m3 0.96 3.5 (4)
Semi-volatile PAH concentration, !g/m3 0.69 3.4 (4)
PM-associated PAH concentration, !g/m3 0.27 0.16 (4)
(1) Particle number and PAH concentrations normalized to a PM mass concentration of 300 !g/m3 to enable a comparison between ETC and idling conditions.
(2) TC = Total carbon content in PM mass
(3) Exposure protocol data from a previously reported study [14]
(4) Un-published DEP characteristics data associated with the exposure conditions during the previously reported studies [12,14]
For the exposure campaign data, mean values are given mean ± std.dev.
Figure 2 Mass size distribution of diluted diesel exhaust
particles in the exposure chamber during the urban running
part of the European Trancient Cycle. MMDa for the fine mode
was 0.116 !m.
Figure 3 Number size distribution of diluted diesel exhaust
particles in the exposure chamber during the urban running
part of the European Transient Cycle. Standard deviations for 3
scans are shown as error bars. A log-normal fitting calculation
showed that the size distribution comprised in principal only one
single mode.
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determined in the chamber distributed as 0.69 !g/m3 in
the semi-volatile fraction and 0.27 !g/m3 as particulate
associated (Table 1). This implies that PAH constituted
< 1% of the total DEP mass in the chamber. During the
idling engine conditions, the PAHs contributing most to
the atmosphere in the exposure chamber were phenan-
threne and methyl derivatives of phenanthrene, equiva-
lent to more than 80% of the PAHs determined. The
corresponding value for the transient engine load (urban
part of ETC) was more than 75%.
Determination of oxidative properties of particles
DEP were collected using a high volume cascade sam-
pler with a multi-stage round slit nozzle impactor,
within the exposure chamber under both idling and
transient (ETC urban part) engine conditions. Coarse
and fine diesel particles were collected onto polyur-
ethane foams by impaction [28] and extracted from the
collection substrate with methanol using extensive vor-
texing and sonication, as described previously [29]. PM
oxidative activity was assessed in a synthetic respiratory
tract lining fluid (RTLF) on an equal mass basis (50 !g/
mL). This involved establishing the capacity of fine
(PM0.1-2.5) and coarse (PM2.5-10) samples to deplete
ascorbate (AA), glutathione (GSH) and urate (UA), each
at a starting concentration of 200 !M, over a 4-h incu-
bation period (37°C). After the 4-h incubation period,
samples were either acidified with metaphosphoric acid
to a final concentration of 5% (w/v) for UA andAA mea-
surement, or diluted into 100 mM phosphate buffer for
the determination of glutathione (GSH). Methodological
details for these antioxidant determinations have been
described previously [30]. The final PM oxidative poten-
tials (OP) were expressed as the percentage loss of
either AA (OPAA) or GSH (OPGSH) over the 4-h incuba-
tion, relative to the particle free control, expressed per
!g of extracted PM. The OP values associated with the
coarse and fine fraction for each antioxidant were com-
bined to derive an expression for PM0.1-10. Urate was
not lost from the synthetic RTLF with any of the PM
samples tested.
Vascular studies
Forearm blood flow (FBF) was measured during unilat-
eral brachial artery infusion of endothelial-dependent
and -independent vasodilators using venous occlusion
plethysmography with mercury-in-silicone elastomer
strain gauges, as described previously [12]. Briefly, the
brachial artery of one arm was cannulated with 27-stan-
dard wire gauge steel needle and 17 gauge venous can-
nulae were inserted in large veins in the antecubital
fossa of both arms. Following a 30-minute baseline sal-
ine infusion, acetylcholine 5, 10, and 20 !g/min
(endothelium-dependent vasodilator which does not
release tissue plasminogen activator [t-PA]; Merck Bios-
ciences); bradykinin at 100, 300, and 1,000 pmol/min
(endothelium-dependent vasodilator which releases t-
PA; Merck Biosciences); and sodium nitroprusside
(SNP) 2, 4, and 8 !g/min (endothelium-independent
vasodilator which does not release t-PA; David Bull
Laboratories) were infused for 6 minutes at each dose
with FBF measured for the last 3 minutes of each infu-
sion. The infusions of the three vasodilators were given
in a random order and separated by 20-minute saline
infusions. Verapamil at 10, 30, and 100 !g/min
(endothelium-and NO-independent vasodilator which
does not release t-PA) was infused at the end of the
study protocol due to its prolonged action. Blood pres-
sure and heart rate were measured during the forearm
study using a validated semi-automated oscillometric
sphygmanometer.
Blood (10 mL) was withdrawn simultaneously from
each arm at baseline and during infusion of each dose
of bradykinin and collected into acidified buffered citrate
(Stabilyte tubes, Biopool International) for tissue plasmi-
nogen activator (t-PA) assay. The samples were kept on
ice until centrifuged at 2,000 g for 30 minutes at 4°C.
Platelet-free plasma was decanted and stored at -80°C
before assay. Plasma t-PA antigen concentrations were
determined by ELISA (TintElize t-PA, Biopool EIA).
Hematocrit was determined by capillary tube centrifuga-
tion at baseline and at the end of the study protocol.
Markers of systemic inflammation
Peripheral blood samples were taken immediately before
and 2 and 6 hours post-exposure and were analyzed for
total and differential cell counts by an autoanalyzer in
the local clinical biochemistry reference laboratory
(Umeå University Hospital, Umeå, Sweden). Serum and
plasma were prepared for measurement of interleukin-6
(IL-6), tumor necrosis factor-alpha (TNF-alpha), soluble
P-selectin, soluble intracellular adhesion molecule-1
(ICAM-1) and CD40 ligand using commercially available
ELISAs (Quantikine, R&D Systems). Serum C-reactive
protein (CRP) was measured using an immunonephelo-
metric assay (Behring BN II nephelometer).
Data analysis and statistics
Plethysmographic data were analyzed as described pre-
viously [31]. The net release of t-PA antigen was defined
as the product of the infused forearm plasma flow
(based on the mean hematocrit and the infused FBF)
and the concentration difference between the infused
and non-infused arms as described previously [31]. Data
were analysed by 2-way ANOVA with repeated mea-
sures or 2-tailed Student’s t-tests, where appropriate,
using GraphPad Prism (GraphPad Software, Version 4
for Macintosh) and SPSS (SPSS inc. Chicago, IL, USA,
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version 15). All data are expressed as mean ± SEM. Sta-
tistical significance was taken at p < 0.05.
Results
Exposure characteristics
Compared to the idling situation, exposure data from
the ETC urban running condition revealed that the par-
ticles were larger but lower in number, despite similar
mass concentration. During ETC, the fraction of organic
carbon/elemental carbon was reduced, indicating higher
soot content, and the total PAH concentration was
reduced compared to the idling situation. Furthermore,
NOx levels were increased under ETC, although the oxi-
dative potential of the diesel particles was reduced
(Table 1).
Oxidative potential
Determination of oxidative potential (OP) of the PM
samples demonstrated that DEP generated under the
present ETC urban engine conditions were less oxidiz-
ing (PM0.1-10 OP
GSH = 0.15 ± 0.12%/!g, PM0.1-10 OP
AA
= 0.25 ± 0.13%/!g) than DEP generated under presently
studied idling engine conditions (PM0.1-10 OP
GSH = 0.43
± 0.11%/!g, PM0.1-10 OP
AA = 0.43 ± 0.16%/!g, ETC ver-
sus idling engine). The oxidative properties observed
from both these experimental tail-pipe emissions were
minor compared with those observed in a previous
study of ambient PM samples collected from roadside
sites (OPGSH = 0.60 ± 0.45 and OPAA = 1.26 ±
0.37) [32].
Vascular and fibrinolytic function
There were no differences in resting heart rate, blood
pressure, or baseline FBF (P > 0.05 for all) after expo-
sure to diesel exhaust or filtered air (Table 2). All infu-
sions of vasoactive drugs increased blood flow in a dose
dependent manner (P < 0.001). Diesel exhaust exposure
significantly attenuated the increase in forearm blood
flow during infusions of both endothelium-dependent
and -independent vasodilators, as compared with filtered
air exposure (P < 0.05 for bradykinin, P < 0.001 for acet-
ylcholine, P < 0.05 for sodium nitroprusside and P <
0.001 for verapamil( Figure 4).The net release of t-PA
following bradykinin infusion was reduced (P < 0.05)
after exposure to diesel exhaust compared with filtered
air (Figure 5).
Systemic inflammation
Peripheral blood leukocyte, neutrophil and platelet
counts, as well as plasma concentrations of TNF-a, IL-
6, soluble P-selectin, soluble ICAM-1, CD40L and CRP
did not differ (P > 0.05 for all) between diesel exhaust
and filtered air exposures (Table 3).
Discussion
We demonstrate that short-term exposure to diesel
exhaust generated under urban transient engine running
conditions, mimicking a ‘real-world’ urban environment,
impairs vascular vasomotor function and endogenous
fibrinolytic function in human subjects. These vascular
effects are consistent with those reported in studies
employing a similar study protocol, but using an idling
engine. This suggests that different diesel engine run-
ning conditions induce similar adverse vascular
responses.
The ETC urban running condition was selected for
this study as it is based on actual recordings from vehi-
cles, and therefore provides a highly relevant model of
ambient air pollution exposures in urban settings.
Whilst the vascular responses were similar after ETC
urban running conditions and idling, it was found that
the chemical and physical properties differed between
exposure situations. The particles generated under the
transient running setting were slightly larger (according
to the mobility diameter, related to the number concen-
tration) and had a higher elemental carbon to organic
carbon ratio, i.e. more soot and less organics, than those
generated from the idling diesel engine. The PAH pro-
files in the present study were also in good agreement
with previous diesel PAH exhaust studies [26,33].
Furthermore, when comparing the PAH profiles from
the idling and the transient running conditions, they
appeared similar, but with the former having more than
4 times greater concentrations of sum PAHs (ng/m3) in
the exposure chamber, mainly related to higher idling
gaseous PAH concentrations. In contrast, PM-associated
PAH concentrations were similar, but differed in profile,
with higher concentrations of phenanthrene, fluor-
anthene and pyrene under transient load and speed con-
ditions (Figure 6). PM-associated PAHs present under
idling conditions were distributed as a higher number of
compounds, including heavier PAH (4-rings) species
(Figure 7). This can be explained by the fact that the
engine’s combustion temperature is at its lowest value
when operating at idling mode. The relatively larger
hydrocarbon emissions at idling reflect unburned fuel
Table 2 Baseline haemodynamic parameters after filtered





Heart rate, bpm 63 ± 1.7 63 ± 2.5
Systolic blood pressure, mmHg 142 ± 3.2 142 ± 2.7
Diastolic blood pressure, mmHg 68 ± 2.9 68 ± 1.8
FBF in infused arm, ml/100 ml tissue/min 3.1 ± 0.3 2.8 ± 0.3
FBF in non-infused arm, ml/100 ml tissue/
min
2.5 ± 0.2 2.9 ± 0.3
Data expressed as mean ± SEM. P > 0.05 for all using paired Student’s t-test
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constituents, indicating that the major part of the PAHs
in the exhaust originates from PAHs originally in the
diesel fuel. It has previously been shown that PAHs in
the diesel fuel represent a significant source for exhaust
PAHs, besides the pyrosynthesis of exhaust PAH [33,34].
The present study demonstrates that inhalation of die-
sel exhaust generated under urban ETC running condi-
tions, causes a reduction in endothelium-dependent and
endothelium-independent vasodilatation, together with
an impairment of t-PA release from the vascular
endothelium. Perturbations of vascular homeostasis are
thought to be important in the triggering of acute myo-
cardial infarction and stroke [8,35]. The vascular assess-
ment in the present study was identical to that used in
previously reported studies employing diesel exhaust
generated under idling conditions [12,13] and was
Figure 4 Forearm blood flow measured six hours after diesel exhaust (solid line) and filtered air (dashed line) exposure during
unilateral intra-brachial infusion of bradykinin (Bk), acetylcholine (Ach), sodium nitroprusside (SNP) and verapamil (Vp) in infused and
non-infused (dotted lines) arms. Effect of exposure compared with using 2-way ANOVA with repeated measures. Data plotted as mean ± SEM.
P-values are given for diesel exhaust exposure vs. air.
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intended to enable comparisons between studies. The
mass concentration of diesel exhaust particles within the
exposure chamber differed slightly between the ETC
and idling exposures (254 versus 330 !g/m3), as did the
particle properties. Irrespective of a slightly lower PM
mass, difference in particle size and composition, as well
as a lower concentration of PAHs in the present study,
we demonstrated similar adverse vascular responses fol-
lowing exposure to diesel exhaust generated by an
engine under the ETC running conditions compared to
the idling situation.
Interestingly, the present investigation demonstrated
that vasodilatation in response to intra-arterial verapamil
was impaired following diesel exhaust generated under
transient running conditions. This suggests that the vas-
cular smooth muscle also demonstrates a calcium flux-
dependent vasomotor function disturbance, which is not
endothelium-dependent. This has not previously been
shown in studies with idling diesel exhaust that has a
higher content of gaseous (semi volatile) PAH and con-
tains a lower fraction of soot particles than the exhaust
generated under ETC urban conditions. It can thus be
speculated that the higher diesel-related soot content
and its associated (adsorbed) organic material in exhaust
generated under transient running conditions may cause
additional vascular smooth muscle effects, but this issue
will need further investigation.
The oxidative capacity of diesel exhaust particles gen-
erated under idling conditions has previously been con-
firmed by analysis of bronchoalveolar lavage and
bronchial mucosal biopsies sampled from human sub-
jects, as well as in vitro studies [30]. Of note, the oxida-
tive potential of diesel exhaust particles generated in the
present study was less pronounced compared to the
previous idling situation. Whilst certain differences in
particle size, organic carbon/elemental carbon-ratio,
PAH-content and oxidative potential exist between the
two exposure situations, the cardiovascular effects were
generally similar following ETC running conditions
although the verapamil-induced vasodilatation was at
variance to our previous studies. One could speculate
that other exhaust components (particle associated or
gaseous) may be the causal link between the exposure
and the different adverse vascular effects. In this con-
text, Xia et al suggest that organic substances such as
quinones may be important in mediating some of the
cardiovascular effects of diesel exhaust [36]. Quinones
and semi-quinones generated during combustion or cell
metabolism have strong oxidative capacity and may
interact with mitochondria and affect membrane poten-
tial and cell breathing [36,37]. This could be mechanisti-
cally linked to diesel exhaust-induced vascular events, as
well as the increase in ST-segment depression, identified
Figure 5 Net release of t-PA antigen in the infused arm during
unilateral intra-brachial infusion of bradykinin (Bk) after diesel
(solid line) and air (dashed line) exposures. Effect of exposure
compared using 2-way ANOVA with repeated measures. Data
plotted as mean ± SEM.









Leukocytes (! 109 cells/L) 5.6 ± 0.3 5.9 ± 0.3 6.0 ± 0.3 5.5 ± 0.2
Neutrophils (! 109 cells/L) 2.4 ± 0.2 3.6 ± 0.3 2.6 ± 0.2 3.1 ± 0.2
Platelets (! 109 cells/L) 226 ± 8 214 ± 8 229 ± 10 214 ± 8
TNF-a (pg/ml) 0.92 ± 0.21 0.89 ± 0.17 1.03 ± 0.17 0.80 ± 0.17
IL-6 (pg/ml) 0.68 ± 0.22 2.58 ± 0.82 0.60 ± 0.14 2.17 ± 0.76
CRP (mg/l) 1.32 ± 0.52 1.30 ± 0.46 2.03 ± 0.56 1.85 ± 0.56
CD40L (pg/ml) 95.4 ± 9.2 88.8 ± 10.8 98.4 ± 11.1 85.6 ± 11.1
P-Selectin (ng/ml) 52.0 ± 5.7 58.4 ± 7.1 57.4 ± 6.7 54.1 ± 7.4
ICAM-1 (ng/ml) 260.0 ± 13.9 273.1 ± 24.4 267.8 ± 14.2 252.8 ± 17.4
Data expressed as mean ± SEM. P > 0.05 for all using 2-way ANOVA with repeated measures.
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in patients with stable coronary disease [19]. Accord-
ingly, it is important to further elucidate the role of qui-
nones in mediating the adverse effects of combustion-
related air pollution.
There was a difference in NOx concentration and the
ratio NO/NO2 between the present and previous study
employing diesel exhaust exposure at idling. The pub-
lished literature strongly suggests that the vascular
effects present in this and previous experimental expo-
sure studies are due to the presence of combustion-
derived particles in diesel exhaust [8]. It has also been
recently shown that exposure to NO2 does not affect
vascular function [38], which further implies the impor-
tance of a particulate-related source for the vascular
effects following exposure to diesel exhaust. However,
further studies employing particle concentrator technol-
ogies or filtration systems are necessary to clarify the
specific role of the particulate and gaseous components,
other than NOx, in diesel exhaust.
Diesel exhaust induces a complex response in the
human lungs, including oxidative stress, activation of
redox-sensitive transcription factors, inflammatory cell
influx, cell activation and secretion of a range of pro-
inflammatory components [15,17,32,39]. It has been sug-
gested that this pulmonary inflammation would “spill-
over” to the circulation, thereby causing systemic effects.
Systemic inflammation has indeed been implicated as an
important component in atherosclerosis, vasomotor dys-
function and coronary events [30]. However, in the pre-
sent investigation we were unable to demonstrate any
increased systemic inflammation as reflected by CRP,
CD40L, sP-selectin, sICAM-1, IL-6 and TNF-alpha levels
in blood at 6 hours post-exposure. This is in line with
our previous experiences from diesel exhaust exposures
in humans that the presence of major inflammatory
events reflected in the blood is not present during the
early stages after exposure, but in the later stage of 18-24
hours coinciding with the peak inflammatory bronchoal-
veolar response [13,17]. This suggests that the diesel
exhaust-induced vascular responses described here and
in previous diesel exhaust studies using an idling engine
are not related to a systemic inflammatory response.
It has been implied that inhaled diesel exhaust parti-
cles might directly elicit adverse effects outside the
lungs, as inhaled particles are believed to have the
potential to translocate from the alveoli to the vascular
system and subsequently cause effects in the vasculature,
heart and other organs. However, in humans, particle
translocation has not yet been consistently proven
[40-42]. Small numbers of diesel exhaust particles with
their complex highly reactive surfaces, or soluble com-
ponents from these particles, may well reach the circula-
tion, affecting the endothelium in the pulmonary and
peripheral vasculature.
Apart from the running conditions, the exposure pro-
tocol was the same as in previous studies and a similar
particle mass concentration was intended to enable
comparisons. It is recognised that a direct comparison
would benefit from having the different engines and
running modes included within the same study. This
was not possible due to practical issues, and would have
demanded even more extensive resources with dual
engines mounted, as well as multiple exposures and
invasive vascular measurements in the same individuals.
It is concluded that exposure to diesel exhaust gener-
ated during urban transient running conditions, a highly
relevant model of urban air pollution, impairs vasomo-
tor function and endogenous fibrinolysis. These findings
are consistent with previous studies employing an idling
engine and indicate that adverse vascular effects of die-
sel exhaust inhalation occur over different running
Figure 6 Relative distribution (in % of total PAH) for specific
particulate associated PAH compounds for the present ETC
running conditions in comparison with idling conditions used
in previous studies [12,14].
Figure 7 Relative distribution (in % of total PAH) for specific
semi-volatile PAH compounds for the present ETC running
conditions in comparison with idling conditions used in
previous studies [12,14].
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conditions with varying gaseous and particle composi-
tion and concentrations as well as physicochemical par-
ticle properties. Of note, exposure to diesel exhaust
under urban running conditions was also associated
with a disturbance of calcium channel-dependent vaso-
motor function, not previously demonstrated. This may
suggest that certain cardiovascular endpoints following
exposure to diesel exhaust are related to exhaust proper-
ties in common between the two studied engine running
conditions, whereas the novel calcium flux-related effect
seems to be associated with exhaust properties more
specific for transient load and speed (ETC) conditions,
for example a higher content of diesel soot particles and
their adsorbed organic compounds.
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The epidemiological links between exposure to air pollution and cardiorespiratory 
morbidity and mortality are well established, and are described in detail earlier in 
this book (Chapters 2 and 3). These well-designed and carefully controlled obser-
vational studies, while of undeniable importance, are limited to describing associa-
tions between air pollution exposure and cardiorespiratory disease, and, by definition, 
cannot prove causation. At best, these studies provide the basis for speculation and 
hypothesis generation regarding potential pathophysiological mechanisms. Moreover, 
fundamental uncertainties remain as to the components of air pollution that might 
cause the observed biological effects.
Human exposure studies have been performed to study the biological and 
pathophysiological mechanisms underlying the observed health effects.
“REAL-WORLD” STUDIES
One approach to human experimental studies has used controlled exposures to 
ambient air pollution in city center locations (McCreanor et al., 2007; Langrish et 
al., 2009). In these studies, human subjects have been studied during and after a 
walk in a busy city center environment, and have thus been exposed to “normal” 
ambient air pollution—at “real-world” concentrations and composition. The expo-
sure has been monitored as closely as possible near the breathing zone of the subject 
using portable monitoring equipment contained in a handcart (McCreanor et al., 
2007) or a backpack (Langrish et al., 2009). Exposures in the breathing zone may 
be much higher than that measured at background monitoring stations (Watt et al., 
1995; Buzzard et al., 2009).
The major advantage of such studies is that the exposures are real, and 
therefore, the results can be extended to similar exposure scenarios. However, 
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concentration and chemical composition, depending on traffic density, activity of 
nearby industry, weather conditions, and a multitude of other factors. As in epide-
miological and panel studies, exposures are to complex mixtures, and attributing 
effects to specific pollutants may not be possible. Furthermore, it is impossible to 
control for environmental factors other than pollutants that may affect the outcome 
measures, such as differences in noise levels or visual cues.
Therefore, an alternative experimental design is required, which provides a 
more stable and predictable exposure, to identify the biological and pathophysiologi-
cal mechanisms underlying the hypothesized health effects.
GENERAL PRINCIPLES
Requirements for Human Exposure Studies
Because of the inherent variability and difficulties in “real-world” exposures 
described above, to study the biological and pathophysiological effects of inhaled 
air pollutants in man, facilities are needed that enable the carefully controlled expo-
sure of human subjects to commonly encountered air pollutants. Such systems need 
to be highly adjustable to produce the required “test atmosphere” on each occasion. 
They must also produce a stable and predictable exposure to prevent excessive 
exposure and potential toxicity.
Any human study needs to be performed within a comfortable environment 
for the study participant. Balancing the need for space and comfort with the need to 
maintain an airtight seal around the exposure “chamber” and retain an ability to 
carefully control the exposure (more difficult in a larger volume of air) and provide 
continuous monitoring of the actual exposure delivered. Such exposures have been 
carried out in both large room-sized facilities, as in Umeå, Sweden (Salvi et al., 
1999); Rochester, NY (Utell et al., 1984; Morrow et al., 1988); and Seattle, WA 
(Gould et al., 2008), and in a modified body box as in the mobile exposure facility 
described by Mills et al. (2008).
Monitoring of Exposures
The key to providing a stable and predictable test environment lies in careful and 
continuous monitoring of the exposure variables. There is really no limit in the 
variables that can be measured, although in general, these can be divided into mea-
surements of the particulate components, gaseous components, and volatile hydro-
carbons. When measuring exposure variables, the key is to sample the air from the 
breathing zone of the subject. In large room-sized exposure facilities, sampling inlets 
are placed in front of the subject, as close to the nose and mouth as practical. In the 
modified body box, the test “atmosphere” is delivered to the subject through an inlet 
situated immediately in front of the face, and sampling is carried out from the inlet 
tube just before it passes into the body box.
Particle Monitoring Particle mass concentration can be measured in “real time” 
using a number of techniques. The most commonly used method is the tapered 
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element oscillated microbalance (TEOM). A TEOM provides a nearly real-time 
measurement of mass concentration by recording the continuous measurement of 
inertial mass. The sampled aerosol is passed through a hollow tapered tube that is 
fixed at its wide end. The narrow end holds a filter cartridge, and the whole tube/
filter unit acts as a harmonic oscillator. The frequency of the oscillations varies with 
the mass deposited on the filter, and thus, by recording the frequency changes, mass 
can be extrapolated following calibration. This can be expressed as mass concentra-
tion as the volume of air sampled is known. In this system, the aerosol is heated to 
around 50°C to prevent any condensation and to provide a standard sampling envi-
ronment. This also removes any semivolatile components in the aerosol, to ensure 
that only the particulate phase of the air pollutant is measured (Moosmüller et al., 
2001).
Nephelometric monitors, such as the DataRAM (Thermo Scientific), work by 
measuring light scattering. Incident aerosol is passed through a near-infrared light 
(780 nm), which is deflected by airborne particulate matter. The subsequent scatter-
ing of light is a function of particle size and refractive index, but is well described. 
The nephelometer detects light scattered at 90° and extrapolates mass density, fol-
lowing calibration using a standardized test dust. As particle size and refractive index 
may not be constant during an exposure, the nephelometric measurements are less 
accurate than those provided by the TEOM. However, they are extremely sensitive 
and offer excellent time resolution.
Whichever method is employed to measure mass concentration, exposures are 
usually also characterized using a gravimetric method. This may be achieved by the 
use of a micro-orifice uniform deposit impactor (MOUDI). This takes the form of 
a series of conventional impactors (see Section 1.3), with each stage having a dif-
ferent cutoff point. Each stage then collects particles of a certain size distribution 
onto a filter media. If those filters are preweighed, and if the volume of air sampled 
is known, the mass concentration (broken down into different size fractions) can be 
determined by weighing the filters again at the end of the test run. As well as being 
used to gravimetrically determine mass concentration, these samples can also be 
collected and used to chemically assess the composition of the particles.
The size distribution of the airborne particulate can also be determined in real 
time using a scanning mobility particle sizer (SMPS). With this device, particles are 
separated into size fractions before being counted using a condensation particle 
counter (CPC). The aerosol is sampled at a low flow rate (around 1 L/min) from the 
breathing zone of the subject. It is then passed through an aerosol neutralizer. This 
consists of a radioactive source of krypton85 gas, which generates a high concentra-
tion of positively and negatively charged ions, and thus “neutralizes” the electrical 
charge of the incident particles to a Fuchs’ equilibrium charge distribution (Fuchs, 
1963). The next step is to pass the aerosol through a differential mobility analyzer 
(DMA). The DMA consists of two concentric cylinders: the outer one kept at ground 
potential and the inner one having a precise negative charge applied. The flow of 
particles is then altered by the electrical charge, with negatively charged particles 
being repelled from the inner electrode and positively charged particles attracted. 
By changing the charge applied, only particles of a certain charge (and therefore 
size distribution) pass through the DMA and onto the next stage. By ramping the 
2
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charge across the DMA, different size fractions can be collected in sequence. After 
passing through the DMA, the next stage is a CPC. The CPC simply counts the 
number of particles passing though the sensor (and in combination with the SMPS, 
creates a size distribution profile). The aerosol is passed into the CPC where it passes 
through a heated saturator containing butanol (or in some models, water). The 
aerosol and alcohol vapor pass together into a cooled condenser, where the alcohol 
vapor condenses around the airborne particles—thus increasing the size of each 
particle in the sample making it easier to be detected. The saturated aerosol is then 
passed through a focused laser in a very fine jet, and as the particles pass through 
the light source, light is deflected to a photodetector at 90° to the laser source, and 
the particle is thus counted. The exhaust stream consisting of the saturated particles 
is discarded after being passed through a charcoal filter to remove the butanol.
Whether or not the size distribution of the particles is measured using an 
SMPS, a CPC is usually used in combination with a measure of mass concentration 
in the monitoring of the particle exposure. This is important as the smallest particles 
carry the least weight and vice versa, and thus, a simple mass concentration may 
not reflect the airborne particle load by itself.
In addition to size distribution, mass concentration, and particle number 
offered by the SMPS, TEOM/RAM, and CPC in turn, surface area can also be 
determined. Ultrafine and nanoparticles in the aerosol carry very little mass, although 
these can be present in very large quantities—especially in fresh combustion-derived 
particulate matter such as diesel exhaust. Although these particles have little mass, 
they have a very large surface area and thus offer a very large reactive surface. There 
is evidence that this ultrafine fraction may be more toxic than the larger particles, 
perhaps mediated by their ability to penetrate deeply into the lungs where they 
provide a large reactive surface for interaction (Donaldson et al., 1998). Thus, par-
ticle surface area offers additional information that both helps in determining the 
size of the particles encountered and also their potential toxicity.
Surface area may be measured using a nanoparticle surface area monitor 
(NSAM). The NSAM samples the incident aerosol at a constant rate of 2.5 L/min 
before splitting the flow into two streams. One stream passes directly into a mixing 
chamber. The second stream passes through a carbon filter and then a HEPA filter 
(highly efficient particle filter) to provide filtered clean air. This clean airstream is 
then passed across an ionizer where it collects a charge of positive ions before being 
passed into the mixing chamber. In the mixing chamber, it encounters the incident 
unfiltered aerosol from earlier, and, by diffusion charging, the particles are brought 
into a defined and electrically charged state. After the removal of excess ions in a 
trap, these charged particles are then drawn through an electrometer, where their 
charge is measured. The degree of charge held by the particles is closely associated 
to their surface area, and thus, an estimate of total surface area can be made.
The chemical composition of the particles in the aerosol can be measured by 
collecting particles on a filter. Particles can then be removed from the filter and 
assessed using mass spectrometry and other methods. An alternative is to use an 
aerosol time-of-flight mass spectrometer (ATOFMS) to measure single-particle 
characteristics at the time of sampling (Freney et al., 2006). The ATOFMS samples 
the aerosol and collimates the particles using a nozzle passing into a low-pressure 
4
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airstream. The aerodynamic size of the incident particle is measured by the time 
delay for the particle to pass through two sequential continuous-wave lasers, and the 
appropriate delay for firing the Nd:YAG ablation/ionization laser (266-nm wave-
length) is determined. As the particle passes through the ablation region, it is ionized 
by the laser, and the resulting positive and negative ions are accelerated in opposite 
directions into time-of-flight mass analyzers, giving a positive and negative ion 
spectra for each individual particle. In this way, “real-time” chemical composition 
of the incident particles can be determined. This is of specific importance when 
assessing “real-world” ambient particles that, by their nature, can vary significantly 
(see Section 1.3).
Monitoring Gaseous and Volatile Organic Copollutants The gaseous com-
ponents of the incident aerosol can be determined by continuous gas analyzers, 
sampling from the breathing zone of the subject. The most abundant gaseous com-
ponents of particulate matter air pollution such as diesel exhaust, are carbon mon-
oxide, nitrogen dioxide (and other oxides of nitrogen), and oxides of sulfur. Real-time 
continuous monitors are available to assess all these gaseous copollutants, and these 
can separate the different oxides of nitrogen into nitric oxide (NO), nitrogen dioxide 
(NO2), and total oxides of nitrogen (NOx).
Volatile organics are usually assessed as total hydrocarbons and measured in 
real-time using a flame ionization detector (FID) (Salvi et al., 1999). The FID works 
by passing the aerosol through a hydrogen flame that is burning in hydrocarbon-free 
air. As the hydrocarbons present in the incident aerosol pass through the flame, they 
are combusted producing CH fragments. These are rapidly oxidized by oxygen in 
the air to form CHO+ ions, which can be detected as an electrical charge. The total 
electrical charge is proportional to the total hydrocarbon content in the aerosol.
CONCENTRATED AMBIENT PARTICLES (CAPs)
Ambient air pollution concentrations vary widely depending on location and envi-
ronmental conditions, and the chemical composition of the ambient fine-particulate 
matter fraction is also highly variable. This makes controlled exposures to ambient 
air pollution fraught with difficulty, as any exposure can be unpredictable, and 
adequate control of the different fractions (gaseous/particulate/volatile) cannot be 
achieved. In addition, while chronic exposure to low levels of particulate air pollu-
tion is associated with increased cardiovascular risk (Miller et al., 2007), and acute 
exposure is related to the triggering of acute myocardial infarction (Peters et al., 
2004), in general, ambient concentrations are too low to study the pathophysiological 
and biological effects in any mechanistic fashion (Cuddihy and McClellan, 1989). 
Therefore, to study the effects of ambient air pollution, specifically designed expo-
sure systems are required that can increase an individual’s exposure while introduc-
ing systems to control exposure to the “unwanted” components.
The strongest epidemiological association between exposure to air pollution 
and cardiovascular health outcomes is with the fine particulate fraction (PM2.5; par-
ticulate matter with a mean aerodynamic diameter of 2.5 µm or less). As discussed 
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previously, to study the biological and pathophysiological effects of particulate as 
opposed to gaseous ambient air pollution, it is necessary to find a way to concentrate 
these particles suspended in the air, without changing the chemical characteristics 
of the particles or concentrations of the gaseous components, prior to introducing 
them into a human exposure facility (Sioutas et al., 1995).
Two systems have been employed to concentrate ambient particulate matter: 
the virtual impactor system and the versatile aerosol concentration enrichment 
system (VACES), of which the virtual impactor system was the first to be developed 
(Sioutas et al., 1995).
Virtual Impactor Systems
A virtual impactor is a device used to separate airborne particulate matter according 
to its aerodynamic size (Sioutas et al., 1995, 1997; Kim et al., 2000). Simply, a 
virtual impactor works by drawing air across an inlet (Fig. 11.1) at a high flow rate. 
As the particle-laden air passes through the inlet, a fraction of that flow is allowed 
to pass straight through into a collection nozzle. This is termed the “minor flow.” 
Larger particles, which have the most mass and therefore the most momentum, travel 
across the collection inlet into the minor flow, but smaller particles, with little inertia, 
get diverted with the deflected air jet—the “major flow.” The major flow is discarded 
as waste, while the minor flow (typically 10–50% of the total flow) is collected for 
the next stage of the process. Particles in the minor flow are concentrated by a factor 
of Qtotal/Qminor, where Qtotal is the total flow entering the impactor and Qminor is the 
Figure 11.1 Schematic diagram of a virtual impactor nozzle. Air is drawn through an inlet 
nozzle, thus accelerating the flow. A small fraction of the air that passes through the nozzle 
continues straight into a collecting nozzle along with the particles with the most mass 
(minor flow). The remaining air is diverted around the collection nozzle with the smaller 
and lighter particles (major flow). By adjusting the size of the slits in the impactor, and the 
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minor flow rate. Therefore, with a minor flow rate of 20%, particles within the minor 
flow are concentrated by a factor of 5.
The use of virtual impactors to concentrate airborne fine particulate matter is 
well described (Sioutas et al., 1999). In general, these impactors are used in series, 
with each stage concentrating the particle concentration yet further.
Exposure systems designed to deliver concentrated ambient particulate matter 
to human volunteers based on virtual impactor technology have been used at 
the Environmental Protection Agency in Chapel Hill, NC (Ghio et al., 2000); at the 
University of Southern California, Los Angeles (Gong et al., 2003, 2008); and the 
Environmental Health Unit in Toronto, Ontario (Brook et al., 2002).
The system used at Chapel Hill is described here in detail. The first stage of 
this system is a “filter” to remove all the particles larger than those of interest. In 
the large epidemiological studies into the health effects of air pollution, the primary 
focus has been on fine particulate matter with a mean diameter of 2.5 µm or less 
(PM2.5), and therefore, the “filter” stage is set with a 50% cutoff of 2.5 µm. However, 
the use of a simple size selective filter requires a low sampling rate to maximize 
efficiency, and this is suboptimal when wanting to concentrate particles further using 
virtual impactors, which, by their nature, further reduce the volume of air in which 
particles are suspended.
To sample at the required flow rates, a conventional inertial impactor is used 
to filter the particles above 2.5 µm from the sampled air prior to delivery to the 
concentrator stage. This, in effect, is similar to the virtual impactor described above. 
Air is drawn through the impactor at a high flow rate and accelerated through the 
inlet nozzle. The shape and size of the nozzle can be altered, based on the well-
described Navier–Stokes equation (Marple and Liu, 1974), to produce a jet with 
predictable flow characteristics. The jet is directed at an impaction plate, usually 
coated with an adhesive surface, to trap particles that hit the impaction plate. Again, 
particles with the most mass and hence inertia continue straight on with the jet 
and become trapped, and smaller particles with less inertia become diverted around 
the impaction plate with the deflected air. By altering the inlet nozzle as described 
above, the cutoff point for the particles that collide with the plate can be altered. 
The air passing through the impactor/filter stage now contains predominantly par-
ticles with a mean diameter less than 2.5 µm (PM2.5) and passes to the next stage for 
concentration.
The concentration of particles is then performed using a series of virtual 
impactors. At Chapel Hill, a three-stage impactor is used (Ghio et al., 2000). The 
first stage is composed of five virtual impactors in parallel, each operating at 1000 L/
min with a minor flow rate of 20% and a slit 50% cutoff of 0.1 µm. The second stage 
of a single impactor again works at 1000 L/min and has a minor flow rate of 20% 
and a cutoff of 0.1 µm. The final stage is a single impactor working at 200 L/min 
with a minor flow rate of 40% and a cutoff of 0.1 µm resulting in 80 L/min of minor 
flow containing the concentrated particles. This is then mixed in a conditioning 
chamber with 120 L/min of fresh filtered air before being introduced into a human 
exposure chamber at 200 L/min. Theoretically, the first stage and second stage of 
the concentrator should each concentrate the ambient particulate matter by a factor 
of 5, and the final stage by a factor of 2.5, although, in practice, concentrations are 
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increased by around half of this. In all, the three-stage concentrator allows a 6- to 
10-fold concentration of ambient particulate matter at the inlet to the exposure 
chamber (Fig. 11.2). Concentrators used in Southern California and Toronto use 
only a two-stage concentration process.
VACES
One disadvantage of virtual impactor technology is that the concentrators cannot 
collect and concentrate the ultrafine particulate component of ambient air. These 
particles, smaller than 0.1 µm in diameter, have virtually no mass and cannot achieve 
sufficient momentum to escape from the deflected flow in the virtual impactor to be 
collected and concentrated. Epidemiological studies have suggested that it is the fine 
particulate matter (PM!2.5) associated with combustion and traffic sources that is 
Figure 11.2 Schematic diagram of the virtual impactor concentrator at Chapel Hill, NC. 
The first stage consists of a conventional impactor working as a filter stage to remove large 
particles, and then three concentration stages employing virtual impactors to increase the 
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most closely associated with adverse health outcomes (Laden et al., 2000). The 
majority of particles (by number) actually fall within the ultrafine fraction (until they 
aggregate), and there is evidence that the ultrafine fraction may actually be more 
toxic than the larger particles (Peters et al., 1997). It is therefore desirable to con-
centrate both the fine and ultrafine fractions of ambient particulate air pollution when 
addressing air pollution-induced health effects in a mechanistic fashion.
The VACES has been developed to enable the concentration of all the different 
fractions of ambient air pollution simultaneously (Kim et al., 2001) and is shown in 
schematic form in Figure 11.3. Briefly, air is drawn through the system using a 
powerful vacuum pump operating at 330 L/min. Ambient air is drawn through three 
inlets, two of which are attached to a conventional inertial impactor to remove larger 
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particulate matter, as described previously. One is set to remove particles larger than 
2.5 µm in diameter, leaving behind the PM2.5 or fine fraction, the other to remove 
particles larger than 0.18 µm in diameter, leaving the ultrafine fraction. The third 
outlet inlet does not have an impactor but instead collects total suspended particles, 
or the coarse fraction.
The coarse fraction is concentrated using a virtual impactor as described previ-
ously, with a 50% cutoff at 1.5 µm. Coarse particles can be concentrated by as much 
as a factor of 33 in this sampling line. The smaller fractions are also concentrated 
using virtual impactors, but to concentrate these smaller fractions, the particles in 
the sampling line are processed first. They are passed through a 10-L stainless steel 
container that is partially filled with warm, distilled, and deionized water. This satu-
rates the aerosol with water vapor. The aerosol is then passed through aluminum 
tubes embedded in a saline–ice mixture, causing condensation and supersaturation. 
This causes all particles to grow to around 3-µm droplets. The aerosol is then passed 
through a virtual impactor with a 50% cutoff at 1.5 µm as previously, and the now 
enlarged and heavier particles pass into the minor flow and are hence concentrated. 
The concentrated aerosol is then passed through a diffusion dryer to remove the 
excess water vapor from the particles and return them to their original size distribu-
tion. Any of the fractions can then be diluted with filtered air in a conditioning box 
before being introduced into the exposure chamber.
Gaseous and Volatile Components
Particle concentrators based on virtual impactor technology do not alter the gaseous 
or volatile components in the concentrated flow, which is one of the strengths of the 
technology. However, it is possible to remove the gaseous and volatile components 
within the concentrated flow prior to delivery into the body box to allow a “pure” 
particle exposure.
Gaseous and semivolatile organic components can be removed using a simple 
denuder (Cheng et al., 2009). These denuders work by passing the aerosol across an 
active surface onto which the organic matter is adsorbed. This may consist of an 
activated carbon surface or a polystyrene-divinylbenzene (XAD) resin. The activated 
carbon denuders consist either of impregnated foam or a series of carbon tubes 
through which the aerosol is passed. They are highly efficient, removing close to 
100% of gaseous organic material, and can be operated at up to 40 L/min for a few 
months before needing to be replaced (Eatough et al., 1999). XAD denuders are less 
efficient. They consist of either a series of glass tubes coated in XAD resin or an 
impregnated honeycomb disk over which the aerosol is passed. To achieve a close 
to 100% efficiency for the carbon-based denuders, lower flow rates (up to a maximum 
of 16.7 L/min) need to be used, and the active surface needs to be replaced every 
10–20 h of operation (Fan et al., 2003).
Denuders can also be used to remove gaseous components from the aerosol 
before delivery to the body box. Small but highly efficient denuders have been 
developed (Koutrakis et al., 1993) that pass the aerosol across a large number of 
glass hexagonal tubes in a honeycomb arrangement coated with sodium carbonate/
glycerol to remove basic gases and citric acid/glycerol to remove acidic gases.
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Advantages and Disadvantages of Using CAPs The key strength of using 
CAPs is also its major weakness. CAPs are “real-world” particles, collected from 
ambient air and concentrated prior to delivery to the exposure chamber. It therefore 
allows assessment of the toxicological effect of particles encountered in peoples’ 
normal daily lives, which are the particles proposed to cause the increased cardio-
respiratory morbidity and mortality observed in epidemiological studies. The par-
ticle concentrators enable the delivery of concentrated particles without significantly 
altering the chemical composition of the particles themselves (Sioutas et al., 1997), 
or increasing the concentration of gaseous and volatile pollutants, which is important 
from a toxicological perspective. Indeed, with the addition of gaseous and semivola-
tile denuders, the concentration of chemicals in the gaseous phase can actually be 
reduced prior to delivery into the exposure chamber.
However, there are problems inherent in the use of “real-world” particles. The 
composition of the airborne particulate matter is dependent on collection location 
and time, and reflects the relative contribution of different sources such as traffic, 
combustion, road and brake wear, dust, and pollen. Indeed, in one recently reported 
study in which no vascular endothelial effects were demonstrated after exposure to 
concentrated ambient particulate matter in Edinburgh, UK, detailed analysis of the 
particulate matter revealed that the major chemical component of the particles was 
in fact inert sodium chloride, reflective of the study’s maritime location (Mills 
et al., 2008). Airborne particulate load is highly dependent on weather conditions 
such as wind speed, wind direction, and precipitation. This means that during the 
course of a clinical study, the exposure given to individual patients may vary con-
siderably in both particle concentration and composition. This fact can limit the 
interpretation of the study results and may also present problematic questions regard-
ing an appropriate statistical approach during analysis.
The concentrators themselves are extremely sensitive to ambient conditions, 
a fact that can prove problematic in the conduct of clinical studies. In wet and very 
humid conditions, particles can adhere to the concentrator inlet slits rather than pass 
through, thus reducing or eliminating the ability to concentrate particles effectively. 
As a consequence, studies cannot be performed in rain (Ghio and Huang, 2004).
DIESEL EXHAUST EXPOSURE
The epidemiological links with combustion-derived particulate matter and cardiore-
spiratory morbidity and mortality are well established. The biological and pathologi-
cal mechanisms behind this observation can be assessed in controlled exposure 
studies, but, as discussed above, simply using concentrated ambient particulate 
matter to assess the effects of combustion-derived particulates presents a number of 
difficulties. The inherent variability of the exposure characteristics and possibility 
for low concentrations of combustion-derived particles within the concentrated 
aerosol have resulted in search for a more stable and predictable model.
In the urban environment, up to 40% of airborne particulate matter is derived 
from diesel exhaust, a fraction that is likely to increase with new restrictions on 
industry and the current drive for “green” taxation on road vehicles linked to carbon 
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dioxide production. Diesel engines produce a cloud of carbon-centered nanoparticu-
late that includes unburnt fuel, lube oil, polycyclic aromatic hydrocarbons, metals, 
and sulfates (Scheepers and Bos, 1992; Sydbom et al., 2001). Although diesel 
engines produce less carbon monoxide and carbon dioxide than gasoline engines, 
they produce more nitrogen oxides and aldehydes, and the particle emissions are up 
to 100 times greater—of which >80% (by particle number) are within the ultrafine 
fraction (<100 nm in diameter), proposed to be the most closely associated with 
adverse health effects.
Exposure to diluted diesel exhaust has been used as a stable and predictable 
model of pure combustion-derived air pollution in the study of the health effects of 
particulate air pollution in human subjects (Nightingale et al., 2000; Sydbom et al., 
2001; Mills et al., 2005; Törnqvist et al., 2007; Gould et al., 2008; Peretz et al., 
2008).
Briefly, fresh diesel exhaust is produced by a commercial diesel engine under 
either idling conditions, or during a European city cycle. More than 90% of the 
exhaust is vented externally, with a small fraction collected and delivered to a con-
ditioning chamber where it is mixed with clean HEPA-filtered air. The conditioning 
chamber allows complete mixing and the maintenance of a stable temperature and 
humidity within the aerosol. This is then drawn through an airtight exposure chamber 
in which the subject is situated. The air within the chamber is sampled from the 
breathing zone of the subject and monitored as described previously. The concentra-
tion of airborne particulate is normally maintained at 200–300 µg/m3 and can be 
adjusted by altering the amount of exhaust drawn into the conditioning chamber. 
Control exposures to filtered air are generated in the same facility, without adding 
any diesel exhaust to the chamber. To “blind” the subject to the exposure situation, 
the diesel engine is running during both exposures to create a similar noise at the 
two different exposure events (Fig. 11.4).
Idling Engine versus European City Cycle
The characteristics of the diesel exhaust generated from the engine differ depending 
on a variety of conditions. The initial studies looking at the effects of diesel exhaust 
inhalation used an unloaded idling engine (Salvi et al., 1999; Mills et al., 2005). In 
these studies, the engine was allowed to reach a steady-state temperature before the 
study commenced, as the particle characteristics change with increasing temperature 
and increasing combustion efficiency. Other studies have been performed using a 
city cycle, designed to mimic the emissions from a diesel vehicle travelling through 
an urban area.
The European city cycle is characterized by low vehicle speed, low engine 
load, and low exhaust gas temperature, and the cycle is repeated throughout the 
study period (Fig. 11.5, Table 11.1). Using the city cycle alters the characteristics 
of the particles produced, more closely mimicking the actual exposure to combustion-
derived air pollution encountered in urban environments. In general, as the engine’s 
speed and load increase, the particulate mass produced increases exponentially—
thus, the bulk of the particle mass is produced at higher speed and load. Nitrogen 
oxides also increase with engine speed and load, although the growth rate slows at 
5
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Figure 11.5 The European city cycle (ECE 15). Data points obtained from http://
www.dieselnet.com/standards/cycles/ece_eudc.html.
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higher velocities. The chemical composition of the particles produced also changes 
(Fig. 11.6): as the engine speed increases, the proportion of soluble organics decreases 
and the proportion of insoluble organics increases (Tan et al., 2004).
Exploring New Fuels: Biodiesel and Fuel Additives
A diesel exhaust exposure setup also offers the perfect opportunity to study alterna-
tive fuels. There is a current drive to move away from reliance on fossil fuels toward 
more sustainable fuels such as biodiesel. While it is presently true that commercially 
available biodiesel is generally mixed with standard diesel fuel as well as suggested 
that the adverse health effects are driven predominantly by the standard diesel fuel, 
the possible health effects of biodiesel are unknown (Swanson et al., 2007). To the 
authors’ knowledge, no studies have yet been published on the effect of biodiesel 
(or commercial fuel additive) exposure on humans, although initial experiments in 
animal models are described (Finch et al., 2002).




















TABLE 11.1 European City Cycle (ECE 15) Characteristics
Characteristics Unit ECE 15
Distance km 4.052
Duration s 780
Average speed km/h 18.7
Maximum speed km/h 50
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Advantages and Disadvantages of  
the Diesel Exhaust Exposure
Using a predictable model of exposure such as diesel exhaust offers many advan-
tages. To ensure consistency of approach, exposures can be performed identically 
on different study days, thus making interpretation of the results much easier. The 
inherent variability of chemical composition and particulate load seen with CAPs is 
not an issue. The technology required to produce a diesel exposure does not rely on 
complex impactors that are sensitive to environmental and weather conditions, 
meaning that studies can be carried out on any particular day—a definite advantage 
in scheduling clinical experiments involving human subjects.
However, for all these advantages, diesel exhaust exposures will always be 
open to criticism. Diesel exhaust is used as a model of ambient combustion-derived 
air pollution. While it is true that diesel exhaust can make up a significant proportion 
of an individual’s exposure to air pollution in urban areas, exposure to pure diesel 
exhaust (or indeed pure combustion-derived particulate) is artificial. Therefore, 
extrapolating the results from experimental diesel exhaust exposure chamber studies 
to the ambient exposure situation is fraught with uncertainty. However, to gain 
important mechanistic information on air pollution-induced health effects, experi-
mental exposure chamber studies are essential and complementary to “real-world” 
exposures.
GASOLINE EXPOSURES
Interest in the potential health effects of gasoline exhaust has been limited in the 
literature. This is largely due to the observation that adverse health effects closely 
correlate with combustion-derived particulate air pollution. Although gasoline 
engines do emit particulate matter, this amount is fairly insignificant compared with 
commercial diesel engines, which can emit over 100 times as many particles. In 
addition, since the introduction of lead-free petrol and catalytic converters, the 
environmental focus in reducing air pollution associated with vehicles has shifted 
toward diesel engines.
Several controlled exposure studies looking at the potential adverse health 
effects of gasoline exhaust have been performed in animals, and these were elegantly 
reviewed by McDonald et al. (2007). To the authors’ knowledge, no human exposure 
studies are described. Human exposures to gasoline exhaust are limited by the 
characteristics of gasoline exhaust itself. Although gasoline produces fewer particu-
late emissions, the gaseous components are more abundant. The predominant 
gaseous emissions are carbon monoxide and carbon dioxide, which can reach rela-
tively high concentrations. In the animal studies described by McDonald et al., the 
average carbon monoxide concentration in the exposure chambers was around 
50–80 ppm (McDonald et al., 2007). As carbon monoxide is a toxic gas with a 
strong affinity to hemoglobin, exposure to high concentrations in both animals 
and man can cause permanent health effects and even death (Ilano and Raffin, 
1990; Penney, 1990). Although controlled exposure studies to pure carbon monoxide 
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have been performed in a variety of patient groups and healthy volunteers, at con-
centrations up to 150 ppm (Allred et al., 1991), human exposure studies to carbon 
monoxide must balance the known risks with any benefits of the knowledge to be 
gained. The current workplace exposure guidelines restrict an individual’s exposure 
to an 8-h average of 30 ppm in the United Kingdom (HSE, 2007) and 50 ppm in the 
United States (OSHA, 1999), levels below those that might be encountered in a 
gasoline exposure facility.
The exposure setup used in the animal experiments is very similar to the diesel 
exposure chamber described above. Fresh gasoline exhaust is generated using a 
commercial “mid-mileage” gasoline engine using standard “national average” fuel 
during a defined control cycle (similar to the European city cycle, ECE 15, described 
above). Exhaust is immediately diluted in the exhaust pipe using fresh HEPA-filtered 
air before entering the exposure chamber. The exposure variables are once again 
measured in the breathing zone of the animal (McDonald et al., 2008).
PURE AND ENGINEERED NANOPARTICLES
Diesel exhaust and CAPs both consist of a complex mixture of gases, volatile agents, 
and particulate matter. Indeed, within each exposure, the chemical composition of 
the particle phase can vary significantly. The exact components of this complex 
“soup” that are responsible for the demonstrated health effects are still debated. 
Combustion-derived particulate matter consists of a carbon core onto which a 
complex mixture of organic compounds and transition metals is adsorbed. To tease 
out the particle-specific effect (rather than that of the adsorbed agents), there has 
been some interest into the use of pure engineered particles in inhalation studies, as 
well as exposures to the gaseous components alone (discussed in Section 1.9).
Human exposures to pure ultrafine carbon particles have been performed. In 
these studies, human subjects are exposed to particles of elemental carbon delivered 
via a mouthpiece while they wear a nose clip. The carbon particles are generated in 
a pure argon environment (to prevent oxidation by ambient oxygen) using an electri-
cal spark discharge between two graphite rods in a commercially available generator. 
The generated particles are then deionized and mixed with HEPA-filtered air to reach 
the required concentration before being delivered to the subject (Chalupa et al., 
2002; Shah et al., 2008; Zareba et al., 2008).
Similarly, some groups have performed human exposures to radiolabeled 
ultrafine carbon particles to track the fate of those particles and to identify whether 
or not inhaled nanoparticles can translocate from the lungs to the systemic circula-
tion (Nemmar et al., 2004; Mills et al., 2006). Although these studies do not reach 
a consensus view on the translocation of particles, the exposure system used was 
identical and in line with well-established clinical protocols (Cook and Clarke, 
1992): 99mTechnetium-labeled carbon particles can be used as a clinical tool in 
nuclear medicine, that is, in the detection of pulmonary embolism. 99mTechnetium-
labeled carbon particles (Technegas) can be generated in a commercially available 
generator, before being delivered to the subject via a mouthpiece in a similar 
fashion to the carbon ultrafine particles described above (Mills et al., 2006). The 
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important difference with these studies is that this system only allows a brief expo-
sure to concentrated labeled particles, and not a prolonged exposure as described 
previously.
HUMAN INSTILLATION STUDIES
Inhalation exposures in humans have been widely employed due to the physiological 
nature, and ease, of the exposure. Animal studies are more complicated however, 
and the inhalation route is fraught with difficulty. In many animals, especially large 
rodents such as rats, the nasal cavity is more complex due to the fact that the animals 
rely much more heavily on the sense of smell. As a result, the nasal cavity is a 
much more efficient filter for inhaled particulate material, and actual pulmonary 
exposure to inhaled particulate is only a fraction of that inhaled and can be difficult 
to predict. For this reason, toxicological studies in animals have predominantly 
employed the technique of tracheal instillation to ensure a pulmonary load of par-
ticulate matter.
In humans, while most of the fine inhaled particles do pass into the lungs, 
some of the larger material is filtered out by the nasal cavity. For this reason, mouth 
breathing is encouraged by asking patients to exercise while inside the chamber. In 
addition to encouraging mouth breathing, this also increases ventilation rate and 
therefore exposure to the ambient test atmosphere.
Some studies have been performed in humans in a similar fashion to the 
rodent studies. While intratracheal exposures are clearly difficult and could be 
hazardous, bronchoscopy has been used to deliver particles in solution directly 
into specific lung segments (Ghio and Devlin, 2001; Schaumann et al., 2004). The 
advantage of these studies, as with the rodent studies, is the fact that the exact pul-
monary exposure to particulate matter is known. In both these studies, the aim was 
to identify the inflammatory potential of a fixed mass of particles collected from 
different sites at different times—clearly something difficult to do if the added 
unpredictability of exercise, respiratory rate, and ratio of mouth : nose breathing is 
taken into account.
While this approach has some advantages in terms of identifying the toxico-
logical potential of different inhaled particles, the delivery route is not physiologi-
cally relevant—large boluses of particles administered to one area of the lung 
directly—and the generalizability of any results can be questioned. The invasive 
nature of this method makes human studies difficult to perform and reduces the 
acceptability to potential volunteers.
EXPOSURE TO POLLUTANT GASES
Air pollution is a complex mixture of gaseous, volatile, and particulate components. 
Driven by the strong epidemiological data, much of the research interest has recently 
focused on the biological effects of the particulate phase of air pollution. However, 
there are also epidemiological associations between exposure to nitrogen dioxide 
7
Cassee_3539_c11_main.indd   233 8/20/2010   3:32:36 PM
Cassee—Cardiovascular Effects of Inhaled Ultrafine and Nanosized Particles
So
234 CHAPTER 11 HUMAN EXPOSURE STUDIES
and cardiovascular morbidity and mortality (Anderson et al., 1996; Hoek et al., 2001; 
Rosenlund et al., 2008). While some have attributed this association to the fact that 
nitrogen oxides are key copollutants in combustion-derived air pollution, and emis-
sions are therefore closely related to the concentration of fine and ultrafine particu-
late matter (Sarnat et al., 2001), others have demonstrated important effects on 
airway inflammatory responses and the incidence of respiratory morbidities (Mostardi 
et al., 1981; Love et al., 1982; Blomberg et al., 1997).
As for particulate air pollution, controlled exposure studies employing nitro-
gen dioxide have been performed in human subjects (Frampton and Utell, 1998; 
Frampton et al., 2002). Briefly, these exposures were performed in a large airtight 
exposure chamber, through which HEPA-filtered air was drawn at a constant flow 
rate of 30 m3/h. Pure nitrogen dioxide (NO2), provided in compressed bottled form, 
was then added to the ventilation duct just before it reached the exposure chamber 
(to allow adequate mixing), its flow rate controlled by a mass flow controller and 
flowmeter. NO2 at high concentrations is known to be highly toxic, and inhalation 
of high concentrations (above 150 ppm) can be rapidly fatal (Last et al., 1994); 
therefore, air was sampled in the breathing zone of the subject and monitored con-
tinually for oxides of nitrogen, and used as a feedback control to maintain a constant 
(and safe) concentration of nitrogen dioxide within the chamber (Blomberg et al., 
1997).
Similarly, studies have been performed using other gaseous pollutants (ATS, 
1996; Frampton and Utell, 2007). Human exposures to sulfur dioxide have been 
performed using a head-dome exposure system, through which air was drawn at 
120 L/min. Bottled sulfur dioxide was once again introduced just prior to entry into 
the exposure chamber, and carefully controlled by digital mass flow controllers to 
maintain a constant concentration of 200 ppb (Routledge et al., 2006). Ozone has 
been used at concentrations between 80 and 600 ppb (Krishna et al., 1997; Torres 
et al., 1997; Frampton et al., 1999; Olin et al., 2001; Samet et al., 2001; Brook 
et al., 2002; Mudway and Kelly, 2004). The ozone exposures were carried out in 
large exposure chambers (Olin et al., 2001; Brook et al., 2002), using a head dome 
(Mudway and Kelly, 2004) and a face mask (Krishna et al., 1997). In the exposure 
chambers, ozone was generated in a commercial on-site arc generator and introduced 
into the ventilation duct for the chamber during constant airflow, as described previ-
ously. During the face-mask exposure, medical compressed air was used to generate 
the ozone, and the ozone was delivered along with a constant flow of medical air to 
maintain constant concentrations. In all experiments, ozone concentrations were 
measured continuously within the breathing zone of the subjects and used as a nega-
tive feedback control.
Although fraught with more difficulty, as discussed above in Section 1.5, 
carbon monoxide—another major gaseous pollutant generated by combustion 
sources—has been used in human clinical studies in both healthy volunteers and 
patient groups. The exposures themselves were carried out in similar exposure facili-
ties as described above, using bottled pure carbon monoxide to produce the test 
atmosphere along with HEPA-filtered air (Allred et al., 1991). As mentioned previ-
ously in Section 1.6, concentrations up to 150 ppm have been used for 1 h. 
Interestingly, in some of these patient studies, the actual exposure has been moni-
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tored by measuring repeated blood samples from patients given the variable uptake 
of carbon monoxide between individuals, and the carbon monoxide concentration 
titrated to achieve a carboxyhemoglobin concentration of 2–4%, thus reducing the 
anxiety of possible carbon monoxide toxicity (Allred et al., 1991).
EXPOSURE TO ALTERNATIVE FUELS: BIOMASS
Most research to date has focused on outdoor air pollution and modeling this expo-
sure in a controlled fashion to study the pathophysiological effects. However, across 
the world, the predominant burden of air pollution exposure arises from indoor air 
pollution. Indeed, some three-quarters of all global particulate air pollution occurs 
indoors in the developing world (Fullerton et al., 2008). Indoor air pollution consists 
predominantly of smoke from biomass fuels (wood, charcoal, dung, and crop resi-
dues) burned for cooking, heating, and lighting. Similar to urban air pollution expo-
sure, exposure to indoor air pollution is associated with the increased incidence of 
cardiorespiratory conditions including respiratory infections and cardiac events 
(Boman et al., 2003).
Although biomass smoke is now increasingly recognized as an important 
influence on health worldwide, there are few reported studies into the potential 
adverse health effects in man. Recently, a number of studies have been reported that 
have used controlled exposures to wood smoke (Sallsten et al., 2006; Barregard et 
al., 2008). These studies have employed a very similar exposure setup for the diesel 
exhaust exposures. Smoke is generated using a mixture of hardwood and softwood 
burned in a cast-iron stove. A fraction of the smoke is diverted from the chimney 
into a conditioning chamber and mixed with HEPA-filtered air, and then fed into 
the human exposure chamber. It takes around 1 h to reach a steady-state concentra-
tion of particulate within the chamber due to the more unpredictable nature of wood 
smoke as compared with diesel exhaust. Again, the exposure is closely monitored 
from the breathing zone of the subject.
SUMMARY
The negative health effects associated with air pollution have been demonstrated in 
elegant and consistent large-scale epidemiological studies. To experimentally prove 
these associations by demonstrating causality and identify the pathophysiological 
mechanisms, a variety of controlled exposure studies have been performed. 
Specifically designed exposure facilities allow controlled exposure of human sub-
jects to ambient and concentrated levels of individual air pollutants including 
complex mixtures of ambient particles and gases, model test atmospheres such as 
diesel exhaust fumes, and individual components such as pure carbon-centered 
particles and copollutant gases. Further studies employing such facilities will help 
to identify the pathophysiological mechanisms underlying the strong epidemiologi-
cal link between air pollution and cardiorespiratory health, and will hopefully lead 
to improvements in both patient care and environmental health policy.
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Introduction
Exposure to air pollution is a major public health problem, 
and is associated with an increased risk of cardiorespira-
tory morbidity and mortality. Epidemiological studies have 
consistently shown a strong association of cardiorespira-
tory illness and "ne particulate matter (Dockery et al., 1993; 
Miller et al., 2007; Pope et al., 2002), although similar posi-
tive associations have been shown for long-term exposure 
to nitrogen dioxide (Anderson et al., 1996; Hoek et al., 2001; 
Rosenlund et al., 2008). Nitrogen dioxide and other oxides 
of nitrogen are major constituents of combustion-derived 
air pollution, such as diesel exhaust, and the associations 
of nitrogen dioxide with adverse outcomes have usually 
been attributed to the close association of "ne particulate 
with nitrogen dioxide concentrations (Sarnat et al., 2001). 
However, isolated real life exposures to nitrogen dioxide 
have been linked to increases in respiratory illness and 
susceptibility to airway infection (Guidotti, 1978; Mostardi 
et al., 1981; Love et al., 1982). Controlled exposure to 
nitrogen dioxide induces airway in#ammation and modi-
"es antioxidants in the respiratory tract lining #uid (Kelly 
et al., 1996).
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Abstract
Background: Exposure to air pollution is associated with increased cardiorespiratory morbidity and mortality. It is 
unclear whether these e!ects are mediated through combustion-derived particulate matter or gaseous compo-
nents, such as nitrogen dioxide.
Objectives: To investigate the e!ect of nitrogen dioxide exposure on vascular vasomotor and six fibrinolytic 
functions.
Methods: Ten healthy male volunteers were exposed to nitrogen dioxide at 4 ppm or filtered air for 1 h during 
intermittent exercise in a randomized double-blind crossover study. Bilateral forearm blood flow and fibrino-
lytic markers were measured before and during unilateral intrabrachial infusion of bradykinin (100–1000 pmol/
min), acetylcholine (5–20 µg/min), sodium nitroprusside (2–8 µg/min), and verapamil (10–100 µg/min) 4 h after 
the exposure. Lung function was determined before and after the exposure, and exhaled nitric oxide at baseline 
and 1 and 4 h after the exposure.
Results: There were no di!erences in resting forearm blood flow after either exposure. There was a dose-depend-
ent increase in forearm blood flow with all vasodilators but this was similar after either exposure for all vasodila-
tors (p > .05 for all). Bradykinin caused a dose-dependent increase in plasma tissue-plasminogen activator, but 
again there was no di!erence between the exposures. There were no changes in lung function or exhaled nitric 
oxide following either exposure.
Conclusion: Inhalation of nitrogen dioxide does not impair vascular vasomotor or fibrinolytic function. Nitrogen 
dioxide does not appear to be a major arbiter of the adverse cardiovascular e!ects of air pollution.



















































2  J. P. Langrish et al.,
!e cardiovascular e$ects of inhaled diesel exhaust are 
well documented. We have demonstrated that controlled 
exposures to diesel exhaust, as a model of combustion-
derived "ne particulate air pollution, causes acute vascular 
endothelial e$ects (Mills et al., 2005; Törnqvist et al., 2007). In 
these models, the actual exposure is a complicated mixture 
of carbon-centered particulate matter, volatile organic com-
pounds, and gaseous pollutants (Scheepers & Bos, 1992). 
!e predominant gaseous components are nitrogen diox-
ide and other oxides of nitrogen, with NOx concentrations 
reaching around 4 ppm in previous controlled exposures to 
diesel exhaust (Mills et al., 2005; Salvi et al., 1999; Behndig 
et al., 2006). !ese models have consistently demonstrated 
an impairment of vascular endothelial function and endog-
enous "brinolysis following exposure to diesel exhaust that 
appears to be mediated through increased oxidative stress 
and reduced nitric oxide bioavailability (Mills et al., 2005; 
Miller et al., 2009). Although particulate matter appears to 
be a major arbiter of these adverse vascular e$ects, the ques-
tion remains as to the independent e$ect of a pure exposure 
to nitrogen dioxide. Nitrogen dioxide is itself a powerful 
oxidizing species, and this is proposed to underlie the air-
way in#ammatory and antioxidant responses, as well as the 
vascular dysfunction previously described (Blomberg et al., 
1997; Patel & Block, 1986).
!e aim of this study was to explore the e$ect of a pure 
exposure to 4 ppm of nitrogen dioxide on vascular endothe-
lial and "brinolytic function, and to test the hypothesis that 




Ten healthy male volunteers were recruited into the trial. 
Women were not included to avoid the potential confound-
ing in#uence of cyclical changes in estrogen on vascular 
endothelial function (Ganz, 2002). One subject developed a 
respiratory tract infection during the study and was excluded 
and replaced. All subjects were nonsmokers, had no inter-
current illness, took no regular medication, and all had nor-
mal lung function. All subjects had been free of symptoms of 
upper airway infection for at least 6 weeks prior to the study. 
All subjects gave their written informed consent, and the 
trial was approved by the local research ethics committee in 
accordance with the Declaration of Helsinki.
Exposure protocol
!e exposures to nitrogen dioxide or "ltered air took place 
at the Medical Division of the National Institute for Working 
Life in Umeå as described previously (Kelly et al., 1996). 
Brie#y, ambient air was drawn continuously through a large 
exposure chamber at a constant rate of 30 m3/h, which was 
maintained at a temperature of 20°C and relative humidity of 
50%. Nitrogen dioxide (AGA Special Gas, Lidingö, Sweden) 
was passed through a mass #ow controller (Model 5850TR, 
Brooks Instrument B.V., Veenendaal, Netherlands) and a 
#ow meter (Rota, Hannover, Germany) to control the gas 
#ow, and was introduced to the ventilating duct just before 
reaching the chamber. Air was sampled in the breathing 
zone of the subjects and analyzed continuously for nitrogen 
dioxide, nitric oxide, and total NOx using a CSI 1600 oxides 
of nitrogen analyzer (Columbia Scienti"c Industries, Austin, 
TX, USA). !e concentration of nitrogen dioxide within the 
chamber was maintained at 4 ppm, a concentration selected 
to match that of NOx concentrations seen in controlled expo-
sures to diesel exhaust as described previously (Mills et al., 
2005; Salvi et al., 1999; Behndig et al., 2006). Filtered air 
exposures were performed by HEPA "ltration of air prior to 
introduction into the exposure chamber without introduc-
tion of additional nitrogen dioxide.
Study design
Subjects attended the clinical research facility at Umeå 
University Hospital on two occasions, each at least 1 week 
apart. In a randomized double-blind crossover trial, subjects 
were exposure to either "ltered air or nitrogen dioxide at 
4 ppm for 1 h with intermittent exercise. Subjects performed 
exercise on a bicycle ergometer while in the chamber at a 
predesignated workload to achieve a mean ventilation rate 
of 25 L/min, based on a prestudy screening exercise ventila-
tion stress test. Subjects then returned to the clinical research 
facility for forearm vascular plethysmography studies with 
active drug infusions commencing 4 h after the exposure.
Outcome measures
Vascular assessments
Subjects underwent forearm venous occlusion plethysmog-
raphy as described previously (Wilkinson & Webb, 2001). 
!e brachial artery of the nondominant arm was cannulated 
with a 27-gauge steel needle under aseptic technique and 
local anaesthesia. After a 30-min baseline saline infusion, 
forearm blood #ow was recorded during infusion of the 
endothelial- dependent (acetylcholine, 5, 10, and 20 µg/min; 
bradykinin, 100, 300, and 1000 pmol/min) and -independent 
(sodium nitroprusside, 2, 4, and 8 µg/min; verapamil, 10, 30, 
and 100 µg/min) vasodilators. !e vasodilators were infused 
for 6 min at each dose, with the blood #ow determined for 
last 3 min of the infusion. Vasodilators were administered 
in a random order, except for verapamil, which was always 
administered last given its prolonged vascular action, and 
were separated by a washout period of 20 min during which 
saline was infused.
Biochemical analyses
Peripheral venous blood samples were obtained at base-
line and at 4 and 6 h after exposure for total and di$erential 
cell counts. Analysis was performed on an autoanalyzer by 
the local hematology reference laboratory (Department 
of Clinical Chemistry, University Hospital, Umeå). Blood 
samples were obtained during the forearm vascular study 
from indwelling 17-gauge venous cannulae inserted into a 
large antecubital vein on both arms before and after each 
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vasodilator that also stimulates the release of stored tissue-
plasminogen activator (t-PA) from the vascular endothe-
lium (Brown et al., 1999, 2000). Samples were collected into 
acidi"ed bu$ered citrate (Stabilyte, Biopool International) 
for analysis of t-PA and into citrate (BD Vacutainer) for plas-
minogen-activator inhibitor type 1 (PAI-1) assays to assess 
the activity of the endogenous "brinolytic pathway.
t-PA and PAI-1 antigen concentrations were determined 
by commercially available enzyme-linked immunosorbent 
assays (ELISAs) (t-PA combi Actibind, Technoclone, Vienna, 
Austria; Elitest PAI-1, Hyphen BioMed, Neuville-sue-Oise, 
France). As much of the t-PA present in the circulation is 
bound to PAI-1, thus rendering both inactive and leading 
to hepatic clearance (Chandler et al., 1997), both t- PA and 
PAI-1 activity were assessed using enzymatic assays (t-PA 
combi Actibind, Zymutest PAI-1) as described previously 
(Mills et al., 2005).
Exhaled nitric oxide and lung function
!e standardized fractional exhaled nitric oxide (FENO) was 
measured in duplicate at expiratory #ow rates of 10, 50, 100, 
and 250 ml/s at baseline, 1 h, and 4 h after both exposures 
using a chemiluminescence analyzer (NiOX; Aerocrine AB, 
Stockholm, Sweden) (ATS/ERS 2005). Lung function was 
measured using simple spirometry (Vitalograph, Bucks, 
UK) at baseline and after the exposure, recording forced 
vital capacity (FVC), forced expiratory volume in 1 second 
(FEV1), and slow vital capacity (VC).
Statistical analysis
We calculate, based on previous studies (Mills et al., 2005), 
that a sample size of 10 gives an 80% power of detecting a 
di$erence in forearm blood #ow responses of 20% at a two-
sided statistical signi"cance level of 5%. All investigators 
were blinded to the exposure received. Plethysmography 
data were analyzed as described previously (Newby et al., 
1999). Data were analysed using two-way analysis-of-
variance (ANOVA) with repeated measures. !e variables 
included in the ANOVA were dose and exposure for the 
forearm blood #ow data, and time and exposure for the 
other outcome measures. All data are expressed as mean ± 
standard deviation unless otherwise stated. Statistical sig-
ni"cance was taken as a two-sided p value of .05. Data were 
analyzed using GraphPad Prism (Version 4 for Macintosh; 
GraphPad Software, San Diego, USA) on a Macintosh per-
sonal computer.
Results
Ten subjects, median age 24 years, completed the study 
(Table 1). !ere were no changes in any indices of lung func-
tion seen following the nitrogen dioxide exposure (Table 2). 
Exhaled nitric oxide (FENO), measured as a surrogate of air-
way in#ammation, was unchanged at all time points follow-
ing either nitrogen dioxide or "ltered air exposure (Table 2).
!e forearm vascular studies revealed a dose-dependent 
increase in blood #ow in the infused arm compared to the 
noninfused arm in all subjects after each infused vasodi-
lator. !ere was no di$erence in the vascular responses 
to any of the vasodilators (endothelium-dependent or 
- independent) following air or nitrogen dioxide exposure 
(Figure 1). Bradykinin stimulated a dose-dependent increase 
in release of plasma tissue-plasminogen activator (t-PA), 
Table 1. Baseline characteristics of the 10 subjects completing the 
study.
Age, years (median, range) 24 (22–28)
Male sex, % 100%
Height, cm 181 ± 5
Weight, kg 79 ± 10
BMI, kg m!2 24 ± 2
FEV1, L 4.95 ± 0.33
FVC, L 5.99 ± 0.52
VC, L 5.91 ± 0.47
Systolic blood pressure, mm Hg 136 ± 11
Diastolic blood pressure, mm Hg 67 ± 8
Heart rate, bpm 60 ± 12
Hemoglobin, g/L 146 ± 7
White cell count, " 109/L 4.9 ± 1.5
Platelet count, " 109/L 224 ± 53
PAI-1 antigen, ng/mL 6.87 ± 4.04
PAI-1 activity, U/mL 0.27 ± 0.22
t-PA antigen, ng/mL 2.82 ± 1.85
t-PA activity, U/mL 1.25 ± 0.54
Note: Data expressed as mean ± standard deviation unless otherwise 
stated. VC, Slow vital capacity; FEV1, forced expiratory volume in 1 
second; FVC, forced vital capacity. Plasminogen activator type 1 (PAI-1) 
and tissue plasminogen activator (t-PA) concentrations measured during 
forearm study on control air day before infusion of bradykinin.
Table 2. Basic spirometry and exhaled nitric oxide (FENO) at #ow rates 
of 10, 50, 100 and 250 ml/s after 1 h of nitrogen dioxide (4 ppm) or $ltered 
air exposure with intermittent exercise.
 Time NO2 Air
p values
Time Exposure
VC, L Pre-exposure 5.82 ± 0.41 5.91 ± 0.47 .9586 .1525
Post-exposure 5.88 ± 0.44 5.87 ± 0.48
FEV1, L Pre-exposure 4.95 ± 0.24 4.95 ± 0.33 .9758 .9200
Post-exposure 4.95 ± 0.33 4.94 ± 0.33
FVC, L Pre-exposure 5.93 ± 0.47 5.99 ± 0.52 .8824 .5704




Pre-exposure 6.28 ± 2.77 6.49 ± 2.36 .7960 .4244
1 hour 5.80 ± 2.31 6.14 ± 2.10




Pre-exposure 10.23 ± 5.62 10.53 ± 3.22 .8667 .8194
1 hour 10.33 ± 5.45 10.52 ± 5.32




Pre-exposure 16.55 ± 9.67 15.71 ± 9.02 .8628 .7003
1 hour 16.94 ± 9.71 16.34 ± 8.32




Pre-exposure 51.15 ± 32.65 51.87 ± 32.59 .8292 .9924
1 hour 55.74 ± 32.00 54.28 ± 33.16
4 hours 58.57 ± 27.16 59.48 ± 35.41
Note: Data shown as mean ± standard deviation. p values shown from 
two-way ANOVA with repeated measures showing e%ect of time and 
exposure. VC, Slow vital capacity; FEV1, forced expiratory volume in 1 
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although the response was similar following each exposure 
(Table 3). Plasma plasminogen-activator inhibitor 1 (PAI-1) 
 concentrations were unchanged (p > .05 for both infused 
and noninfused arms (data not shown) following infusion 
of bradykinin, with no di$erences following either exposure 
(p > .05 for all, data not shown).
!ere was no di$erence in white cell count, di$erential 
cell count, or platelet count through the study following 
either exposure (Table 4). We did observe a small fall in 
systemic hemoglobin concentrations through the study 
period consistent with repeated venesection, although 
there was no di$erence between the study exposures 
(Table 4).
Discussion and conclusions
We have demonstrated for the "rst time that direct exposure 
to nitrogen dioxide is not associated with vascular vasomo-
tor or "brinolytic dysfunction. !is suggests there are com-
ponents other than nitrogen dioxide that are responsible for 
the previously documented adverse cardiovascular e$ects 
of air pollution.
Table 3. Plasma tissue-plasminogen activator (t-PA) antigen concentrations and activity and estimated net t-PA release following infusion of bradykinin 
after 1 hour of nitrogen dioxide (4 ppm) or $ltered air exposure with intermittent exercise.
Bradykinin (pmol/min)
Air NO2 p Value
Baseline 100 300 1000 Baseline 100 300 1000 Time Exp.
t-PA antigen 
ng/ml
Infused arm 2.82 ± 1.85 2.46 ± 1.26 4.22 ± 2.78 8.52 ± 4.74 3.01 ± 1.98 2.67 ± 3.32 3.32 ± 2.42 5.98 ± 3.10 .0005 .0982
Noninfused arm 2.50 ± 1.54 1.81 ± 1.01 2.08 ± 1.16 2.24 ± 1.23 2.82 ± 1.88 1.99 ± 1.44 2.17 ± 1.35 2.36 ± 1.51 .6724 .2562
Estimated net t-PA 
release (ng/100ml 
tissue/min)
0.43 ± 0.67 3.78 ± 1.87 16.54 ± 13.90 54.27 ± 30.52 0.33 ± 0.64 2.93 ± 4.59 8.89 ± 12.29 36.71 ± 25.87 < .0001 .0833
t-PA activity 
U/ml
Infused arm 1.25 ± 0.54 1.81 ± 0.55 2.60 ± 0.72 3.48 ± 1.57 1.25 ± 0.43 1.82 ± 0.77 2.11 ± 1.11 2.95 ± 1.01 < .0001 .2130
Noninfused arm 0.98 ± 0.49 1.08 ± 0.32 1.20 ± 0.36 1.54 ± 0.49 1.00 ± 0.34 1.04 ± 0.44 1.13 ± 0.42 1.53 ± 0.54 .0009 .8191




0.43 ± 0.42 4.82 ± 2.66 12.24 ± 6.59 17.29 ± 10.14 0.39 ± 0.26 3.97 ± 3.23 7.60 ± 5.73 15.09 ± 10.20 < .0001 .2158
Note: Data shown as mean ± standard deviation. p values shown from two-way ANOVA with repeated measures showing e%ect of time and exposure (Exp.).
Figure 1. Forearm venous occlusion plethysmography with intra-arterial infusion of vasodilators performed 4 h after exposure. Data plotted as mean 
and T-bars show standard error of the mean. Solid lines show infused arm, dotted lines show noninfused arm after exposure to air (open symbols) or 
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Vascular e!ects
In this study we have employed a robust and well-validated 
technique to assess vascular endothelial function following 
a short-term exposure to nitrogen dioxide. Exposure to nitro-
gen dioxide, a major component of combustion-derived 
air pollution, has been linked to cardiovascular morbidity 
and mortality in epidemiological studies. Why then did we 
not observe adverse vascular e$ects? Many workers have 
attributed the epidemiological link with nitrogen dioxide 
to a bystander association or epi-phenomenon rather than 
a casual relationship. Nitrogen dioxide is a copollutant that 
correlates tightly with "ne and ultra"ne particulate matter 
(Sarnat et al., 2001). Our current and previous "ndings are in 
agreement with this hypothesis. Using controlled exposures 
to dilute diesel exhaust, we have previously demonstrated 
marked adverse e$ects on vascular endothelial function 
(Mills et al., 2005) that are present 2 and 6 h after the expo-
sure but have largely resolved by 24 h (Törnqvist et al., 2007). 
In the present study, performed 4 h after the exposure and 
well within the time window of the previously demonstrated 
adverse vascular e$ects, we aimed to separate the e$ects of 
the major gaseous copollutant, nitrogen dioxide, by using a 
pure gaseous exposure.
It is important to note that the nitrogen dioxide concen-
tration employed in this study has been previously demon-
strated to cause airway in#ammatory responses (Blomberg 
et al., 1997; Sandstrom et al., 1991). In homes with gas stoves 
and in certain industries, nitrogen dioxide concentrations 
may peak at 1–2 ppm (Samet et al., 1987). Alongside busy 
roads, nitrogen dioxide concentrations may reach 0.6 ppm 
(WHO, 1999). Whereas the concentration of nitrogen dioxide 
chosen for this study was matched to the overall concentra-
tion of oxides of nitrogen from previous diesel exhaust expo-
sure studies (Mills et al., 2005; Salvi et al., 1999), in these 
studies nitrogen dioxide concentrations reached an average 
of 1.6 ppm. !erefore, even at levels above those encoun-
tered in dilute diesel exposures, when pronounced adverse 
vascular e$ects were demonstrated, we have clearly dem-
onstrated that short-term exposure to pure nitrogen dioxide 
is not associated with vascular endothelial dysfunction in 
healthy young male subjects, although we cannot rule out a 
small e$ect in women or elderly people with comorbidities 
who may be more sensitive to environmental pollutants.
Nitrogen dioxide is a powerful oxidizing species, and we 
have demonstrated that its inhalation is associated with mild 
airway in#ammation (Blomberg et al., 1997) and changes in 
airway antioxidant responses (Kelly et al., 1996; Blomberg 
et al., 1997). Moreover, after exposure to nitrogen dioxide 
in in vitro studies, porcine pulmonary artery and aortic 
endothelial cells have been shown to su$er a signi"cant oxi-
dant injury, with lipid peroxidation and impaired cell mem-
brane function (Patel & Block, 1986). We have suggested that 
the vascular e$ects of air pollution exposure are mediated 
by oxidative stress (Miller et al., 2008), so why has inhalation 
of nitrogen dioxide failed to have an e$ect on vascular func-
tion? Nitrogen dioxide is relatively insoluble, and does not 
easily di$use across to the bloodstream from the lungs. In 
fact, its penetration of the alveolar space is further inhibited 
by the normal respiratory tract lining #uid (Postlethwait 
et al., 1991). !erefore it is likely that inhaled nitrogen diox-
ide is con"ned mainly to the lungs where it exerts a localized 
and speci"c pulmonary in#ammatory stimulus (Blomberg 
et al. 1997), without any signi"cant vascular or systemic 
oxidative insult. In light of these "ndings, we suggest that 
the vascular endothelial e$ects we have previously demon-
strated following exposure to diesel exhaust are driven by 
exposure to "ne and ultra"ne particulate matter, rather than 
any gaseous component.
"rombotic e!ects
!rombosis plays a central role in coronary heart disease. 
Formation of thrombus on disrupted atherosclerotic plaques 
may cause acute vessel occlusion, and acute coronary syn-
dromes. Exposure to air pollution is proposed to be proco-
agulant. Exposure to ambient nitrogen dioxide and carbon 
monoxide has been associated with increased plasma "brin-
ogen (Pekkanen et al., 2000) and a reduced prothrombin 
time (Baccarelli et al., 2007), and ambient sulfur dioxide with 
plasma viscosity (Peters et al., 1997), but again the question 
of whether exposure to nitrogen dioxide and carbon mon-
oxide is a surrogate for exposure to combustion-derived 
particulate matter arises. We have previously demonstrated 
that short-term exposure to dilute diesel exhaust results in 
increased platelet activation and enhanced thrombus for-
mation (Lucking et al., 2008), and at the same time impairs 
vascular release of tissue-plasminogen activator (t-PA), an 
endogenous "brinolytic enzyme (Mills et al., 2005) respon-
sible for local dissolution of formed blood clot.
Table 4. Di%erential cell count and hemoglobin concentrations before 
and after a 1-hour nitrogen dioxide (4 ppm) or $ltered air exposure with 
intermittent exercise.





Pre-exposure 148 ± 8 146 ± 7 .0124 .2842
4 hours 142 ± 8 143 ± 7
6 hours 139 ± 7 137 ± 7
White cell 
count (" 109/L)
Pre-exposure 4.8 ± 0.9 4.9 ± 1.5 .2434 .4340
4 hours 5.6 ± 1.5 5.7 ± 1.6
6 hours 6.2 ± 2.1 5.7 ± 1.5
Platelet count 
(" 109/L)
Pre-exposure 209 ± 44 224 ± 53 .8358 .2365
4 hours 214 ± 55 226 ± 50
6 hours 209 ± 46 209 ± 45
Neutrophils 
(" 109/L)
Pre-exposure 2.37 ± 0.75 2.34 ± 1.14 .1580 .2961
4 hours 3.14 ± 1.10 3.15 ± 1.21
6 hours 3.57 ± 1.78 3.00 ± 1.22
Lymphocytes 
(" 109/L)
Pre-exposure 1.89 ± 0.34 1.91 ± 0.47 .6226 .6763
4 hours 1.91 ± 0.55 1.92 ± 0.44
6 hours 2.12 ± 0.54 2.04 ± 0.48
Monocytes 
(" 109/L)
Pre-exposure 0.39 ± 0.11 0.40 ± 0.10 .6687 .9647
4 hours 0.41 ± 0.15 0.43 ± 0.13
6 hours 0.45 ± 0.16 0.43 ± 0.12
Note: Data shown as mean ± standard deviation. p values shown from 
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In this study we have not shown impaired release of 
tissue-plasminogen activator, or any increase in its endog-
enous inhibitor plasminogen-activator inhibitor type 1 
(PAI-1), following exposure to nitrogen dioxide. !erefore 
we propose that the previously demonstrated procoagulant 
and anti"brinolytic e$ects of air pollution exposure are pri-
marily driven by exposure to "ne and ultra"ne particulate 
matter rather than the gaseous copollutants.
Pulmonary e!ects
Our study demonstrated no change in exhaled nitric oxide 
(FENO) or simple spirometry following exposure to nitrogen 
dioxide. Spirometry provides a basic measure of lung func-
tion, assessing airway restriction and obstruction, and forms 
a critical part of the diagnosis of chronic lung conditions 
such as asthma and chronic obstructive pulmonary disease. 
Small e$ects on lung function have been demonstrated in 
patients with asthma following exposure to inhaled ambi-
ent air pollution (McCreanor et al., 2007). In light of this, we 
chose to assess changes in airway reactivity using simple 
spirometry in this group of healthy volunteers. Our study 
"ndings of no change in spirometry indices are in concord-
ance with similar studies performed after exposure to diesel 
exhaust in healthy volunteers (Nightingale et al., 162).
Exhaled nitric oxide is proposed as a marker of airway 
in#ammation, especially in asthmatic patients (ATS/ERS, 
2005), and is closely correlated with eosinophilic in#am-
mation (Lim & Mottram, 2008). As a marker, it is helpful in 
obtaining a diagnosis of asthma (Dupont et al., 2003) and 
may be used to track response to treatment (Yates et al., 
1995). Although FENO has been used in other airway con-
ditions, such as chronic obstructive pulmonary disease, 
interstitial lung diseases, and allergic rhinitis (2005), its use-
fulness as a marker of airway in#ammation in healthy vol-
unteers is unclear. Although exposure to the strong oxidative 
air pollutant ozone does not a$ect exhaled nitric oxide con-
centrations at an ozone dose known to induce a pronounced 
neutrophilic airway in#ammation (Olin et al., 2001), we 
have recently demonstrated a signi"cant increase in FENO 
following a 1-h exposure to dilute diesel exhaust in young 
healthy volunteers (Barath et al., 2007) and for this reason 
we chose FENO as a marker of airway in#ammation in this 
study. In healthy volunteers we have previously demon-
strated a mild airway in#ammatory response, with increases 
in interleukin-8 (IL-8) concentrations in bronchial washings 
90 min after a 4-h exposure to nitrogen dioxide (2 ppm). At 
6 h after the exposure, we demonstrated increased IL-8 con-
centrations and neutrophil counts within bronchial wash-
ings but no signs of in#ammatory cell recruitment into the 
endobronchial mucosa (Blomberg et al., 1997). We therefore 
believe that our measurements of FENO were performed 
within the established timeframe of an early airway in#am-
matory response.
Allowing for the limitations of FENO as a sensitive marker 
of airway in#ammation as a result of air pollution exposure, 
we suggest that our study provides no strong evidence for an 
early marked airway in#ammatory response following short-
term nitrogen dioxide exposure. However, we also acknowl-
edge that measurements of FENO can be highly variable 
(Olin et al., 2001), and therefore that our small study may be 
underpowered to detect a clinically signi"cant change. We 
therefore suggest that further investigation into the ability of 
short-term high-dose nitrogen dioxide to cause an in#am-
matory response is warranted.
Using a robust controlled study design, we have demon-
strated for the "rst time that exposure to nitrogen dioxide 
is not associated with any vascular vasomotor or "brino-
lytic dysfunction. !e adverse cardiovascular e$ects of 
combustion-derived air pollution appear to be mediated via 
components other than nitrogen dioxide, and it is plausible 
that these vascular e$ects are rather driven by the "ne and 
ultra"ne particle fractions.
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Air Pollution and Endothelin
Contribution of Endothelin 1 to the Vascular Effects of
Diesel Exhaust Inhalation in Humans
Jeremy P. Langrish, Magnus Lundbäck, Nicholas L. Mills, Neil R. Johnston, David J. Webb,
Thomas Sandström, Anders Blomberg, David E. Newby
Abstract—Diesel exhaust inhalation impairs vascular function, and, although the underlying mechanism remains unclear,
endothelin (ET) 1 and NO are potential mediators. The aim of this study was to identify whether diesel exhaust
inhalation affects the vascular actions of ET-1 in humans. In a randomized, double-blind crossover study, 13 healthy
male volunteers were exposed to either filtered air or dilute diesel exhaust (331!13 !g/m3). Plasma concentrations of
ET-1 and big-ET-1 were determined at baseline and throughout the 24-hour study period. Bilateral forearm blood flow
was measured 2 hours after the exposure during infusion of either ET-1 (5 pmol/min) or the ETA receptor antagonist,
BQ-123 (10 nmol/min) alone and in combination with the ETB receptor antagonist, BQ-788 (1 nmol/min). Diesel
exhaust exposure had no effect on plasma ET-1 and big-ET-1 concentrations (P"0.05 for both) or 24-hour mean blood
pressure or heart rate (P"0.05 for all). ET-1 infusion increased plasma ET-1 concentrations by 58% (P#0.01) but
caused vasoconstriction only after diesel exhaust exposure ($17% versus 2% after air; P#0.001). In contrast, diesel
exhaust exposure reduced vasodilatation to isolated BQ-123 infusion (20% versus 59% after air; P#0.001) but had no
effect on vasodilatation to combined BQ-123 and BQ-788 administration (P"0.05). Diesel exhaust inhalation increases
vascular sensitivity to ET-1 and reduces vasodilatation to ETA receptor antagonism despite unchanged plasma ET-1
concentrations. Given the tonic interaction between the ET and NO systems, we conclude that diesel exhaust inhalation
alters vascular reactivity to ET-1 probably through its effects on NO bioavailability. (Hypertension. 2009;54:910-915.)
Key Words: air pollution ! particulate matter ! endothelial function ! endothelin receptor antagonists ! ET-1
! endothelin-1 ! blood pressure
Exposure to combustion-derived fine particulate air pollu-tion is a recognized risk factor for cardiorespiratory
mortality and morbidity.1,2 There is a strong relationship
between acute exposure to traffic-derived particulate matter
and the incidence of acute myocardial infarction3 and hospital
readmission in survivors of myocardial infarction.4 The
World Health Organization estimates that annually %3 mil-
lion deaths worldwide can be attributable to air pollution.5
Recent controlled exposure studies have demonstrated that
inhalation of concentrated ambient particles and ozone causes
acute arterial vasoconstriction 2 hours after the exposure.6
Inhalation of diesel exhaust, a major component of fine
particulate air pollution in urban environments, impairs va-
somotor function and endogenous fibrinolysis.7 The funda-
mental mechanisms underlying these detrimental vascular
endothelial effects remain poorly understood. Furthermore,
the exact components of air pollution responsible for these
effects have not been defined, although it is proposed that
airborne particulate matter is likely to be the major arbiter.2
Endothelin (ET) 1, an endogenous vasoconstrictor 100-fold
more potent that norepinephrine,8 is a 21-amino acid peptide
produced by the vascular endothelium in response to stress. It
is produced initially as preproendothelin-1, which is pro-
cessed to form big-ET-1, before being cleaved by ET-
converting enzyme into ET-1. The actions of ET-1 are
mediated by 2 G protein–coupled receptors, the ETA and ETB
receptors. Stimulation of either the ETA or ETB receptor
causes vasoconstriction, although the ETB receptor is also
expressed on endothelial cells where it releases NO. The ET
system plays a major role in cardiovascular and renal phys-
iology,9 and although its actions are complex, ET-1 contrib-
utes to the maintenance of basal vascular tone and blood
pressure in humans.10,11
Recent work has suggested that plasma ET-1 concentra-
tions are increased by exposure to air pollution. Rats raised
with daily exposure to diesel exhaust particles and urban
particulate matter have increased blood pressure, plasma
ET-1 concentrations,12 and ET-1 expression in cardiac tis-
sue.13 In children from Mexico City, Mexico, plasma ET-1
concentrations correlated with the degree of air pollution
exposure.14 Peretz et al15 recently demonstrated elevated
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plasma ET-1 concentrations in a heterogeneous population of
healthy volunteers and patients with the metabolic syndrome
3 hours after a controlled 2-hour resting exposure to diesel
exhaust.
The aims of this study were to assess the effect of diesel
exhaust inhalation on plasma ET-1 and big-ET-1 concentra-
tions, ET-1–mediated vasoconstriction, and the contribution
of ET-1 to basal vascular tone.
Methods
Subjects
Fifteen healthy male volunteers were recruited between February and
March 2008 at Umeå University Hospital. All of the subjects had
normal lung function, were nonsmokers, and took no regular
medication. Those with a significant occupational exposure to air
pollution and those with an intercurrent illness were excluded. The
trial was performed with the approval of the local research ethics
committee, in accordance with the Declaration of Helsinki, and with
the written informed consent of each participant.
Study Design
Subjects attended for 2 consecutive days on 4 occasions "1 week
apart. In a double-blind, randomized crossover study, subjects were
exposed to either filtered air or dilute diesel exhaust at 300 !g/m3 for
1 hour in a specially built diesel exposure chamber, as described
previously.16 During the exposure, subjects performed 15-minute
periods of exercise on a bicycle ergometer (minute ventilation: 25
L/min per meter squared) alternated with 15-minute periods of rest.
On the basis of previous studies,7 vascular assessments and
intra-arterial infusions were commenced 2 hours after the exposure.
All of the subjects abstained from alcohol for 24 hours and
caffeine-containing drinks for "8 hours and fasted for "4 hours
before commencement of the vascular study. All of the subjects
remained indoors at rest between the exposure and the vascular
assessment to minimize additional exposure to air pollution. A
validated ambulatory blood pressure monitor (model 90217,
SpaceLabs Healthcare) was applied to the right arm 2 hours before
the start of the exposure, and monitoring was continued for a total of
24 hours.
Diesel Exposure
Diesel exhaust emissions were generated using an idling Volvo
(Volvo TD45, 4.5 L, 4 cylinders, 680 rpm) diesel engine. More than
90% of the exhaust was shunted away, and the remaining part was
diluted with air and fed into the exposure chamber at steady-state
concentration. During the exposure, air was sampled in the breathing
zone of the subjects and monitored for nitrogen oxides, particle
number, and total hydrocarbons (measured as propane). Filter
samples were collected and analyzed for mass concentration. The
exposures were standardized by keeping the particle (diameter:
#10 !m) mass concentration at %300 !g/m3. Temperature and
humidity in the chamber were controlled at 22°C and 50%,
respectively.
Vascular Studies
All of the subjects underwent brachial artery cannulation in the
nondominant arm using a 27-gauge steel needle under controlled
conditions. After a 30-minute baseline infusion of 0.9% saline,
subjects received either a 60-minute infusion of ET-1 (American
Peptide) at 5 pmol/min17 or infusion of BQ-123 (an ETA receptor
antagonist, American Peptide) at 10 nmol/min for 60 minutes,18
followed by coinfusion of BQ-123 (10 nmol/min) and BQ-788 (an
ETB receptor antagonist, American Peptide; 1 nmol/min)19,20 for a
further 60 minutes.
Forearm blood flow was measured in the infused and noninfused
arms by venous occlusion plethysmography with mercury-in-
silicone elastomer strain gauges, as described previously.21 Supine
heart rate and blood pressure were determined in the noninfused arm
at intervals throughout the study using the ambulatory blood pressure
monitor.
Venous cannulae (17-gauge) were inserted into large subcutane-
ous veins in the antecubital fossae of both arms. Blood (10 mL) was
drawn simultaneously from each arm at the end of the baseline saline
infusion and at the end of each 60-minute infusion period. Blood
samples were also obtained by separate venipuncture at baseline,
immediately, and 6 and 24 hours after the exposure.
Biochemical Analyses
Blood samples taken at baseline and 6 and 24 hours after the
exposure were analyzed for total and differential cell counts by an
autoanalyzer. Plasma samples were collected into ethylene diamine
tetra-acetic acid and kept on ice until centrifuged at 3000 rpm for 30
minutes. Plasma samples were immediately frozen and stored at
$80°C. Plasma ET-1 and big-ET-1 concentrations were measured
according to an acetic acid extraction technique using a commercial
radioimmunoassay with rabbit antihuman ET-1 or big-ET-1 (Penin-
sular Laboratories Europe Ltd), as described previously.22
Data and Statistical Analysis
Nursing staff at the clinical research facility at the Umeå University
Hospital randomized exposure type and the associated vascular study
protocol. The investigators were blinded to the exposure received.
Plethysmography data were analyzed as described previously.23 Data
are expressed as mean!SEM unless otherwise stated. Statistical
analyses were performed using paired Student t tests and 2-way
ANOVA with repeated measures, including time and exposure as
variables, where appropriate. Statistical significance was taken at the
5% level. All of the analyses were performed using GraphPad Prism
(version 4 for Macintosh, GraphPad Software) on a Macintosh
personal computer.
Results
Thirteen subjects, with a median age of 23 years (Table),
completed the study (Figure 1). The diesel exposure gener-
ated a mean particle mass concentration of 331!13 !g/m3,
and this was associated with concentrations of NO2 of
1.0!0.04 ppm, NO of 3.3!0.13 ppm, and total hydrocarbons
of 1.4!0.04 ppm. There were no differences in 24-hour mean
systolic or diastolic blood pressures or mean heart rate after
exposure to air or diesel exhaust (P"0.05 for all), although
there was a slightly lower nocturnal diastolic blood pressure
after diesel exhaust exposure (62!1 versus 65!1 mm Hg;
P#0.01). There was a rise in blood pressure after exercise on
both study visits, although there was no difference between
the 2 exposures (data not shown; P"0.05).
Table. Baseline Characteristics of the 13 Subjects Who
Completed the Study
Parameter Data (N&13)
Age, median (range), y 23 (21 to 28)
Height, cm 181!2
Weight, kg 79!3
Body mass index, kg/m2 24!1
Hemoglobin concentration, g/L 153!3
White blood cell count, '109/L 5.1!0.4
Neutrophil count, '109/L 2.5!0.3
Lymphocyte count, '109/L 2.0!0.1
Monocyte count, '109/L 0.40!0.03
Platelet count, '109/L 209!11
Data show the mean!SEM unless otherwise stated.
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Infusion of ET-1 caused a slow-onset vasoconstriction
after diesel exhaust inhalation (17!10% peak reduction in
blood flow), although there was little effect after filtered air
(Figure 2; ANOVA, P#0.001 for exposure effect). Infusion
of the ET receptor antagonists, BQ-123 and BQ-788, caused
a slow-onset vasodilatation (77!14% peak increase in blood
flow after filtered air; Figure 3). This vasodilatation was
greater after filtered air compared with the diesel exhaust
exposure (Figure 3; ANOVA, P#0.001). The difference was
greatest at 60 minutes, but, after infusion of the BQ-788, there
was little difference in blood flow by 120 minutes (P"0.05).
Plasma ET-1 and big-ET-1 concentrations were unchanged
at all of the time points after diesel exhaust or filtered air
exposure (P"0.05 for both). Comparison of the infused and
noninfused arm plasma ET-1 concentrations confirmed that
the ET-1 infusion increased local plasma ET-1 concentrations
by 58!9% (Figure 2; P#0.01 for infused arms and P"0.05
for noninfused arms for both exposures).
Discussion
Although diesel exhaust inhalation had no effect on plasma
ET-1 or big-ET-1 concentrations, there was an increase in
vascular sensitivity to ET-1 associated with a reduced ETA
induced vasodilatation. These apparently contradictory find-
ings can be explained by impaired ET-1–induced NO release
and are consistent with preclinical evidence of NO-mediated
alterations in vascular reactivity to ET-1.24 We conclude that
diesel exhaust inhalation, at levels commonly encountered in
the urban environment, does not affect plasma ET-1 concen-
trations but alters vascular reactivity to ET-1 probably
through effects on NO release and bioavailability.
Endothelin 1
We did not demonstrate any change in plasma concentrations
of ET-1 or its immediate precursor, big-ET-1, after exposure
to filtered air or diesel exhaust. Although this is consistent
with our own previous work,7 it is at odds with other reports.
15 patients recruited
Screening visit
Randomization – 4 visits
(n=14)
Air Exposure Diesel exposure (~300µg/m3)
ET-1 BQ-123 & BQ-788 ET-1
BQ-123 & 
BQ-788
13 patients completed study
1 subject withdrawn 
by investigators due 
to abnormal ECG for 
further investigation
1 subject withdrawn 
by investigators due 
to difficulties with 
arterial cannulation
Figure 1. Consort flowchart of study participants.
Figure 2. A, Forearm blood flow (FBF)
during infusion of ET-1 (5 pmol/min) after
exposure to air (E) and diesel exhaust (F;
ANOVA, P#0.001). B, Maximal effect at
60 minutes and (C) comparison of plasma
ET-1 concentrations in infused and nonin-
fused arms before and at the end of the
forearm vascular study after air (u;
P#0.001 for infused and P"0.05 for non-
infused) and diesel exhaust inhalation (f;
P#0.0001 for infused and P"0.05 for
noninfused). Data are from a paired Stu-
dent t test of air vs diesel.
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In rodent studies, plasma ET-1 (and ET-3) concentrations
were upregulated after exposure to diesel exhaust and con-
centrated urban particles.12,13 It is possible that there are
species differences in the response to diesel exhaust inhala-
tion, and upregulation of ET-1 in rats may not translate into
humans. However, Peretz et al15 studied a heterogeneous
group of individuals composed of patients with metabolic
syndrome and healthy volunteers and showed an increase in
plasma ET-1 concentrations 3 hours after diesel exhaust
exposure. Their study was not designed specifically to look at
ET-1 and was limited by missing data and small numbers in
a heterogeneous population in whom vascular endothelial
function may not be equivalent.25 In contrast, our study was
specifically designed to address the ET hypothesis and used a
robust crossover study design, in a homogenous group of
healthy volunteers, with samples optimally collected to assess
plasma ET-1 and big-ET-1 concentrations.22 Taken together
with our previous study, our experience represents the largest
sample size to date (n&43). Therefore, we think it is unlikely
that diesel exhaust inhalation causes major changes in plasma
ET concentrations.
We recognize that plasma ET-1 concentrations may not
reflect the activity of the ET system because 90% of ET-1
synthesized by the vascular endothelium is secreted ablumi-
nally and acts locally on vascular smooth muscle in a
paracrine manner.8 Therefore, in addition to measuring
plasma ET-1 concentrations, we assessed the effects of ET
agonism and antagonism on peripheral vascular tone.
ET Agonism
We demonstrated increased vasoconstriction after exposure
to diesel exhaust, but little effect after exposure to filtered air,
suggesting an increased vascular sensitivity to ET-1. We were
surprised to see little vasoconstriction with ET-1 after expo-
sure to filtered air, having previously reported %30% to 40%
reductions in forearm blood flow during infusions of 5
pmol/min.10,26 In the present study, we used an alternative
preparation of ET-1 and suggest that the disparity in vascular
effects is attributable to differing potencies of the prepara-
tions. Because of this, we measured plasma ET-1 concentra-
tions in both forearms and demonstrated a selective 60%
increase in plasma ET-1 concentrations in the infused arm.
Assuming a forearm blood flow of 25 mL/min, we achieved
an end-organ concentration approximately one tenth of that
anticipated. However, this simple calculation does assume
that there is no clearance or extraction of ET-1 across the
forearm, but we do not believe that the modest increase in
venous ET-1 concentrations can be solely accounted for by
clearance, and conclude that it reflects a reduced activity of
the infused peptide preparation. Although the reduced activity
of ET-1 limits comparisons with other studies, this was
perhaps fortuitous, because it enabled us to assess the
vasoreactivity to ET-1 at the threshold for vasoconstriction
and to observe an alteration in ET-1 sensitivity.
ETA Receptor Antagonism
The reduction in vasodilatation to BQ-123 infusion after
diesel exhaust inhalation has several potential explanations.
First, this may relate to reduced production or increased
clearance of active ET-1 from the vasculature. However, this
seems unlikely given that plasma ET-1 and big-ET-1 concen-
trations were unchanged, although we acknowledge that an
effect on the abluminal release of ET-1 cannot be excluded.
Second, a reduced sensitivity of the vascular smooth muscle
ETA receptor could have occurred, but this is at odds with the
increased ET-1 vasoconstriction and is, therefore, unlikely.
We believe that there is a third, more likely, explanation.
Looking closely at ETA receptor antagonism, it is clear that
the mechanism of vasodilatation is complex. This reflects the
distribution and basal activity of both the ETA and ETB
receptors. Both receptors contribute to the maintenance of
basal vascular tone but have differing actions and vascular
distributions: ETA receptors are present on vascular smooth
muscle cells only and mediate vasoconstriction, whereas ETB
receptors are present on both vascular smooth muscle and
endothelial cells, where they mediate vasoconstriction and
vasodilatation, respectively. Moreover, selective ETA recep-
tor antagonism leads not only to inhibition of the ETA
Figure 3. A, Forearm blood flow (FBF)
during infusion of BQ-123 (10 nmol/min)
and BQ-788 (1 nmol/min) after exposure
to air (E) and diesel exhaust (F; ANOVA,
P#0.001). B, Maximal effect after BQ-123
infusion alone and (C) after dual endothe-
lin receptor antagonism.
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receptor but potentially to hyperstimulation of the ETB
receptor. Indeed, we have demonstrated that BQ-123–in-
duced vasodilatation can be markedly attenuated by concom-
itant blockade of NO release,18 suggesting that selective ETA
receptor antagonism does indeed lead to significant ETB
receptor–mediated vasodilatation through endothelial NO
release. Given the central role of NO in modulating and
balancing the effects of the ET system, we propose that
changes in the L-arginine-NO pathway offer the most plausi-
ble hypothesis for the impaired vasodilatation to BQ-123.
This would also explain the enhanced vasoconstriction to
ET-1 with a reduction in the opposing vasodilatory actions of
NO. Moreover, we have shown previously that diesel exhaust
impairs NO bioavailability7,27 and suggest that the observed
effects on ET-1 vasoreactivity can be explained by the
reduction in ET-induced NO release and bioavailability.
The finding of reduced vasodilatation in response to ETA
receptor blockade is at odds with previous studies demon-
strating enhanced response in patients with conditions such as
hypertension and hypercholesterolemia who have preexisting
endothelial dysfunction mediated by reduced NO bioavail-
ability.28,29 The reason for this discrepancy is unclear, but
here we have induced an acute and brief episode of endothe-
lial dysfunction in an otherwise healthy population of volun-
teers. Chronic dysfunctional states are likely to invoke
compensatory mechanisms that may result in important dif-
ferences in these vascular responses.
Combined ETA and ETB Receptor Antagonism
Previous data, including our own work,18 would suggest that
combined ETA/ETB receptor antagonism should produce less
vasodilatation than selective ETA receptor antagonism. We
were, therefore, surprised to observe the continued further
modest vasodilatation when ETB receptor antagonism was
superimposed on ETA receptor antagonism. We believe that
the explanation for this observation is 3-fold. First, vasodila-
tation to ET agonism and antagonism is of slow onset and
offset. In our own hands, BQ-123–induced vasodilatation
appears to reach a peak effect by 60 minutes18 but may take
up to 90 minutes.10 The continued vasodilatation may, there-
fore, reflect further and more complete ETA receptor antag-
onism. Second, we chose this study design to minimize the
number of visits given the invasive nature of the studies. We
attempted to assess both ETA receptor antagonism and
combined ETA/ETB receptor antagonism on the same visit.
This approach has been used once before by Cardillo et al30
in a small subgroup of patients with diabetes mellitus. Here,
they demonstrated a brisk vasodilatation to BQ-123 of %65%
with maximal vasodilatation by 60 minutes. Importantly, the
predicted “tailing off” of the response when BQ-788 was
added did not occur, and the vasodilatation plateaued rather
than fell. This is consistent with the findings in our study.
Finally, there may be an interaction when ETA receptor
antagonism precedes combined ETA/ETB receptor antago-
nism. This may reflect alterations in ETB receptor expression
on both the endothelium and vascular smooth muscle cells in
the face of ETA receptor antagonism. Indeed, there is consid-
erable cross-talk between the receptors, as we have described
previously.31 Thus, the differing profile of responses may
reflect the dynamic interaction of the 2 receptors over the
course of the study.
This altered profile of vasodilatation does not detract from
the comparison between the filtered air and diesel exhaust
exposure. Combined ETA and ETB receptor antagonism
appears to be unaffected by diesel exhaust exposure, whereas
selective ETA receptor antagonism is impaired. This is likely
to reflect the greater and marked dependence of ETA receptor
antagonism on NO release in comparison with combined ETA
and ETB receptor antagonism.
Conclusions
Our data demonstrate that the previously documented impair-
ment of endothelium-dependent vasodilatation after a 1-hour
exposure to combustion-derived air pollutants is not mediated
by an upregulation of the ET system. Furthermore, we have
shown that diesel exhaust inhalation has no effect on plasma
ET-1 concentrations or systemic blood pressure. Our data are
consistent with the hypothesis that the diesel exhaust–induced
vascular effects are predominantly driven by reduced endo-
thelial NO bioavailability. However, we cannot exclude a role
for other vasoactive mediators, such as endothelium-derived
hyperpolarizing factor, and further studies are warranted to
investigate the L-arginine:NO and other pathways in more
detail.
Perspectives
Air pollution exposure is associated with increased cardio-
vascular morbidity and mortality and is thought to lead to %3
million deaths worldwide each year. Understanding the un-
derlying mechanism for these detrimental effects is crucial in
trying to reduce this significant disease burden. In this study,
we show that the well-established adverse vascular endothe-
lial effects demonstrated after inhalation of diesel exhaust are
not directly mediated through the ET system. We propose
instead that these may be driven by changes in NO bioavail-
ability. Additional studies are warranted to investigate this
hypothesis in more detail.
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D, Adamson I, Desjardins S, Burnett R, Miller F, Battistini B. Inhalation
toxicology of urban ambient particulate matter: acute cardiovascular
effects in rats. Res Rep Health Eff Instit. 2001;104:5–54.
13. Ito T, Suzuki T, Tamura K, Nezu T, Honda K, Kobayashi T. Examination
of mRNA expression in rat hearts and lungs for analysis of effects of
exposure to concentrated ambient particles on cardiovascular function.
Toxicology. 2008;243:271–283.
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Abstract
Background: Exposure to air pollution is an important risk factor for cardiovascular morbidity
and mortality, and is associated with increased blood pressure, reduced heart rate variability,
endothelial dysfunction and myocardial ischaemia. Our objectives were to assess the cardiovascular
effects of reducing air pollution exposure by wearing a facemask.
Methods: In an open-label cross-over randomised controlled trial, 15 healthy volunteers (median
age 28 years) walked on a predefined city centre route in Beijing in the presence and absence of a
highly efficient facemask. Personal exposure to ambient air pollution and exercise was assessed
continuously using portable real-time monitors and global positional system tracking respectively.
Cardiovascular effects were assessed by continuous 12-lead electrocardiographic and ambulatory
blood pressure monitoring.
Results: Ambient exposure (PM2.5 86 ± 61 vs 140 ± 113 g/m3; particle number 2.4 ± 0.4 vs 2.3 ±
0.4 ! 104 particles/cm3), temperature (29 ± 1 vs 28 ± 3°C) and relative humidity (63 ± 10 vs 64 ±
19%) were similar (P > 0.05 for all) on both study days. During the 2-hour city walk, systolic blood
pressure was lower (114 ± 10 vs 121 ± 11 mmHg, P < 0.01) when subjects wore a facemask,
although heart rate was similar (91 ± 11 vs 88 ± 11/min; P > 0.05). Over the 24-hour period heart
rate variability increased (SDNN 65.6 ± 11.5 vs 61.2 ± 11.4 ms, P < 0.05; LF-power 919 ± 352 vs
816 ± 340 ms2, P < 0.05) when subjects wore the facemask.
Conclusion: Wearing a facemask appears to abrogate the adverse effects of air pollution on blood
pressure and heart rate variability. This simple intervention has the potential to protect susceptible
individuals and prevent cardiovascular events in cities with high concentrations of ambient air
pollution.
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Introduction
Air pollution, and especially traffic-derived particulate
matter [1], is now established as a major cause of cardi-
orespiratory morbidity and mortality [2-4]. Epidemiolog-
ical studies have shown that chronic air pollution
exposure is associated with the degree of atherosclerosis
[5,6], and the risk of cardiovascular events [7]. Acute expo-
sure causes exacerbation of existing cardiorespiratory con-
ditions leading to an increase in hospital admissions [8]
and deaths [9].
The mechanisms of these associations are unclear but
recent controlled exposure studies have demonstrated
that air pollution causes vascular endothelial dysfunction
[10], arterial vasoconstriction [11], increased blood pres-
sure [12] and myocardial ischaemia [13]. Observational
studies have also suggested that air pollution exposure
impairs regulation of the autonomic nervous system and
reduces heart rate variability [14,15]. A combination of
these effects is likely to account for the increase in cardio-
vascular events seen following exposure to air pollution.
There is therefore a need to consider approaches that can
reduce ambient air pollution exposure on both a personal
and societal level.
In Beijing China, particulate matter (particle diameter <
10 m; PM10) air pollution averages around 150 g/m3
and, in 2006, levels exceeded the World Health Organisa-
tion recommended national standards
(PM10concentration < 50 g/m3) on 241 out of 365 days
[16]. Despite considerable efforts to improve air quality,
pollution remains the single largest environmental and
public health issue affecting Beijing. The extensive use of
coal and the growing number of motor vehicles (esti-
mated 3.3 million vehicles on the roads in August 2008)
have contributed to air pollution. In addition, the city's
geographical location exacerbates the problem with the
surrounding mountain ranges impeding air circulation
and dispersion of pollutants.
Increasing concern relating to the health effects of air pol-
lution has led many individuals to use facemasks to
reduce personal exposure. The efficiency of these masks
and the potential cardiovascular benefits on people
exposed to urban air pollution has yet to be established.
The aims of this study were to assess the efficacy of face-
masks in removing potentially hazardous particulate air
pollution and to determine the potential cardiovascular




Fifteen healthy volunteers were recruited from the Fuwai
Hospital, Beijing in August 2008. All subjects were non-
smokers, received no regular medication, and had no
intercurrent illnesses. All subjects gave their written con-
sent to participate in the study, which was reviewed and
approved by the local ethics committee, in accordance
with the Declaration of Helsinki.
Assessment of mask efficacy
Masks designed for use by cyclists, pedestrians and occu-
pational settings were tested for penetrance of fresh diesel
exhaust particulate. Diesel engine exhaust was generated
from the idling (1500 rpm) engine (F3M2011, Deutz Ag,
Köln, Germany) of a 35 KVA generator (Bredenoord,
Apeldoorn, Netherlands). The exhaust was diluted with
filtered air to obtain a mass concentration of 75 ± 12 g/
m3 (as measured by gravimetric analysis) and a particle
number concentration of 500,000 particles/cm3 (conden-
sation particle counter [CPC] model 3022, TSI Instru-
ments, High Wycombe, UK). Sections of each mask filter
were mounted in a filter holder. After 5 min of baseline
measurements, filters were introduced between the
exhaust and the CPC that sampled at a flow rate of 1.5 L/
min. Particle number was recorded for 5 min and pene-
trance defined as the percentage of particles passing
through the filter compared to baseline.
Study design
All 15 subjects attended the Fuwai Hospital on two occa-
sions, each at least one week apart, during August 2008. In
a randomised open-label controlled cross-over study, sub-
jects were randomised to wear no mask or a highly effi-
cient facemask filter (Dust Respirator 8812, 3 M, St Paul
USA). When randomised to wear the facemask, subjects
were asked to wear the mask for 24 hours prior to the
study day and 24 hours of the study day. Subjects were
asked to wear the mask at all times when outside, and as
much as possible whilst indoors. On the study day, sub-
jects were asked to walk for 2 hours in a city centre loca-
tion (Figure 1) along the inner ring road in Beijing
between 8 and 10 am.
Pollution and activity monitoring
Personal exposure to air pollutants was monitored using
a collection of portable monitoring equipment mounted
in a backpack. Particle mass concentration (particle diam-
eter < 2.5 m; PM2.5) was measured in using a light-scat-
tering nephelometric method using a DataRAM monitor
(pDR-1500, Thermo Scientific, Franklin, USA). Particle
number was measured using a handheld condensation
particle counter (CPC 3007, TSI Instruments Ltd, High
Wycombe, UK). Ambient temperature and relative
humidity were recorded using a sensor on the outside of
the backpack (Omegaette® HH-314, Omega Engineering
Ltd, Connecticut, USA). Gaseous pollutants were meas-
ured using a multigas analyser (X-am 7000, Dräger Safety,
Pittsburgh, USA) measuring carbon monoxide (CO),
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nitrogen dioxide (NO2) and sulphur dioxide (SO2) using
electrochemical sensors with a sensitivity of 1 part per mil-
lion.
Physical activity was assessed using a portable global posi-
tioning system (GPS) monitor secured to the outside of
the bag (eTrex Summit HC, Garmin, USA). This recorded
the route taken by volunteers, their total distance trav-
elled, and average speed. This information was used,
along with baseline anthropometric measurements, to
calculate the energy expended during the walk in kilocal-
ories and metabolic equivalents (METS).
Holter monitoring
Subjects were fitted with a 12-lead continuous electro-
graphic Holter monitor (Lifecard 12, Spacelabs, UK) at
the beginning of the study day for 24 hours. Holter elec-
trographic traces were analysed using DelMar Reynolds
proprietary software packages by two blinded observers.
The quality of the electrocardiographic trace was manu-
ally inspected before arrhythmias were automatically
detected using the Pathfinder software package. Identified
arrhythmias were then individually inspected, verified or
deleted as appropriate. Average heart rate and heart rate
variability in both time and frequency domains were ana-
lysed using the HRV Tools software package, with identi-
fied arrhythmias excluded from this analysis.
Ambulatory blood pressure
Subjects were fitted with an ambulatory blood pressure
monitor (Model 90217, Spacelabs, UK) at the beginning
of the study day. Blood pressure was recorded at the left
brachial artery every 15 minutes during the 2-hour walk,
every 30 minutes for the rest of the daytime (07:00 to
22:00), and every hour overnight (22:00 – 07:00).
City centre route chosen in central BeijingFigur  1
City centre route chosen in central Beijing. A representative recording from the GPS device contained in the monitoring 
backpack is shown. The walk goes from the Fuwai Hospital (A), along the inner ring road (B) and towards the city centre (C) 
before turning back. Image courtesy of Google™ Earth.
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Symptom questionnaire
Subjects were asked to complete a symptom question-
naire using a visual analogue scale at the beginning of the
study day, after the 2-hour walk and at the 24-hour visit.
They were asked to record any physical symptoms, as well
as report a perception of the degree of pollution and the
tolerability of the mask.
Data analysis and statistical methods
Subjects were randomised to wearing a mask on their first
or second visit using a random number generator. All data
are expressed as mean (95% confidence interval [CI])
unless otherwise stated. The symptom questionnaire was
based on a visual analogue scale. Scores were converted
into a percentage, and analysed using 2-way analysis of
variance (ANOVA) with repeated measures using time
and the mask intervention as variables. The occurrences of
arrhythmias during the 24-hour monitoring period were
compared using the Wilcoxon matched pairs method. All
other parameters were evaluated using paired Student's t-
tests. Statistical significance was taken at the 5% level. All
data were analysed using GraphPad Prism (Version 4 for




Mask penetrance was highly dependent on mask type
(Figure 2). The 3 M Dust Respirator (Model 8812, 3 M, St
Pauls, USA) was selected for the intervention study as it
provided good filtration performance and was extremely
efficient and comfortable to wear.
Table 1: Exposure characteristics during city centre walks.













NO2, number of peaks Nil Nil









Data expressed as mean (95% confidence interval).
P > 0.05 compared to control (without mask) day for all, Student's 
paired t-test.
Penetrance of commercially available filters: 3 M Dust Respirator 8812, Dust Respirators A and B, Cyclist Masks A to DFigure 2
Penetrance of commercially available filters: 3 M Dust Respirator 8812, Dust Respirators A and B, Cyclist 
Masks A to D. The Teflon filter is an industry standard filter for aerosol studies included as a control. Cotton handkerchiefs 
and surgical masks are often seen worn in public areas in parts of Asia.
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Intervention study
Fifteen subjects (20–45 years) completed the study. Sub-
jects were predominantly female (13:2) with a mean
height of 164 cm (95% CI, 160 – 167), weight of 55 kg
(95% CI, 50 – 60) and body mass index of 20.5 kg/m2
(95% CI, 19.3 – 21.7). There were no differences (P > 0.05
for all parameters) in ambient pollution exposure during
the 2-hour walk between the two visits (Table 1). Based on
the measured penetrance of 3.4%, assuming a perfect
facial fit and similar flow rates, we predict that the particle
count to which subjects were exposed when wearing a
mask was reduced to just 795 (95% CI, 726 – 864) parti-
cles/cm3.
There were no differences in 24-hour average heart rate or
blood pressure during the two study days (Table 2). Hol-
ter analysis revealed an increased SDNN (65.6 ± 11.5 vs
61.2 ± 11.4 ms, P < 0.05) and LF-power (919 ± 352 vs 816
Table 2: 24-hour ambulatory blood pressure monitoring and Holter analysis for heart rate variability with each visit.
Without Mask With Mask
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All data expressed as mean (95% confidence interval). *P < 0.05 compared to control (no mask) day, Student's paired t-test.
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± 340 ms2, P < 0.05) over the 24 hours when subjects wore
the mask. There were no clinically relevant arrhythmias
recorded in any subject (Table 3).
During the 2-hour walk, there was no difference in exer-
cise intensity in the presence or absence of the facemask
(Table 4) although subjects had a lower systolic blood
pressure (114 ± 10 vs 121 ± 11 mmHg; P < 0.01) when
wearing a mask. This was not associated with a change in
diastolic blood pressure, heart rate or in heart rate varia-
bility measurements.
Subjects reported only very minor symptoms (Table 5)
during the study period. The mask was generally well tol-
erated with an average score of 24.8% (95% CI, 16.2 –
33.3%); 0% being completely tolerable and 100% being
intolerable.
Discussion
In this study, we have shown for the first time that a sim-
ple well-tolerated personal intervention to reduce expo-
sure to airborne particulate air pollution leads to a
reduction in systolic blood pressure during exercise and
an increase in heart rate variability. If translated into a sus-
ceptible population, our findings would suggest that
wearing a simple facemask has the potential to reduce the
incidence of acute cardiovascular events in cities with high
levels of air pollution, and could influence the advice
given to patients with chronic cardiovascular diseases.
We tested a range of facemasks that differed widely in
their efficiency as particle filters. In general, those masks
designed to reduce occupational exposure to dusts were
more efficient than those marketed as personal protection
to cyclists and pedestrians in an environmental setting.
The choice of the mask used in this study was influenced
by efficiency and comfort. The chosen mask was very well
tolerated by subjects as demonstrated by the visual ana-
logue score, and was predicted to reduce the exposure to
particulate matter dramatically. When wearing the masks,
the subjects did report slightly greater difficulty breathing
whilst walking although this did not reduce the level of
exercise undertaken by the subjects. This increased resist-
ance to respiration is unlikely to affect the main study
findings since such stresses would be predicted to increase
blood pressure rather than reduce it.
Recent studies have confirmed a link between blood pres-
sure and exposure to air pollution. Population-based
studies have shown increases in both systolic blood pres-
sure and pulse pressure [17,18] with increasing levels of
ambient pollution exposure. Controlled exposure studies
to concentrated ambient particles and ozone have dem-
onstrated an increase in diastolic blood pressure during a
two-hour exposure [12]. Although there were no differ-
ences in blood pressure over the whole 24-hour period,
we observed a marked difference in systolic blood pres-
sure with exercise. In both groups, blood pressure
increased during exercise compared to the 24-hour aver-
age, although this increase was less when wearing a face-
mask. This, in combination with previous controlled
exposure studies [12], suggests that particulate air pollu-
tion may augment exercise-induced increases in blood
pressure, and that the use of a simple facemask can abro-
gate this. Exercise induced increases in systolic blood pres-
sure have been linked to myocardial infarction [19] as
well as stroke [20], and increased blood pressure is an
established major risk factor for the development of both
atherosclerosis and cardiovascular mortality [21,22]. The
reduction in systolic blood pressure seen in this study is
similar to that seen with many antihypertensive agents,
which have been shown to reduce major cardiovascular
events. Therefore we predict that the use of a facemask in
a susceptible population has the potential to reduce the
incidence of acute cardiovascular events as well as myo-
cardial ischaemia [13,23].
Heart rate variability is a measure of the variation in the R-
R interval on the electrocardiogram. A balance of the par-
asympathetic and sympathetic nervous systems controls
the heart rate in order to maintain a constant cardiac out-
put at rest or to respond to increased demands during
exercise. A reduction in heart rate variability occurs in var-
ious pathophysiological conditions including hyperten-
sion [24], heart failure [25] and diabetes mellitus [26],
Table 3: Arrhythmia analysis from 24-hour Holter 
electrocardiograms.
Without Mask With Mask
Pause 0 0
Dropped beat 0 0




Bradycardia (=50 bpm) 71 227
Supraventricular tachycardia 0 0
Bigeminy 57 157
Trigeminy 4 7
"R on T" 0 0
Premature aberrant 3246 4698
Isolated aberrant 18 3
Premature normal 11 17








Data shown are total number of events recorded in each condition 
over all subjects.
P > 0.05 for all (Wilcoxon matched pairs test). Maximum and 
minimum heart rates shown as mean (95% confidence intervals), P > 
0.05 for both, Student's paired t-test.
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and predicts cardiovascular outcomes [27]. Previous stud-
ies have demonstrated a reduction in measures of heart
rate variability, particularly the robust and simple time-
domain measurement SDNN following exposure to air
pollution [14,15,28-33]. In our study we report an
increase in overall heart rate variability (SDNN) when
subjects wore a mask, suggesting that wearing a mask can,
at least in part, prevent the adverse effects of air pollution
exposure on heart rate variability.
LF-power also increased with the use of a mask to prevent
exposure to air pollution although interpreting this
change is more challenging. LF-power is associated with
changes in sympathetic tone, and an increase might sug-
gest an increased contribution of the sympathetic nervous
system to basal heart rate control. However, simply wear-
ing the facemask may have had a small effect on the meas-
ures of heart rate variability described. As previously
discussed, subjects did report an increased resistance to
breathing when wearing the facemask that may have
increased subject anxiety. This in turn could have
increased sympathetic nervous system tone and hence
lead to a small increase in LF-power. This is a limitation of
our study, and the use of a sham facemask in a blinded
fashion would have helped minimise the effect of anxiety
on these sensitive outcome measures.
Our study has a number of important public health mes-
sages. First we have demonstrated that exposure to ambi-
ent air pollution has direct and measurable effects on
cardiovascular physiological parameters, even young
healthy individuals habitually exposed to such elevated
levels. Second we have shown that wearing a facemask can
abrogate some of these effects in a short period of time.
Particle traps are increasingly being fitted to new vehicles
to reduce the emissions of particulate matter, both by
mass and number concentrations, and this may well go
some way to offsetting the associated health effects. Cur-
rently, patients with chronic respiratory and cardiovascu-
lar conditions are advised to limit their exposure outdoors
Table 4: Exercise performed and physiological parameters during 2-hour walk.
Without Mask With Mask
























Heart rate variability Data validity, % 99.1 97.8








































All data expressed as mean (95% confidence interval).
*P < 0.01 compared to control (without mask) day, paired Student's t-test.
P > 0.05 for all other parameters compared to control (without mask) day.
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on days when ambient air pollution levels are high [34-
36]. We have shown that wearing a simple inexpensive
and well-tolerated facemask can provide an alternative
that may lead to reduced cardiovascular morbidity and
mortality. We believe that this intervention now needs to
be tested in patients with pre-existing coronary heart dis-
ease to define its potential role in reducing the burden of
cardiovascular disease in polluted environmental settings.
Our study has a number of important limitations. We
recruited young healthy volunteers rather than those most
susceptible to the effects of air pollution exposure, such as
those with coronary heart disease. Whilst it is likely that
our findings will be transferrable to this population, fur-
ther studies are required to confirm our findings. In addi-
tion, it was not possible to assess accurately the efficacy of
the mask filter when worn by the subjects. Leaks around
the facemask will lead to a reduction in the efficacy of par-
ticle filtration [37,38] and therefore our predicted expo-
sures during application of the facemask are likely to be
an underestimate. However, despite this, we were still able
to demonstrate beneficial cardiovascular effects during
their use.
Conclusion
Air pollution exposure is associated with increased cardi-
ovascular morbidity and mortality, and adverse effects on
the cardiovascular system. We have shown for the first
time that a wearing a facemask appears to abrogate the
adverse effects of air pollution on blood pressure and
heart rate variability. This simple intervention has the
potential to protect susceptible individuals and prevent
cardiovascular events in cities with high concentrations of
ambient air pollution.
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Response to Bhaskaran et al’s
“Effects of air pollution on the
incidence of myocardial
infarction”
TotheEditor: I amwriting to comment on the
excellentarticle byBhaskaran et al inHeart,1 and
especially on the editorial by David Newby2
who commented on this paper. In my opinion,
Dr Newby has missed the most important
conclusion of Bhaskaran et al’s paper.
Dr Newby ’s editorial was focused mainly
on the cardiac effects of !ne particulate
pollution and included a graph of data from
Beijing, China.
However, it seems to me that a far more
important contribution of the Bhaskaran
paper was the observation of an “ozone
protective effect” in several parts of the
world. The authors pointed out that this
effect is probably due to some pollutant that
is negatively correlated with ozone and cited
my previous paper,3 suggesting that the
effect could be due to unsuspected methyl
nitrite (MN) in the air. This hypothesis has
a high degree of plausibility because it is
known that MN, unlike ozone, is rapidly
destroyed by sunlight and so would be
negatively correlated with ozone. To the best
of my knowledge, this ozone protective
effect is totally inexplicable unless an
unknown pollutant, such as MN, is present.
If Dr Newby ’s point of view is to be
accepted, then presumably he must argue
that !ne particulate pollution is also the
cause of the ozone protective effect.
However, that hypothesis has been thor-
oughly discredited in another paper.4 In that
paper, I showed that !ne particulate matter
cannot explain the negative ozone associa-
tions in any parts of the world in which
there is published evidence for the negative
effects. I particularly showed that explana-
tion is extremely unlikely in Hong Kong,
China.
Hence, I feel that the most important
contribution of the Bhaskaran paper is to
alert the world to the possible existence of
a very important toxic pollutant whose
presence has escaped attention. Most
desperately needed is funding for research to
identify MN in engine exhaust. To date, such
funding has not been available in the USA.
P M Joseph
School of Medicine, University of Pennsylvania,
Philadelphia, Pennsylvania, USA
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University of Pennsylvania, 3400 Spruce Street,
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Response to Peter Joseph
The authors’ reply: We would like to thank
Dr Joseph for his interest and comments on
our editorial 1 accompanying the excellent
systematic review by Bhaskaran et al.2 As Dr
Joseph points out, one of the systematic
review’s !ndings was a weak negative asso-
ciation between ozone exposure and the
incidence of myocardial infarction.
As Bhaskaran et al indicate, a reduction in
ozone concentrations is likely to be a marker
of increased combustion-derived !ne partic-
ulate matter (PM2.5) from vehicle exhaust.
Sarnat similarly found that ambient
concentrations of O3, NO2, CO and SO2
serve as “surrogates for personal exposure to
PM2.5 alone.”3 Fine combustion-derived
particulate matter is robustly and consis-
tently associated with increased cardiovas-
cular morbidity and mortality.4 5 Indeed, this
was the major !nding of the Bhaskaran
systematic review2 and has many plausible
underlying mechanisms.6
The production of methyl nitrite in
vehicle exhaust is suggested by Dr Joseph7 to
explain the cardiovascular toxicity of air
pollution and the apparent protective effect
of ozone. Its generation requires additives to
“oxygenate” the fuel and to increase its
octane content. Such additives are being
phased out in the USA (prohibited in some
states), never seen in Australia and used in
minute quantities in Europe.8 Thus, methyl
nitrite is not a major current or future public
health concern.
Dr Joseph has argued that the paradoxical
relationship between cardiorespiratory
morbidity and ozone cannot be explained by
PM2.5 because they are positively correlated.9
Figure 1 Daily mean PM2.5 and ozone
concentrations (mg/m3) in Edinburgh, UK, from
January to November 2009. Data for the (A)
first and fourth quarters and (B) second and
third quarters. Linear regression lines shown
(95% CI) with Spearman’s rank correlation
coefficients. (C) Composite data for 2009 with
the non-linear regression line (95% CI) and
correlation coefficient.
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However, this is based on analyses restricted
to the summer months. In Dr Joseph’s
previous paper,9 there is a negative correla-
tion in the winter months: a time when
most myocardial infarctions occur. We have
reproduced these !ndings using local data
(!gure 1). As Dr Joseph points out, many
epidemiological studies perhaps incorrectly
use a simple linear model. Used here over the
whole data set, there is a weak negative
correlation (r!"0.1417, p!0.0145),
suggesting that as ozone concentrations
increase, PM2.5 concentrations fall. However,
these data best !t with a parabolic second-
order non-linear regression, and we believe
there is a complex interrelationship between
PM and ozone that may explain some of the
weak paradoxical relationships described.
We concur with Bhaskaran et al and
maintain that it is the !ne combustion-
derived particulate matter that mediates the
adverse cardiovascular effects demonstrated.
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Response to Peter Joseph
The authors’ reply: We thank Professor
Joseph for his thoughtful comments on our
study. As his letter points out, our review
identi!ed a number of studies that showed
an apparently reduced risk of myocardial
infarction associated with higher ambient
ozone levels.1 Similar short-term !protective"
associations with ozone have been observed
in studies of other outcomesdfor example,
cardiovascular admissions2 and general
practitioner consultations for upper respira-
tory diseases.3 On the other hand, a recent
review of mortality studies suggested
broadly detrimental health associations with
ozone.4 Protective associations were largely
restricted to the cold season when levels
are characteristically low, suggesting
confounding may play a role.5
These inconsistencies clearly require some
explanation; a causally protective effect of
ozone seems implausible for any outcome.
As we discussed in our review, various
theories have been put forward. For example,
the correlation between ozone and sunlight
means that ozone levels could in some
settings be associated with time spent
indoors, and therefore exposure to indoor
pollutants; outdoor ozone levels may also be
an unreliable proxy for personal exposure.
However, the most commonly suggested
explanation is that a negative correlation
between ozone and some other harmful
pollutant explains apparent protective
effects. The studies that our review high-
lighted did not consider the effects of ozone
in multipollutant models, leaving open the
possibility that exposure to particulate
matter or nitrogen oxidesdfor example,
could explain the !ndings. But studies of
other outcomes suggest that adjustment for
the commonly measured pollutants does not
remove the protective effect,2 3 and Professor
Joseph’s recent work suggests that !ne
particulates would not explain the effect in
some parts of the world.6
As we mentioned in our paper, methyl
nitrite is a potential candidate pollutant.
Sunlight tends to increase ozone levels and
destroy methyl nitrite, leading to a negative
correlation with ozone. However, disen-
tangling individual pollution effects in
population-based studies is problematic.
Experimental exposure studies into the
health effects of individual pollu-
tantsdincluding methyl nitritesdare likely
to be needed.
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EDITORIAL
Air pollution: the new cardiovascular risk factor
In August of this year, the XXIXth Olympic Games held in
Beijing China brought the hazards of air pollution expos-
ure into the public eye. International headlines stressed
the poor air quality and the potential health effects that
might have an adverse impact on the performance of
athletes, as well as on thosewith chronic cardiorespiratory
diseases. At least one high-profile marathon runner
declared that he would not run in Beijing because of
the poor air quality andonarrival toBeijing, theUS cycling
team wore close-fitting face masks designed to reduce
personal exposure to airborne particles. So was this inter-
national concern justified?
Epidemiological studies have confirmed the link
between exposure to air pollution and increased cardio-
respiratory mortality.1–3 Chronic exposure to traffic-
derived fine-particulate air pollution is associated with
the degree of coronary atherosclerosis and coronary artery
calcium scores assessed using electron-beam computed
tomography.4 Consistent with this and animal models of
atherosclerosis,5,6 human exposure to PM2.5 (particles
with a mean diameter of 2.5 lm or less) correlates to
carotid intima-medial thickness, a measure of subclinical
atherosclerosis.7 In the largest study to date (n = 65 893),
Miller et al. showed that in postmenopausal women with-
out pre-existing vascular disease, each 10 lg/m3 increase
in background fine-particulate air pollution concentra-
tions was associated with a 24% increase in the risk of
a cardiovascular event and a 76% increase in the risk of
death from cardiovascular disease, including myocardial
infarction or stroke.8 In addition to the adverse health
effects of chronic exposure, traffic-derived air pollution is
associated with the triggering of acute myocardial infarc-
tion, with people experiencing a myocardial infarction
being three times more likely to have been in road traffic
in the hour before the onset of symptoms.9
Although well-described mechanisms underlie the
development of cardiovascular disease with traditional
risk factors, the pathophysiological effects of air pollution
are poorly understood. The exact components of air pol-
lution responsible have yet to be specifically identified, but
the epidemiological link is strongest for fine-particulate
matter associated with combustion sources and particu-
larly that associated with road traffic.10 Recent studies
have used controlled exposures to either concentrated
ambient particles or dilute diesel exhaust, the latter being
the predominant component of airborne fine-particulate
matter in the urban environment. Diesel exhaust is of par-
ticular relevance, as in addition to all commercial vehicles
approximately 40% of all new domestic vehicles are diesel
powered. This proportion may well increase, given the
current trend for ‘green taxation’ linking tax paid by the
motorist to carbon dioxide emissions. Although diesel
engines produce less gaseous pollution, they emit greater
than 100-fold more fine-particulate matter than an
equivalent-sized petrol engine with a catalytic converter.11
Short-term exposure to concentrated ambient particu-
late matter and ozone causes acute arterial vasoconstric-
tion.12 In healthy volunteers, we showed that a 1-h
exposure to dilute diesel exhaust at a particle concentra-
tion of 300 lg/m3 resulted in vascular endothelial dys-
function, with impaired vasomotor tone and endogenous
fibrinolysis.13 Furthermore, using a similar exposure,
patients with stable coronary heart disease developed
more pronounced myocardial ischaemia during exer-
cise.14 This is further compounded by an increase in
platelet activation and thrombogenicity in the first 6 h
after exposure.15,16 In combination, these findings may
explain the excess of acute and chronic cardiovascular
events in the epidemiological studies of air pollution.
Regarding global and public health, controlled exposure
studies have been criticized due to the relatively high
concentration of fine-particulate matter used and some
have questioned the relevance of these findings to every-
day life. TheWHOhas set air quality targets for particulate
air pollution (PM10 – particles with a mean diameter less
than 10 lm) to remain below 50 lg/m3. In many of the
world’s important cities (Table 1), levels offine-particulate
air pollution regularly exceed this target. InBeijing, China,
this target was exceeded on 241 days out of 365 in 200617
and levels often exceed 300 lg/m3,18 as used in controlled
exposure studies. In Christchurch, New Zealand, this air-
quality target has been exceeded on average 29 days each
year for the last 5 years, with a peak of 184 lg/m3.19
Many epidemiological studies have been carried out in
various countries, with differing estimates of the associ-
ated economic impact. For example, it is estimated that
each year in New Zealand, air pollution leads to 1100
additional deaths, 700 additional hospital admissions for
ª 2008 The Authors
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cardiorespiratory diseases and nearly 2 million ‘restricted
activity days’ costing the economy around $1.1 billion
each year.20 In fact, the World Health Organization
(WHO) estimates that approximately 3 million deaths
worldwide (representing 5%of the total) can be attributed
to air pollution exposure annually.18
Although average background pollution levels may not
exceed the WHO target in many cities around the world,
there is a large variation in the individuals’ actual exposure
to particulate matter. Traffic-derived air pollution is in the
fine and ultrafine range and these particles remain air-
borne for a considerable length of time, given their small
size and tiny mass. The particle concentration, when
measured kerbside, can therefore actually be far higher
than recorded at background monitoring stations, which
tend tobe located inquieter areas away from the important
roads. This can be important, especially for those, such as
traffic wardens, who spend a long time in kerbside envir-
onments. Their personal exposure can be as much as 5–10
times higher than thatmeasured at the background sites.21
So how does the risk attributable to air pollution com-
pare to traditionally quoted cardiovascular risk factors?
The well-defined risk factors of hypertension, hypercho-
lesterolaemia, diabetes mellitus, family history and smok-
ing have been studied in depth in large epidemiological
studies. In comparison to these variables, chronic exposure
to fineparticulate air pollution gives a dose-dependent and
similar risk to hypertension or hypercholesterolaemia
(Fig. 1). Modern medical practice is very focused on low-
ering patients’ cardiovascular risk. We regularly monitor
patients’ blood pressure, cholesterol concentrations and
blood sugar and often offer primary prevention medica-
tion. There are, in most places, smoking cessation services
to help patients reduce tobacco consumption and many
countries now have laws banning smoking in all public
areas. These primary prevention strategies have a signifi-
cant influence on the incidence of cardiovascular disease
and the implementation of a smoking ban in Scotland
recently led to a 17% reduction in the incidence of myo-
cardial infarction.24 What then can we do about air pol-
lution exposure to reduce the potential health effects?
Public awareness of the problem of air pollution has led to
significant pressures on countries, and local authorities, to
tryand reduce local emissions fromboth traffic and industry.
Environmental policy interventions have shown that the
reduction of air pollution can have substantial health
Table 1 Average PM10 concentrations (particulate matter with mean
diameter of 10 lm or less) in important cities worldwide (2004)
City Urban PM10 (lg/m
3)
Los Angeles, USA 34
New York, USA 21
Toronto, Canada 22
Mexico City, Mexico 51



















Source: The World Bank, Development Economics Research Group
Estimates (2004). (http://siteresources.worldbank.org/DATASTATISTICS/
Resources/table3_13.pdf).
Figure 1 Percentage increase in popula-
tion attributable risk with traditional cardio-
vascular risk factors fromtheFramingham22
(solid bars) and QRESEARCH (striped bars)
cohorts.23 For comparison, risk attributed
to each 10 lg/m3 increase in PM2.5 concen-
trations (hashed bars) is shown.8 All values
shown are for women only to allow com-
parison. Hypertension means incidence of
hypertension in Framingham study and per
20 mmHg increase in systolic blood pres-
sure in QRESEARCH. All other parameters
refer only to their incidence.
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benefits. For example, inDublin, Ireland, banning the sale of
bituminous coal led to a reduction in cardiovascular
deaths.25 Traffic emissions are also modifiable. Modern
engines are more fuel efficient, meaning more complete
combustion and fewer particle emissions. Automotive
industries arenowproducing carswith exhaustparticle traps
to try and reduce the environmental impact of their prod-
ucts. More recently, during the Beijing Olympic Games,
traffic restrictions were implemented to halve the number
of vehicles on the roads based on an odd–evennumber plate
control system. Given Beijing has more than 3.3 million
registered vehicles, one would expect this to have a signifi-
cant environmental and health impact, and, indeed when
theChinesegovernmenthada trial run, theyreporteda40%
reduction in airborne particulatematter. Personal protective
equipment, such as the masks worn by the US athletes, also
have a potential role in this, although their ability to negate
the described health effects has yet to be shown.
Air pollution exposure, and particularly fine-particulate
matter derived from combustion sources, has emerged as
a new risk factor for cardiovascular morbidity and mor-
tality and may actually lead to a similar degree of risk to
the well-described risk factors, such as hypertension and
hypercholesterolaemia. These effects may be mediated by
changes in vascular endothelial function, leading both to
the acceleration of the development of atherosclerosis and
to the triggering of acute cardiovascular events. Public
health measures are now needed to reduce these harmful
emissions, such as the introduction of particle traps for
diesel exhausts or the development of better fuels.
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Heat and haze: a forecast for
myocardial infarction?
Jeremy P Langrish, Nicholas L Mills, David E Newby
Exposure to ambient air pollution is
increasingly recognised as a risk factor
for cardiovascular morbidity and mortal-
ity. Associations between exposure to
combustion-derived fine particulate air
pollution and cardiovascular mortality
are consistently demonstrated in a num-
ber of large-scale epidemiological studies.1
These reported associations have even
withstood legal challenge in the USA,
where industry representatives attempted
to sue the US Environment Protection
Agency after this evidence was used to
impose strict air quality standards. An
independent review of the evidence by the
Health Effects Institute reaffirmed these
associations and the case was lost.2 3
The World Health Organization esti-
mates that indoor air pollution from the
combustion of solid fuelmay be responsible
for up to 2.4 million deaths worldwide each
year, representing the fourth leading cause
of mortality in developing countries. In
addition, urban air pollution may be
responsible for a further 800 000 premature
deaths each year.4 Taken together, air
pollution exposure is thought to be respon-
sible for approximately 5% of deaths
worldwide each year and therefore repre-
sents a significant public health concern.
Isolating the risk attributable to a single
factor in epidemiological studies is challen-
ging due to the myriad potential mediators
and confounders. The effect of air pollution
exposure can be modified by many factors,
including temperature, geographical area
and social deprivation. Similarly, investiga-
tions of the effects attributable to meteor-
ological variables are also susceptible to
confounding by exposure to ambient air
pollutants, seasonal effects and infectious
disease epidemics. Effects of temperature
may be further modified in areas of
extreme weather whereby inhabitants
modify their behaviour by, for example,
wearing warm clothing.
In order to tease out the effects
attributable to these individual factors, a
carefully performed and robust analysis of
the available evidence is crucial.
AIR POLLUTION AND MYOCARDIAL
INFARCTION?
In a pivotal study, Peters and colleagues5
demonstrated in a careful case–control
study employing 691 subjects with acute
myocardial infarction that patients were
three times more likely to have been in
traffic in the hour before the onset of
symptoms. The authors proposed that
exposure to traffic-derived air pollution
may trigger an acute myocardial infarction.
In this issue of Heart, Bhaskaran and
colleagues6 (see page 1746) present the
first systematic analysis of the current
evidence linking short-term exposure to
air pollution and the incidence of acute
myocardial infarction. The authors per-
formed a systematic review of 26 studies
that demonstrate an effect of exposure to
particulate matter, ozone, carbon monox-
ide, nitrogen oxides or sulphur dioxide. The
authors included only those studies that
specifically addressed the incidence of
myocardial infarction as an outcome and
carefully controlled for potential confoun-
ders. They conclude that there is ‘‘fairly
persuasive evidence of [a] short-term effect
on myocardial infarction risk’’, with the
risk of increasing by 5–17% for each 10 mg/
m3 increase in PM2.5 (particulate matter
with a mean diameter of (2.5 mm) expo-
sure. This latter measure of exposure is
most strongly associated with acute myo-
cardial infarction and most closely repre-
sentative of traffic-derived pollution.
Unfortunately, PM2.5 is not routinely
measured in monitoring stations in many
parts of the world including the UK.
WHAT ABOUT OTHER ENVIRONMENTAL
VARIABLES?
Ambient air pollution exposure is highly
variable, and depends on many different
factors: the proximity of major highways,
heavy industry, construction and not least
local weather conditions. Meteorological
conditions are often cited as a potential
confounder for any studies looking at air
pollution exposure. Weather is intimately
linked with air pollution burden: airborne
particulate is highest on cold crisp or hot
humid days. In large smoggy cities, rainfall
results in ‘‘clear air’’ as particulate matter is
precipitated and washed away. This is
most clearly demonstrated in the world’s
large polluted cities (fig 1).
Temperature itself is associated with
overall (and cardiovascular) mortality.
Room temperature appears to represent
the ‘‘optimal’’ environment, with an
increased incidence of events at both
extremes of temperature in a ‘‘U-shaped’’
relationship.7 Moreover, the effect of
temperature modifies the statistical rela-
tionship between air pollution exposure
and cardiovascular disease.8
In a separate article in this issue of Heart,
Bhaskaran and colleagues9 (see page 1760)
present a second review employing the
same robust and systematic approach to
evaluate the evidence of an association
between temperature changes and the
incidence of acute myocardial infarction.
The authors identify 19 studies that have
looked at the incidence of myocardial
infarction as a specific outcome, and con-
trolled for potential confounders. They find
that the body of evidence from these
generally large and well-controlled studies
suggests a similar effect on the incidence of
myocardial infarction, with eight of 12
studies showing an increased short-term
risk at low temperatures and seven of 13
showing increased risk at higher tempera-
tures. While the reported effect size was
highly variable, the risk of acute myocardial
infarction was increased by 31–44% at the
extremes of the temperature scale.
WHAT ARE THE LIKELY UNDERLYING
MECHANISMS?
Epidemiological evidence requires a clear
and plausible underlying mechanism. In
both articles, the authors address this
issue and acknowledge that these large-
scale epidemiological studies can, by their
very nature, demonstrate only an associa-
tion and that careful controlled mechan-
istic studies are needed in order to tease
out both the underlying mechanisms and,
in the case of air pollution, the effect of
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the different components of the air pollu-
tion mixture.
Chronic exposure to ambient air pollu-
tion increases the atherosclerotic burden
in animal models and, in humans, is
linked to increases in both coronary artery
calcium scores and carotid intima-medial
thickness. Inhaled particulate matter can
also cause acute increases in blood pres-
sure, arterial stiffness, arterial vasocon-
striction and thrombogenicity.10 Similarly,
there is a consistent low-grade local
inflammatory response in the lungs fol-
lowing exposure to fine particulate matter
that appears to be driven by oxidative
stress and leads to a systemic inflamma-
tory response 6–24 h later.
The increased incidence of myocardial
infarction at the extremes of temperature
may share similar underlying triggers to
those of air pollution. Transient and rapid
increases in vasoconstriction, blood pres-
sure and cardiac work may lead to
increased arterial tissue stresses and pla-
que rupture. Along with increased plasma
viscosity, this may also be associated with
increased thrombogenicity11 leading to
acute coronary thrombosis. However,
although similarities exist between the
associations of acute myocardial
infarction with both air pollution and
temperature, there are important differ-
ences and many of the pathways will be
distinct. For example, at extremes of
temperature, there is a clear increase in
events that are followed by a subsequent
fall in the normal event rate; the so-called
‘‘harvesting effect’’, in which an acute
trigger brings forward impending events.12
This phenomenon is not seen in epide-
miological studies of air pollution expo-
sure, and indeed the opposite appears to
occur, with the cumulative dose appear-
ing most important.13 Clearly, further
work is needed to help identify the
mechanisms and mediators of these asso-
ciations if corrective or preventive strate-
gies can be implemented.
Funding: JPL is supported by a British Heart Foundation
clinical PhD studentship (FS/07/048). DEN is the holder
of a British Heart Foundation programme grant to
investigate the ‘‘atherothrombotic effects of air pollution’’
(RG/05/003).
Competing interests: None.
Provenance and peer review: Commissioned; not
externally peer reviewed.




1. Miller K, Siscovick D, Sheppard L, et al. Long-term
exposure to air pollution and incidence of
cardiovascular events in women. N Engl J Med
2007;356:447–58.
2. Kaiser J. Showdown over clean air science. Science
1997;277:466–9.
3. Ware J. Particulate air pollution and mortality –
clearing the air. N Engl J Med 2000;343:1798–9.
4. UNEP. GEO Year Book 2006: an overview of our
changing environment. Malta: Progress Press Ltd,
2006.
5. Peters A, von Klot S, Heier M, et al. Exposure to
traffic and the onset of myocardial infarction.
N Engl J Med 2004;351:1721–30.
6. Bhaskaran K, Hajat S, Haines A, et al. Effects of air
pollution on the incidence of myocardial infarction.
Heart 2009;95:1746–59.
7. Curriero FC, Heiner KS, Samet JM, et al.
Temperature and mortality in 11 cities of the eastern
United States. Am J Epidemiol 2002;155:80–7.
8. Ren C, Williams GM, Tong S. Does particulate matter
modify the association between temperature and
cardiorespiratory diseases? Environ Health Perspect
2006;114:1690–6.
9. Bhaskaran K, Hajat S, Haines A, et al. Effects of
ambient temperature on the incidence of myocardial
infarction. Heart 2009;95:1760–9.
10. Mills NL, Donaldson K, Hadoke PW, et al. Adverse
cardiovascular effects of air pollution. Nat Clin Pract
Cardiovasc Med 2009;6:36–44.
11. Keatinge WR, Coleshaw SR, Cotter F, et al.
Increases in platelet and red cell counts, blood
viscosity, and arterial pressure during mild surface
cooling: factors in mortality from coronary and cerebral
thrombosis in winter. BMJ 1984;289:1405–8.
12. Schwartz J, Samet JM, Patz JA. Hospital
admissions for heart disease: the effects of
temperature and humidity. Epidemiology
2004;15:755–61.
13. Schwartz J. Harvesting and long term exposure
effects in the relation between air pollution and
mortality. Am J Epidemiol 2000;151:440–8.
Take home messages
Both exposure to ambient air pollution and extremes of temperature are consistently
associated with an increase in cardiovascular morbidity and mortality. In two carefully
performed systematic reviews published in this issue of Heart, Bhaskaran and colleagues6 9
have robustly demonstrated an increased incidence of acute myocardial infarction
following short-term exposure to these environmental factors. Whereas local weather
conditions are outwith our control, strict attention to the reduction of ambient air pollution
has the potential to reduce the burden of cardiovascular disease and result in significant
public health benefits. Interestingly, environmental interventions to control ambient
particulate air pollution are also likely to reduce carbon dioxide emissions that are widely
accepted as being a major contributor to increasing global temperatures and may have
further benefits into the future.
Figure 1 Recorded background urban particulate (PM10; particulate matter with mean
aerodynamic diameter 10 mm) air pollution from Beijing China in 2006 with average monthly
minimum (blue line) and maximum (red line) temperatures. Narrow blue bars show average monthly
rainfall. Data reproduced with permission from ‘‘Beijing 2008 Olympic Games: An Environmental
Review’’ United Nations Environment Programme, 2008 (http://www.unep.org/publications/eBooks/
Default.aspx) and BBC weather website (http://www.bbc.co.uk/weather/world/city_guides/results.
shtml?tt=TT002100).
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Epidemiology and Prevention
Particle Traps Prevent Adverse Vascular and Prothrombotic
Effects of Diesel Engine Exhaust Inhalation in Men
Andrew J. Lucking, MD*; Magnus Lundbäck, MD, PhD*;
Stefan L. Barath, MD; Nicholas L. Mills, MD, PhD; Manjit K. Sidhu, MD;
Jeremy P. Langrish, MD; Nicholas A. Boon, MD; Jamshid Pourazar, PhD;
Juan J. Badimon, MD, PhD; Miriam E. Gerlofs-Nijland, PhD; Flemming R. Cassee, PhD;
Christoffer Boman, PhD; Kenneth Donaldson, PhD; Thomas Sandstrom, MD, PhD;
David E. Newby, MD, PhD; Anders Blomberg, MD, PhD
Background—In controlled human exposure studies, diesel engine exhaust inhalation impairs vascular function and
enhances thrombus formation. The aim of the present study was to establish whether an exhaust particle trap could
prevent these adverse cardiovascular effects in men.
Methods and Results—Nineteen healthy volunteers (mean age, 25!3 years) were exposed to filtered air and diesel exhaust
in the presence or absence of a particle trap for 1 hour in a randomized, double-blind, 3-way crossover trial. Bilateral
forearm blood flow and plasma fibrinolytic factors were assessed with venous occlusion plethysmography and blood
sampling during intra-arterial infusion of acetylcholine, bradykinin, sodium nitroprusside, and verapamil. Ex vivo
thrombus formation was determined with the use of the Badimon chamber. Compared with filtered air, diesel exhaust
inhalation was associated with reduced vasodilatation and increased ex vivo thrombus formation under both low- and
high-shear conditions. The particle trap markedly reduced diesel exhaust particulate number (from 150 000 to
300 000/cm3 to 30 to 300/cm3; P"0.001) and mass (320!10 to 7.2!2.0 !g/m3; P"0.001), and was associated with
increased vasodilatation, reduced thrombus formation, and an increase in tissue-type plasminogen activator release.
Conclusions—Exhaust particle traps are a highly efficient method of reducing particle emissions from diesel engines. With
a range of surrogate measures, the use of a particle trap prevents several adverse cardiovascular effects of exhaust
inhalation in men. Given these beneficial effects on biomarkers of cardiovascular health, the widespread use of particle
traps on diesel-powered vehicles may have substantial public health benefits and reduce the burden of cardiovascular
disease.
Clinical Trial Registration—http://www.clinicaltrials.gov. Unique identifier: NCT00745446. (Circulation. 2011;123:1721-1728.)
Key Words: air pollution ! endothelium ! thrombosis
There is a robust and consistent association between airpollution and cardiorespiratory morbidity and mortal-
ity.1–4 These harmful effects are most strongly associated
with exposure to traffic-derived fine particles (particulate
matter [PM] with a mean diameter "2.5 !m [PM2.5]) that
originate predominantly from diesel engine exhaust emis-
sions.5 Diesel engines are popular because of their reliability,
efficiency, and relatively low running costs. However, they
generate up to 100 times more fine particles than petroleum
engines of a similar size and contribute substantially to the
global burden of PM air pollution.
Editorial see p 1705
Clinical Perspective on p 1728
According to the World Health Organization, air pollution
is responsible for at least 800 000 premature deaths world-
wide each year, with an average loss of life of 1 year.6 The
long-term risk of cardiovascular death rises by 76% for each
10-!g/m3 increase in PM2.5.7,8 Short-term exposure has been
linked to the triggering of acute myocardial infarction,9 with
patients 3 times more likely to be exposed to traffic-derived
air pollution in the hours before their acute myocardial
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infarction.10 Despite the strength and consistency of observa-
tional studies, the underlying pathophysiological mechanisms
remain unclear. Using well characterized and controlled
diesel engine exhaust exposure studies in healthy volunteers,
we have previously demonstrated impaired vascular vasomo-
tor and fibrinolytic function,11 increased arterial stiffness,12
and enhanced ex vivo thrombus formation.13 Furthermore, in
patients with coronary heart disease, we have shown that
diesel engine exhaust inhalation exacerbates exercise-induced
ST-segment depression during light exercise.14 Taken to-
gether, these adverse cardiovascular effects provide important
mechanisms that help to explain the detrimental health effects
of air pollution exposure.
One approach to limit traffic emissions has been the
introduction of diesel engine exhaust particle traps or filters.
Although the efficiency of particle traps to reduce particle
emission is #90%, particles are not completely eliminated,
and traps have the potential to create new and potentially
more toxic particles that may outweigh the benefits of
reducing the emitted particle mass.15 We therefore sought to
determine whether the introduction of a particle trap would
attenuate or worsen the adverse cardiovascular effects of
diesel engine exhaust inhalation.11–14
Methods
Twenty-one subjects were screened, and 1 subject was excluded at
the initial screening. A further subject was excluded after random-
ization because of inability to complete all exposures, leaving 19
healthy nonsmoking men who completed the full study protocol (see
Figure I in the online-only Data Supplement). The study was
approved by the local research ethics committee and conducted in
accordance with the Declaration of Helsinki and with the written
informed consent of all volunteers.
All subjects had normal lung function and no symptoms of upper
airway infection for the 4 weeks before or during the study.
Exclusion criteria were regular medication, clinical evidence of
atherosclerotic vascular disease, arrhythmias, diabetes mellitus, hy-
pertension, renal or hepatic failure, asthma, significant occupational
exposure to air pollution, or intercurrent illness. All subjects ab-
stained from caffeine-containing drinks or food for at least 4 hours
and from alcohol for 24 hours before each assessment.
Study Design
The primary end points were endothelial vasomotor and fibrinolytic
function and ex vivo thrombus formation. Secondary end points were
soluble markers of inflammation and platelet activation. Exploratory
end points were markers of arterial stiffness and airway inflamma-
tion. Sample size was determined a priori and based on power
calculations for the primary end points derived from our previous
studies (see the online-only Data Supplement).11,13
In a randomized, double-blind, 3-way crossover design, subjects
were exposed to filtered air, unfiltered dilute diesel engine exhaust,
and dilute diesel engine exhaust that had passed through a particle
trap. The order of the exposures was randomized, with an indepen-
dent predetermined exposure sequence. Exposures were performed
at a separate dedicated exposure facility by technical staff with no
involvement in the clinical studies. Clinical studies were performed
in a dedicated clinical research facility by clinical staff blinded to
exposure allocation. Exposures were separated by at least 1 week and
performed in a purpose-built exposure chamber, according to a
previously described standard protocol.11 During each 1-hour expo-
sure, subjects performed moderate exercise (minute ventilation, 25
L/min per m2 body) on a bicycle ergometer for 15 minutes alternated
with 15 minutes of rest.
Diesel Exhaust
A Volvo diesel engine (Volvo TD40 GJE, 4.0 L, 4 cylinders) running
on Volvo standard diesel fuel (SD-VSD-10) was used to generate the
diesel exhaust. The specification of the Volvo diesel fuel is similar to
the European automotive standard diesel (EN590), with a sulfur
content of 5 to 7 mg/kg and polycyclic aromatic hydrocarbon content
of 2% to 6% by mass. The engine worked under transient speed and
load conditions in accordance with the standardized European
transient cycle that mimics real-world urban driving conditions.16
More than 90% of the exhaust was shunted away, and the residual
exhaust was mixed with filtered air (Figure 1).
The concentrations of nitrogen oxides (NO, NO2, and other nitrogen
oxides) in the chamber were monitored continuously together with total
gaseous hydrocarbons. During diesel exhaust exposures, we sought to
generate a PM mass concentration of 300 !g/m3. This PM mass
concentration was maintained for the inlet conditions of the particle trap.
Actual exposure was measured gravimetrically with standard glass fiber
filter sampling together with the use of a tapered element oscillating
microbalance online instrument and in accordance with a well-
established protocol, as described previously.17 In addition, a scanning
mobility particle sizer system was used to determine fine ("1 !m)
particle number concentration.
Particle Trap
The particle trap (diesel particulate filter–continuously regenerating trap
[DPF-CRT], Johnson Matthey, Royston, UK) used is an unmodified,
continuously regenerating trap filter, available commercially throughout
the world as a factory-fit option or as a retrofit unit to buses and heavy
goods vehicles. It is similar in design to filters produced by a number of
manufacturers. It consists of a honeycomb-like complex of channels
through which the exhaust is passed. A catalyst at the front of the filter
oxidizes part of the NO gas in the exhaust into NO2, which flows
through the particle filter and subsequently reacts with trapped carbo-
naceous particles to generate CO2 and N2. This increases NO2 levels in
the exhaust after the particle trap, without causing significant changes in
total nitrogen oxide concentrations, while achieving an efficient reduc-
tion in particle emissions.
Vascular Studies
On the basis of data from previous exposure studies,13,14,16,18
vascular assessment was performed 6 to 8 hours after each exposure.
Assessments were performed with subjects resting supine in a quiet
temperature-controlled (22°C to 24°C) room. Venous cannulas (17
gauge) were inserted into large subcutaneous veins in the antecubital
fossae of both arms. The brachial artery of the nondominant arm was
cannulated with a 27-standard-wire-gauge steel needle. After a
baseline 30-minute saline infusion, bradykinin at 100, 300, and 1000
pmol/min (endothelium-dependent vasodilator that releases tissue-
type plasminogen activator [tPA]; Merck Biosciences, Nottingham,
UK); acetylcholine at 5, 10, and 20 !g/min (endothelium-dependent
vasodilator that does not release tPA; Merck Biosciences); and
sodium nitroprusside at 2, 4, and 8 !g/min (endothelium-
independent vasodilator that does not release tPA; David Bull
Laboratories, Warwick, UK) were infused for 6 minutes at each
dose. The 3 vasodilators were given in random order, separated by a
20-minute saline infusion. Verapamil was infused at 10, 30, and 100
!g/min (endothelium-independent and NO-independent vasodilator
that does not release tPA) at the end of the study protocol. The
infusion of these vasodilators was undertaken to allow the assess-
ment of distinct aspects of vascular function, including NO, endo-
thelium, fibrinolysis, and vasomotion.
Forearm blood flow was measured in both infused and noninfused
arms with venous occlusion plethysmography incorporating
mercury-in-silicone elastomer strain gauges as described previ-
ously.11 Heart rate and blood pressure were monitored in the
noninfused arm throughout each study with a noninvasive, semiau-
tomated oscillometric sphygmomanometer (Boso Medicus, Jungin-
gen, Germany). Blood was drawn simultaneously from the venous
cannulas in each arm at baseline and during infusion of each dose of
bradykinin. Samples were collected into acidified buffered citrate
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(Stabilyte, Biopool International) for tPA assays and into citrate (BD
Vacutainer) for plasminogen activator inhibitor type 1 assays.
Samples were kept on ice before being centrifuged at 2000g for 30
minutes at 4°C. Platelet-free plasma was decanted and stored at
$80°C before assay. Plasma tPA and plasminogen activator inhib-
itor type 1 antigen concentrations were determined by enzyme-linked
immunosorbent assay (TintElize tPA, Biopool EIA, Trinity Biotech,
Ireland; Coaliza plasminogen activator inhibitor type 1, Chromoge-
nix AB, Milan, Italy). Hematocrit was determined by capillary tube
centrifugation of samples collected at baseline and during infusion of
bradykinin at 1000 pmol/min.
Inflammatory Measures
Venous blood samples were obtained before and at 2, 6, and 8 hours
after exposure. Samples were analyzed for total and differential cell
count with an autoanalyzer. Plasma interleukin-6, tumor necrosis
factor-", soluble CD40 ligand, soluble P-selectin, intercellular ad-
hesion molecule-1, and C-reactive protein were measured with
commercially available enzyme-linked immunosorbent assays (R&D
Systems, Abingdon, UK).
Ex Vivo Thrombosis Studies
On the basis of previous studies,13 ex vivo thrombus formation was
determined with the use of the Badimon chamber 2 hours after each
exposure. In brief, a pump was used to draw blood from an
antecubital vein through a series of 3 cylindrical perfusion chambers
maintained at 37°C in a water bath. Carefully prepared strips of
porcine aorta, from which the intima and a thin layer of media had
been removed, acted as the thrombogenic substrate. The rheological
conditions in the first chamber simulate those of patent coronary
arteries (low-shear rate, %212 s$1), and those in the second and third
chambers simulate those of mildly stenosed coronary arteries (high-
shear rate, %1690 s$1). The model thus acts as one of deep coronary
arterial injury. Each study lasted for 5 minutes, during which flow
was maintained at a constant rate of 10 mL/min. All studies were
performed with the same perfusion chamber, by the same operator,
and according to a well-established protocol.13
Immediately after each study, porcine strips with thrombus at-
tached were removed and fixed in 4% paraformaldehyde. Strips were
paraffin-wax embedded, sectioned, and stained with Masson’s
trichrome. Images were acquired at &20 magnification, and throm-
bus area was measured with a semiautomated image acquisition
system (Ariol, Applied Imaging) by a blinded operator. Results from
at least 6 sections were averaged to determine thrombus area for each
chamber as described previously.19,20
Assessment of Arterial Stiffness
Please see the online-only Data Supplement.
Assessment of Airway Inflammation
Please see the online-only Data Supplement.
Data Analysis and Statistics
Plethysmographic data were analyzed as described previously.11
Estimated net release of tPA antigen was defined as the product of
the infused forearm plasma flow (based on the mean hematocrit and
the infused forearm blood flow) and the concentration difference
between the infused and noninfused arms, as described previ-
ously.11,14 Continuous variables are reported as mean!SEM. Statis-
tical analyses were performed with GraphPad Prism (Graph Pad
Software, CA). All studies, data analysis, and data exclusion were
performed before the data were unblinded.
To address our primary hypothesis, the analysis plan required 2
independent assessments of the responses in the 3 randomized arms
of the study. First, to confirm our previous findings, we assessed
whether the inhalation of diesel engine exhaust impaired vascular
function and promoted thrombogenesis. Second, we assessed
whether the particle trap improved these surrogate measures of
cardiovascular health. Comparisons between exposures were under-
taken with a 2-sided paired t test and 2-way ANOVA with repeated
measures, as appropriate. Factors assessed in the 2-way ANOVA
were exposure and vasodilator dose. Exposure data were analyzed
with a 2-sided unpaired t test. Statistical significance was taken at
P"0.05.
Results
The 19 healthy male volunteers were young and normoten-
sive, and had normal lung function (Table 1). All volunteers
Figure 1. Schematic illustration of the
diesel exhaust setup from the engine to
the flow of diluted exhaust to the cham-
ber. HEPA indicates high-efficiency par-
ticulate air; NOx, nitrogen oxides.




Body mass index, kg/m2 23.4!2
Pulse, bpm 54!8
Systolic blood pressure, mm Hg 113!6
Diastolic blood pressure, mm Hg 73!8
FEV1, L 4.6!0.6
% Predicted FEV1 100!12
FVC, L 5.6!0.8
% Predicted FVC 103!14
Data shown are mean!SEM (n'19). FEV1 indicates forced expiratory
volume in 1 second; FVC, forced vital capacity.
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completed the 3 study visits. Exposures were well tolerated,
with no adverse symptoms reported.
The particle trap reduced the total particle mass concen-
tration in the chamber by %98% and the fine ("1 !m)
particle number concentration by #99.8%. As anticipated,
the particle trap, with an integrated oxidation catalyst, altered
the composition of nitrogen oxides (ie, increased NO2 and
decreased NO) (Table 2). However, it had no significant
effect on the concentrations of gaseous hydrocarbons.
There were no changes in blood pressure, resting heart rate,
baseline forearm blood flow, or markers of arterial stiffness in
between the 3 study visits (Tables II and III in the online-only
Data Supplement). Hematologic variables, markers of inflam-
mation, and soluble markers of platelet activation did not
differ between exposures (Tables IV and V in the online-only
Data Supplement). Markers of airway inflammation did not




There was a dose-dependent increase in forearm blood flow
with both endothelium-dependent (bradykinin and acetylcho-
line) and endothelium-independent (sodium nitroprusside and
verapamil) vasodilators after each exposure (P"0.0001 for
all; Figure 2).
Compared with filtered air, vasodilatation was impaired after
diesel engine exhaust exposure in response to bradykinin
(P'0.009), acetylcholine (P'0.01), and verapamil (P'0.03;
Figure 2). There was no significant difference in response to
sodium nitroprusside (P'0.15; Figure 2). However, with the
introduction of the particle trap, vasodilatation increased in
response to all vasodilators: bradykinin (P"0.0001), acetylcho-
line (P"0.0001), verapamil (P'0.001), and sodium nitroprus-
side (P'0.04; Figure 2). Indeed, there were no differences in
vasomotor responses between filtered air and filtered diesel
engine exhaust except for acetylcholine, with which vasodilata-
tion was lower with filtered air (P'0.02).
Fibrinolytic Function
There were no differences in baseline plasma tPA and plasmin-
ogen activator inhibitor type 1 concentrations between exposures
(Table VI in the online-only Data Supplement). There was a
dose-dependent increase in tPA release in response to bradykinin
infusion after each exposure (P"0.0001 for all; Figure 3).
Although numerically lower, there was no statistical difference
in tPA release after exposure to diesel engine exhaust inhalation
compared with filtered air (P'0.30; Figure 3). However, appli-
cation of the particle trap was associated with an improvement in
the net release of tPA compared with unfiltered diesel engine
exhaust (P'0.03; Figure 3). There was no difference in tPA
release between filtered air and filtered diesel engine exhaust
(P'0.22).
Ex Vivo Thrombosis
Compared with filtered air, inhalation of diesel exhaust was
associated with an increase of thrombus formation in the
low-shear (21.8%; P"0.001; Figure 4) and high-shear (14.8%;
P'0.02; Figure 4) chambers. Compared with unfiltered exhaust,
the introduction of the particle trap was associated with a
reduction in thrombus formation in the low-shear chamber
($15.7%; P'0.02; Figure 4), whereas the apparent reduction in
the high-shear chamber did not reach statistical significance
(P'0.11; Figure 4). There were no differences in thrombus
formation between filtered air and filtered diesel exhaust
(P'0.78 and P'0.76 for the low- and high-shear chambers,
respectively).
Discussion
Short-term exposure to traffic-derived air pollution is associated
with acute cardiovascular events.9,10,21 In the present study,
using complementary and relevant measures of cardiovascular
health, we have reconfirmed the adverse effects of exposure to
diesel engine exhaust on endothelial function and ex vivo
thrombosis. In addition, for the first time, we demonstrate that
reducing the particulate component of diesel exhaust with the
use of a commercially available particle trap can prevent these
detrimental cardiovascular effects. Our study provides support
for the application of particle traps to diesel-powered vehicles to
reduce urban particulate concentrations and limit a range of
adverse cardiovascular effects of exposure to traffic-derived air
pollution.
In a series of controlled exposure studies in human sub-
jects, we have previously shown an impairment of vasomotor
responses to endothelium-dependent and endothelium-
independent vasodilators after diesel exhaust exposure.18
These observations are consistent with other reports of
brachial artery vasoconstriction shortly after exposure to
dilute diesel exhaust22 and concentrated ambient particles.23
Such vascular impairment is not restricted to vasomotor
function. We have also demonstrated increased thromboge-
nicity with reduced tPA release from the endothelium,11
enhanced platelet activation,13 and increased ex vivo throm-
bus formation.13
In the present study, we used a range of these complemen-
tary measures of cardiovascular function in a comprehensive
assessment of the potential for particle traps to improve
human health. We were able to confirm our earlier findings
that diesel exhaust inhalation causes detrimental vascular and
prothrombotic effects. On this occasion, we did not observe a
statistically significant reduction in tPA release from the
Table 2. Exposure Conditions in the Chamber
Filtered Diesel
Exhaust Diesel Exhaust P
NO, ppm 2.09!0.15 5.72!0.33 "0.001
NO2, ppm 3.44!0.33 0.69!0.02 "0.001









30–300 150 000–200 000 "0.001
Data shown are mean!SEM (n'19) unless indicated otherwise. Data were
analyzed by 2-tailed unpaired t test. NO indicates nitric oxide; NO2, nitrogen
dioxide; NOx, nitrogen oxides; and PM, particulate matter.
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endothelium after diesel exhaust exposure, and this may
represent a type II error or reflect the subtle differences
between study protocols. However, more importantly, we
were able to demonstrate that the introduction of a particle
trap not only improved vasomotion, endogenous fibrinolysis,
and ex vivo thrombosis but appeared to normalize them.
Although there are many potentially harmful components
in ambient air pollution, traffic-derived fine and ultrafine
particles are most closely and consistently linked to acute
cardiovascular events. This has been the rationale for the
development of, and legislation for, targeted interventions to
reduce the particulate matter content of vehicle emissions.24
Figure 2. Infused forearm blood flow 4
to 6 hours after exposure, during intra-
brachial infusion of bradykinin, acetyl-
choline, sodium nitroprusside, and ve-
rapamil. The left panel displays
vasomotor response after exposure to
air and diesel exhaust, confirming the
vascular effects from previous investiga-
tions. Filtered air exposure is shown by
open circles, and diesel engine exhaust
exposure by filled circles. The right panel
displays the main comparison of vaso-
motor function after exposure to unfil-
tered diesel exhaust (filled circles) and
filtered diesel exhaust (crosses).
Figure 3. Tissue-type plasminogen activator (tPA)
release from the forearm endothelium 4 to 6 hours
after exposure, during intrabrachial infusion of
bradykinin. The left panel displays fibrinolytic
response after exposure to air and diesel exhaust.
Filtered air exposure is shown by open circles and
diesel engine exhaust exposure by filled circles.
The right panel displays the main comparison of
fibrinolytic function after exposure to unfiltered die-
sel exhaust (filled circles) and filtered diesel
exhaust (crosses).
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Although there is little doubt that particle traps are effective
in reducing PM mass and number, concerns have been raised
regarding the oxidation catalysts required to regenerate and
maintain filter efficiency, because they may alter the toxicity
of particulate and gaseous emissions. For example, soot
particles generated from a low-emission diesel engine appear
to have greater cytotoxic and proinflammatory effects.15 The
potential for particle traps to reduce the adverse cardiovas-
cular effects of diesel exhaust emissions therefore needs to be
assessed in humans. In the present study, we observed no
adverse cardiovascular effects arising from the use of a
particle trap. In fact, the only difference between filtered air
and filtered diesel exhaust observed for any variable we
assessed was an enhancement of vasodilatation in response to
acetylcholine after exposure to filtered diesel exhaust. Al-
though this difference was statistically significant, it was
numerically small, and unlikely to be of major physiological
significance. In light of these factors, we suspect that this may
be a result of a type I error, although we cannot rule out an
effect related to alterations in 1 or more unmeasured gaseous
components.
We used a commercially available particle trap to reduce
particle emissions from a heavy-duty diesel engine operating
under the transient cycling conditions used as the standard for
engine testing across the European Union. Particle filtration
markedly reduced the mass and number of particle emissions.
Taken together with our previous findings and data from
observational studies, we believe that this reduction is respon-
sible for rectifying the adverse cardiovascular effects of
diesel engine exhaust inhalation. As expected, oxidation
catalysts within the particle trap altered the composition of
nitrogen oxides, with an increase in NO2 and decrease in NO
concentrations. However, we have recently assessed the
effects of NO2 on healthy volunteers, and did not identify any
adverse effects on vascular or fibrinolytic function.25 Al-
though we did not observe an effect on the other gaseous
components of the exposure, we acknowledge that the parti-
cle trap may have altered the composition of the exposures
beyond those variables assessed during this study.
Consistent with previous studies,11,16,18 vasodilatation was
impaired after exposure to diesel engine exhaust in response
to bradykinin and acetylcholine. However, there was also a
reduction in vasodilatation to verapamil, implying an addi-
tional calcium flux– dependent impairment of vascular
smooth muscle function. A reduction in vasodilatation in
response to verapamil has been demonstrated previously after
exposure to diesel exhaust generated under transient engine
speed and load,16 but not when generated under idling
conditions.11 We have speculated previously that, in exhaust
generated under transient running conditions, the higher
diesel-related soot content and its associated (adsorbed)
organic material may cause these additional vascular smooth
muscle effects, and we believe that this observation warrants
further investigation.16 Interestingly, impaired vasodilatation
in response to verapamil was also normalized by the intro-
duction of a particle trap. Although variations in responses
between studies with different exposure protocols might
provide insights into the pathophysiological mechanisms
responsible for the adverse vasomotor effects of diesel
exhaust exposure, these studies were designed and powered
to detect differences within rather than between studies. Thus,
although tempting, we believe that we should be cautious and
circumspect in drawing conclusions from comparisons made
between studies and that any such differences should be
regarded as hypothesis generating and the subject of future
investigations.
The exact mechanisms underlying the vascular and pro-
thrombotic effects we observed in the current and previous
studies remain only partially understood. Regarding the
increase in ex vivo thrombosis seen after diesel exhaust
Figure 4. Ex vivo thrombus formation
assessed with the Badimon chamber at
2 hours after exposure. Data from the
low-shear chamber are shown in the top
panels. Data from the high-shear cham-
ber are shown in the bottom panels. Fil-
tered air exposure is shown in white,
diesel engine exhaust exposure in black,
and filtered diesel exposure in hatched
bars.
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exposure, data from previous in vitro26 and animal studies,27
as well as our own previous controlled exposure studies in
humans,13 suggest that platelet activation plays a central role.
Platelets are key components of arterial thrombosis, a process
that underpins acute coronary syndromes, including myocar-
dial infarction. Platelet-leukocyte aggregates, increasingly
recognized as the gold standard measure of in vivo platelet
activation,28 were increased after tracheal instillation of
carbon nanotubes in a murine model of vascular injury29 and
after diesel exhaust exposure in humans.13 Debate remains
regarding whether inhaled components of diesel exhaust can
translocate into the systemic circulation to mediate direct
effects on blood and vascular components,30,31 or whether the
induction of pulmonary inflammation and the subsequent
generation of free radicals may activate platelets by reducing
endothelium- and platelet-derived nitric oxide and antioxi-
dants. Although a single observational study reported a small
reduction in prothrombin time associated with ambient expo-
sure to PM10,32 the authors are not aware of any controlled
exposure study demonstrating an effect of pollution exposure
on plasma concentrations of coagulation factors.
The potential mechanisms underlying the adverse vasomo-
tor effects observed in response to diesel exhaust exposure
remain only partly understood,33 and a full discussion is
beyond the scope of this article. However, on the basis of data
from our earlier studies in which the exposure was generated
by an idling diesel engine,11,18 we have speculated previously
that oxidative stress and impaired NO-dependent signaling
play a central role in the adverse vasomotor effects. Given the
broader impairment of vasomotor function we observed here
and in a previous study in which a transient cycling diesel
engine was used,16 we acknowledge that we cannot discount
upregulation of other circulating or cellular vasoconstrictor
mediators (such as Rho kinase34) or activation of the sympa-
thetic nervous system as an alternative explanation for the
general blunting of vasodilator responses observed.
Limitations
Our principal objective was to assess the impact of a
commercially available particle trap on markers of cardiovas-
cular health by comparing the effects of unfiltered and
filtered diesel exhaust. In this regard, we clearly demonstrate
that vasodilatation, endothelial tPA release, and thrombus
formation are improved by particle filtration. However, we
acknowledge that our approach has limitations. The use of
multiple and complementary surrogates of cardiovascular
health is both a strength and a weakness of this study.
Replication of previous observations suggests that the find-
ings are real and provides a clear and consistent message:
Diesel exhaust impairs vascular function11,16,18 and increases
ex vivo thrombus formation.13 The use of multiple end points
with 3 exposure conditions requires multiple comparisons
and increases the possibility of type I and II errors. We have
not adjusted for multiple comparisons because the initial
comparison between diesel exhaust and filtered air was made
simply to confirm our previous findings. Both the direction
and magnitude of the changes seen here are consistent with
our previous findings, although the differences in net tPA
release failed to achieve statistical significance. Although the
study was powered prospectively on the basis of measure-
ments of the primary end points made during previous diesel
exposure studies, we acknowledge that the sample size is
modest. Although we are confident that we have not missed
effects on endothelial function or ex vivo thrombosis, we
acknowledge that we may have insufficient power to detect
changes in some of the secondary end points (Table I in the
online-only Data Supplement), and thus cannot exclude the
possibility of false-negative findings confounding their as-
sessment. In addition, the study cohort consisted exclusively
of young, healthy men. Although one might postulate that the
benefit of particle traps may actually be greater in those with
preexisting cardiovascular disease, we concede that further
studies are required to assess the role of particle traps in
mitigating cardiovascular effects in women and the broader
population.
Conclusion
With the use of several surrogate measures, a range of
adverse cardiovascular effects of diesel exhaust inhalation in
men appears to be prevented by the introduction of a particle
trap. Given these beneficial effects on biomarkers of cardio-
vascular health, the widespread use of particle traps on
diesel-powered vehicles may have substantial public health
benefit and reduce the burden of cardiovascular disease.
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CLINICAL PERSPECTIVE
There is a robust and consistent association between air pollution and cardiovascular morbidity and mortality. These
harmful effects are most strongly associated with exposure to traffic-derived fine particles that predominantly originate
from diesel engine exhaust emissions. Using a purpose-built exposure chamber, we have demonstrated previously the
adverse vascular and prothrombotic effects of exposure to diesel exhaust in healthy men. In the present study, using
complementary and relevant measures of cardiovascular health, we have reconfirmed the adverse effects of exposure to
diesel engine exhaust on endothelial function and ex vivo thrombosis. In addition, for the first time, we demonstrate that
reducing the particulate component of diesel exhaust with a commercially available particle trap can prevent these
detrimental cardiovascular effects. Our study provides support for the application of particle traps to diesel-powered
vehicles to reduce urban particulate concentrations and limit a range of adverse cardiovascular effects related to exposure
to traffic-derived air pollution.
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Diesel exhaust inhalation does not affect heart rhythm
or heart rate variability
Nicholas L Mills,1 Alexander E Finlayson,1 Manuel C Gonzalez,2 Håkan Törnqvist,3,4
Stefan Barath,3,4 Elen Vink,1 Colin Goudie,1 Jeremy P Langrish,1 Stefan Söderberg,2
Nicholas A Boon,1 Keith A A Fox,1 Ken Donaldson,5 Thomas Sandström,3,4
Anders Blomberg,3,4 David E Newby1
ABSTRACT
Objective Exposure to air pollution is associated with
increases in cardiovascular morbidity and mortality. This
study was undertaken to determine the effect of diesel
exhaust inhalation on heart rhythm and heart rate
variability in healthy volunteers and patients with
coronary heart disease.
Design and setting Double-blind randomised crossover
studies in a university teaching hospital.
Patients 32 healthy non-smoking volunteers and 20
patients with prior myocardial infarction.
Interventions All 52 subjects were exposed for 1 h to
dilute diesel exhaust (particle concentration 300 mg/m3)
or filtered air.
Main outcome measures Heart rhythm and heart rate
variability were monitored during and for 24 h after the
exposure using continuous ambulatory
electrocardiography and assessed using standard time
and frequency domain analysis.
Results No significant arrhythmias occurred during or
following exposures. Patients with coronary heart
disease had reduced autonomic function in comparison
to healthy volunteers, with reduced standard deviations
of the NN interval (SDNN, p<0.001) and triangular index
(p<0.001). Diesel exhaust did not affect heart rate
variability compared with filtered air (p>0.05 for all) in
healthy volunteers (SDNN 10166 vs 9166, triangular
index 2061 vs 2161) or patients with coronary heart
disease (SDNN 4765 vs 3864, triangular index 861 vs
761).
Conclusions Brief exposure to dilute diesel exhaust
does not alter heart rhythm or heart rate variability in
healthy volunteers or well-treated patients with stable
coronary heart disease. Autonomic dysfunction does not
appear to be a dominant mechanism that can explain the
observed excess in cardiovascular events following
exposure to combustion-derived air pollution.
INTRODUCTION
Observational and epidemiological studies consis-
tently report that exposure to air pollutants is
associated with excess cardiovascular morbidity
and mortality,1 and may be an important modi!-
able risk factor for cardiovascular disease.2 If public
health measures are to be implemented to reduce
this risk, a better understanding of the mechanisms
and components of urban air pollution responsible
for these observations is urgently required.
Short-term increases in air pollution exacerbate
cardiorespiratory disease leading to hospitalisation
for conditions including acute myocardial infarc-
tion3 and deaths from coronary heart disease, heart
failure and arrhythmia.2 Furthermore, in patients
with implanted cardiac de!brillators there appears
to be a relationship between ambient particulate
matter (PM) and the incidence of ventricular
tachycardia and !brillation.4e6 These associations
are strongest for !ne particulate air pollutants,
with emissions from road traf!c implicated both
directly and indirectly in these reports.
There is an important relationship between
autonomic regulation of the cardiac cycle and
cardiovascular mortality.7 Variation in the interval
between consecutive heart beats, or heart rate
variability, is controlled by the contrasting effects
of the sympathetic and parasympathetic nervous
systems. Reduction in heart rate variability re"ects
either an increase in sympathetic drive or
a decrease in vagal parasympathetic tone. Reduced
heart rate variability increases the risk of cardio-
vascular morbidity and mortality in both healthy
individuals8 and patients following myocardial
infarction.9
Several panel studies have reported associations
between measures of heart rate variability and high
ambient PM.10e13 There is marked heterogeneity in
the nature, magnitude, direction and duration of
these associations between studies with no clear
and consistent effect apparent. Differences may in
part be due to imprecision in the measurement of
pollution exposure and the effect of potential
confounding environmental and social factors.
Controlled exposures of air pollutants can help
to address these shortcomings by providing
a precisely de!ned exposure in a regulated envi-
ronment. Using a carefully characterised exposure
system, we have previously shown in healthy
volunteers that exposure to dilute diesel exhaust
causes lung in"ammation,14 depletion of airway
antioxidant defences15 and impairment of vascular
and !brinolytic function.16 Furthermore, we have
described ischaemic and prothrombotic effects in
patients with coronary heart disease.17 To date,
there have been no controlled exposure studies to
assess the direct effects of diesel exhaust on heart
rate variability in patients with coronary heart
disease.
We aimed to assess the effect of dilute diesel
exhaust inhalation on heart rhythm and heart rate
variability in healthy volunteers and an ‘at-risk’
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METHODS
Subjects
Fifty-two men participated in this study, which was performed
with the approval of the local research ethics committee, in
accordance with the Declaration of Helsinki and with the
written informed consent of all volunteers. Thirty-two healthy
non-smoking volunteers and 20 patients with stable coronary
artery disease were recruited.
Healthy non-smoking volunteers (age 20e38 years) on no
regular medications and patients with coronary heart disease
were recruited from the University Hospital, Umeå, Sweden. All
patients (age 51e67 years) had proven coronary heart disease
with a previous myocardial infarction (>6 months previously)
treated by primary angioplasty and stenting, and were receiving
standard secondary preventive therapy. Patients with angina
pectoris (Canadian Cardiovascular Society grade $2), diabetes
mellitus, uncontrolled hypertension, renal or hepatic failure, or
those with unstable coronary disease (acute coronary syndrome
or unstable symptoms within 3 months) were excluded. All
volunteers were invited to a prestudy screening visit for exercise
stress testing and patients unable to achieve stage 2 of the Bruce
protocol were excluded. Current smokers and those with
asthma, signi!cant occupational exposure to air pollution or an
intercurrent illness were excluded from the study. In patients,
regular medications were continued throughout the study, with
the exception of ACE inhibitor therapy that was withdrawn
7 days before each exposure.
Study design
All subjects underwent an identical randomised double-blind
crossover study design, with healthy volunteers and patients
attending at 08.00 h on two occasions at least 2 weeks apart for
controlled exposure to dilute diesel exhaust or !ltered air. Each
subject was exposed for 1 h in a specially built diesel exposure
chamber according to a previously described standard protocol.14
During each exposure, subjects performed two 15 min periods of
exercise on a bicycle ergometer separated by two 15 min periods
of rest. The ergometer workload required to achieve a minute
ventilation of 25 l/min/m2 for each healthy volunteer and
15 l/min/m2 for each patient with coronary heart disease was
determined to ensure that subjects within each group received
a similar exposure.
All subjects were !tted with Holter electrocardiographic
monitors (Reynolds Medical Lifecard, Delmar Reynolds,
Hertford, UK) prior to each exposure. ECG monitoring was
continued for 24 h following the start of the exposure. All subjects
remained indoors for the 24 h period following exposure to mini-
mise additional exposure to ambient air pollution. Subjects were
asked to abstain from alcohol for 24 h and from food, tobacco and
caffeine-containing drinks for at least 4 h before each exposure.
To assess the acute effects of exposure on heart rate variability,
15 healthy volunteers and all patients were asked to rest supine
in a quiet temperature-controlled room maintained at 22e248C
for 20 min immediately before and 2 and 6 h after the start of
each exposure. All volunteers also underwent blood pressure
measurements and a vascular assessment after the !nal rest
period as detailed in our previous publications.16 17
Diesel exhaust exposure
The diesel exhaust was generated from an idling Volvo diesel
engine (Volvo TD45, 4.5L, 4 cylinders, 680 rpm) from Swedish
Low Sulphur Gasoil E10 (Preem, Gothenburg, Sweden) as
described previously.14 16 Over 90% of the exhaust was shunted
away and the remaining part was diluted with ambient !ltered
air heated to 208C (humidity w50%) before being fed into
a whole body exposure chamber at a steady state concentration.
Air in the exposure chamber was continuously monitored with
exposures standardised using online measurements of nitrogen
oxide concentrations (NOx) to deliver approximately 1.23106
suspended particles/cm3 at a particulate concentration of
300 mg/m3. There was little variation in NOx (4.4560.02 parts
per million, ppm), NO2 (0.9260.02 ppm), NO (3.3560.02 ppm),
CO (2.9760.08 ppm) and total hydrocarbon (2.5060.09 ppm)
concentrations between exposures.
Data analysis
ECG recordings were analysed using the Reynolds Medical
Path!nder Digital 700 Series Analysis System (Delmar
Reynolds). An experienced single operator, blinded to both
subject characteristics and exposure, veri!ed any abnormal
rhythms and performed manual editing of aberrant beats and
electrical interference prior to generating RR data tables. Where
less than 95% of the RR data was valid, the subject was excluded
and the recording was not analysed further. RR data were
analysed using the HRV Tools software package (Delmar
Reynolds) to determine time and frequency components of heart
rate modulation over the entire 24 h period and during the !nal
5 min of each rest period prior to exposure and 2 h and 6 h
following the start of each exposure.
Standard time domain measures were calculated including the
mean NN interval (time interval between consecutive sinus
beats), SD of NN interval values (SDNN, an index that expresses
overall variability), percentage successive NN interval differences
>50 ms (PNN50), root mean square of successive NN interval
differences (RMSSD) and the triangular index (an estimate of
overall heart rate variability). SDNN, PNN50 and RMSSD are
measures of high frequency variation mediated primarily by the
vagus nerve. Frequency domain analysis determined the low
frequency (LF; 0.1 Hz) and high frequency (HF; 0.25 Hz)
components of the power spectrum in absolute values of power
(ms2). LF and HF were also expressed in normalised units (LFn
and HFn) to account for variation in the total power and very
low frequency components, as well as the HF/LF ratio.
Statistical analysis
Continuous variables are reported as mean6SEM. Statistical
analyses were performed with GraphPad Prism (Graph Pad
Software, USA) using analysis of variance (ANOVA) with
repeated measures and the two-tailed Student t test where
appropriate. Statistical signi!cance was taken at p<0.05.
RESULTS
Although one healthy volunteer and one patient were excluded
from the analysis due to interference on the ECG recording, 98%
and 99% of the data were valid in the remaining healthy
volunteers (n!31) and patients (n!19) respectively. Patients
were middle aged (6061 years) men who were on typical cardiac
medication (table 1). Patients and healthy controls did not
experience any symptoms or serious arrhythmias during either
exposure or during the 24 h study period.
Heart rate and heart rate variability over the 24 h study period
were reduced in patients with coronary heart disease compared
with young healthy controls (table 2). Inhalation of dilute diesel
exhaust for 1 h did not affect time or frequency domain measures
of heart rate variability over the 24 h period in either healthy
volunteers or patients with coronary heart disease (table 2).
Baseline measures of heart rate and heart rate variability
averaged over a 5 min interval immediately before both exposures
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were similar in each group (tables 3 and 4). Blood pressure
was not affected by exposure (data not shown). There were
no differences in either time or frequency domain measures of
heart rate variability at 2 or 6 h in healthy volunteers. In
patients with coronary artery disease there was an increase in
SDNN at 2 and 6 h compared with baseline (p!0.029), but
this was not affected by exposure to diesel exhaust (p!0.483).
DISCUSSION
Exposure to dilute diesel exhaust for 1 h did not affect heart
rhythm or heart rate variability in healthy volunteers or patients
with coronary heart disease. We suggest that the induction of
autonomic dysfunction and arrhythmia is unlikely to explain
the association between combustion-derived air pollution and
adverse cardiovascular events. Our !ndings contrast with several
observational studies that report associations between ambient
air pollution and heart rate variability, and this apparent
discrepancy requires further discussion.
Controlled exposure studies
Controlled exposures of air pollutants provide a precisely de!ned
exposure in a regulated environment and can overcome many of
the potential biases and confounders inherent to observational
studies. Our !ndings are consistent with the only previous study
of diesel exhaust exposure on autonomic function by Peretz et al
who also did not identify any reproducible effects on heart rate
variability in 16 young healthy volunteers.18 Taken together
with our !ndings, we believe this clearly demonstrates that
diesel exhaust inhalation does not impact on heart rate vari-
ability or induce autonomic dysfunction.
We believe that our model of exposure is relevant both in
composition and magnitude of exposure for the assessment of
the acute effects of combustion-derived air pollution on auto-
nomic function and heart rhythm in man. This is the largest
controlled exposure study to date, and we have studied
the effects of exposure in a cohort of patients who may be
particularly susceptible to the effects of air pollution. The
crossover study design employed minimises the potential for
confounding by other environmental factors and within-
subject comparisons increase the power to detect small changes
in autonomic function. Despite this, we were unable to
demonstrate an acute or persistent effect of exposure to dilute
diesel exhaust on heart rhythm or heart rate variability,
whether this was assessed using time or frequency domain
analysis in either healthy subjects or patients with coronary
heart disease.
Observational studies
While more than 30 epidemiological studies report associations
between air pollution and changes in heart rate variability,
there is considerable heterogeneity between these studies in the
nature, magnitude, direction and duration of the associations
between PM and heart rate variability (table 5). Liao et al were
the !rst to report an association between !ne particulate air
pollution (PM2.5) and heart rate variability in a panel of elderly
subjects.11 The authors considered their !nding somewhat
exploratory, but the analysis revealed an inverse correlation
between same day PM2.5 concentrations and both the HF and
LF power components of heart rate variability. Reduced heart
rate variability is associated with an increase in sudden cardiac
death and all-cause mortality in survivors of acute myocardial
infarction.9 Liao et al hypothesised that an effect of PM
exposure on the autonomic control of heart rate and rhythm
may explain the association between PM and adverse cardio-
vascular outcomes. Subsequently, numerous panel studies have
explored this mechanistic hypothesis by examining the asso-
ciations between levels of different air pollutants and changes
in heart rate variability or incidence of cardiac arrhythmia.
Most observational studies report negative associations
between !ne particulate air pollution and either time or
frequency domain parameters of heart rate variability, but there
is considerable disagreement between these studies. Differences
may be due to variation in the composition of PM or the effect
of confounding environmental and social factors. For example, in
a multicentre study, Timonen et al found the effects of PM on
heart rate variability in patients with coronary heart disease
were dependent on local sources of PM.19 Increases in PM2.5
were associated with a reduction in HF power in Finland, but
a similar increase in PM2.5 was associated with an increase in HF
power in Germany. In the study by Wheeler et al, exposure to
PM2.5 was associated with reductions in SDNN in patients with
previous myocardial infarction.20 However, the direction of
this effect was reversed in patients with chronic obstructive
Table 1 Baseline characteristics of patients with coronary heart
disease (n!20) and healthy non-smoking volunteers (n!32)
Patients Heathy volunteers
Age (years) 6061 2661
Cigarette smokers (non-/ex-/current) 12/8/0 32/0/0
Height (cm) 17366 18262
Weight (kg) 7963 8463
Body mass index (kg/m2) 2761 2661
Hypertension 8 0
Lipid profile
Total cholesterol (mmol/l) 4.660.2 e
LDL-cholesterol (mmol/l) 2.660.2 e
HDL-cholesterol (mmol/l) 1.360.1 e
Triglycerides (mmol/l) 1.560.3 e





ACE inhibitor*/ARB 4 e
Values are presented as number or mean6SEM.
*ACE inhibitor therapy was withdrawn 7 days prior to each study. All other regular
medications were continued throughout the study.
ARB, angiotensin receptor blocker; HDL, high density lipoprotein; LDL, low density
lipoprotein.
Table 2 Measures of heart rate variability averaged over 24 h in
patients with coronary heart disease (n!19) and healthy volunteers
(n!31)
Patients Healthy volunteers
Filtered air Diesel exhaust Filtered air Diesel exhaust
Heart rate (bpm) 6262 6062 7162 7162
NN interval (ms) 977631 1008628 848622 843620
SDNN (ms) 3864 4765 9166 10166
RMSSD (ms) 2864 2963 4363 4063
PNN50 (%) 1064 963 2062 1863
Triangular index 761 861 2161 2061
HF power (ms2) 269670 314694 607679 540671
LF power (ms2) 6226182 6936245 16856159 15336144
HFn (ms) 3365 3365 2362 2361
LFn (ms) 6565 6566 7562 7561
HF/LF ratio 0.960.3 1.160.4 0.460 0.360
All variables are presented as mean6SEM.
Filtered air vs diesel exhaust, p>0.05 for all (paired t test).
HF, high frequency; HFn, normalised high frequency; ; LF, low frequency; LFn, normalised
low frequency; PNN50, percentage of successive NN interval differences >50 ms; RMSSD,
root mean square of successive NN interval differences; SDNN, SD of NN interval values.
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pulmonary disease where SDNN increased following exposure
to ambient PM2.5.20
Differences in statistical analyses make comparison of the
effect size between observational studies dif!cult. In the largest
study to date, Liao et al report weak associations between
particulate air pollution and heart rate variability in a population
of 6784 healthy adults, suggesting a small role for PM in
modulating autonomic function.21 An increase in 1SD of PM10
(11.5 mg/m3) in the 3-day period prior to assessment was asso-
ciated with an increase in heart rate of 0.32 beats/min and
a decrease in SDNN of 1.03 ms. Previous studies showing that
heart rate variability is an important prognostic marker have
assessed the relationship between heart rate variability and long-
term outcome.9 Whether transient hourly or daily "uctuations
in heart rate and heart rate variability of this magnitude impact
on cardiovascular outcome is unknown.
The implication from these observational studies is that
reduced heart rate variability following exposure to air pollution
may predispose to serious tachyarrhythmias resulting in hospi-
talisation or sudden cardiac death. Direct evidence that PM may
be a trigger for arrhythmia is derived from studies of high-risk
patients with implantable cardioverter de!brillators (ICD). In
a pilot study, !ne particulate and other traf!c-derived air
pollutants were associated with an increase in the number of
de!brillator interventions among 100 patients with ICDs.4
However, in a larger more complete analysis with longer follow-
up, there was no increase in the risk of ventricular arrhythmia
unless the analysis was restricted only to those patients
requiring frequent de!brillator interventions.5 Indeed, in a much
larger study, Anderson et al recently reported a !xed stratum
case crossover analysis in 705 patients who experienced 5462
activation days over an average of 1200 days observation in
London. Overall they concluded that there was little evidence of
an association between air pollution and activation of ICDs.22
Particle composition
While controlled exposure to dilute diesel exhaust is a good
model for studying the effects of combustion-derived air pollu-
tion and diesel exhaust is a major source of ambient ultra!ne
particles, it is important to appreciate that ambient air pollution
contains a range of particulate pollutants from a variety of
atmospheric sources. Notably, diesel exhaust does not contain
appreciable quantities of atmospheric metals and there is some
experimental evidence to suggest that metals may modify the
effect of PM on the autonomic nervous system.23 In a cohort of
boiler construction workers exposed to high concentrations of
PM and metals, cardiac autonomic function was associated with
six common atmospheric metals including vanadium and lead.12
Furthermore, circulating concentrations of common atmo-
spheric metals have been found to correlate with measures of
heart rate variability in healthy persons without occupational
exposure.24 Consistent with this hypothesis, exposure to pure
ultra!ne carbon particles does not affect heart rate variability in
either healthy volunteers25 or patients with coronary heart
Table 3 Acute effect of exposure on heart rate variability in healthy volunteers during rest (n!15)
Filtered air Diesel exhaust Two-way ANOVA
Baseline 2 h 6 h Baseline 2 h 6 h p value
Heart rate (bpm) 6962 6562 6562 6662 6762 6462 0.554
NN interval (ms) 889632 934628 937630 920626 915629 952636 0.542
SDNN (ms) 9169 7966 6765 7164 9067 7467 0.836
RMSSD (ms) 5466 5865 4864 5065 5465 5267 0.787
PNN50 (%) 2764 3364 2664 2965 3164 2966 0.600
Triangular index 1961 1761 1461 1561 1861 1461 0.141
HF power (ms2) 7706139 8926166 6696105 6656111 9146144 8876269 0.682
LF power (ms2) 30586467 21306273 17036244 21436334 24746406 15916247 0.346
HFn (ms) 2263 2963 2863 2463 2662 3064 0.827
LFn (ms) 7663 6863 7063 7463 7162 6864 0.915
HF/LF ratio 0.360.1 0.560.1 0.460.1 0.460.1 0.460.1 0.560.1 0.862
All variables are presented as mean6SEM.
Two-way ANOVA filtered air vs diesel exhaust at each time point.
HF, high frequency; HFn, normalised high frequency; LF, low frequency; LFn, normalised low frequency; PNN50, percentage of successive NN interval differences >50 ms; RMSSD, root mean
square of successive NN interval differences; SDNN, SD of NN interval values.
Table 4 Acute effect of exposure on heart rate variability in patients with coronary heart disease (n!19)
Filtered air Diesel exhaust Two-way ANOVA
Baseline 2 h 6 h Baseline 2 h 6 h p value
Heart rate (bpm) 6262 6062 5962 6262 6062 5962 0.595
NN interval (ms) 983628 1010629 1040629 1010625 1053631 1052630 0.080
SDNN (ms) 3264 4465 4065 3463 4866 4163 0.482
RMSSD (ms) 2563 2863 2863 2662 3263 3063 0.190
PNN50 (%) 662 962 962 762 1363 1263 0.072
Triangular index 761 861 861 761 861 861 0.897
HF power (ms2) 265664 286662 286662 246644 367676 306670 0.446
LF power (ms2) 5086152 7946200 6736207 4076107 7486293 541676 0.494
HFn (ms) 3764 3264 3463 4165 4065 3464 0.215
LFn (ms) 6064 6564 6363 5665 5765 6364 0.211
HF/LF ratio 0.860.2 0.760.1 0.660.1 1.060.2 1.060.3 0.960.3 0.094
All variables are presented as mean6SEM.
Two-way ANOVA filtered air vs diesel exhaust at each time point.
HF, high frequency; HFn, normalised high frequency; LF, low frequency; LFn, normalised low frequency; PNN50, percentage of successive NN interval differences >50 ms; RMSSD, root mean
square of successive NN interval differences; SDNN, SD of NN interval values.
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Table 5 Summary of observational studies assessing associations between particulate air pollution and heart rate variability
Author Population N Pollutant HR SDNN RMSSD HF LF HF/LF
Liao et al. Environ Health Perspect
1999;107:521e5
Elderly 26 PM2.5 e Y e e e e
Pope et al. Am Heart J 1999;138:890e9 Healthy 7 PM [ Y [ e e e
Gold et al. Circulation 2000;101:1267e73 Elderly 21 PM Y Y Y e e e
Magari et al. Circulation
2001;104:986e91
Occupational 40 PM2.5 [ Y e e e e
Brauer M et al. J Expo Anal Environ
Epidemiol 2001;11:490e500
COPD 16 PM10 4 4 4 e e e
Holguin et al. Epidemiology
2003;14:521e7
Elderly 34 PM2.5 e e e Y Y [
Pope et al. Environ Health Perspect
2004;112:339e45
Elderly 88 PM2.5 4 Y Y e e e
Liao et al. Am J Epidemiol
2004;159:768e77
Community 6784 PM10 [ Y e Y 4 e
Chan et al. Environ Health Perspect
2004;112:1063e7
Healthy 19 PN0.02e1 e Y Y Y Y e
De Paula Santos et al. Eur Heart J
2005;26:193e200
Occupational 48 PM10 4 4 4 e e e
Park et al. Environ Health Perspect
2005;113:304e9
Elderly 497 PM2.5 e e e Y 4 [
Schwartz et al. Thorax 2005;60:455-61 Elderly 28 PM2.5 e 4 Y e e 4
Sullivan et al. Thorax 2005;60:462e6 Elderly 34 PM2.5 e e 4 4 e e
Vallejo et al. J Expo Sci Environ Epidemiol
2006;16:125e30
Young 40 PM2.5 e 4 e e e e
Timonen et al. J Expo Sci Environ
Epidemiol 2006;16:332e41
CHD 84 PN e 4 4 4 e Y
PM2.5 e 4 4 4 e 4
Chung et al. Environ Health Perspect
2005;113:1693e7
CHD, HTN 26 PM2.5e10 e 4 4 4 4 4
PM1e2.5 e 4 4 4 4 4
PM0.3e1 e Y Y Y Y 4
Wheeler et al. Environ Health Perspect
2006;114:560e6
COPD 18 PM2.5 e [ 4 4 [ 4
CHD 12 PM2.5 e 4 4 4 4 4
Lipsett et al. Environ Health Perspect
2006;114:1215e20
CHD 19 PM2.5 e 4 4 4 4 e
PM2.5e10 e Y [ 4 4 e
Luttman-Gibson et al. J Occup Environ
Med 2006;48:780e8
Healthy 32 PM2.5 [ Y Y Y Y e
Park et al. Circulation
2006;114:2798e805
Elderly 518 PM2.5 e e e Y e e
Chuang et al. Am J Respir Crit Care Med
2007;176:370e6
Young 76 PM10, PM2.5 e 4 4 4 4 e
Chahine et al. Environ Health Perspect
2007;115:1617e22
Elderly 476 PM2.5 e Y e Y 4 e
Park et al. J Expo Sci Environ Epidemiol
2007;17:488e97
Elderly 497 PM2.5 e 4 e 4 4 [
Chang et al. Bull Environ Contam Toxicol
2007;79:552e6
Elderly 15 PM1 4 4 4 e e [
PM1e2.5 [ 4 4 e Y [
PM2.5e10 4 Y Y e e [
Min et al. Inhal Toxicol 2008;20:435e44 Community 1349 PM10 e Y e 4 Y e
Cavallari et al. Inhal Toxicol
2008;20:415e22
Occupational 36 PM2.5 e Y e e e e
Cardenas et al. Environ Res
2008;108:1e6
Young 52 PM2.5 e e e Y Y e
Baccarelli et al. Circulation
2008;117:1802e9
Elderly 549 PM2.5 e 4 e 4 4 e
Cavallari et al. Environ Health 2008;7:36 Occupational 26 PM2.5 metal e e Y e e e
Barcley et al. Occup Environ Med
2009;66:325e34
Heart failure 132 PM10, PM2.5 4 4 4 e e e
Whitsel et al. Am J Epidemiol
2009;169:693e703
Diabetes mellitus 770 PM10 [ 4 Y e e e
Wu et al. Environ Health Perspect
2010;118:87e91
Occupational 11 PM2.5 e Y e Y 4 e
These studies were selected following a systematic search of PubMed (MEDLINE) in July 2010 using the following MeSH key words: particulate matter AND heart rate variability. Where
multiple publications have arisen from a single cohort, only the primary analysis of the association between PM and heart rate variability was included.
COPD, chronic obstructive pulmonary disease; HTN, hypertension; HF, high frequency; LF, low frequency; CHD, coronary heart disease; PM, particulate matter; PN, particle number;
RMMSD, root mean square of successive NN interval differences; SDNN, SD of NN interval values.
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disease,26 whereas exposure to concentrated ambient particles
with a range of organic and inorganic components may in"uence
autonomic function.27 The effects following exposure to
concentrated ambient particles are more pronounced with !ne
particles28 and in elderly individuals,29 but no study to date has
attributed these differences to the metal content of PM. It
appears that, even when controlling for potential environmental
confounders and individual subject differences through
controlled exposures, particle composition is a major determi-
nant of the health effects of PM.
While we do not believe limitations in our study design can
explain our negative !ndings, we acknowledge that a number of
relevant factors may have in"uenced the outcome of our studies.
Given potential safety concerns, we recruited patients who had
stable and symptomatically well-controlled coronary heart
disease on optimal medical therapy, which included maintenance
beta-blocker therapy in the majority of patients. The bene!cial
effects of beta-blockade in patients with coronary artery disease
and heart failure are well established and are thought to be
mediated in part through enhanced cardiac vagal control,30e32
with treatment increasing HF power by as much as 50%.33 It is
possible that an adverse effect of diesel exhaust on autonomic
function could have been masked by beta-blockers or other
pharmacological therapies in our patients with coronary heart
disease. Indeed, a recent reanalysis of the study by Timonen19
suggests that the use of beta-blockers in patients with coronary
heart disease may have modi!ed the association between PM2.5
and heart rate variability, partly explaining the inconsistencies
identi!ed in the original analysis.34 However, exposure to diesel
exhaust did not affect time or frequency domain measures of
heart rate variability in our young healthy volunteers, none of
whom were on regular medication, suggesting that the use of
cardiovascular therapies is not the primary explanation for the
absence of an effect of diesel exhaust on autonomic function in
our patients with coronary heart disease.
We chose to assess heart rate variability under controlled
conditions 1 h following the end of the exposure to minimise
any effect of exercise during the exposure on heart rate and heart
rate variability. We cannot discount the possibility that exposure
to diesel exhaust may have caused an immediate effect on
autonomic function during the exposure itself or within the !rst
1 h following the exposure. While it is possible that our study
was insuf!ciently powered to detect small effects on autonomic
function, the study size was larger than any previous human
exposure study addressing the effect of particle exposure on
autonomic function.
Conclusions
Brief exposure to dilute diesel exhaust does not alter heart
rhythm or heart rate variability in healthy volunteers or patients
with coronary heart disease on optimal cardioprotective medi-
cation. While we cannot exclude an immediate effect during
exposure, diesel exhaust did not impair autonomic function in
the hours following exposure or over the 24 h period. Our
!ndings from a carefully controlled exposure to an important air
pollutant suggest that autonomic dysfunction may not be the
central mechanism with which to explain the observed excess in
cardiovascular events following exposure to road traf!c or
combustion-derived air pollution.
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Research
Air pollution exposure is an established 
risk factor for cardiovascular morbidity and 
mortality (Brook et al. 2010), especially 
exposure derived from tra!c and industrial 
sources (Laden et al. 2000; Lall et al. 2011; 
Lipfert et al. 2006; Pope et al. 2002; Sarnat 
et al. 2008). Acute exposure to combustion-
derived particulate matter (PM) is associated 
with the onset of myocardial infarction 
and admissions to hospital in survivors of 
myocardial infarction and has been proposed 
as a trigger for acute cardiovascular events 
(Peters et al. 2004; von Klot et al. 2005). 
Although estimates vary, chronic exposure to 
air pollution has been estimated to increase 
all-cause mortality by 2–4% per 10-µg/m3 
increase in PM (Dockery et al. 1993; Pope 
et al. 2002), with most deaths due to cardio-
vascular disease (Miller et al. 2007). The 
World Health Organization estimates that 
outdoor urban air pollution results in around 
800,000 deaths worldwide each year (United 
Nations Environment Programme 2006).
In controlled exposure studies, inhalation 
of PM air pollution affects blood pressure 
and causes abnormalities in vascular func-
tion, coagulation, and myocardial perfusion 
(Mills et al. 2009). "ese responses provide a 
plausible mechanism to explain the observed 
increase in acute cardiovascular events and 
cardiovascular mortality after exposure to PM 
air pollution. However, although acute expo-
sure induces these adverse effects, whether 
improvements in cardiovascular health can be 
achieved by interventions targeted to reduce 
exposure in those living and working in highly 
polluted urban environments is unclear.
Major environmental health policy inter-
ventions can have a substantial impact on 
the health of populations, as evidenced by 
major reductions in cardiovascular events after 
the banning of bituminous coal in Dublin, 
Ireland, in 1990 (Clancy et al. 2002) and, 
more recently, with the restriction of smoking 
in public places (Pell et al. 2008). However, 
such environmental interventions may be 
di!cult to implement in rapidly developing 
countries where economic growth is depen-
dent on road tra!c and heavy industry (Smith 
et al. 2009). More practical solutions to reduce 
individual exposure and protect susceptible 
persons are urgently required. "erefore, we 
investigated the e#ects of a simple face mask 
intervention to reduce PM air pollution expo-
sure on measures of cardiovascular health in 
patients with coronary heart disease.
Methods
Subjects. One hundred and two patients were 
recruited from the Fuwai Hospital, Beijing, 
China, in March 2009. All patients were 
nonsmokers and had a history of coronary 
heart disease. Exclusion criteria were a history 
of arrhythmia, severe coronary artery disease 
without revascularization, resting conduction 
abnormality, digoxin therapy, uncontrolled 
hypertension, renal or hepatic failure, or an 
acute coronary syndrome within the previous 
3 months. Patients’ medical histories were 
recorded from the case notes, and baseline 
anthropometric and biochemical measures 
were performed on recruitment. All subjects 
gave their written informed consent, and the 
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Reducing Personal Exposure to Particulate Air Pollution Improves 
Cardiovascular Health in Patients with Coronary Heart Disease
Jeremy P. Langrish,1,* Xi Li,2,* Shengfeng Wang,2 Matthew M.Y. Lee,1 Gareth D. Barnes,1 Mark R. Miller,1 
Flemming R. Cassee,3 Nicholas A. Boon,1 Ken Donaldson,1 Jing Li,4 Liming Li,2 Nicholas L. Mills,1 David E. Newby,1 
and Lixin Jiang4 
1Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, United Kingdom; 2Department of Epidemiology and 
Biostatistics, School of Public Health, Peking University, Beijing, People’s Republic of China; 3National Institute for Public Health and 
the Environment, Centre for Environmental Health Research, Bilthoven, the Netherlands; 4Fuwai Hospital and Cardiovascular Institute, 
Chinese Academy of Medical Sciences, and Peking Medical Union College, Beijing, People’s Republic of China
BACKGROUND: Air pollution exposure increases cardiovascular morbidity and mortality and is a 
major global public health concern.
OBJECTIVES: We investigated the benefits of reducing personal exposure to urban air pollution in 
patients with coronary heart disease.
METHODS: In an open randomized crossover trial, 98 patients with coronary heart disease walked 
on a predefined route in central Beijing, China, under di!erent conditions: once while using a 
highly e"cient face mask, and once while not using the mask. Symptoms, exercise, personal air 
pollution exposure, blood pressure, heart rate, and 12-lead electrocardiography were monitored 
throughout the 24-hr study period.
RESULTS: Ambient air pollutants were dominated by fine and ultrafine particulate matter (PM) 
that was present at high levels [74 µg/m3 for PM2.5 (PM with aerodynamic diamater <2.5 µm)]. 
Consistent with tra"c-derived sources, this PM contained organic carbon and polycyclic aromatic 
hydrocarbons and was highly oxidizing, generating large amounts of free radicals. #e face mask 
was well tolerated, and its use was associated with decreased self-reported symptoms and reduced 
maximal ST segment depression (–142 vs. –156 µV, p = 0.046) over the 24-hr period. When 
the face mask was used during the prescribed walk, mean arterial pressure was lower (93 ± 10 
vs. 96 ± 10 mmHg, p = 0.025) and heart rate variability increased (high-frequency power: 54 vs. 
40 msec2, p = 0.005; high-frequency normalized power: 23.5 vs. 20.5 msec, p = 0.001; root mean 
square successive di!erences: 16.7 vs. 14.8 msec, p = 0.007). However, mask use did not appear to 
influence heart rate or energy expenditure.
CONCLUSIONS: Reducing personal exposure to air pollution using a highly efficient face mask 
appeared to reduce symptoms and improve a range of cardiovascular health measures in patients with 
coronary heart disease. Such interventions to reduce personal exposure to PM air pollution have the 
potential to reduce the incidence of cardiovascular events in this highly susceptible population.
KEY WORDS: air pollution, blood pressure, face mask, heart rate variability, myocardial ischemia. 
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study was reviewed and approved by the local 
research ethics committee.
Study design. Subjects attended the Fuwai 
Hospital or the ChaoYang Hospital in Beijing 
on two occasions, with at least a week between 
visits (median time between visits was 9 days), 
between March and May 2009. Each subject 
attended the same hospital on each visit. In a 
prospective randomized open blinded end point 
(PROBE) crossover study, subjects walked for 
2 hr between 0900 hours and 1100 hours along 
prescribed city center routes [see Supplemental 
Material, Figure S1 (http://dx.doi.org/10.1289/
ehp.1103898)] in Beijing, using a highly e!-
cient face mask on one study visit but not the 
other (Dust Respirator 8812; 3M, St. Paul, 
MN, USA). This mask consists of a light-
weight polypropylene filter, which is e#ective at 
removing airborne PM without a#ecting ambi-
ent gases. The mask has an expiration valve, 
complies with EN149:2001 FFP1 European 
Standard (British Standards Institute 2001), 
and has an assigned protection factor of 4 [i.e., 
it can be worn in atmospheres containing up to 
four times the workplace exposure limit (WEL) 
as defined by the U.K. Health and Safety 
Executive (2011). ["e WEL for respirable car-
bon particles (carbon black), is 3.5 mg/m3 over 
an 8-hr time weighted average.] Mask use was 
randomly assigned to the first or second visit 
using balanced computer-generated random-
ization. In order to maximize the di#erence in 
PM air pollution exposure, subjects wore the 
mask for 24 hr before the mask study day, in 
addition to wearing it during the 24 hr study 
day, and were given instructions to wear the 
mask at all times while outdoors and as much as 
possible when indoors. Subjects’ activities after 
the prescribed walk were not restricted, and 
they were instructed to continue their  normal 
daily routines.
Personal pollution exposure and activity 
monitoring. Personal air pollutant exposure 
was determined using monitoring equipment 
contained within a backpack. Fine particulate 
matter (PM2.5; PM with aerodynamic diameter 
$ 2.5 µm) was determined using a DataRAM 
monitor (model pDR-1500; "ermo Scientific, 
Franklin, MA, USA), and particle number was 
measured using a condensation particle coun-
ter (model CPC 3007; TSI Instruments Ltd., 
High Wycombe, UK). Ambient temperature 
and relative humidity were recorded using an 
external sensor (Omegaette® model HH-314; 
Omega Engineering Ltd., Stamford, CT, 
USA). Gaseous pollutants were measured using 
a multigas analyzer with electrochemical sen-
sors for carbon monoxide, sulfur dioxide, and 
nitrogen dioxide (model X-am 7000; Dräger 
Safety, Lübeck, Germany). During the pre-
scribed walk, physical activity was measured 
using global positioning system (GPS) track-
ing (eTrex Summit HC GPS unit; Garmin, 
Olathe, KS, USA), and energy expenditure was 
estimated using activity data and anthropomet-
ric data as described previously (Langrish et al. 
2009). "e estimated PM exposure when wear-
ing the mask was determined based on mea-
surements of mask filter e!cacy as described 
previously (Langrish et al. 2009).
Background pollution monitoring. 
Background exposure was recorded from 
permanent monitoring stations in the district 
where the patients walked on the study day 
(Beijing Municipal Environmental Protection 
Bureau 2009). Airborne PM was collected 
onto Teflon filters (Pall Corp., Ann Arbor, 
MI, USA) in three size fractions: coarse 
(mean aerodynamic diameter, 2.5–10 µm), 
fine (0.18–2.5 µm), and ultrafine (< 0.18 µm) 
using a MOUDI cascade impactor (MSP 
Corp., Shoreview, MN, USA).
PM mass was determined gravi metrically 
for each size fraction from the above filters 
after temperature and humidity conditioning 
and subsequently analyzed for elemental and 
organic carbon fractions, metals and cations, 
nitrate and sulfate anions, and organic matter.
Chemical and toxicological analysis of 
collected PM. Collected PM samples were 
analyzed for total carbon content, as well 
as elemental and organic carbon fractions, 
using the Sunset method (National Institute 
for Occupational Safety and Health 2003). 
Metals and cations were determined using 
inductively coupled plasma mass spectrometry 
(ICP-MS) after pretreatment with nitric acid. 
Nitrate and sulfate anions were determined 
after extraction with water using liquid chro-
matography paired with ICP-MS. Organic 
matter was extracted from filters by ultrasoni-
fication with toluene and analyzed using gas 
 chromatography/mass spectrometry.
"e oxidative potential of PM was assessed 
using electron paramagnetic resonance (EPR) 
(Miller et al. 2009). EPR was used to estab-
lish oxygen-centered free radical generation 
from the collected PM in the absence of tis-
sue. Filters for all size fractions were pooled 
and sonicated in phosphate-bu#ered saline to 
give a final concentration of 1 mg particles/mL. 
Solutions were incubated with the spin-trap 
1-hydroxyl-2,2,6,6,-tetra methyl-4-oxo-
piperidine (Tempone-H; 1 mM) (Enzo Life 
Sciences, Exeter, UK), loaded into a capillary 
tube and assessed at 37°C in an X-band EPR 
spectrometer (model MS-200; Magnettech, 
Berlin, Germany) as described previously (Miller 
et al. 2009). Pyrogallol (100 µM) was used as a 
positive control, and samples were compared 
with the National Institute of Standards and 
Technology (NIST; Gaithersburg, MD, USA) 
standard reference materials for urban dust 
(SRM-1649a; 1 mg/mL) and diesel exhaust 
PM (SRM-2975; 10 µg/mL).
Electrocardiography and blood pressure 
monitoring. Continuous 12-lead electro-
cardiography (ECG) was assessed with a 
digital Holter recorder (Lifecard 12; Spacelabs 
Healthcare Ltd., Hertford, UK) using the 
Pathfinder automated arrhythmia analysis 
package (version 8.701, DelMar Reynolds’ 
Pathfinder Digital; Spacelabs Healthcare 
Ltd.). Identified arrhythmias were individually 
inspected and verified or deleted as appro-
priate, and heart rate variability was assessed 
using the DelMar Reynolds’ HRV Tools soft-
ware package as described previously (Langrish 
et al. 2009). ST segment analysis was per-
formed at the J-point +80 msec in three rep-
resentative leads (II, V2, and V5) that were 
analyzed separately for each subject. Maximal 
ST segment depression and ischemic burden 
(product of the change in ST segment ampli-
tude and the duration of the recording) were 
determined for each lead and as a composite 
(Mills et al. 2007).
Ambulatory blood pressure was measured 
automatically (model 90217 ultralite ambu-
latory blood pressure monitor; Spacelabs 
Healthcare Ltd.) every 15 min during the 2-hr 
walk and then every 30 min during the day 
and every hour overnight (i.e., 2200 hours to 
0700 hours).
Symptom questionnaire. Subjects com-
pleted a symptom questionnaire at the begin-
ning of the study day, after the 2-hr walk, and 
at the end of the 24-hr visit. "ey were asked 
to report physical symptoms (e.g., headaches, 
dizziness, nausea), their perception of the pol-
lution, their perceived workload, and the tol-
erability of the mask after the prescribed walk 
using a visual analog scale.
Data analysis and statistical methods. 
In our previous study of healthy volunteers, 
we demonstrated a difference (mean ± SD) 
in systolic blood pressure of 7 ± 5 mmHg 
after a 2-hr walk when a face mask was used 
(Langrish et al. 2009). Based on the assump-
tion that the e#ect size in the present study 
would be considerably smaller because of the 
use of cardiac medications, we powered the 
study to detect a 2-mmHg di#erence in sys-
tolic blood pressure, giving a sample size of 
101 at 80% power and two-sided p < 0.05.
Blood pressure and ECG end points were 
analyzed by investigators unaware of treatment 
allocation. All data are expressed as medians 
(interquartile ranges) or means ± SD unless 
otherwise stated. Treatment % period (order in 
which the mask intervention was used) interac-
tions were assessed as described previously (Hills 
and Armitage 1979), before data were com-
pared using paired Student’s t-tests or Wilcoxon 
matched pairs signed rank test as appropriate. 
Occurrence of arrhythmias, reported symp-
toms, and ST segment event frequency, were 
compared using the chi-squared analysis. All 
data were analyzed using GraphPad Prism (ver-
sion 4 for Macintosh; GraphPad Software, San 
Diego, CA, USA). Statistical significance was 
taken as a two-sided p < 0.05.
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Results
Subjects and face mask intervention. Ninety-
eight patients (87% male; mean age, 62 years) 
completed the study protocol (Table 1). Four 
of those originally enrolled did not complete 
the protocol because of withdrawn consent, 
cataract extraction, or withdrawal by investi-
gators because of smoking or failure to walk 
the prescribed route. All subjects tolerated the 
mask intervention well, scoring the comfort 
of the mask as 0.64 ± 1.06 on a 0–10 scale (0 
represents completely comfortable, and 10, 
intolerable). The mask intervention reduced 
self-reported general symptoms (Figure 1) and 
patients’ perceived e#ort of work, as well their 
perception of the level of ambient air pollution 
(2.46 ± 1.67 vs. 2.73 ± 1.64 on the 0–10 visual 
analog scale; p = 0.03). "ere were no signifi-
cant treatment % period interactions for any 
outcome measure.
Air quality and pollutants. Personal  levels 
of ambient air pollutants were similar on both 
study days (Table 2), although we predict 
from previous studies of filter e!cacy (97% 
reduction in particle number) that the PM 
exposure in the presence of the mask would 
be reduced from 89 µg/m3 and 43,900 par-
ticles/cm3 to approximately 2 µg/m3 and 
1,200 particles/cm3 (Langrish et al. 2009). 
Temperature (17.3°C vs. 16.8°C) and ambi-
ent relative humidity (30% vs. 35%) were 
similar on both visits. Airborne PM was pre-
dominantly (> 99% by particle number) in 
the fine and ultrafine fractions (Figure 2) and 
contained a large amount of organic carbon 
and high concentrations of polycyclic aro-
matic hydrocarbons, nitrates, hopanes, and 
steranes, suggesting that much of the PM 
was combustion derived and related to tra!c 
sources [see Supplemental Material, Table S1 
(http://dx.doi.org/10.1289/ehp.1103898)]. 
These collected particles were highly oxi-
dizing and generated large amounts of free 
radicals as detected by EPR, exceeding the 
signal seen with both the standard reference 
NIST urban dust material at an equivalent 
concentration and the intense free-radical– 
generating  oxidant pyrogallol (Figure 2).
E!ect of the face mask on cardio vascular 
health. Over the 24-hr period, the maximal 
ST segment depression recorded was lower 
[median (interquartile range), –142 µV 
(–179 to –110) vs. –156 µV (–202 to –123); 
p = 0.046] when the face mask was used. 
However, measures of myocardial ischemic 
burden were similar during the 2-hr walk and 
over the entire 24-hr period between visits 
(Table 3).
During the 2-hr prescribed city center 
walks, subjects walked a comparable distance 
(6.37 ± 1.44 km vs. 6.40 ± 1.51 km), at a 
similar average speed (4.25 ± 0.96 km/hr vs. 
4.27 ± 1.01 km/hr), and expended the same 
amount of energy [2.32 ± 0.52 metabolic 
equivalent tasks (METs) vs. 2.33 ± 0.55 
METs] between visits when the face mask was 
or was not used. Despite this similar workload, 
mean ambulatory arterial blood pressure 
was significantly lower (93 ± 10 mmHg 
Table 1. Baseline characteristics of subjects 
(n = 98) completing the study.
Characteristic Measure
Age (years) 62 ± 7
Male 85
Height (cm) 169 ± 6
Weight (kg) 75 ± 10





Peripheral vascular disease 5
Previous myocardial infarction 68
Previous PCI 60
Previous CABG 38
LV ejection fraction (%; n = 31) 62 ± 9
Angina status
CCS class I 67
CCS class II 31
Seattle angina score (maximum, 500) 387 ± 34
Clinical biochemistry
Random glucose (mmol/L) 5.5 ± 1.8
Triglycerides (mmol/L) 1.5 ± 0.7
Cholesterol (mmol/L) 3.9 ± 0.9
HDL cholesterol (mmol/L) 1.2 ± 0.3





ACE inhibitor or ARB 54
Beta blocker 73
Calcium channel blocker 42




Traditional Chinese medicine 19
Abbreviations: ACE, angiotensin converting enzyme; ARB, 
angiotensin II receptor blocker; BMI, body mass index; 
CABG, coronary artery bypass graft; CCS, Canadian 
Cardiovascular Society; HDL, high density lipoprotein; 
LDL, low density lipoprotein; LV, left ventricle; PCI, percu-
taneous coronary intervention. Data are mean ± SD, or n.










































Table 2. Personal ambient pollution exposures and background pollution levels on days defined according 
to mask use.
Parameter Mask No mask
Personal PM2.5 exposure (!g/m3)
Measured 61 (20–88) 89 (25–170)
Estimated ~ 2 (0.6–2.6) 89 (25–170)
Personal particle count (" 104 particles/cm3)
Measured 4.19 ± 1.29 4.39 ± 1.45
Estimated ~ 0.12 ± 0.04 4.39 ± 1.45
Personal temperature (°C) 17.3 ± 5.2 16.8 ± 5.8
Personal relative humidity (%) 30.4 ± 14.0 34.8 ± 18.2
Personal peaks > 1 ppm (number)
NO2 None None
SO2 None None
CO 5 (2–7.5) 4 (2–8)
Background exposure 
PM10 (!g/m3) 92 (70–117) 103 (83–180)
SO2 (ppb) 38 (29–53) 54 (32–77)
NO2 (ppb) 36 (29–42) 36 (32–47)
Abbreviations: CO, carbon monoxide; NO2, nitrogen dioxide; SO2, sulfur dioxide. Data are mean ± SD or median (inter-
quartile range). Personal monitoring data were collected using portable monitoring equipment during the 2-hr walk. 
Background data were collected from permanent monitoring stations for the whole 24-hr period. Estimated PM exposure 
is calculated based on filter efficacy studies where 97% of fresh diesel exhaust PM were removed (Langrish et al. 2009).
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vs. 96 ± 10 mmHg) when the face mask 
was used, although heart rate was similar 
(Table 3). During the 2-hr walk, heart rate 
variability [high-frequency (HF) power, high-
frequency normalized power (HFn), HF:low-
frequency (LF) ratio, and root mean square 
successive di#erences (RMSSD)] was higher 
when wearing the face mask (Table 3). "ere 
were no significant differences in overall 
24-hr ambulatory blood pressure or heart 
rate variability. There were no significant 
differences in the incidence of arrhythmias 
between the two visits (Table 4).
Discussion
PM air pollution is a major public health 
concern and is associated with increases in 
cardio vascular morbidity and mortality. In this 
study, we demonstrated that reducing personal 
exposure to urban airborne PM by means of a 
simple face mask is associated with a reduction 
in self-reported symptoms and improvements 
in objective measures of myocardial ischemia, 
blood pressure, and heart rate variability in 
patients with coronary heart disease. Reducing 
personal exposure to PM air pollution has the 
potential to reduce the incidence of cardio-
vascular events in patients with coronary heart 
disease living and working in industrialized or 
urban environments.
Using a robust PROBE design, we con-
ducted a randomized controlled trial to assess 
the impact of reducing personal air pollu-
tion exposure in patients with coronary heart 
disease in a polluted urban environment. 
Through the use of portable monitoring 
devices and sample collection, we completed 
a detailed characterization of air pollutant 
exposure that demonstrated the remarkably 
complex and toxic composition and extremely 
high prooxidative potential of ambient air 
PM in Beijing. We combined individualized 
pollution monitoring with a comprehensive 
cardiovascular assessment that incorporated 
hemodynamic and electrophysiological mon-
itoring in conjunction with GPS tracking. 
Despite reducing exposure only for a 48-hr 
period in patients chronically exposed to a 
polluted urban environment, we observed 
evidence of consistent beneficial e#ects on a 
range of biomarkers of cardiovascular health 
after the introduction of this simple but 
highly e!cient face mask intervention.
Myocardial ischemia. In a cohort of 20 
men with stable asymptomatic coronary 
disease, we previously demonstrated greater 
exercise-induced maximum ST segment 
depression during exposure to diesel exhaust 
(Mills et al. 2007). However, although acute 
air pollution exposure exacerbates myocardial 
ischemia, many persons around the world are 
chronically exposed to high levels of air pollu-
tion, and it is unknown whether interventions 
targeted at reducing exposure will decrease 
myocardial ischemia.
In the present study, we showed that 
decreasing personal exposure to ambient 
air pollution reduces maximal ST segment 
depression over a 24-hr period in patients 
with coronary heart disease. "e significance 
of silent myocardial ischemia is still debated, 
but it has been associated with major car-
diac events in the general population (Fleg 
et al. 1990). Moreover, in patients with recent 
myocardial infarction or unstable angina, the 
occurrence of silent ischemia is a poor prog-
nostic factor and is associated with a signifi-
cant increase (relative risk ~ 3–4) in major 
cardiac events and death (Cohn et al. 2003). 
It seems plausible, therefore, that the mod-
est reduction in silent myocardial ischemia 
seen in this study might, if sustained, result in 
significant reductions in major cardiac events 
and cardiovascular mortality.
Blood pressure. Chronic exposure to air 
pollution is associated with increases in blood 
pressure in large epidemiological studies 
(Auchincloss et al. 2008). Similarly controlled 
exposure to concentrated ambient PM and 
ozone in healthy volunteers results in an acute 
increase in diastolic blood pressure (Urch et al. 
2005). Hypertension is a major risk factor for 
atherosclerosis, and acute increases in blood 
pressure may trigger plaque rupture leading 
to an acute cardiovascular event. Consistent 
with this, exercise-related increases in blood 
pressure are predictive of the incidence of myo-
cardial infarction (Mundal et al. 1996), stroke 
(Kurl et al. 2001), and cardiovascular mortality 
(Kikuya et al. 2000).
We recently reported that use of a face 
mask that decreased personal PM air pollu-
tion exposure reduced systolic blood pressure 
in healthy volunteers during a 2-hr walk by 
7 mmHg (Langrish et al. 2009). The more 
modest 3-mmHg di#erence in mean arterial 
blood pressure after a 2-hr walk observed in 
the present study may be explained at least in 
part by the lower workload during walking 
in this older population with heart disease 
(estimated energy expenditures of 2.32 METs 
vs. 3.61 METs in the previous study popu-
lation), coupled with the modifying effects 
of anti hypertensive medications (Barclay 
et al. 2009), which were used by most of the 
present study population. However, inter-
ventional trials of blood pressure reduction 
Figure 2. (A) Representative filter samples collected showing contribution by mass of the three size fractions averaged over 3 days. (B) Estimated contribution 
of each size fraction collected on filters by particle number. (C) Oxidative potential of the collected Beijing PM (1 mg/mL) using EPR to assess oxygen-centered 
free radical generation, compared with NIST diesel exhaust PM (10 !g/mL) and urban dust (1 mg/mL) and the prooxidant positive control (pyrogallol 100 !M) as 
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suggest that even modest changes in blood 
pressure would reduce the incidence of major 
cardiovascular events at the population level 
(Williams 2005).
Heart rate variability. Heart rate vari-
ability is a reflection of the autonomic control 
(a balance of the sympathetic and parasym-
pathetic nervous systems) of the heart and is 
a measure of the variation in the RR inter-
vals on a continuous electrocardiogram. A 
reduction in heart rate variability has been 
demonstrated in patients with a variety of 
pathophysiological conditions, including 
hypertension, heart failure, and diabetes melli-
tus (Task Force 1996). Indeed, reduced heart 
rate variability has been linked to increased 
cardiovascular mortality (Nolan et al. 1998), 
and a large number of studies link exposure 
to air pollutants with a reduction in heart rate 
variability (Brook et al. 2010).
In the present study, we have shown that 
reducing personal exposure to PM air pollu-
tion in patients with coronary heart disease 
is associated with an improvement in heart 
rate variability during exercise, based on gen-
eral measures of variability and variability in 
specific frequency bands. In this study, the 
changes demonstrated were predominantly 
in the HF-power band, which is associated 
with changes in parasympathetic tone, and 
an improvement may suggest an increased 
contribution of parasympathetic (vagal) tone 
to heart rate control. In our previous healthy 
volunteer study (Langrish et al. 2009), heart 
rate variability also increased after the face 
mask intervention, but changes were seen 
predominantly in the LF-power band, sug-
gesting effects on sympathetic nervous sys-
tem control. We suggest that this di#erence 
(HF-power vs. LF-power changes) may be 
related to the high use of beta-blocker ther-
apy (74% of patients) in the present study 
population, which is likely to blunt any 
e#ects of exposure on sympathetic tone. "e 
clinical relevance of acute changes in heart 
rate variability is not clear, although it has 
been demonstrated that the higher the vari-
ability, the lower the cardiovascular mortality 
(Kikuya et al. 2000). We suggest that a sus-
tained improvement in heart rate variability 
has the potential to improve patients’ prog-
nosis and reduce the impact of air pollution 
on cardiovascular morbidity and mortality.
Symptoms. Patients perceived fewer self-
reported symptoms, a reduction in effort of 
work, and lower background pollution levels 
when they wore the face mask. Although we 
observed no change in the occurrence of self-
reported anginal symptoms, this is perhaps 
not surprising given that we recruited a highly 
selected popu lation with stable coronary disease, 
without significant clinical angina, and who 
were maintained on optimal medical therapy.
Limitations. We chose a PROBE study 
design because we wanted to determine the 
acceptability of wearing a face mask, as well as 
its potential beneficial e#ects on both symp-
toms and objective measures of cardiovascu-
lar health. We recognize that a double-blind 
approach incorporating a sham mask would 
reduce the potential for subjective bias and 
would therefore be considered more scientifi-
cally robust (Smith et al. 2007). In addition, 
we acknowledge that such an intervention 
may be more readily accepted in Chinese 
and Asian societies, where use of face masks 
is commonplace because of concerns over air-
borne diseases, pollution, and even fashion, 
and furthermore, that this may have a#ected 
patients’ reporting of symptom improvement. 
However, even a sham mask will filter air pol-
lutants to some degree (Langrish et al. 2009), 
Table 3. Ambulatory blood pressure, heart rate variability during the 2-hr city center walk and the 24-hr study period, and myocardial ischemia measured as 
ischemic burden, in each individual territory and as a composite according to face mask use.
Walk 24 hr
Parameter Mask No mask Mask No mask
Systolic blood pressure (mmHg) 126.9 ± 15.9 128.1 ± 16.5 121.2 ± 11.9 120.8 ± 12.4
Diastolic blood pressure (mmHg) 78.0 ± 9.3 79.5 ± 8.6 73.8 ± 7.2 74.0 ± 7.3
Mean arterial pressure (mmHg) 93.3 ± 9.7* 95.7 ± 10.0 89.8 ± 7.5 90.0 ± 7.9
Heart rate (bpm) 81.5 ± 8.7 81.5 ± 10.1 77.6 ± 11.3 76.7 ± 11.1
LF power (msec2) 133 (68–97) 136 (52–227) 81 (40–172) 93 (46–208)
HF power (msec2) 54 (27–108)* 40 (20–69) 27 (11–77) 31 (11–68)
LFn (msec) 58.4 (45.6–69.1)* 62.9 (51.1–75.5) 67.2 (55.5–78.0) 71.1 (59.4–81.1)
HFn (msec) 23.5 (18.0–32.4)* 20.5 (13.5–27.9) 21.4 (15.0–31.6) 20.9 (12.7–30.1)
HF:LF ratio 0.418 (0.258–0.712) 0.328 (0.207–0.573) 0.301 (0.190–0.554) 0.306 (0.161–0.492)
pNN50 (%) 1.2 (0.2–2.8) 0.7 (0.0–2.3) 0.5 (0.0–3.1) 0.6 (0.0–2.6)
RMSSD (msec) 16.7 (13.2–22.5)* 14.8 (10.9–19.6) 15.5 (11.0–22.6) 14.4 (10.3–20.3)
SDNN (msec) 59.8 (46.4–79.1) 60.1 (41.0–79.3) 45.6 (30.8–70.4) 48.2 (30.0–66.3)
Ischemic burden (mV-sec)
Inferior (II) territory –66 (–118 to –26) –52 (–149 to –21) –641 (–767 to –504) –615 (–820 to –473)
Anterior (V2) territory –66 (–142 to –16) –50 (–124 to –13) –597 (–859 to –435) –632 (–905 to –489)
Lateral (V5) territory –37 (–104 to –8) –43 (–85 to –18) –604 (–811 to –429) –586 (–790 to –412)
Sum (II + V2 + V5) –189 (–382 to –90) –188 (–340 to –112) –1,930 (–2,306 to –1,541) –1,934 (–2,391 to –1,575)
Abbreviations: LFn, low frequency–normalized; pNN50, percentage of successive RR intervals that differ by > 50 msec; SDNN, standard deviation of RR intervals. Data are mean ± SD, 
or median (interquartile range). LFn and HFn are normalized units to account for variation in the total power and very low-frequency components. LF and SDNN reflect mainly sympa-
thetic nervous stimulation; HF, pNN50, and RMSSD reflect parasympathetic tone.
*p < 0.05 from Wilcoxon matched pairs signed rank test or Student’s paired t-tests as appropriate, mask versus no mask.
Table 4. Cardiac arrhythmias during 24-hr electrocardiographic monitoring periods among 98 coronary 
heart disease patients according to face mask use.
No. patients
Median no. of events per patient 
(interquartile range)
Arrhythmia Mask No mask Mask No mask
Dropped beat 2 2 1 (1–1) 1 (1–1)
VT 1 2 2 (2–2) 1 (1–1)
Salvo 1 2 4 (4–4) 2 (1–3)
Bigeminy 15 18 4 (1–33) 6 (2–36)
Triplet 1 0 11 (11–11) 0 (0–0)
Couplet 9 4 2 (1–5) 2 (1–10)
Bradycardia 20 19 52 (3–275) 89 (9–347)
SVT 2 5 1 (1–1) 1 (1–1)
Trigeminy 3 4 12 (6–134) 10 (6–230)
Premature aberrant 79 77 17 (3–122) 22 (3–181)
Isolated aberrant 52 54 3 (1–16) 5 (1–25)
Premature normal 81 84 12 (3–56) 12 (3–42)
Abbreviations: SVT, supraventricular tachycardia; VT, ventricular tachycardia. Bradycardia defined as heart rate < 50 bpm.
p > 0.05 for all using chi-squared (number of patients) and Mann–Whitney U-tests (number of events).
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and true blinding is di!cult to achieve given 
that large di#erences in mask e!ciency would 
be readily apparent to trial participants, and 
di#erences in mask design would be obvious 
to investigators. It would also be anticipated 
that the greater e#ort of breathing through a 
mask during exercise would lead to an increase 
in blood pressure rather than the reverse.
We have assessed an acute intervention, 
and it remains to be seen whether wearing a 
face mask for more prolonged periods would 
have sustained benefits that could a#ect clinical 
outcomes.
Conclusions
In this randomized controlled crossover 
intervention trial, we observed that reducing 
personal exposure to PM air pollution was 
associated with small but consistent improve-
ments in objective measures of myocardial 
ischemia, exercise-related increases in blood 
pressure, and heart rate variability in patients 
with coronary heart disease. Although e#orts 
to reduce emissions are critical to reducing 
exposures to the population as a whole, use 
of a face mask may be an e#ective individual-
level intervention for high-risk populations. 
The use of a face mask has the potential to 
reduce the incidence of acute cardiovascular 
events, as well as improving patients’ general 
well-being, particularly in developing coun-
tries where pollutant exposures are high and 
resources to reduce emissions are limited.
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